Sentence,class,file
France September 2005.http://www.ehma.org/files/WP-6-HealthBASKETSP21-CT-2004-501588_D18_France.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e5/ce/520_2016_Article_3363.PMC5082582.pdf
http://www.has-sante.,Non-OADS,/arxiv_data1/oa_pdf/e5/ce/520_2016_Article_3363.PMC5082582.pdf
http://www.has-sante.,Non-OADS,/arxiv_data1/oa_pdf/e5/ce/520_2016_Article_3363.PMC5082582.pdf
"Registered studies are of vari- ous types, comprising interventional ( *80 % of cases), observational ( *19 %, including drug treatments, behav- ioral studies, and surgical procedures), and other US Food and Drug Administration (FDA)-regulated studies thatmeet the criteria of ‘expanded access’ ( http://www.fda.gov/ ).",Non-OADS,/arxiv_data1/oa_pdf/f7/0b/40265_2016_Article_646.PMC5082589.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f7/0b/40265_2016_Article_646.PMC5082589.pdf
"Based on a genome-wide  linkage scan and whole exome sequencing, novel mutations  in ARR3  (Gene ID: 407; OMIM 301770 ) are responsible for  X-linked female-limited eoHM in the three families, the first  human disease associated with ARR3  and the second X-linked  female-limited disease identified thus far.Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > Received 5 October 2016 | Accepted 24 October 2016 | Published 26 October 2016© 2016 Molecular Vision 1257X-linked heterozygous mutations in ARR3  cause female-limited  early onset high myopia Xueshan Xiao, Shiqiang Li, Xiaoyun Jia, Xiangming Guo, Qingjiong Zhang (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
"Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1258METHODS Three large families with eoHM limited to female family  members and with no affected male family members were  examined during a genetic study on eoHM (Figure 1, Figure  2, and Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
"Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1259of family XF1, one affected individual of family XF2, and  one affected individual of family XF3, using a commercial  service from Macrogen , as described in our previous study  [25,30].",Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1260 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1261 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
"Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1262family members, as well as the novelty of the variants by  analyzing controls.",Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1263mutation was predicted to be damaging with a SIFT score of  zero and probably damaging with a PolyPhen2 score of 1.0.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1264ACKNOWLEDGMENTS The authors are grateful to the families for their participation.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1265severe myopia in humans.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
Molecular Vision  2016; 22:1257-1266 <http://www.molvis.org/molvis/v 22/1257 > © 2016 Molecular Vision  1266cone arrestin (cArr).,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/mv-v22-1257.PMC5082638.pdf
"There are three Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > Received 15 April 2016 | Accepted 24 October 2016 | Published 26 October 2016© 2016 Molecular Vision 1267Genetic analysis of CHST6  and TGFBI  in Turkish patients with  corneal dystrophies: Five novel variations in CHST6 Fulya Yaylacioglu Tuncay,1,2 Gülsüm Kayman Kurekci,2 Sezen  Guntekin Ergun,3 Ozge Tugce Pasaoglu,4  Rustu Fikret Akata,5 Pervin Rukiye Dincer2 1Polatlı Duatepe State Hospital, Ophthalmology Department, Ankara.",Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1268subtypes of MCD (I, IA, and II) based on the absence or  presence of antigenic keratan sulfate (AgKS) in the serum  and corneal tissue [ 11].",Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1269mouse origins was evaluated using Clustal Omega .,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1270Table  2.,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1271Table  3.,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1272variations (c.164 T>C, p. F55S; c.526 G>A, p. V176M; and  c. 610 C>T, p. P204S), and two novel frameshift varia - tions (c.894_895 insG, p. Q298fs and c. 462_463 delGC, p.  R155Afs).",OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1273R555W in GCD1, R124C in LCDI, R124H in ACD, and  R124L in RBCD [ 6].",Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1274condition was reported in the literature for patients with GCD  and ACD and explained by semidominancy: Patients who are  homozygous for ACD (R124H) or GCD (R555W) mutations  have been reported, and these patients were more severely  affected than heterozygotes [ 32-34].",Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1275or there could be other genetic and/or environmental factors  that affect protein–protein interactions [ 35,36] or protein  degradation mechanisms [ 37,38], which should be evaluated  to reveal the exact mechanism of corneal deposit formation  in TGFBI -associated CDs.",Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1276with MCD type I.,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  1277ACKNOWLEDGMENTS This study was supported by Scientific Research Fund of  The Scientific and Technological Research Council of Turkey  (TUBITAK).,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  127826.,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
Molecular Vision  2016; 22:1267-1279 <http://www.molvis.org/molvis/v 22/1267 > © 2016 Molecular Vision  127952.,Non-OADS,/arxiv_data1/oa_pdf/f8/9d/mv-v22-1267.PMC5082643.pdf
"Compstatin family peptides func - tion by binding to complement protein C3 and sterically  inhibiting the cleavage of C3 to C3a and C3b by convertase,  thus impeding the formation of the chemotactic fragment Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > Received 23 July 2016 | Accepted 24 October 2016 | Published 26 October 2016© 2016 Molecular Vision 1280Peptide redesign for inhibition of the complement system:  Targeting age-related macular degeneration Rohith R. Mohan,1 Andrea P. Cabrera,1 Reed E. S. Harrison,1 Ronald D. Gorham Jr.,1 Lincoln V .",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1281C3a, the opsoninizing fragment C3b, and the propagation of  the complement system through the common pathway that  ultimately results in the assembly of C5b-9n (also known as  the membrane attack complex, MAC), a protein complex that  forms pores on cell membranes.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1282Apparent solubility measurements:  Compstatin analogs were  dissolved in PBS at pH 7.4 to concentrations of 10, 7.5, and  5 mg/ml.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1283Molecular dynamics simulation:  An explicit-solvent molec - ular dynamics simulation was performed, for 90 ns, using  as the initial structure the modeled Peptide 2 structure.",OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1284similar IC50 values within the confidence intervals from four  replicate experiments, and therefore similar potencies (Table  2).",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1285anti-C5b-9 immunofluorescence from whole mounts revealed  that Peptide 2 causes a remarkable 80% inhibition (p<0.001)  of complement activation (Figure 4).,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1286 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1287DISCUSSION We report the design of a new compstatin peptide that has  superior aqueous solubility and comparable complement  inhibitory activity characteristics, compared to previously  known peptides of the compstatin family.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1288addition, acetylation at the N-terminus and amidation at the  C-terminus contribute to improved activity [ 43].",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1289(dmorikis@ucr.edu) and Kaustabh Ghosh (kghosh@engr.ucr.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1280-1290 <http://www.molvis.org/molvis/v 22/1280 > © 2016 Molecular Vision  1290MJ, Anderson DH.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/mv-v22-1280.PMC5082644.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > Received 1 September 2016 | Accepted 25 October 2016 | Published 27 October 2016© 2016 Molecular Vision 1291IRBP deficiency permits precocious ocular development and  myopia Shanu Markand,1 Natecia L. Baskin,1 Ranjay Chakraborty,1,2 Erica Landis,2,3 Sara A. Wetzstein,1 Kevin J.  Donaldson,1 Priyanka Priyadarshani,1 Shannon E. Alderson,1 Curran S. Sidhu,1 Jeffrey H. Boatright,1,2 P.  Michael Iuvone,1,4 Machelle T. Pardue,1,2,3,5 John M. Nickerson1 1Department of Ophthalmology, Emory University, Atlanta, GA; 2Atlanta Veterans Administration Center of Visual and  Neurocognitive Rehabilitation, Decatur, GA; 3Neuroscience Program, Laney Graduate School, Emory University, Atlanta, GA;  4Department of Pharmacology, Emory University, Atlanta, GA; 5Department of Biomedical Engineering, Georgia Institute of  Technology and Emory University, Atlanta, GA Purpose:  Interphotoreceptor retinoid-binding protein (IRBP) is abundant in the subretinal space and binds retinoids  and lipophilic molecules.",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1292Interphotoreceptor retinoid-binding protein (IRBP; gene  symbol, RBP3;  Gene ID 19661; OMIM 180290 ) is found  in high abundance and is the major soluble protein of the  subretinal space, also known as the interphotoreceptor space  [1].",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1293counts.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  129410), P7 (WT, n = 4; KO, n = 4), P8 (WT, n = 6; KO, n = 6),  P9 (WT, n = 6; KO, n = 8), and P10 (WT, n = 5; KO, n = 3).",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1295indicated in the text or figure legend.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1296 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1297and WT mice.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1298of TH-positive cells than in standard cross sections.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1299 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1300 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1301mice for 4 weeks (from P28 to P56) produced no myopic  shift, and the refractive error in the goggled eyes was not  significantly different from that in the ungoggled fellow eyes  or naïve controls (Figure 8).",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1302of the globe is the result of a larger vitreous chamber in  the IRBP KO mice or vice versa.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1303eye peaking at about P30 [ 22].,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1304be part of visually-driven refractive development, including  potential candidates such as Egr-1  [70]?",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1305the timing is off, with growth coming too early and focus  coming too late.",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  1306isolated mouse retina ARVO Annual Meeting; 2015 May 3-7;  Seattle, (WA).",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  130743.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
Molecular Vision  2016; 22:1291-1308 <http://www.molvis.org/molvis/v 22/1291 > © 2016 Molecular Vision  130870.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/mv-v22-1291.PMC5082647.pdf
"Type I IFN-dependent,  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/emss-70303.PMC5082731.pdf
2  147–149 https://doi.org/10.1083/jcb.201609135Neurons of the vertebrate nervous system are usually born in a  different site than where they will ultimately reside.,Non-OADS,/arxiv_data1/oa_pdf/11/a0/JCB_201609135.PMC5082754.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"9, 1429 –1430 http://dx.doi.org/10.1080/15548627.2016.1203489",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Am JPathol 2007; 170:75-86; PMID:17200184; http://dx.doi.org/10.2353/ ajpath.2007.060524[ 2 ]N i s h i d aY ,A r a k a w aS ,F u j i t a n iK ,Y a m a g u c h iH ,M i z u t aT , Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimizu S. Dis-covery of Atg5/Atg7-independen t alternative macroautophagy.",OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Nature 2009; 461:654-8; PMID:19794493; http://dx.doi.org/ 10.1038/nature08455 [3] Klionsky DJ, Lane JD.",OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Autophagy 2010; 6:201; PMID:20083899; http://dx.doi.org/10.4161/auto.6.2.11151 [4] Tamura G, Ando K, Suzuki S, Takatsuki A, Arima K. Antiviral activity of brefeldin A and verrucarin A. J Antibiot (Tokyo) 1968;21:160-1; PMID:4299889; http://dx.doi.org/10.7164/antibiotics.21.160 [5] Zeghouf M, Guibert B, Zeeh JC, Cher ﬁls J. Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibi tion of guanine nucleotide-exchange factors.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Biochem Soc Trans 2005; 33:1265-8; PMID:16246094; http://dx.doi.org/10.1042/BST0331265 [6] Purhonen P, Pursiainen K, Reunanen H. Effects of brefeldin A on autophagy in cultured rat ﬁbroblasts.",OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"J Biol Chem 2007; 282:4702-10; PMID:17135238; http://dx.doi.org/10.1074/jbc.M609267200 [8] Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mar- ino G, Cianfanelli V, Ben-Youn /C18es A, Troncoso R, Markaki M, Sica V, et al.",OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Unsaturated fatty acids induce non-canonical autophagy.EMBO J 2015; 34:1025-41; PMID:25586377; http://dx.doi.org/ 10.15252/embj.201489363 [9] Laniosz V, Dabydeen SA, Havens MA, Meneses PI.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"J Virol 2009; 83:8221-32; PMID:19494002; http://dx.doi.org/10.1128/JVI.00576-09 [10] Verheije MH, Raaben M, Mari M, Te Lintelo EG, Reggiori F, van Kup- peveld FJ, Rottier PJ, de Haan CA.",OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"PLoS Pathog 2008; 4:e1000088; PMID:18551169; http://dx.doi.org/10.1371/journal.ppat.1000088 [11] Whealy ME, Card JP, Meade RP, Robbins AK, Enquist LW.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
J Virol 2010; 84:4816-20; PMID:20164217; http://dx.doi.org/10.1128/JVI.00010-10 [13] Jackson WT.,OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Autophagy 2015; 11:716-7; PMID:25905782; http://dx.doi.org/10.1080/15548627.2015.1017223 [15] Ge L, Melville D, Zhang M, Schekman R. The ER-Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Elife 2013; 2:e00947; PMID:23930225;http://dx.doi.org/10.7554/eLife.00947 [16] Yen W-L, Shintani T, Nair U, Cao Y, Richardson BC, Li Z, Hughson FM, Baba M, Klionsky DJ.",Non-OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
The conserved oligomeric Golgi complex is involved in double-membrane vesicle formation during autophagy.J Cell Biol 2010; 188:101-14; PMID:20065092; http://dx.doi.org/10.1083/jcb.2009040751430 C. GROSE AND D. J. KLIONSKY,OADS,/arxiv_data1/oa_pdf/29/9a/kaup-12-09-1203489.PMC5082769.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/kaup-12-09-1203490.PMC5082772.pdf
"9, 1683 –1684 http://dx.doi.org/10.1080/15548627.2016.1203490",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/kaup-12-09-1203490.PMC5082772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"9, 1487 –1506 http://dx.doi.org/10.1080/15548627.2016.1190072",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Lancet Neurol 2014; 13:1045-60; PMID:25231526; http://dx.doi.org/10.1016/S1474- 4422(14)70117-6 [2] Dusek P, Jankovic J, Le W. Iron dysregulation in movement disor- ders.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Neurobiol Dis 2012; 46:1-18; PMID:22266337; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Cell 2010; 142:24- 38; PMID:20603012; http://dx.doi.org/10.1016/j.cell.2010.06.028 [4] Blaby-Haas CE, Merchant SS.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2014; 289:28129-36;PMID:25160625; http://dx.doi.org/10.1074/jbc.R114.592618 [5] Nixon RA, Yang DS, Lee JH.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Autophagy 2008; 4:590-9; PMID:18497567; http://dx.doi.org/10.4161/auto.6259 [6] Grimm C, Hassan S, Wahl-Schott C, Biel M. Role of TRPML and two-pore channels in endolysosomal cation homeostasis.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
J Pharma- col Exp Ther 2012; 342:236-44; PMID:22518024; http://dx.doi.org/10.1124/jpet.112.192880 [7] Patel S. Function and dysfunction of two-pore channels.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Am J Physiol Renal Physiol 2009; 296:F1245-54; PMID:19158345; http://dx.doi.org/10.1152/ajprenal.90522.2008 [9] Cang C, Zhou Y, Navarro B, Seo YJ, Aranda K, Shi L, Battaglia-Hsu S, Nissim I, Clapham DE, Ren D. mTOR regulates lysosomal ATP- sensitive two-pore Na( C) channels to adapt to metabolic state.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Cell 2013; 152:778-90; PMID:23394946; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Cell 2012; 151:372-83; PMID:23063126; http://dx.doi.org/ 10.1016/j.cell.2012.08.036 [11] Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysoso- mal iron release channel.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2008; 455:992-6; PMID:18794901; http://dx.doi.org/10.1038/nature07311 [12] Eichelsdoerfer JL, Evans JA, Slaugenhaupt SA, Cuajungco MP.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2010; 285:34304-8; PMID:20864526; http://dx.doi.org/10.1074/jbc.C110.165480 [13] Kiselyov K, Colletti GA, Terwilliger A, Ketchum K, Lyons CW, Quinn J, Muallem S. TRPML: transporters of metals in lysosomes essential for cell survival?",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Cell Calcium 2011; 50:288-94;PMID:21621258; http://dx.doi.org/10.1016/j.ceca.2011.04.009 [14] Ruas M, Davis LC, Chen CC, Morgan AJ, Chuang KT, Walseth TF, Grimm C, Garnham C, Powell T, Platt N, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Sci Signal 2014; 7(326):ra46; PMID:24847115; http://dx.doi.org/10.1126/scisignal.2004854 [16] Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X, Tang J, Rietdorf K, Teboul L, Chuang KT, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2009; 459:596-600; PMID:19387438; http://dx.doi.org/10.1038/nature08030 [17] Zong X, Schieder M, Cuny H, Fenske S, Gruner C, R €otzer K, Gries- beck O, Harz H, Biel M, Wahl-Schott C. The two-pore channelTPCN2 mediates NAADP-dependent Ca( 2C)-release from lysosomal stores.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
P ﬂugers Arch 2009; 458:891-9; PMID:19557428; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2012; 287:2308-15;PMID:22117077; http://dx.doi.org/10.1074/jbc.M111.306563 [19] Lin-Moshier Y, Walseth TF, Churamani D, Davidson SM, Slama JT, Hooper R, Brailoiu E, Patel S, Marchant JS.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
J Biol Chem 2012; 287:2296-307; PMID:22117075; http://dx.doi.org/10.1074/jbc.M111.305813 [20] Guse AH.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Sci Signal 2012; 5:pe18; PMID:22534131; http://dx.doi.org/10.1126/scisignal.2002890 [21] Jha A, Ahuja M, Patel S, Brailoiu E, Muallem S. Convergent regula- tion of the lysosomal two-pore channel-2 by Mg 2C, NAADP, PI(3,5) P, and multiple protein kinases.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"EMBO J 2014; 33:501-11; PMID:24502975; http://dx.doi.org/10.1002/embj.201387035 [22] Lin-Moshier Y, Keebler MV, Hooper R, Boulware MJ, Liu X, Chura- mani D, Abood ME, Walseth TF, Brailoiu E, Patel S, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 1997; 272:4391-7; PMID:9020161; http://dx.doi.org/10.1074/jbc.272.7.4391[24] Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Mol Biol Cell 2000; 11:467-80;PMID:10679007; http://dx.doi.org/10.1091/mbc.11.2.467 [25] Hyttinen JM, Niittykoski M, Salminen A, Kaarniranta K. Maturation of autophagosomes and endosomes: a key role for Rab7.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Biochim Biophys Acta 2013; 1833:503-10; PMID:23220125; http://dx.doi.org/10.1016/j.bbamcr.2012.11.018 [26] Ruas M, Rietdorf K, Arredouani A, Davis LC, Lloyd-Evans E, Koegel H, Funnell TM, Morgan AJ, Ward JA, Watanabe K, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Curr Biol 2010; 20:703-9; PMID:20346675; http://dx.doi.org/10.1016/j.cub.2010.02.049 [27] Marchant JS, Patel S. Two-pore channels at the intersection of endo- lysosomal membrane traf ﬁc.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Biochem Soc Trans 2015; 43:434-41; PMID:26009187; http://dx.doi.org/10.1042/BST20140303 [28] Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A ,R o s e nD ,T h o m a sJ M ,I z u m iM ,G a n e s a nA ,e ta l .I d e n t i ﬁcation of a chemical probe for NAADP by virtual screening.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Biomed Res Int 2014; 2014:581256; PMID:24527451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
J Neurochem 1991; 56:978-82; PMID:1704426; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Neurochem Int 2013; 62:637-52; PMID:23220386; http://dx.doi.org/ 10.1016/j.neuint.2012.11.015 [32] Lane DJ, Merlot AM, Huang ML, Bae DH, Jansson PJ, Sahni S, Kali- nowski DS, Richardson DR. Cellular iron uptake, traf ﬁcking and metabolism: Key molecules and mechanisms and their roles in dis- ease.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Biochim Biophys Acta 2015; 1853:1130-44; PMID:25661197;http://dx.doi.org/10.1016/j.bbamcr.2015.01.021 [33] Rouault TA.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nat Rev Neurosci 2013; 14:551-64; PMID:23820773; http://dx.doi.org/10.1038/nrn3453 [34] Mills E, Dong XP, Wang F, Xu H. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Future Med Chem 2010; 2:51-64; PMID:20161623; http://dx.doi.org/10.4155/fmc.09.140 [35] Salvador GA, Oteiza PI.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Neurotoxicology 2011; 32:75- 82; PMID:21130806; http://dx.doi.org/10.1016/j.neuro.2010.11.006 [36] You LH, Li F, Wang L, Zhao SE, Wang SM, Zhang LL, Zhang LH, Duan XL, Yu P, Chang YZ.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Neuroscience 2015; 284:234-46; PMID:25301748; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Methods Enzymol 2008; 438:77-93; PMID:18413242; http://dx.doi.org/ 10.1016/S0076-6879(07)38006-3 [38] Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2004; 279:22284- 93; PMID:14985369; http://dx.doi.org/10.1074/jbc.M312847200 [39] Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Cell Death Differ 2015; 22:377-88; PMID:25257172; http://dx.doi.org/10.1038/cdd.2014.150 [40] Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Methods Enzy- mol 2009; 452:181-97; PMID:19200883; http://dx.doi.org/10.1016/ S0076-6879(08)03612-4 [41] Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
J Biol Chem 2007; 282:24131-45; PMID:17580304; http://dx.doi.org/10.1074/jbc.M7028242001504 B. FERN /C19ANDEZ ET AL.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2009; 284:8023-8032; PMID:19150980; http://dx.doi.org/10.1074/jbc.M900301200 [43] Lichtenberg M, Mansilla A, Zecchini VR, Fleming A, Rubinsztein DC.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Cell Death Dis 2011; 2:e196; PMID:21866175; http://dx.doi.org/10.1038/cddis.2011.81 [44] Nixon RA.,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Nat Med 2013; 19:983-97; PMID:23921753; http://dx.doi.org/10.1038/nm.3232 [45] Klionsky DJ.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2006; 441:819-20; PMID:16778876; http://dx.doi.org/10.1038/441819a [46] Shintani T, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Science 2004; 306:990-5; PMID:15528435; http://dx.doi.org/10.1126/science.1099993 [47] Butler D, Nixon RA, Bahr BA.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Autophagy 2006; 2:234-7; PMID:16874061; http://dx.doi.org/10.4161/auto.2729 [48] Rubinsztein DC.,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"The roles of intracellular protein-degradation path- ways in neurodegeneratio n. Nature 2006; 443:780-6; PMID:17051204; http://dx.doi.org/10.1038/nature05291 [49] Mizushima N, Levine B, Cuervo AM, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2008; 451:1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639 [50] Falc /C19on-P /C19erez JM, Nazarian R, Sabatti C, Dell ’Angelica EC.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci 2005; 118:5243-55; PMID: Can ’t; http://dx.doi.org/10.1242/jcs.02633 [51] Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Oncogene 2008; 27:6434-51; PMID:18955971; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2006; 281:7294-301; PMID:16361256; http://dx.doi.org/10.1074/jbc.M508211200 [53] Brailoiu E, Churamani D, Cai X, Schrlau MG, Brailoiu GC, Gao X, Hooper R, Boulware MJ, Dun NJ, Marchant JS, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Biol 2009; 186:201-9; PMID:19620632; http://dx.doi.org/10.1083/jcb.200904073 [54] Brailoiu E, Rahman T, Churamani D, Prole DL, Brailoiu GC, Hooper R, Taylor CW, Patel S. An NAADP-gated two-pore channel targetedto the plasma membrane uncouples triggering from amplifying Ca 2C signals.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Biol Chem 2011; 286:22934-42; PMID:21540176; http://dx.doi.org/10.1074/jbc.M110.210930 [56] Dionisio N, Albarr /C19an L, L /C19opez JJ, Berna-Erro A, Salido GM, Bobe R, Rosado JA.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Biochim Biophys Acta 2011; 1813:1483- 94; PMID:21601596; http://dx.doi.org/10.1016/j.bbamcr.2011.05.005 [57] Zdolsek JM, Roberg K, Brunk UT.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Free Radic Biol Med 1993; 15:1-11;PMID:8359707; http://dx.doi.org/10.1016/0891-5849(93)90120-J [58] Agola JO, Hong L, Surviladze Z, Ursu O, Waller A, Strouse JJ, Simpson DS, Schroeder CE, Oprea TI, Golden JE, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"ACS Chem Biol 2012; 7:1095-108; PMID:22486388; http://dx.doi.org/10.1021/cb3001099 [59] G /C19omez-Suaga P, Rivero-R /C19ıos P, Fdez E, Blanca Ram /C19ırez M, Ferrer I, Aiastui A, L /C19opez De Munain A, Hil ﬁker S. LRRK2 delays degradative receptor traf ﬁcking by impeding late endosomal budding throughdecreasing Rab7 activity.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Hum Mol Genet 2014; 23:6779-96; PMID: Can ’t; http://dx.doi.org/10.1093/hmg/ddu395 [60] Hockey LN, Kilpatrick BS, Eden ER, Lin-Moshier Y, Brailoiu GC, Brailoiu E, Futter CE, Schapira AH, Marchant JS, Patel S. Dysregula- tion of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci 2015; 128:232-8; PMID:25416817; http://dx.doi.org/10.1242/jcs.164152 [61] Fares H, Greenwald I.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Clin Invest 1991;88:1207-15; PMID:1918375; http://dx.doi.org/10.1172/JCI115423 [63] Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, Vargas L, Lothian A, McAllum E, Volitakis I, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
Redox Biol 2015; 4:363-74; PMID:25703232; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"PLoS One 2013; 8(10):e77023; PMID:24146952; http://dx.doi.org/10.1371/journal.pone.0077023 [65] Asano T, Komatsu M, Yamaguchi-Iwai Y, Ishikawa F, Mizushima N, Iwai K. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Mol Cell Biol 2011; 31:2040-52; PMID:21444722; http://dx.doi.org/10.1128/MCB.01437-10 [66] Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nat Cell Biol 2014; 16:1069-79; PMID:25327288; http://dx.doi.org/10.1038/ncb3053 [67] Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2014; 509:105-9; PMID:24695223; http://dx.doi.org/10.1038/nature13148 [68] Shawki A, Knight PB, Maliken BD, Niespodzany EJ, Mackenzie B. H (C)-coupled divalent metal-ion transp orter-1: functional properties, physiological roles and therapeutics.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Curr Top Membr 2012; 70:169-214;PMID:23177986; http://dx.doi.or g/10.1016/B978-0-12-394316-3.00005-3 [69] Zhu MX, Ma J, Parrington J, Galione A, Evans AM.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"FEBS Lett 2010; 584:1966-74; PMID:20159015; http://dx.doi.org/10.1016/j.febslet.2010.02.028 [70] Chavrier P, Parton RG, Hauri HP, Simons K, Zerial M. Localization of low molecular weight GTP binding proteins to exocytic and endo-cytic compartments.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci 2004; 117:2687-97; PMID:15138286; http://dx.doi.org/ 10.1242/jcs.01114 [72] J €ager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci2004; 117:4837-48; PMID:Can ’t; http://dx.doi.org/10.1242/jcs.01370 [73] Hyttinen JM, Niittykoski M, Salminen A, Kaarniranta K. Maturation of autophagosomes and endosomes: a key role for Rab7.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"BiochimBiophys Acta 2013; 1833:503-10; PMID:23220125; http://dx.doi.org/ 10.1016/j.bbamcr.2012.11.018 [74] Bento CF, Puri C, Moreau K, Rubinsztein DC.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci 2013; 126:1059-69; PMID:23620509; http://dx.doi.org/ 10.1242/jcs.123075 [75] Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Nature 2010; 465:942-6; PMID:20526321; http://dx.doi.org/10.1038/nature09076 [76] Parkesh R, Lewis AM, Aley PK, Arredouani A, Rossi S, Tavares R, Vasudevan SR, Rosen D, Galione A, Dowden J, et al.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Cell Calcium 2008; 43:531-8; PMID:17935780; http://dx.doi.org/10.1016/j.ceca.2007.08.006 [77] G /C19omez-Suaga P, Luz /C19on-Toro B, Churamani D, Zhang L, Bloor- Young D, Patel S, Woodman PG, Churchill GC, Hil ﬁker S. Leucine- rich repeat kinase 2 regulates autophagy through a calcium-depen-dent pathway involving NAADP.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Hum Mol Genet 2012; 21:511-25; PMID:Can ’t; http://dx.doi.org/10.1093/hmg/ddr481 [78] Fdez E, Mart /C19ınez-Salvador M, Beard M, Woodman P, Hil ﬁker S. Trans- membrane-domain determinant s for SNARE-mediated membranefusion.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"J Cell Sci 2010; 123:2473-80; PM ID:20571052; http://dx.doi.org/ 10.1242/jcs.061325 [79] Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells.",OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
"Anal Biochem 2004; 331:370-5; PMID:15265744; http://dx.doi.org/10.1016/j.ab.2004.03.049 [80] Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, W o n gB X ,A d l a r dP A ,C h e r n yR A ,L a mL Q ,e ta l .T a ud e ﬁciency induces parkinsonism with dementia by impairing APP-mediated iron export.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
NatMed 2012; 18:291-5; PMID:22286308; http://dx.doi.org/10.1038/nm.26131506 B. FERN /C19ANDEZ ET AL.,OADS,/arxiv_data1/oa_pdf/2f/7d/kaup-12-09-1190072.PMC5082776.pdf
J Neurochem 2016; Epub ahead of print; PMID:27015757; http://dx.doi.org/10.1111/jnc.13625 /C2112016 Yoshinori Tanaka and Masato Hasegawa.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"This is an Open Access article distributed under t he terms of the Creative Commons Attribution- Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
J Cell Sci 2008; 121:3778-85; PMID: 18957508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Front Biosci 2008; 13:867-78;PMID:17981595; http://dx.doi.org/10.2741/2727[4] Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
J Mol Biol 2005; 348:575-88; PMID:15826655;http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"J Biol Chem 2001; 276:36337-43; PMID:11470789; http://dx.doi.org/ 10.1074/jbc.M104236200 [8] Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
J Biol Chem 2005; 280:37572-84; PMID:16157593; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Biochem Biophys Res Commun 2006; 351:602-11; PMID:17084815; http://dx.doi.org/10.1016/j.bbrc.2006.10.093 [11] NeumannM,SampathuDM,KwongLK,TruaxAC,Mic- senyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Sci- ence 2006; 314:130-3; PMID:17023659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Ann Neurol 2008; 64:60-70; PMID:18546284; http://dx.doi.org/10 .1002/ana.21425 [13] Lee EB, Lee VM, Trojanowski JQ.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Science2008; 319:1668-72; PMID:18309045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Lancet Neurol 2010; 9:995-1007; PMID:20864052; http://dx.doi.org/10.1016/S1474-4422(10)70195-2 [17] Pesiridis GS, Lee VM, Trojanowski JQ.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Hum Mol Genet2009; 18:R156-62; PMID:19808791; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"NatStruct Mol Biol 2011; 18:822-30; PMID:21666678; http://dx.doi.org/10.1038/nsmb.2053 [19] Wang IF, Chang HY, Hou SC, Liou GG, Way TD, James Shen CK.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Nat Commun 2012; 3:766; PMID:22473010; http://dx.doi.org/10.1038/ncomms1766 [20] Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S,Mann DM, Akiyama H, et al.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Cell Rep 2013; 4:124-34; PMID:23831027;http://dx.doi.org/10.1016/j.celrep.2013.06.007 [21] Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M. Templated aggregation of TAR DNA- binding protein of 43 kDa (TDP-43) by seedingwith TDP-43 peptide ﬁbrils.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"J Biol Chem 2016; 291:8896-907; PMID:26887947; http://dx.doi.org/ 10.1074/jbc.M115.713552 [22] Wang YT, Kuo PH, Chiang CH, Liang JR, Chen YR, Wang S, Shen JC, Yuan HS.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
J Biol Chem 2013; 288:9049-57; PMID: 23372158; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Mutations in the proﬁlin 1 gene cause familial amyotrophic lateral sclerosis.Nature 2012; 488:499-503; PMID:22801503; http://dx.doi.org/10.1038/nature11280 [25] Carlsson L, Nystrom LE, Sundkvist I, Markey F, Lindberg U. Actin polymeri zability is inﬂuenced by proﬁlin, a low molecular weight protein in non-muscle c e l l s .JM o lB i o l1 9 7 7 ;1 1 5 :465-83; PMID:563468; http://dx.doi.org/10.101 6/0022-2836(77)90166-8 [26] Staiger CJ, Yuan M, Valenta R, Shaw PJ, Warn RM, Lloyd CW.",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Curr Biol 1994;4:215-9; PMID:7922326; http://dx.doi.org/10.1016/ S0960-9822(00)00050-6 [27] Witke W. The role of proﬁlin complexes in cell motility and other cellular processes.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Proﬁlin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics.J Neurosci 2014; 34:8083-97; PMID:24920614; http://dx.doi.org/10.1523/JNEUROSCI.0543-14.2014 [29] Smith BN, Vance C, Scotter EL, Troakes C, Wong CH, Topp S, Maekawa S, King A, Mitchell JC, LundK, et al.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Neurobiol Aging 2015; 36:1602.e17-27; PMID:25 499087; http://dx.doi.org/ 10.1016/j.neurobiolaging.2014.12.037 [30] Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hase- gawa M. Gain-of-function proﬁlin 1 mutations linkedto familial amyotrophic lateral sclerosis cause seed- dependent intracellular TDP-43 aggregation.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Hum Mol Genet 2016; 25:1420-33; PMID:26908597;http://dx.doi.org/10.1093/hmg/ddw024 [31] Ratti A, Buratti E. Physiological functions and pathobi- ology of TDP-43 and FUS/TLS proteins.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Exp Gerontol 2005; 40:622- 33; PMID:16125351; http://dx.doi.org/10.1016/j.exger.2005.07.005 [33] Olzmann JA, Li L, Chin LS.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Curr Med Chem 2008; 15:47-60; PMID:18220762; http://dx.doi.org/10.217 4/092986708783330692 [34] Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"J Proteome Res 2010; 9:1104-20; PMID:20020773 http://dx.doi.org/10 .1021/pr901076y [36] Yamashita M, Nonaka T, Hirai S, Miwa A, Okado H, Arai T, Hosokawa M, Akiyama H, Hasegawa M. Dis- tinct pathways leading to TDP -43-induced cellular dys- functions.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Hum Mol Genet 2014; 23:4345-56; PMID:24698978; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
Mol Cell 2006;23:607-18; PMID:16916647; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Science 2009; 325:834-40; PMID:19608861; http://dx.doi.org/10.1126/science.1175371 [39] Ingre C, Landers JE, Rizik N, Volk AE, Akimoto C, Birve A, Hubers A, Keagle PJ, Piotrowska K, Press R, et al.",OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"Neurobiol Aging 2013;34:1708.e1-6; PMID:23141414; http://dx.doi.org/ 10.1016/j.neurobiolaging.2012.10.009MUTANT PROFILIN 1, AN INDUCER OF TDP-43 AGGREGATION 289",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/kprn-10-04-1207033.PMC5082967.pdf
"The number of events and person years followed are shown insupplementary Table S1 (SDC, http://links.lww.com/TXD/A28).",OADS,/arxiv_data1/oa_pdf/2a/61/txd-2-e96.PMC5082996.pdf
http://optn.transplant.,Non-OADS,/arxiv_data1/oa_pdf/81/85/txd-2-e94.PMC5082997.pdf
Available at http://ctep.cancer.gov/protocolDevelopment/electronic_ applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/b0/txd-2-e91.PMC5083001.pdf
"Correspondence to: D. BermudesContract grant sponsor: NIHContract grant number: SC3GM098207 Contract grant sponsor: NIH Research Initiative for Scientiﬁc Enhancement (RISE) Contract grant number: GM063787Received 1 March 2016; Revision received 25 May 2016; Accepted 29 May 2016Accepted manuscript online 4 June 2016; Article ﬁrst published online 8 July 2016 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.26026/abstract).DOI 10.1002/bit.26026ARTICLE 2698 Biotechnology and Bioengineering, V ol.",Non-OADS,/arxiv_data1/oa_pdf/15/92/BIT-113-2698.PMC5083144.pdf
"In analyses of Rab GTPase proteins as controls, the expression of Rab5 was found to be increased 1.8-fold in MRL/lpr mice ( P50.009) (results in Supple- mentary Figure 2, http://onlinelibrary.wiley.com/doi/10.2730 OAKS ET AL",OADS,/arxiv_data1/oa_pdf/85/b7/ART-68-2728.PMC5083168.pdf
"Inter-estingly, aPL production was similar between B6 miceand (NZB/NZW)F1 mice at age 4 weeks (results in Sup- plementary Figure 3, http://onlinelibrary.wiley.com/doi/ 10.1002/art.39791/abstract).",Non-OADS,/arxiv_data1/oa_pdf/85/b7/ART-68-2728.PMC5083168.pdf
Increased expression of HRES-1/Rab4 (also designated as Rab4A by NCBI;http://www.ncbi.nlm.nih.gov/gene/5867) mediates thedepletion of Drp1 and the accumulation of oxidativestress–generating mitochondria in T cells (5) and HeLa cells (32).,Non-OADS,/arxiv_data1/oa_pdf/85/b7/ART-68-2728.PMC5083168.pdf
"Of the 200 SNPs selected, none of them was associated sig- nificantly with OS of these patients (Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/ FPC/B78 ), suggesting that they might not serve as pan- creatic cancer risk factors.",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"However, our findings showed that four SNPs in four genomic regions located in chromo- somes 1, 3, 9, and 20, respectively, were strongly associated with OS ( P<0.01) of patients when exposed to gemcitabine in the interaction analysis using a Wald test (Table 2 and Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/FPC/B78 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"The effects of four SNPs on gemcitabine response were i n the same direction as that observed in our GWAS analysis using the LCLs, implying that variations in these SNP s might modify the outcome of gemcitabine treatment for pancreatic cancer (Table 2 and Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/FPC/B78 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"We imputed regions 200 kbpon either side of those four SNPs to explore additional genetic variants around those genomic regions, followed by an SNP –gemcitabine interaction analysis with OS of the discovery cohort patients to determine whether any of the imputed SNPs might have pharmacogenomic effects on gemcitabine during pancreatic cancer treatment (Supplementary Table 2, Supplemental digital content 2, http://links.lww.com/FPC/B79 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"These results are shown as the main effect of SNP in Supplementary Table 1 (Supplemental digital content 1, http://links.lww.com/FPC/ B78).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"We carried out an eQTL (expression quan- titative trait loci) analysis for these two corresponding geno- typed SNPs (rs9637468 and rs4925193) using 15 tumor and eight normal samples from pancreatic cancer patients who were a subset of the samples from the discovery cohort forwhich we had both genotype and mRNA expression data (Supplementary Table 3A, Supplemental digital content 3, http://links.lww.com/FPC/B80 and 3B, Supplemental digital content 4, http://links.lww.com/FPC/B81 ).",OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"However, we found that both rs1122269 and rs4925193 showed negative correlations with all three probe sets of CDH4 in a cis-manner, with values of Requal to −0.5 in normal samples ( P=0.2) (Supplementary Table 3C, Supplemental digital content 5, http://links.lww.com/FPC/B82 ), but no cis-associations were found in the tumor tissue sam- ples.",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"1A, Supplemental digital content 6, http://links.lww.com/ FPC/B83 ) were associated with OS of those pancreatic cancer patients [hazard ratio (HR) <1 for all the four probe sets of CDH4 ] (Supplementary Table 3D, Supplemental digital content 7, http://links.lww.com/FPC/B84 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"The score levels of CDH4 staining in normal tissues were significantly higher than those in tumor tissues in the 45 pairs of samples (Supplementary Table 4, Supplemental digital content 8, http://links.lww.com/FPC/B85 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"1B, Supplemental digital content 6, http://links.lww.com/FPC/ B83), stronger immunostaining of CDH4 was noted in the membranes of normal pancreatic duct epithelium cells, whereas the staining was much weaker or negative inneoplastic epithelium cells as well as in extracellular matrix components.",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"2 (Supplemental digital content 9, http://links.lww.com/FPC/B86 ), the protein levels of CDH4 were relatively high enough to be detected in SU86, HupT3, and MIApaca-2 cell clines compared with the others.",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"As shown in Supplementary Table 5 (Supplemental digital content 10, http://links.lww.com/FPC/B87 ), the results implied that the SNPs in KRT8P35 andCDH4 might be predictive markers for gemcitabine response.",OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"3, Supplemental digital content 11, http://links.lww.com/ FPC/B88 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"3, Suppl emental digital content 11,http://links.lww.com/FPC/B88 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"The rs9637468 did not show any cis-relationships in either normal or tumor samples, but we did observe trans-associations (P<10−4) with the expression of other genes in both normal and tumor samples (Supplementary Table 3A, Supplemental digital content 3, http://links.lww.com/FPC/B80 and 3B, Supplemental digital content 4, http://links.lww.com/FPC/B81 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"However, in our eQTL analysis, the two SNPs (rs1122269 and rs4925193) of CDH4 showed negative cis-correlations with the expression of CDH4 mRNA for all three of its probe sets in the normal tissue samples, although the P-values were not statistically significant (Supplementary Table 3C, Supplemental digital content 5, http://links.lww.com/FPC/B82 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"We also found that the mRNA expression levels of CDH4 were associated with the OS of these pancreatic cancer patients (HR <1 for all the four probe sets of CDH4) (Supplementary Table 3D, Supplemental digital content 7, http://links.lww.com/FPC/B84 ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"1A and 1B, Supplemental digital content 6, http://links.lww.com/ FPC/B83 ), suggesting the tumor-suppressive function of CDH4 in pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
Acknowledgements The microarray data and SNP data from the LCL-basedGWAS study have been submitted to the NCBI Gene Expression Omnibus databases ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"phs000206.v5.p3, along with the weblink of genotype/ phenotype interaction studies ( http://epi.grants.cancer.gov/ PanScan/ ).",Non-OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
The microarray data from the PanScan study to perform our eQTL analysis have been deposited in the NCBI GEO databases ( http://www.ncbi.nlm.nih.gov/geo ) with Series accession no.,OADS,/arxiv_data1/oa_pdf/06/13/fpc-26-527.PMC5083195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.293Intest Res 2016;14(4):293-294EDITORIAL Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?",Non-OADS,/arxiv_data1/oa_pdf/a4/e2/ir-14-293.PMC5083256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.295Intest Res 2016;14(4):295-296EDITORIAL Received September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/ir-14-295.PMC5083257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.297Intest Res 2016;14(4):297-304REVIEW   Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are  falling into place Rafiz Abdul Rani1, Raja Affendi Raja Ali2, Yeong Yeh Lee3 1Gastroenterology Unit, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, 2Gastroenterology Unit, Faculty of Medicine, Universiti  Kebangsaan Malaysia, Kuala Lumpur, 3School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia Irritable bowel syndrome (IBS), a common gastrointestinal disorder involving the gut-brain axis, and inflammatory bowel dis - ease (IBD), a chronic relapsing inflammatory disorder, are both increasing in incidence and prevalence in Asia.",Non-OADS,/arxiv_data1/oa_pdf/f9/32/ir-14-297.PMC5083258.pdf
https://doi.org/10.5217/ir.2016.14.4.297 • Intest Res 2016;14(4):297-304 299 www.irjournal.org immune activation in both of these diseases.,Non-OADS,/arxiv_data1/oa_pdf/f9/32/ir-14-297.PMC5083258.pdf
https://doi.org/10.5217/ir.2016.14.4.297 • Intest Res 2016;14(4):297-304 301 www.irjournal.org with IBS are 15 times more likely to develop IBD compared  to those with no IBS-like symptoms.3 The question is what may have caused the ongoing low- grade inflammation in the early or pre-IBD period?,Non-OADS,/arxiv_data1/oa_pdf/f9/32/ir-14-297.PMC5083258.pdf
https://doi.org/10.5217/ir.2016.14.4.297 • Intest Res 2016;14(4):297-304 303 www.irjournal.org 25.,Non-OADS,/arxiv_data1/oa_pdf/f9/32/ir-14-297.PMC5083258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.305Intest Res 2016;14(4):305-313ORIGINAL ARTICLE   Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease Hui Won Jang1, Hyun Sook Kim2, Soo Jung Park1, Sung Pil Hong1, Tae Il Kim1, Won Ho Kim1,   Jae Hee Cheon1 Departments of 1Internal Medicine, Institute of Gastroenterology and 2Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea Background/Aims: Several studies have found that the measurement of fecal calprotectin is useful for the early diagnosis of inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/5f/60/ir-14-305.PMC5083259.pdf
https://doi.org/10.5217/ir.2016.14.4.305 • Intest Res 2016;14(4):305-313 307 www.irjournal.org and Spearman’s rank correlation.,OADS,/arxiv_data1/oa_pdf/5f/60/ir-14-305.PMC5083259.pdf
"https://doi.org/10.5217/ir.2016.14.4.305 • Intest Res 2016;14(4):305-313 309 www.irjournal.org tectin and EliATM Calprotectin correlated significantly with  CDAI ( P=0.004 and P=0.041, respectively; r=0.66 and r=0.49,  respectively).",OADS,/arxiv_data1/oa_pdf/5f/60/ir-14-305.PMC5083259.pdf
https://doi.org/10.5217/ir.2016.14.4.305 • Intest Res 2016;14(4):305-313 311 www.irjournal.org diseases.,Non-OADS,/arxiv_data1/oa_pdf/5f/60/ir-14-305.PMC5083259.pdf
https://doi.org/10.5217/ir.2016.14.4.305 • Intest Res 2016;14(4):305-313 313 www.irjournal.org 16.,Non-OADS,/arxiv_data1/oa_pdf/5f/60/ir-14-305.PMC5083259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.314Intest Res 2016;14(4):314-321ORIGINAL ARTICLE Narrow-band imaging with magnifying endoscopy for Peyer’s patches is useful in predicting the recurrence of remissive patients with ulcerative colitis Satoshi Hiyama1,2, Hideki Iijima1, Syoichiro Kawai1, Akira Mukai3, Eri Shiraishi3, Shuko Iwatani1,   Toshio Yamaguchi1, Manabu Araki1, Yoshito Hayashi1, Shinichiro Shinzaki1, Tsunekazu Mizushima2,4,  Masahiko Tsujii5, Tetsuo Takehara1 Departments of 1Gastroenterology and Hepatology and 2Therapeutics for Inflammatory Bowel Diseases, Osaka University Graduate School of  Medicine, Osaka, 3Department of Gastroenterology, Sumitomo Hospital, Osaka, 4Department of Gastroenterological Surgery, Osaka University  Graduate School of Medicine, Osaka, 5Department of Gastroenterology, Osaka Rosai Hospital, Osaka, Japan Background/Aims: Peyer’s patches (PPs) are aggregates of lymphoid follicles that are mainly located in the distal ileum; they play a major role in mucosal immunity.",Non-OADS,/arxiv_data1/oa_pdf/57/ad/ir-14-314.PMC5083260.pdf
"https://doi.org/10.5217/ir.2016.14.4.314 • Intest Res 2016;14(4):314-321 315 www.irjournal.org Taken together, this suggests that PPs are involved in the  pathogenesis of gut immune diseases, such as IBD.",OADS,/arxiv_data1/oa_pdf/57/ad/ir-14-314.PMC5083260.pdf
https://doi.org/10.5217/ir.2016.14.4.314 • Intest Res 2016;14(4):314-321 317 www.irjournal.org regard to either the extent of disease involvement or inflam- mation in the terminal ileum (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/57/ad/ir-14-314.PMC5083260.pdf
"https://doi.org/10.5217/ir.2016.14.4.314 • Intest Res 2016;14(4):314-321 319 www.irjournal.org DISCUSSION This is the first report showing that alterations in the  villi of PPs, determined using NBI-ME, are associated with  clinical relapse in patients with UC.",Non-OADS,/arxiv_data1/oa_pdf/57/ad/ir-14-314.PMC5083260.pdf
https://doi.org/10.5217/ir.2016.14.4.314 • Intest Res 2016;14(4):314-321 321 www.irjournal.org 19.,Non-OADS,/arxiv_data1/oa_pdf/57/ad/ir-14-314.PMC5083260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.322Intest Res 2016;14(4):322-332ORIGINAL ARTICLE Surgical management of inflammatory bowel disease in China: a systematic review of two decades Qiao Yu1*, Ren Mao1*, Lei Lian2*, Siew chien Ng3, Shenghong Zhang1, Zhihui Chen4, Yanyan Zhang1,   Yun Qiu1, Baili Chen1, Yao He1, Zhirong Zeng1, Shomron Ben-Horin1,5, Xinming Song4, Minhu Chen1 1Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 2Department of Colorectal Surgery, The  Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 3Department of Medicine and Therapeutics, Institute of Digestive Disease,  State Key Laboratory of Digestive Diseases, Chinese University of Hong Kong, Hong Kong, 4Department of General Surgery, The First Affiliated  Hospital of Sun Yat-sen University, Guangzhou, China, 5IBD Service, Department of Gastroenterology, Sheba Medical Center & Sackler School  of Medicine, Tel-Aviv University, Tel Hashomer, Israel Background/Aims:  The past decades have seen increasing incidence and prevalence of inflammatory bowel disease (IBD)  in China.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
"https://doi.org/10.5217/ir.2016.14.4.322 • Intest Res 2016;14(4):322-332 323 www.irjournal.org increasing in recent decades, indicating its emergence as a  global disease.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
"https://doi.org/10.5217/ir.2016.14.4.322 • Intest Res 2016;14(4):322-332 325 www.irjournal.org ple t-tests were used for statistical analysis in large versus  small centers, and a P-value less than 0.05 was considered  statistically significant.",OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
"https://doi.org/10.5217/ir.2016.14.4.322 • Intest Res 2016;14(4):322-332 327 www.irjournal.org (TPC-IP AA), followed by TPC and ileoanal anasto- mosis (24.8%±3.32%), TPC and ileorectal anastomo-sis (17.7%±23.2%), and pure ileostomy or colostomy (3.6%±0.8%).",Non-OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
"https://doi.org/10.5217/ir.2016.14.4.322 • Intest Res 2016;14(4):322-332 329 www.irjournal.org compared to men, while there is no sex-based difference in  UC.26,27 This skewed distribution varies between geographic  regions, and it might also reflect the demographic deficit of women as well as different levels of access to healthcare in China.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
https://doi.org/10.5217/ir.2016.14.4.322 • Intest Res 2016;14(4):322-332 331 www.irjournal.org larger than that of studies before 2010.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/ir-14-322.PMC5083261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.333Intest Res 2016;14(4):333-342ORIGINAL ARTICLE Thirty-day mortality after percutaneous gastrostomy by endoscopic versus radiologic placement: a systematic review and meta-analysis Joo Hyun Lim*, Seung Ho Choi*, Changhyun Lee, Ji Yeon Seo, Hae Yeon Kang, Jong In Yang, Su Jin Chung, Joo Sung Kim Department of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea Background/Aims: A percutaneous gastrostomy can be placed either endoscopically (percutaneous endoscopic gastros - tomy, PEG) or radiologically (radiologically-inserted gastrostomy, RIG).",Non-OADS,/arxiv_data1/oa_pdf/a4/58/ir-14-333.PMC5083262.pdf
"https://doi.org/10.5217/ir.2016.14.4.333 • Intest Res 2016;14(4):333-342 335 www.irjournal.org Identification828Records identified through database searching 3Cochrane librar y 196Medline 362Embase 267Scopus0Additional records identified through other sources 445Records afterduplicates removed 31Full-text articles assessed foreligibility414Records excluded 15Studies included in qualitative synthesis16Full-text articles excluded, with reasons 15Studies included in quantitative synthesis (meta-analysis)Screening Eligibility Included Fig.",OADS,/arxiv_data1/oa_pdf/a4/58/ir-14-333.PMC5083262.pdf
https://doi.org/10.5217/ir.2016.14.4.333 • Intest Res 2016;14(4):333-342 337 www.irjournal.org 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/58/ir-14-333.PMC5083262.pdf
"https://doi.org/10.5217/ir.2016.14.4.333 • Intest Res 2016;14(4):333-342 339 www.irjournal.org erogeneity, we next used a random effects model to perform  a pooled analysis of the ORs.",OADS,/arxiv_data1/oa_pdf/a4/58/ir-14-333.PMC5083262.pdf
https://doi.org/10.5217/ir.2016.14.4.333 • Intest Res 2016;14(4):333-342 341 www.irjournal.org laborating Center (SNUH MRCC) contributed to the statisti- cal analysis in this report.,OADS,/arxiv_data1/oa_pdf/a4/58/ir-14-333.PMC5083262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.343Intest Res 2016;14(4):343-350ORIGINAL ARTICLE Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial Vinay G Zanwar, Sunil V Pawar, Pravir A Gambhire, Samit S Jain, Ravindra G Surude, Vinaya B Shah,  Qais Q Contractor, Pravin M Rathi Department of Gastroenterology, Topiwala National Medical College & Bai Yamunabai Laxman Nair Ch Hospital, Mumbai, India Background/Aims: The existence of non-celiac gluten sensitivity has been debated.",Non-OADS,/arxiv_data1/oa_pdf/7c/c8/ir-14-343.PMC5083263.pdf
"https://doi.org/10.5217/ir.2016.14.4.343 • Intest Res 2016;14(4):343-350 345 www.irjournal.org free breads, each morning for the course of the rechallenge.",Non-OADS,/arxiv_data1/oa_pdf/7c/c8/ir-14-343.PMC5083263.pdf
"https://doi.org/10.5217/ir.2016.14.4.343 • Intest Res 2016;14(4):343-350 347 www.irjournal.org The placebo group also showed similar changes in the VAS  symptom scores over the study period; however, only the changes in abdominal pain and wind VAS scores after re-challenge remained significantly different following  post hoc   analysis ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/7c/c8/ir-14-343.PMC5083263.pdf
"https://doi.org/10.5217/ir.2016.14.4.343 • Intest Res 2016;14(4):343-350 349 www.irjournal.org and the presence of serum antinuclear antibodies, which, in  turn, were correlated with the HLA DQ2/DQ8 haplotypes.31  There is an urgent need for validated biomarker to diagnose the condition with acceptable sensitivity and specificity.",Non-OADS,/arxiv_data1/oa_pdf/7c/c8/ir-14-343.PMC5083263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.351Intest Res 2016;14(4):351-357ORIGINAL ARTICLE   A wide variation of the quality of colonoscopy reporting system in the real clinical practice in southeastern area of Korea Jung Min Lee1*, Yu Jin Kang1*, Eun Soo Kim2, Yoo Jin Lee1, K yung Sik Park1, Kwang Bum Cho1,   Seong Woo Jeon2, Min K yu Jung2, Hyun Seok Lee2, Eun Young Kim3, Jin Tae Jung3, Byung Ik Jang4,   K yeong Ok Kim4, Yun Jin Chung5, Chang Hun Yang6; Daegu-Gyeongbuk Gastrointestinal Study Group (DGSG) 1Division of Gastroenterology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, 2Division of Gastroenterology  and Hepatology, Department of Internal Medicine, K yungpook National University School of Medicine, Daegu, 3Division of Gastroenterology  and Hepatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, 4Division of Gastroenterology and  Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, 5Division of Gastroenterology, Department  of Internal Medicine, Fatima Hospital of Daegu, Daegu, 6Division of Gastroenterology and Hepatology, Department of Internal Medicine,  Dongguk University School of Medicine, Gyeongju, Korea Background/Aims: Establishment of a colonoscopy reporting system is a prerequisite to determining and improving quality.",Non-OADS,/arxiv_data1/oa_pdf/fc/c8/ir-14-351.PMC5083264.pdf
https://doi.org/10.5217/ir.2016.14.4.351 • Intest Res 2016;14(4):351-357 353 www.irjournal.org with interquartile ranges.,OADS,/arxiv_data1/oa_pdf/fc/c8/ir-14-351.PMC5083264.pdf
"https://doi.org/10.5217/ir.2016.14.4.351 • Intest Res 2016;14(4):351-357 355 www.irjournal.org DISCUSSION  The results of the present questionnaire-based study re- vealed broad variability in the quality of colonoscopy report - ing systems among physicians, thus reflecting the real-world  experience in a southeastern area of South Korea.",Non-OADS,/arxiv_data1/oa_pdf/fc/c8/ir-14-351.PMC5083264.pdf
https://doi.org/10.5217/ir.2016.14.4.351 • Intest Res 2016;14(4):351-357 357 www.irjournal.org 14.,Non-OADS,/arxiv_data1/oa_pdf/fc/c8/ir-14-351.PMC5083264.pdf
http://gie.or.kr/bbs/?code=file.,OADS,/arxiv_data1/oa_pdf/fc/c8/ir-14-351.PMC5083264.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.358Intest Res 2016;14(4):358-364ORIGINAL ARTICLE   The submucosal fibrosis: what does it mean for colorectal endoscopic submucosal dissection?",Non-OADS,/arxiv_data1/oa_pdf/bf/53/ir-14-358.PMC5083265.pdf
https://doi.org/10.5217/ir.2016.14.4.358 • Intest Res 2016;14(4):358-364 359 www.irjournal.org association of the presence of fibrosis with the outcome of  colorectal ESD.,Non-OADS,/arxiv_data1/oa_pdf/bf/53/ir-14-358.PMC5083265.pdf
https://doi.org/10.5217/ir.2016.14.4.358 • Intest Res 2016;14(4):358-364 361 www.irjournal.org resections.,Non-OADS,/arxiv_data1/oa_pdf/bf/53/ir-14-358.PMC5083265.pdf
https://doi.org/10.5217/ir.2016.14.4.358 • Intest Res 2016;14(4):358-364 363 www.irjournal.org submucosal fibrosis.,Non-OADS,/arxiv_data1/oa_pdf/bf/53/ir-14-358.PMC5083265.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.365Intest Res 2016;14(4):365-368CASE REPORT Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis  K Arivarasan, Vaishali Bhardwaj, Sukrit Sud, Sanjeev Sachdeva, Amarender Singh Puri Department of Gastroenterology, GB Pant Hospital, New Delhi, India Pyoderma gangrenosum (PG) is an uncommon extra-intestinal manifestation of inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/b7/06/ir-14-365.PMC5083266.pdf
"https://doi.org/10.5217/ir.2016.14.4.365 • Intest Res 2016;14(4):365-368 367 www.irjournal.org cm perforation was detected in the sigmoid colon, with mini- mal peritoneal soiling.",Non-OADS,/arxiv_data1/oa_pdf/b7/06/ir-14-365.PMC5083266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.369Intest Res 2016;14(4):369-374CASE REPORT Obstructive ileus caused by phlebosclerotic colitis Seung Hyun Lee, Jong Wook Kim, Se Jin Park, Ju Yeol Heo, Woo Hyun Paik, Won Ki Bae, Nam-Hoon Kim, K yung-Ah Kim, June Sung Lee Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea A 57-year-old man with chronic kidney disease and a history of using numerous herbal medications visited Inje University Il-san Paik Hospital for abdominal pain and vomiting.",Non-OADS,/arxiv_data1/oa_pdf/30/55/ir-14-369.PMC5083267.pdf
https://doi.org/10.5217/ir.2016.14.4.369 • Intest Res 2016;14(4):369-374 371 www.irjournal.org possible (Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/55/ir-14-369.PMC5083267.pdf
"https://doi.org/10.5217/ir.2016.14.4.369 • Intest Res 2016;14(4):369-374 373 www.irjournal.org fibrotic degeneration of the venous walls with calcifications,  and markedly fibrous thickening in the submucosa of the co-lonic wall without hemorrhage or thrombosis of the mesen-teric vein.",Non-OADS,/arxiv_data1/oa_pdf/30/55/ir-14-369.PMC5083267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.375Intest Res 2016;14(4):375-378CASE REPORT Sclerosing encapsulating peritonitis in a long-term propranolol user Se Hui Noh1*, Byong Duk Ye1,2, Hoonsub So1, Yu Seok Kim1*, Dong Jin Suh1*, Sang Nam Yoon3* 1Department of Gastroenterology, 2Inflammatory Bowel Disease Center, 3Department of Colon & Rectal Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Sclerosing encapsulating peritonitis (SEP) is a rare cause of bowel obstruction that is characterized by the encasement of the small bowel by a thick, whitish, and fibrous membrane.",Non-OADS,/arxiv_data1/oa_pdf/3f/69/ir-14-375.PMC5083268.pdf
"https://doi.org/10.5217/ir.2016.14.4.375 • Intest Res 2016;14(4):375-378 377 www.irjournal.org DISCUSSION SEP is a rare clinical entity that can cause acute, subacute,  or chronic small intestinal obstruction.",Non-OADS,/arxiv_data1/oa_pdf/3f/69/ir-14-375.PMC5083268.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.379Intest Res 2016;14(4):379-380IMAGES OF THE ISSUE Two hyperemic polypoid lesions in the colon Hyun Il Seo Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea Received September 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/eb/6b/ir-14-379.PMC5083269.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.231 Intest Res 2016;14(3):231-239 In this article, the third author’s name was spelled incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/37/ab/ir-14-381.PMC5083270.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 https://doi.org/10.5217/ir.2016.14.4.381Intest Res 2016;14(4):381ERRATUM Erratum: Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2 nd Asian Organization for Crohn’s and Colitis  (AOCC) meeting in Seoul Hiroshi Nakase1*, Bora Keum2*, Byong Duk Ye3, Soo Jung Park4, Hoon Sup Koo5, Chang Soo Eun6 1Department of Gastroenterology and Hepatology, Sapporo Medical University, School of Medicine, Sapporo, Japan, 2Department of Internal  Medicine, Korea University College of Medicine, Seoul, Korea, 3Department of Gastroenterology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, 5Department of  Internal Medicine, Konyang University College of Medicine, Daejeon, Korea, 6Department of Internal Medicine, Hanyang University Guri  Hosptial, Guri, Korea",Non-OADS,/arxiv_data1/oa_pdf/37/ab/ir-14-381.PMC5083270.pdf
"Female gender (HR, hazard ratio, 1.10, 95% CI, conﬁdence interval, 1.02–1.19, p=0.04) and the presence of chronic kidney disease (HR 1.47, 95% CI 1.16–1.86,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 41E6F0604FED8324 .",Non-OADS,/arxiv_data1/oa_pdf/bd/aa/12325_2016_Article_412.PMC5083763.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bd/aa/12325_2016_Article_412.PMC5083763.pdf
"Cardiovascular disease: risk assessment andreduction, including lipid modiﬁcation (CG 181).Clinical guideline, published: July 2014; updated: July 2016. http://www.nice.org.uk/guidance/cg181 .",Non-OADS,/arxiv_data1/oa_pdf/bd/aa/12325_2016_Article_412.PMC5083763.pdf
22.8% of placebo-treated patientsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D395F0600606EF5E .,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/12325_2016_Article_405.PMC5083764.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provideAdv Ther (2016) 33:2012–2031 2029",Non-OADS,/arxiv_data1/oa_pdf/c1/b3/12325_2016_Article_405.PMC5083764.pdf
Penthrox European Summary of Product Characteristics October 2015. http://www.mhra.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/12325_2016_Article_405.PMC5083764.pdf
2008. ftp://ftp.cordis.europa.eu/pub/ fp7/docs/ethical-considerations-paediatrics_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/12325_2016_Article_405.PMC5083764.pdf
"For 3 patients (0.8%), the chemotherapy was delayed following the ﬁrstEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ CAF6F0602B26798D .",Non-OADS,/arxiv_data1/oa_pdf/8a/7a/12325_2016_Article_419.PMC5083766.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8a/7a/12325_2016_Article_419.PMC5083766.pdf
Available: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/001142/WC500093661.pdf Date accessed 9/27/2016.,Non-OADS,/arxiv_data1/oa_pdf/8a/7a/12325_2016_Article_419.PMC5083766.pdf
This initialEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/9E76 F06048096649 .,Non-OADS,/arxiv_data1/oa_pdf/f8/ec/12325_2016_Article_406.PMC5083770.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Adv Ther (2016) 33:1947–1963 1961",Non-OADS,/arxiv_data1/oa_pdf/f8/ec/12325_2016_Article_406.PMC5083770.pdf
http://www.info.pmda.go .jp/go/pac k/2399402F10 26_1_37/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/ec/12325_2016_Article_406.PMC5083770.pdf
"June 2015 11th May, 2016]; http://www.info.pmda.go.jp/go/pack/ 3999426G1024_2_07/ .",Non-OADS,/arxiv_data1/oa_pdf/f8/ec/12325_2016_Article_406.PMC5083770.pdf
Compared to other participants healthcare policy makers gave greater importance to the economic impact related to oncology treatments.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 14E6F0601466A5CC .,Non-OADS,/arxiv_data1/oa_pdf/88/69/12325_2016_Article_415.PMC5083772.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/88/69/12325_2016_Article_415.PMC5083772.pdf
Available at http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/88/69/12325_2016_Article_415.PMC5083772.pdf
Keywords: Multiple myeloma; Oncology; Panobinostat; Relapsed; Relapsed and refractory INTRODUCTION Multiple myeloma (MM) is a hematologic disorder characterized by clonal proliferation of malignant plasma cells in the bone marrowEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A1E6F06042D48AA2 .,Non-OADS,/arxiv_data1/oa_pdf/82/b6/12325_2016_Article_413.PMC5083773.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/12325_2016_Article_413.PMC5083773.pdf
https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/82/b6/12325_2016_Article_413.PMC5083773.pdf
"However research on hip OA has generally languished behind knee OA-speciﬁc research, possibly owing to the even higher prevalence ofEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ DFD6F0602CC1D0AD .",Non-OADS,/arxiv_data1/oa_pdf/86/3f/12325_2016_Article_409.PMC5083776.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/86/3f/12325_2016_Article_409.PMC5083776.pdf
"This review explores the concepts related to appetite and reward-induced eating behavior, as well as the pharmacologicalEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 53E6F0606CEEE6CA .",Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
"T-P-3153, Available at http://2015.obesityweek.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
"T-P-3154, Available athttp://2015.obesityweek.com/app/uploads/2015/11/1104-Wednesday-ObesityWeek-2015-TOS-Poster- Abstracts.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
http://general.takedapharm.com/ content/ﬁle.aspx?ﬁletypecode=CONTRAVEPI&cac heRandomizer=eedcee06-8dad-4cf0-910b-06e1300 4a474 Accessed 17 Aug 2016.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/085128s065lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/12325_2016_Article_414.PMC5083777.pdf
Funding : Bristol-Myers Squibb.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ FED6F0607B3FA4B5 .,Non-OADS,/arxiv_data1/oa_pdf/9f/4e/12325_2016_Article_407.PMC5083780.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/9f/4e/12325_2016_Article_407.PMC5083780.pdf
A high safety proﬁle was observed.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0D07F0600A84C640 .,Non-OADS,/arxiv_data1/oa_pdf/b5/08/12325_2016_Article_420.PMC5083781.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b5/08/12325_2016_Article_420.PMC5083781.pdf
Red Book TM.http://micromedex.com/products/ product-suites/clinical-knowledge/redbook .,Non-OADS,/arxiv_data1/oa_pdf/b5/08/12325_2016_Article_420.PMC5083781.pdf
"We propose the following could contribute to erythema after application: (1) local inﬂammation and perivascular inﬂammatory cells with abnormally functioning ARs may lead to vasodilatation; (2) abnormal saturation and cells expressing different AR subtypes with varying ligand afﬁnity; (3) barrier dysfunction and increased skin concentrations of brimonidine with increased actions at endothelial and presynaptic receptors, resulting in increased vasodilation; and (4) genetic predispositionEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8295F060021A86F4 .",Non-OADS,/arxiv_data1/oa_pdf/1a/68/12325_2016_Article_404.PMC5083782.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1a/68/12325_2016_Article_404.PMC5083782.pdf
Systemic exposures [maximum drug concentration ( Cmax) and area under theEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A295F0600813A917 .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2014.http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2015/01/WC500180219.,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2015. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm 291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2009. http://www.who.int/biologicals/areas/ biological_therapeutics/BIOTHERAPEUTICS_FOR_ WEB_22APRIL2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
1998. http://www.fda.gov/downloads/drugs/development approvalprocess/howdrugsaredevelopedandapproved/approvalapplications/therape uticbiologicapplications/ ucm107706.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2011. http://www.mun.ca/pharmacy/ aboutpharmacy/REMICADEPME.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2015. http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/medicines/000240/human_ med_001023.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
http://www.fda.gov/downloads/drugs/ guidancecomplianceregulator yinformation/guidances/ ucm291134.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2012. http://www.ema.europa.eu/docs/en_ GB/document_library/Scientiﬁc_guideline/2012/06/WC500128686.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2011. http://grants.nih.gov/ grants/guide/notice-ﬁles/NOT-OD-12-025.html .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2011. http://www.ich.org/ﬁleadmin/ Public_Web_Site/ICH_Products/Guidelines/Safety/ S6_R1/Step4/S6_R1_Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
2013. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Public_assessment_report/human/002576/WC500151486.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/12325_2016_Article_403.PMC5083783.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Myeong Jun Song, MD, PhD,  Division  of Hepatology, Department of Internal Medicine, Daejeon St.  Mary’s Hospital, College of Medicine, The Catholic University  of Korea, Daeheung-ro 64, Jung-gu, Daejeon 34943,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/de/b0/WJG-22-8853.PMC5083790.pdf
"World J  Gastroenterol  2016; 22(40): 8853-8861  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 8853 .htm  DOI: EDITORIALSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8853 8853 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8853-8861  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/de/b0/WJG-22-8853.PMC5083790.pdf
"http://dx.doi.org/10.3748/wjg.v22.i40.8853 INTRODUCTION Hepatocellular carcinoma (HCC) is the most common  liver malignancy worldwide[1,2].",Non-OADS,/arxiv_data1/oa_pdf/de/b0/WJG-22-8853.PMC5083790.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/de/b0/WJG-22-8853.PMC5083790.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Kenya Kamimura, MD, PhD,  Division of  Gastroenterology and Hepatology, Graduate School of Medical  and Dental Sciences, Niigata University, 1-757 Asahimachido-ri,  Chuo-ku, Niigata 951-8510, Japan.",Non-OADS,/arxiv_data1/oa_pdf/bd/4c/WJG-22-8862.PMC5083791.pdf
"Key words:  Gene therapy; liver; Hydrodynamic gene  delivery; Non-viral; image-guidedTHERAPEUTICS ADVANCESSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8862 8862 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8862-8868  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bd/4c/WJG-22-8862.PMC5083791.pdf
World J  Gastroenterol  2016; 22(40): 8862-8868  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 8862 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i40.8862 INTRODUCTION The liver is the largest organ in the body and is the  center of numerous metabolic pathways.,Non-OADS,/arxiv_data1/oa_pdf/bd/4c/WJG-22-8862.PMC5083791.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/bd/4c/WJG-22-8862.PMC5083791.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Anna L Fracanzani, MD,  Unit of Internal  Medicine, Department of Pathophysiology and Transplantation,  Ca’ Granda IRCCS Foundation, Policlinico Hospital, University  of Milan, Via F. Sforza 35, 20122 Milan,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/13/28/WJG-22-8869.PMC5083792.pdf
"Moreover, such studies will help to  identify the timing of disease progression and damage, REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8869 8869 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8869-8882  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/13/28/WJG-22-8869.PMC5083792.pdf
World J Gastroenterol  2016; 22(40): 8869-8882  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i40/8869.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i40.8869 EVIDENCE OF CARDIOVASCULAR  DISEASE IN PATIENTS SUBMITTED TO  ORTHOTOPIC LIVER TRANSPLANTATION  Orthotopic liver transplantation (OLT) represents  the only therapy for several end stage liver diseases  of different etiology.,Non-OADS,/arxiv_data1/oa_pdf/13/28/WJG-22-8869.PMC5083792.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/13/28/WJG-22-8869.PMC5083792.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Katarzyna Guzinska-Ustymowicz,  MD, PhD, Assistant Professor,  Department of General  Pathomorphology, Medical University of Bialystok, ul.",Non-OADS,/arxiv_data1/oa_pdf/5f/a5/WJG-22-8883.PMC5083793.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8883 8883 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8883-8891  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5f/a5/WJG-22-8883.PMC5083793.pdf
World J Gastroenterol  2016; 22(40): 8883-8891   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i40/ 8883 .htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/5f/a5/WJG-22-8883.PMC5083793.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/5f/a5/WJG-22-8883.PMC5083793.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Dr. James WT Toh, BSc, MBBS  (UNSW), FRACS,  Department of Colorectal Surgery, Concord  Repatriation General Hospital, Hospital Rd, Concord, NSW  2139, Australia.",Non-OADS,/arxiv_data1/oa_pdf/91/ac/WJG-22-8892.PMC5083794.pdf
"Approximately 20 %-40% of CD patients will REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8892 8892 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8892-8904  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/91/ac/WJG-22-8892.PMC5083794.pdf
World J Gastroenterol  2016;  22(40): 8892-8904  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/91/ac/WJG-22-8892.PMC5083794.pdf
com/1007-9327/full/v22/i40/ 8892 .htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/ac/WJG-22-8892.PMC5083794.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/91/ac/WJG-22-8892.PMC5083794.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mei Zhang, MD, Chief Physician,  Professor,  Department of Gastroenterology, Xuanwu Hospital,  Capital Medical University No.",Non-OADS,/arxiv_data1/oa_pdf/b1/7e/WJG-22-8905.PMC5083795.pdf
wjgnet.com/1007-9327/full/v22/i40/8905.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/7e/WJG-22-8905.PMC5083795.pdf
"org/10.3748/wjg.v22.i40.8905MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8905 8905 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8905-8909  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b1/7e/WJG-22-8905.PMC5083795.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/b1/7e/WJG-22-8905.PMC5083795.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dimas Alexandre Kliemann, MD, PhD,  Hospital Nossa Senhora da Conceição - Serviço de Infectologia,  Av.",Non-OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
METHODS The sequences were downloaded from the euHCVdb  (https://euhcvdb.ibcp.fr/euHCVdb /).,OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
"The search was  performed for full-length NS3 protease, NS5A and NS5B  polymerase sequences of HCV, separated by genotypes  1a, 1b, 2a, 2b and 3a, and resulted in 798 NS3, 708  NS5A and 535 NS5B sequences from HCV genotypes  8910 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Polymorphisms and resistance mutations of hepatitis  C virus on sequences in the European hepatitis C virus  databaseBasic Study Dimas Alexandre Kliemann, Cristiane Valle Tovo, Ana Beatriz Gorini da Veiga, Angelo Alves de Mattos,  Charles WoodSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8910World J Gastroenterol   2016 October 28; 22(40): 8910-8917  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
World  J Gastroenterol  2016; 22(40): 8910-8917  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 8910 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i40.8910 INTRODUCTION Chronic hepatitis C virus (HCV) infection affects around  180 million people worldwide and is a significant cause  of liver-related morbidity and mortality[1] until recently.,Non-OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
"Three HCV databases are currently  available to provide insight into the basic biology,  immunology, and evolution of the virus: the Japanese  database (http://s2as02.genes.nig.ac.jp), the  European database (http://euhcvdb.ibcp.fr) and the  American database (Los Alamos National Laboratory)  (http://hcv.lanl.go v).",Non-OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
MATERIALS AND METHODS HCV database The sequences were downloaded from the euHCVdb  (https://euhcvdb.ibcp.fr/euHCVdb /).,OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/55/de/WJG-22-8910.PMC5083796.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Josieli Raskopf Colares, MD,  Cellular  Biology and Molecular Applied to Health, Laboratory of  Oxidative Stress and Antioxidants, Universidade Luterana do  Brasil, Avenida Farroupilha 8001, Canoas 92425-900, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJG-22-8918.PMC5083797.pdf
"METHODS Male Wistar rats ( n = 32, weight ± 300 g) were  8918 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Antioxidant and anti-inflammatory action of melatonin in an  experimental model of secondary biliary cirrhosis induced  by bile duct ligationBasic Study Josieli Raskopf Colares, Elizângela Gonçalves Schemitt, Renata Minuzzo Hartmann, Francielli Licks, Mariana  do Couto Soares, Adriane Dal Bosco, Norma Possa MarroniSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8918World J Gastroenterol   2016 October 28; 22(40): 8918-8928  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJG-22-8918.PMC5083797.pdf
wjgnet.com/1007-9327/full/v22/i40/8918.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJG-22-8918.PMC5083797.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJG-22-8918.PMC5083797.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Gang Liu, MD, PhD,  Department of  General Surgery, Tianjin Medical University General Hospital,  Tianjin 300052, China.",Non-OADS,/arxiv_data1/oa_pdf/50/f1/WJG-22-8929.PMC5083798.pdf
"In addition, the proportion of the  dominant microbiota, which was negatively correlated  with the disease activity of UC ( r = -6.591, P < 0.01),  8929 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Fecal microbiota in pouchitis and ulcerative colitisBasic Study Kai-Yu Li, Jian-Lin Wang, Jiang-Peng Wei, Sen-Yang Gao, Ying-Ying Zhang, Li-Tian Wang, Gang LiuSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8929World J Gastroenterol   2016 October 28; 22(40): 8929-8939  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/50/f1/WJG-22-8929.PMC5083798.pdf
World J  Gastroenterol  2016; 22(40): 8929-8939  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 8929 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i40.8929 INTRODUCTION One of the most common complications in ulcerative  colitis (UC) patients who undergo ileal pouch-anal  anastomosis (IPAA) surgery is pouchitis[1].,Non-OADS,/arxiv_data1/oa_pdf/50/f1/WJG-22-8929.PMC5083798.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/50/f1/WJG-22-8929.PMC5083798.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Wataru Gonoi, MD, PhD,  Department  of Radiology, Graduate School of Medicine, The University of  Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/WJG-22-8940.PMC5083799.pdf
"RESULTS Compared with the community group [5/587 (0.85%)],  patients with recurrent acute pancreatitis had a  significantly higher frequency of ansa pancreatica [2/18  8940 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Ansa pancreatica as a predisposing factor for recurrent  acute pancreatitisRetrospective Study Takana Yamakawa Hayashi, Wataru Gonoi, Takeharu Yoshikawa, Naoto Hayashi, Kuni OhtomoSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8940World J Gastroenterol   2016 October 28; 22(40): 8940-8948  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6a/17/WJG-22-8940.PMC5083799.pdf
World J Gastroenterol  2016; 22(40): 8940-8948   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i40/8940.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/WJG-22-8940.PMC5083799.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/6a/17/WJG-22-8940.PMC5083799.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Akihiro Nishie, MD, PhD,  Department  of Clinical Radiology, Graduate School of Medical Sciences,  Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka  812-8582, Japan.",Non-OADS,/arxiv_data1/oa_pdf/64/a3/WJG-22-8949.PMC5083800.pdf
"anishie@radiol.med.kyushu-u.ac.j p Telephone:  +81-92-6425695 Fax:  +81-92-6425708 Received:  June 24, 2016 Peer-review started:  June 28, 2016 First decision:  August 22, 2016 Revised:  September 2, 2016 Accepted:  September 28, 2016 8949 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Fibrosis in nonalcoholic fatty liver disease: Noninvasive  assessment using computed tomography volumetryRetrospective Study Nobuhiro Fujita, Akihiro Nishie, Yoshiki Asayama, Kousei Ishigami, Yasuhiro Ushijima, Yukihisa Takayama,  Daisuke Okamoto, Ken Shirabe, Tomoharu Yoshizumi, Kazuhiro Kotoh, Norihiro Furusyo, Tomoyuki Hida,  Yoshinao Oda, Taisuke Fujioka, Hiroshi HondaSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8949World J Gastroenterol   2016 October 28; 22(40): 8949-8955  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/64/a3/WJG-22-8949.PMC5083800.pdf
World J Gastroenterol  2016;  22(40): 8949-8955  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/64/a3/WJG-22-8949.PMC5083800.pdf
com/1007-9327/full/v22/i40/8949.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/a3/WJG-22-8949.PMC5083800.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/64/a3/WJG-22-8949.PMC5083800.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to: Banumathi Ramakrishna, MD, MAMS,  Former Professor and Head,  Department of Pathology,  Christian Medical College, Vellore 632004, Tamil Nadu,  India.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/WJG-22-8956.PMC5083801.pdf
"8956 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Neuroendocrine neoplasms of liver - A 5-year retrospective  clinico-pathological study applying World Health  Organization 2010 classificationRetrospective Study Deepak Kalyansingh Burad, Thomas Alex Kodiatte, Sayd Mohamed Rajeeb, Ashish Goel, Chundamannil  Eapen Eapen, Banumathi RamakrishnaSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8956World J Gastroenterol   2016 October 28; 22(40): 8956-8966  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/WJG-22-8956.PMC5083801.pdf
World J Gastroenterol  2016;  22(40): 8956-8966  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/cf/ab/WJG-22-8956.PMC5083801.pdf
"com/1007-9327/full/v22/i40/8956.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i40.8956 INTRODUCTION Neuroendocrine neoplasms (NEN) are tumors arising  from the neuroendocrine cells which are distributed  throughout the body[1,2].",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/WJG-22-8956.PMC5083801.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/WJG-22-8956.PMC5083801.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Takahiro Yamasaki, MD, PhD,  Department  of Oncology and Laboratory Medicine, Yamaguchi University  Graduate School of Medicine, 1-1-1 Minami Kogushi, Ube,  Yamaguchi 755-8505, Japan.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/WJG-22-8967.PMC5083802.pdf
"t.yama@yamaguchi-u.ac.j p Telephone:  +81-836-222336 Fax:  +81-836-222338 Received:  June 28, 2016 Peer-review started:  June 29, 2016 First decision: August 19, 2016 Revised:  September 6, 2016 Accepted:  September 28, 2016 Article in press:  September 28, 2016 Published online: October 28, 2016 8967 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Effects of an oral iron chelator, deferasirox, on advanced  hepatocellular carcinomaClinical Trials Study Issei Saeki, Naoki Yamamoto, Takahiro Yamasaki, Taro Takami, Masaki Maeda, Koichi Fujisawa, Takuya  Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Koichi Uchida, Kenji Tani, Isao SakaidaSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8967World J Gastroenterol   2016 October 28; 22(40): 8967-8977  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ca/11/WJG-22-8967.PMC5083802.pdf
wjgnet.com/1007-9327/full/v22/i40/8967.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/11/WJG-22-8967.PMC5083802.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/ca/11/WJG-22-8967.PMC5083802.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ 8978 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Factors affecting the quality of life of patients after  gastrectomy as assessed using the newly developed  PGSAS-45 scale: A nationwide multi-institutional studyObservational StudySubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8978World J Gastroenterol   2016 October 28; 22(40): 8978-8990  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/34/2b/WJG-22-8978.PMC5083803.pdf
World  J Gastroenterol  2016; 22(40): 8978-8990  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 8978 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i40.8978 INTRODUCTION Gastrectomy is widely used as an effective curative  treatment modality in patients with gastric cancer.,Non-OADS,/arxiv_data1/oa_pdf/34/2b/WJG-22-8978.PMC5083803.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/34/2b/WJG-22-8978.PMC5083803.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sandro Passaretti, MD,  Gastroenterology  and Gastrointestinal Endoscopy Division, IRCCS San Raffaele  Scientific Institute, via Olgettina 60, 20132 Milan,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/69/3f/WJG-22-8991.PMC5083804.pdf
"Significant differences were found in the  median upper esophageal sphincter resting pressure  8991 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comORIGINAL ARTICLE Oropharyngeal acid reflux and motility abnormalities of the  proximal esophagusProspective Study Sandro Passaretti, Giorgia Mazzoleni, Cristian Vailati, Pier Alberto TestoniSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8991World J Gastroenterol   2016 October 28; 22(40): 8991-8998  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/69/3f/WJG-22-8991.PMC5083804.pdf
"World J Gastroenterol  2016; 22(40): 8991-8998  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i40/ 8991 .htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i40.8991 INTRODUCTION Gastro-esophageal reflux disease (GERD) is very  common in Western countries, with a prevalence of  typical manifestations of 10%-20%[1].",Non-OADS,/arxiv_data1/oa_pdf/69/3f/WJG-22-8991.PMC5083804.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/69/3f/WJG-22-8991.PMC5083804.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ahilan Arulanandan, MD,  Division of  Gastroenterology, University of California San Diego, 9500  Gilman Drive, La Jolla, CA 92037,  United States.",Non-OADS,/arxiv_data1/oa_pdf/d2/c6/WJG-22-8999.PMC5083805.pdf
"Eighty-six percent SYSTEMATIC REVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.8999 8999 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 8999-9011  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d2/c6/WJG-22-8999.PMC5083805.pdf
World J Gastroenterol  2016; 22(40): 8999 ­9011   Available from: URL: http://www.wjgnet.com/1007 ­9327/full/ v22/i40/8999.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/d2/c6/WJG-22-8999.PMC5083805.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/d2/c6/WJG-22-8999.PMC5083805.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Berrie Meijer, MD,  Department of  Gastroenterology and Hepatology, VU University Medical  Center, De Boelelaan 1118, 1081 HV Amsterdam,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/ba/2c/WJG-22-9012.PMC5083806.pdf
"Eight studies were conducted in a prospective SYSTEMATIC REVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.9012 9012 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 9012-9021  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ba/2c/WJG-22-9012.PMC5083806.pdf
World J Gastroenterol  2016;  22(40): 9012-9021  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/WJG-22-9012.PMC5083806.pdf
com/1007-9327/full/v22/i40/ 9012 .htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/WJG-22-9012.PMC5083806.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/ba/2c/WJG-22-9012.PMC5083806.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Toshio Kuwai, MD, PhD,  Department of  Gastroenterology, National Hospital Organization Kure Medical  Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure  737-0023, Japan.",Non-OADS,/arxiv_data1/oa_pdf/67/37/WJG-22-9022.PMC5083807.pdf
"kuwait@kure-nh.go.j p Telephone:  +81-823-223111  Fax:  +81-823-210478 Received:  May 16, 2016CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.9022 9022 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 9022-9027  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/67/37/WJG-22-9022.PMC5083807.pdf
World J Gastroenterol  2016;  22(40): 9022-9027  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/67/37/WJG-22-9022.PMC5083807.pdf
com/1007-9327/full/v22/i40/9022.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/37/WJG-22-9022.PMC5083807.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/67/37/WJG-22-9022.PMC5083807.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Tetsuya Ueo, MD, PhD,  Department  of Gastroenterology, Oita Red Cross Hospital, 3 Chome-2-37  Chiyomachi, Oita, Oita Prefecture 870-0033,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/4a/84/WJG-22-9028.PMC5083808.pdf
"Endoscopic examination revealed a small reddish CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.9028 9028 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 9028-9034  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/4a/84/WJG-22-9028.PMC5083808.pdf
World J  Gastroenterol  2016; 22(40): 9028-9034  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i40/ 9028 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i40.9028 INTRODUCTION Gastric fundic gland polyps (FGPs) are the most  common non-adenomatous gastric polyps composed  of cystically dilated fundic glands beneath a normal  gastric foveolar epithelium without Helicobacter pylori  (H. pylori ) infection and atrophic gastritis[1].,Non-OADS,/arxiv_data1/oa_pdf/4a/84/WJG-22-9028.PMC5083808.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/4a/84/WJG-22-9028.PMC5083808.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Hidenori Ojima, MD, PhD,  Division of  Molecular Pathology, National Cancer Center Research Institute,  5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/ad/77/WJG-22-9035.PMC5083809.pdf
"Core tip:  Although the need for developing novel LETTERS TO THE EDITORSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i40.9035 9035 October 28, 2016 |Volume 22 |Issue 40 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 28; 22(40): 9035-9038  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ad/77/WJG-22-9035.PMC5083809.pdf
World J Gastroenterol  2016;  22(40): 9035-9038  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/ad/77/WJG-22-9035.PMC5083809.pdf
com/1007-9327/full/v22/i40/ 9035 .htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/77/WJG-22-9035.PMC5083809.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   0",Non-OADS,/arxiv_data1/oa_pdf/ad/77/WJG-22-9035.PMC5083809.pdf
"2016 Oct;46(5):291-302 https://doi.org/10.5051/jpis.2016.46.5.291 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Mar 9, 2016 Accepted:  Jul 13, 2016 *Correspondence to Valérie Orti Laboratory of Bioengineering and  Nanoscience, EA4203, University of  Montpellier, 545 Avenue du Professeur Jean- Louis Viala, Montpellier Cedex 34193, France.",Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
"ORCID Valérie Orti http://orcid.org/0000-0002-7901-9227 Philippe Bousquet http://orcid.org/0000-0002-4444-2703 Paul Tramini http://orcid.org/0000-0002-8227-9150 Cesar Gaitan http://orcid.org/0000-0001-6452-2578 Brenda Mertens http://orcid.org/0000-0002-3649-4351 Frédéric Cuisinier http://orcid.org/0000-0001-6870-0490 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Valérie Orti,1,2,* Philippe Bousquet,1,2 Paul Tramini,2 Cesar Gaitan,3  Brenda Mertens,1 Frédéric Cuisinier1,2 1Department of Periodontology, Montpellier University Hospital, Montpellier, France 2Laboratory of Bioengineering and Nanoscience, University of Montpellier, Montpellier, France 3Department of Stomatology, Centro Ciencias de la Salud, Universidad Autónoma, Aguascalientes, MexicoBenefits of mineralized bone cortical  allograft for immediate implant  placement in extraction sites: an in  vivo  study in dogs 291 http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
Mineralized bone cortical allograft particles treated with Tutoplast®  https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 292 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 293 http://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 294 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 295 http://jpis.org A B CTi TiTi /two.LP/zero.LP/zero.LP µm /two.LP/zero.LP/zero.LP µm /two.LP/zero.LP/zero.LP µmFigure 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 296 http://jpis.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 297 http://jpis.org A B CTiTi Ti /two.LP/zero.LP/zero.LP µm /two.LP/zero.LP/zero.LP µm /two.LP/zero.LP/zero.LP µmAFigure 4.,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 298 http://jpis.org A BABBCD 30 20 1030 20 10LI Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 299 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 300 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
PUBMED https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 301 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
PUBMED https://doi.org/10.5051/jpis.2016.46.5.291Bone allograft for immediate post-extraction implant 302 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4f/72/jpis-46-291.PMC5083813.pdf
"2016 Oct;46(5):303-319 https://doi.org/10.5051/jpis.2016.46.5.303 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 29, 2016 Accepted:  Jul 28, 2016 *Correspondence to Marco Montevecchi Division of Periodontology and Implantology,  Department of Biomedical and Neuromotor  Sciences, Alma Mater Studiorum, University of  Bologna School of Dentistry, Via San Vitale 59,  Bologna 40100, Italy.",Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
"ORCID Marco Montevecchi http://orcid.org/0000-0001-7312-802X Annapaola Parrilli http://orcid.org/0000-0003-0251-5094 Milena Fini http://orcid.org/0000-0002-3732-3570 Maria Rosaria Gatto http://orcid.org/0000-0003-0216-9056 Aurelio Muttini http://orcid.org/0000-0002-2133-4144 Luigi Checchi http://orcid.org/0000-0002-2578-3983Marco Montevecchi,1,* Annapaola Parrilli,2 Milena Fini,3 Maria Rosaria Gatto,1  Aurelio Muttini,4 Luigi Checchi1 1 Division of Periodontology and Implantology, Department of Biomedical and Neuromotor Sciences, Alma  Mater Studiorum, University of Bologna School of Dentistry, Bologna, Italy 2BITTA Laboratory, Rizzoli Orthopaedic Institute, Bologna, Italy 3Preclinical and Surgical Studies Laboratory, Rizzoli Orthopaedic Institute, Bologna, Italy 4Faculty of Veterinary Medicine, Teramo University, Teramo, ItalyThe influence of root surface distance  to alveolar bone and periodontal  ligament on periodontal wound  healing http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
304 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.orgConflict of Interest No potential conflict of interest relevant to this  article was reported.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
Analgesic/anti-inflammatory therapy  305 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
306 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org /two.LP mm h Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
307 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
308 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org% A/one.LP A/two.LPBV/TV tot Tb.Th tot A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP01030507080 0204060 mm 0.050.100.150.200.30 0.25mm/hyphen.cap/one.LP A/one.LP A/two.LPTb.N tot Tb.Sp tot A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP012345 mm 00.10.20.30.40.5 control h=/three.LP h=/five.LP h=/seven.LP h=/nine.LP h=/one.LP/one.LPB A D C Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
309 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org % A/one.LP A/two.LPBV/TV coronal third Tb.Th coronal third A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP01030507080 0204060 mm 0.050.100.150.200.30 0.25mm/hyphen.cap/one.LP A/one.LP A/two.LPTb.N coronal third Tb.Sp coronal third A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP012345 mm 00.10.20.30.40.5B A D C control h=/three.LP h=/five.LP h=/seven.LP h=/nine.LP h=/one.LP/one.LP Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
For  310 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
311 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org /zero.LP µm /two.LP/five.LP/zero.LP µm A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LPA/one.LP A/two.LP A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LPh=/three.LP h=/seven.LP h=/one.LP/one.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LPcontrol A B D  A/one.LP A/two.LP A/three.LP A/four.LP A/five.LPh=/five.LP C A/one.LP A/two.LP A/three.LP A/four.LP A/five.LP A/one.LP A/two.LP A/three.LP A/four.LP A/five.LPh=/nine.LP EF Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
312 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.orgBmm/two.LP h=/three.LPBRC tot RR tot h=/five.LP h=/nine.LP h=/one.LP/one.LP0246810 h=/seven.LP A mm/three.LP control h=/three.LP h=/five.LP h=/nine.LP h=/one.LP/one.LP00.20.40.60.81.0 h=/seven.LP control Cmm/two.LP control h=/three.LPBRC coronal third RR coronal third h=/five.LP h=/nine.LP h=/one.LP/one.LP0246810 h=/seven.LP mm/three.LP control h=/three.LP h=/five.LP h=/nine.LP h=/one.LP/one.LP00.20.40.60.81.0 h=/seven.LP Fmm/two.LP control h=/three.LPBRC medial third RR medial third h=/five.LP h=/nine.LP h=/one.LP/one.LP0246810 h=/seven.LP mm/three.LP control h=/three.LP h=/five.LP h=/nine.LP h=/one.LP/one.LP00.20.40.60.81.0 h=/seven.LP G Dmm/two.LP control h=/three.LPBRC apical third RR apical third h=/five.LP h=/nine.LP h=/one.LP/one.LP0246810 h=/seven.LP mm/three.LP control h=/three.LP h=/five.LP h=/nine.LP h=/one.LP/one.LP00.20.40.60.81.0 h=/seven.LP H E Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
313 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.orgh=/three.LP h=/five.LP h=/nine.LP h=/one.LP/one.LPh=/seven.LPcontrol  B A D E FC /one.LP mm/one.LP mm /one.LP mm/one.LP mm /one.LP mm/one.LP mm Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
314 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
Another relevant advantage of this non-destructive examination method  315 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
316 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
PUBMED  | CROSSREF 317 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
Available from: http://altweb.jhsph.edu/pubs/books/ humane_exp/het-toc.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
PUBMED  | CROSSREF 318 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
PUBMED  | CROSSREF 319 https://doi.org/10.5051/jpis.2016.46.5.303Root surface distance affects periodontal wound healing http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpis-46-303.PMC5083814.pdf
"2016 Oct;46(5):320-328 https://doi.org/10.5051/jpis.2016.46.5.320 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Mar 18, 2016 Accepted:  Aug 18, 2016 *Correspondence to Sang Wook Oh Department of Biology Education, Institute of  Fusion Science, Chonbuk National University,  Backjedae-ro 567, Deokjin-gu, Jeonju 54907,  Korea.",OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
"ORCID Seok-Mo Heo http://orcid.org/0000-0002-2511-8123 Sol Lee http://orcid.org/0000-0003-0452-9625 HongTao Wang http://orcid.org/0000-0001-9030-3715 Jeong Hyeok Jeong http://orcid.org/0000-0002-5543-7600 Sang Wook Oh http://orcid.org/0000-0002-3919-8769 Funding This research was supported by Ministry of  Trade, Industry and Energy (10047748).",Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
"Conflict of Interest No potential conflict of interest relevant to this  article was reported.Seok-Mo Heo,1,5 Sol Lee,1,5 HongTao Wang,2 Jeong Hyeok Jeong,3 Sang Wook Oh4,* 1Department of Periodontology, Chonbuk National University School of Dentistry, Jeonju, Korea 2Boditech (Qingdao) Biotechnology Co., LTD, Qingdao, China 3BoditechMed Inc., Chuncheon, Korea 4Department of Biology Education, Institute of Fusion Science, Chonbuk National University, Jeonju, Korea 5 Research Institute of Clinical Medicine of Chonbuk National University, Biomedical Research Institute of  Chonbuk National University Hospital, Jeonju, KoreaLevels of common salivary protein 1  in healthy subjects and periodontal  patients 320 http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 321 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 322 http://jpis.org CSP/one.LP by ELISA (/three.LP times) Assessed for eligibility (n=/one.LP/zero.LP/six.LP) Excluded (n=/three.LP/seven.LP)    Not meeting inclusion criteria (n=/three.LP/seven.LP) Allocation Healthy group  Periodontal group Analyzed (n=/three.LP/six.LP)  Analyzed (n=/three.LP/three.LP)Enrollment AnalysisFigure 1.,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 323 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
The median values (25th to 75th percentiles) of the  https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 324 http://jpis.org MkDa /seven.LP/zero.LP /five.LP/zero.LP CSP/one.LP/three.LP/zero.LP /two.LP/five.LP /two.LP/zero.LP/two.LP /one.LP /one.LP /two.LP CB WB Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
"https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 325 http://jpis.orgHealthy group Periodontal groupSaliva CSP/one.LP level (ng/mL) 4,0006,0008,00010,00012,00014,000 Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
Our findings may suggest that CSP1 could  https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 326 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 327 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2016.46.5.320Higher level of salivary CSP1 in periodontitis patients 328 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/82/8c/jpis-46-320.PMC5083815.pdf
"2016 Oct;46(5):329-336 https://doi.org/10.5051/jpis.2016.46.5.329 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Jun 14, 2016 Accepted:  Aug 16, 2016 *Correspondence to Hyun-Seung Shin Department of Periodontology, Dankook  University College of Dentistry, 119 Dandae-ro,  Dongnam-gu, Cheonan 31116, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
ORCID Chang-Soon Kim http://orcid.org/0000-0001-7348-6003 Hieu Pham Duong http://orcid.org/0000-0001-5409-0361 Jung-Chul Park http://orcid.org/0000-0002-2041-8047 Hyun-Seung Shin http://orcid.org/0000-0002-1410-9731 Funding The present research was conducted with  the use of a research fund from Dankook  University in 2013 (R-0001-18842).,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
"Conflict of Interest No potential conflict of interest relevant to this  article was reported.Chang-Soon Kim,1 Hieu Pham Duong,2 Jung-Chul Park,1 Hyun-Seung Shin1,* 1Department of Periodontology, Dankook University College of Dentistry, Cheonan, Korea 2 Department of Maxilo-Stomatology, Vietnam National University School of Medicine and Pharmacy, Hanoi,  VietnamPreservation of keratinized mucosa  around implants using a prefabricated  implant-retained stent: a case-control  study http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
330 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.org Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
331 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
"At baseline, the mean width of the keratinized mucosa around the healing  332 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.org A B C Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
333 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
"In contrast, the  utilization of stents has the following benefits [ 14]: 1) the flap can be displaced in the bucco- apical direction with the existing keratinized mucosa, securing its position ( Figure 4 ); 2) the flap  334 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.org A B  Prefabricated implant-retained stent Horizontal external sutureFigure 4.",Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
PUBMED  | CROSSREF 335 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
PUBMED  | CROSSREF 336 https://doi.org/10.5051/jpis.2016.46.5.329Preservation of keratinized mucosa around implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/jpis-46-329.PMC5083816.pdf
"2016 Oct;46(5):337-349 https://doi.org/10.5051/jpis.2016.46.5.337 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Jun 17, 2016 Accepted:  Sep 1, 2016 *Correspondence to Young-Kyun Kim Department of Oral and Maxillofacial Surgery,  Section of Dentistry, Seoul National University  Bundang Hospital, 82 Gumi-ro 173-beon-gil,  Bundang-gu, Seongnam 13620, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"ORCID Hyun-Suk Kim http://orcid.org/0000-0001-7010-4153 Pil-Young Yun http://orcid.org/0000-0001-6097-1229 Young-Kyun Kim http://orcid.org/0000-0002-7268-3870 Funding This study was partially supported by Osstem  Implant Co. (Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"Conflict of Interest No potential conflict of interest relevant to this  article was reported.Hyun-Suk Kim,1 Pil-Young Yun,1 Young-Kyun Kim1,2,* 1 Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang  Hospital, Seongnam, Korea 2 Department of Dentistry and Dental Research Institute, Seoul National University School of Dentistry,  Seoul, KoreaRandomized controlled clinical trial  of 2 types of hydroxyapatite-coated  implants on moderate periodontitis  patients http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
338 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
The severity  339 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
340 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"For both  linear and dimensional accuracy of the intraoral radiographs, the paralleling technique  341 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org A B/one.LP mm /one.LP mmFigure 1.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"Satisfaction levels  were rated on an 11-point scale, where 10 was the most positive response (completely satisfied)  342 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org A B Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"The differences were also not statistically  significant between the MBL of the maxilla (group I, 0.31±0.33 mm; group II, 0.41±0.67 mm;  343 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.orgTable 3.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"344 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org /seven.LP/five.LP participants screened for eligibility /six.LP/four.LP participants randomized (group I: /three.LP/two.LP , group II: /three.LP/two.LP) /five.LP/three.LP patients underwent implant surgery; RFA, periapical radiograph (/seven.LP/one.LP implants; group I: /three.LP/six.LP , group II: /three.LP/five.LP) At /six.LP weeks (mandible) or /one.LP/two.LP weeks (maxilla): ﬁnal prosthesis seated, RFA, periapical radiograph At /one.LP/two.LP months: periapical radiograph, occlusion check, soft tissue indices check Group I: Osstem TS III, partially HA-coated Group II: Osstem TS III, fully HA-coated /four.LP/four.LP patients with /six.LP/two.LP implants remained for analysis Group I (/two.LP/one.LP patients, 30 implants [maxilla: /one.LP/five.LP , mandible: /one.LP/five.LP]) Group II (/two.LP/three.LP patients, 32 implants [maxilla: /one.LP/nine.LP, mandible: /one.LP/three.LP]) /one.LP/one.LP subjects excluded:    Consent withdrawn (group I: /five.LP , group II: /four.LP)    Out of contact (group II: /two.LP) /one.LP/one.LP subjects excluded:    No consent form (n=/one.LP)   Not suﬃcient residual alveolar bones (n=/one.LP)   No evidence of moderate periodontitis (n=/nine.LP) /one.LP patient dropped out:    Unspeciﬁed pain (group II: /one.LP/parenright.cap /eight.LP patients dropped out:    ISQ /less.cap/five.LP/zero.LP: (group I: /four.LP , group II: /two.LP)    Poor bone quality (group I: /one.LP)   Sinus perforation (group I: /one.LP)Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
345 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.orgTable 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
346 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
CROSSREF 347 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
PUBMED  | CROSSREF 348 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
PUBMED  | CROSSREF 349 https://doi.org/10.5051/jpis.2016.46.5.337Two types of HA-coated implants http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/c7/58/jpis-46-337.PMC5083817.pdf
"2016 Oct;46(5):350-359 https://doi.org/10.5051/jpis.2016.46.5.350 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Jul 8, 2016 Accepted:  Aug 25, 2016 *Correspondence to Kyoo-Sung Cho Department of Periodontology, Research  Institute for Periodontal Regeneration, Yonsei  University College of Dentistry, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
"ORCID Jae-Shin Kim http://orcid.org/0000-0002-2238-2965 Jae-Kook Cha http://orcid.org/0000-0002-6906-7209 Jung-Seok Lee http://orcid.org/0000-0003-1276-5978 Seong-Ho Choi http://orcid.org/0000-0001-6704-6124 Kyoo-Sung Cho http://orcid.org/0000-0002-6777-5287Jae-Shin Kim,† Jae-Kook Cha,† Jung-Seok Lee, Seong-Ho Choi, Kyoo-Sung Cho* Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College  of Dentistry, Seoul, KoreaIncreased osteoinductivity  and mineralization by minimal  concentration of bone morphogenetic  protein-2 loaded onto biphasic  calcium phosphate in a rabbit sinus http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
The required sample size per group was 6;  351 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.orgFunding This study was supported by a faculty  research grant of Yonsei University College of  Dentistry for 2014 (6-2014-0084).,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
352 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org A B Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
Despite the occurrence  353 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
Although the concentration of BMP-2 used in the present study was only half of the  354 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
355 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org A B D EC F/one.LP mm /one.LP mm RP RP /one.LP/zero.LP/zero.LP µm FV RPRPNBFVRP NB /one.LP/zero.LP/zero.LP µm RP SMNB RP SMNB/one.LP/zero.LP/zero.LP µm/one.LP/zero.LP/zero.LP µm Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
356 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.orgControl group BMP group0%20%40%60%80%100% FV RP NB** Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
"Moreover, in the present study, the hypothetical concentration  357 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
PUBMED  | CROSSREF 358 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
PUBMED  | CROSSREF 359 https://doi.org/10.5051/jpis.2016.46.5.350Increased bone maturation by BMP-2 http://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/f2/35/jpis-46-350.PMC5083818.pdf
2015 Dec;45(6):238-246.  https://doi.org/10.5051/jpis.2015.45.6.238 The authors recently found a mistake in their previously published article and sincerely regret  these errors.,Non-OADS,/arxiv_data1/oa_pdf/04/af/jpis-46-360.PMC5083819.pdf
"2016 Oct;46(5):360 https://doi.org/10.5051/jpis.2016.46.5.360 pISSN 2093-2278·eISSN 2093-2286 Erratum Correspondence to Ui-Won Jung Department of Periodontology, College of  Dentistry, Yonsei University, 50-1, Yonsei-ro,  Seodaemoon-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/04/af/jpis-46-360.PMC5083819.pdf
"ORCID Won-Sun Baek http://orcid.org/0000-0002-3427-4101 So-Ra Yoon http://orcid.org/0000-0003-2474-9828 Hyun-Chang Lim http://orcid.org/0000-0001-7695-1708 Jung-Seok Lee http://orcid.org/0000-0003-1276-5978 Seong-Ho Choi http://orcid.org/0000-0001-6704-6124 Ui-Won Jung http://orcid.org/0000-0001-6371-4172Won-Sun Baek,1 So-Ra Yoon,1 Hyun-Chang Lim,2 Jung-Seok Lee,1 Seong-Ho Choi,1  Ui-Won Jung1 1 Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College  of Dentistry, Seoul, Korea 2Department of Periodontology, Kyung Hee University School of Dentistry, Seoul, KoreaErratum: Body text Bone formation around rhBMP-2- coated implants in rabbit sinuses  with or without absorbable collagen  sponge grafting 360  http://jpis.org►  This corrects the article “ Bone formation around rhBMP-2-coated implants in rabbit sinuses with  or without absorbable collagen sponge grafting ” in volume 45 on page 238.",Non-OADS,/arxiv_data1/oa_pdf/04/af/jpis-46-360.PMC5083819.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Editorial http://dx.doi.org/10.5213/inj.1620edi005 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNALInt Neurourol J 2016;20:169-170 The Potential Application of Virtual, Augmented, and Mixed  Reality in Neurourology Khae Hawn Kim      http://orcid.org/0000-0002-7045-8004 Department of Urology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea E-mail: kimcho99@gilhospital.com The application of virtual/augmented reality (VR/AR) in medi - cine and healthcare has been evolving more actively than we  are aware.",Non-OADS,/arxiv_data1/oa_pdf/6a/1b/inj-1620edi005.PMC5083821.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Editorial http://dx.doi.org/10.5213 /inj.1620edi006 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNALInt Neurourol J 2016;20:171-171 Role of 5´-AMP-Activated Protein Kinase Activators in Regulating  Nuclear Factor Kappa B Signaling   Tack Lee       http://orcid.org/0000-0001-8508-9099 Editor-in-Chief Department of Urology, Inha University Hospital, Incheon, Korea E-mail: lee.tack33@gmail.com The role of nuclear factor kappa B (NF-κB) is well known in im - munity, inflammation, and cancer.",Non-OADS,/arxiv_data1/oa_pdf/8f/3e/inj-1620edi006.PMC5083822.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Caroline Massot     http://orcid.org/0000-0001-6246-4749 Service de Médecine Physique et Réadaptation Fonctionnelle, Hôpital Saint  Philibert, 115 rue du grand But, 59160 Lomme, Lille, France E-mail: carolinemassot29@gmail.com / Tel: +33-320-22-5047 /  Fax: +33-320-22-3855 Submitted:  December 15, 2015 / Accepted after revision:  January 18, 2016INTRODUCTION Multiple sclerosis (MS) is an autoimmune, inflammatory,  chronic disease that results in demyelinating lesions of the cen - tral nervous system.",Non-OADS,/arxiv_data1/oa_pdf/a0/e7/inj-1630490-245.PMC5083823.pdf
Many risk factors of Original Article http://dx.doi.org/10.5213/inj.1630490.245 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To report the prevalence and risk factors of stress urinary incontinence (SUI) and the prevalence of intrinsic sphinc - ter deficiency in women with multiple sclerosis (MS).,Non-OADS,/arxiv_data1/oa_pdf/a0/e7/inj-1630490-245.PMC5083823.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Mai Banakhar     http://orcid.org/0000-0002-2341-1270 Department of Urology, King Abdulaziz University, Faculty of Medicine, Jeddah,  Saudi Arabia E-mail: drmaibanakher@hotmail.com / Tel: +966-593435049 / Fax: +966-126408347 Submitted:  December 9, 2015 / Accepted after revision:  February 11, 2016INTRODUCTION InterStim device (Medtronic Inc., Minneapolis, MN, USA) is  an U.S. Food and Drug Administration approved therapy for sacral nerve stimulation for refractory overactive bladder  (OAB), frequency-urgency syndrome and nonobstructive uri - nary retention [1-5].",Non-OADS,/arxiv_data1/oa_pdf/ea/6b/inj-1630498-249.PMC5083824.pdf
Patients’ eligibility for sacral neuromodu - lation (SNM) therapy is determined by their response to an ex -Original Article http://dx.doi.org/10.5213/inj.1630498.249 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  InterStim device is an U.S. Food and Drug Administration approved minimal invasive therapy for sacral neuromod - ulation for lower urinary tract dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/ea/6b/inj-1630498-249.PMC5083824.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Nermin Tanik     http://orcid.org/0000-0002-7567-9244 Department of Neurology, Bozok University Medical School, 66200, Y ozgat,  Turkey E-mail: drnermin27@hotmail.com / Tel: +90-505-950-4844 / Fax: +90-354-217-7150 Submitted:  February 4, 2016 / Accepted after revision:  February 16, 2016INTRODUCTION Diabetes mellitus (DM) is a chronic disease that can lead to  many complications, including  peripheral sensorimotor poly - neuropathy, which is very common [1].",Non-OADS,/arxiv_data1/oa_pdf/a0/06/inj-1632508-254.PMC5083825.pdf
"Diabetic bladder dysfunction (DBD), which commonly ac -Original Article http://dx.doi.org/10.5213/inj.1632508.254 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Diabetes mellitus (DM) is a chronic metabolic disorder that often leads to complications.",Non-OADS,/arxiv_data1/oa_pdf/a0/06/inj-1632508-254.PMC5083825.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Pietro Ferrara     http://orcid.org/0000-0001-9449-3464 Institute of Pediatrics, Catholic University Medical School, L.go Francesco Vito,  1, 00168, Rome, Italy E-mail: pietro.ferrara@unicatt.it / Tel: +39-6-30154348 / Fax: +39-6--3383211 Submitted:  January 11, 2016 / Accepted after revision:  February 29, 2016INTRODUCTION Nocturnal Enuresis (NE) is a very common disorder among  children.",Non-OADS,/arxiv_data1/oa_pdf/35/ee/inj-1632518-259.PMC5083826.pdf
"According to the Diagnos - tic and Statistical Manual of Mental Disorders, 5th ed.,  NE is de - fined as repeated voiding of urine into a bed or clothes while  asleep by children older than 5 years, at least twice a week for 3 Original Article http://dx.doi.org/10.5213/inj.1632518.259 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  This study aims to evaluate and compare the efficacy of exogenous melatonin associated with desmopressin  (dDAVP) and dietary recommendations.",Non-OADS,/arxiv_data1/oa_pdf/35/ee/inj-1632518-259.PMC5083826.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Kirill Vladimirovich Kosilov     http://orcid.org/0000-0001-9747-3100 Department of Social Sciences, School of Humanities, Far Eastern Federal  University, Ayax 10, F733, DVFU, Vladivostok, Russian Federation E-mail: oton2000@mail.ru / Tel +7-914-717-3915 / Fax 8-4232-312169 Submitted:  January 19, 2016 / Accepted after revision:  July 23, 2016Original Article http://dx.doi.org/10.5213/inj.1632520.260 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB)  and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7b/c9/inj-1632520-260.PMC5083827.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Ankur Bansal     http://orcid.org/0000-0001-6396-4403 Department of Urology, King George Medical College, Lucknow, Uttar Pradesh  226003, India E-mail: ankurbansaldmc@gmail.com / Tel: +91-885-3807160 / Fax: +91-522-2257539 Submitted:  February 2, 2016 / Accepted after revision:  February 16, 2016INTRODUCTION Intravesical or intraurethral foreign bodies usually result from  iatrogenic injuries, self-insertion, sexual abuse, assault, and mi - gration from adjacent sites, although migration from adjacent  sites is rare [1].",Non-OADS,/arxiv_data1/oa_pdf/62/74/inj-1632524-262.PMC5083828.pdf
"A wide range of foreign bod - ies has been reported in the urinary bladder, including electri - cal wires, chicken bones, wooden sticks, thermometers, bullets,  intrauterine contraceptive devices (IUCDs), encrusted sutures,  surgical staples with stones, needles, pencils, household batter - ies, gauze, screws, pessaries, ribbon gauze, parts of Foley cathe - ters, broken parts of endoscopic instruments, and knotted su -Original Article http://dx.doi.org/10.5213/inj.1632524.262 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  This study was performed to characterise the nature, clinical presentation, mode of insertion, and management of  intravesical foreign bodies in patients treated at our hospital.",Non-OADS,/arxiv_data1/oa_pdf/62/74/inj-1632524-262.PMC5083828.pdf
Keywords:  Endoscopy; Foreign Bodies; Iatrogenic Disease; Urinary Bladder •  Research Ethics: This study was performed according to the Helsinki Declaration (http://www.wma.net/en/30publications/10policies/b3/) and  was approved by the Institutional Ethical Committee of King George Medical College (IEC: 92/2014).,Non-OADS,/arxiv_data1/oa_pdf/62/74/inj-1632524-262.PMC5083828.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Jae Hyun Bae     http://orcid.org/0000-0001-9862-3545 Department of Urology, Korea University Ansan Hospital, Korea University  College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea E-mail: urobae@genetherapy.or.kr / Tel: +82-31-412-5190 / Fax: +82-31-412-5194 Submitted:  February 15, 2016 / Accepted after revision:  April 4, 2016INTRODUCTION Overactive bladder (OAB) is defined as urinary urgency, with  or without urge incontinence and usually with frequency and  nocturia, in the absence of an infection or other obvious patho -logic conditions [1].",Non-OADS,/arxiv_data1/oa_pdf/0b/52/inj-1632534-267.PMC5083829.pdf
The overactive bladder symp -Original Article http://dx.doi.org/10.5213/inj.1632534.267 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The goal of this study was to compare the International Prostate Symptom Storage Subscore (IPSS-s) and the over - active bladder symptom score (OABSS) as tools for assessing the symptoms of overactive bladder (OAB).,Non-OADS,/arxiv_data1/oa_pdf/0b/52/inj-1632534-267.PMC5083829.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Magdy Hassouna     http://orcid.org/0000-0002-1096-3391 Department of Urology, Toronto Western Hospital, 399 Bathurst St, Toronto,  ON, Canada E-mail: Magdy.Hassouna@uhn.ca / Tel: +1-416-603-5018 / Fax +1-4166031961 Submitted:  February 17, 2016  / Accepted after revision:  April 4, 2016The incidence of urinary urgency, frequency, and urge inconti - nence increases with age, with an estimated prevalence of  16.9% in women and 16% in men [1].",Non-OADS,/arxiv_data1/oa_pdf/80/e1/inj-1632536-268.PMC5083830.pdf
"The mechanism of action of sacral neuro -Case Report http://dx.doi.org/10.5213/inj.1632536.268 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency,  urge incontinence, and chronic urinary retention in patients with cardiac pacemakers.",Non-OADS,/arxiv_data1/oa_pdf/80/e1/inj-1632536-268.PMC5083830.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  M. İrfan Dönmez     http://orcid.org/0000-0002-2828-7942 Department of Urology, Hacettepe University School of Medicine, Sıhhiye, Ankara  06100, Turkey E-mail: m_irfan83@yahoo.com / Tel: +90-312-305 1969 / Fax: +90-312-311 2262  †Deceased.",Non-OADS,/arxiv_data1/oa_pdf/60/f9/inj-1632548-274.PMC5083831.pdf
Platelet-rich plasma (PRP) is leukocyte-free autologous plas -Original Article http://dx.doi.org/10.5213/inj.1632548.274 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To evaluate the early histological effects of the intravesical instillation of platelet-rich plasma (PRP) in rabbit models  of interstitial and hemorrhagic cystitis.,Non-OADS,/arxiv_data1/oa_pdf/60/f9/inj-1632548-274.PMC5083831.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Limin Liao      http://orcid.org/0000-0002-7092-6576 Department of Urology, China Rehabilitation Research Centre, Rehabilitation  School of Cap-ital Medical University, Beijing100068, China E-mail: lmliao@263.net / Tel: +86-10-87569346 / Fax: +86-10-67570492 Submitted:  March 1, 2016 / Accepted after revision:  April 4, 2016INTRODUCTION Urodynamic studies have been used as a functional tool to quan -titatively evaluate symptoms of lower urinary tract (LUT) dys - function and to identify the underlying causes through the mea - surement of relevant physiologic parameters [1].",Non-OADS,/arxiv_data1/oa_pdf/6e/75/inj-1632556-278.PMC5083832.pdf
It is essential for Original Article http://dx.doi.org/10.5213/inj.1632556.278 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The goal of this study was to establish typical value ranges (TVRs) and to analyze typical signal patterns (TSPs) of  the initial cough (cough before bladder filling) for quality control in urodynamic studies.,Non-OADS,/arxiv_data1/oa_pdf/6e/75/inj-1632556-278.PMC5083832.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Seung-June Oh     http://orcid.org/0000-0002-0322-3539 Department of Urology, Seoul National University Hospital, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea  E-mail: sjo@snu.ac.kr / Tel: +82-2-2072-2406 / Fax: +82-2-742-4665 Submitted:  March 14, 2016 / Accepted after revision:  April 2, 2016INTRODUCTION Overactive bladder (OAB) is a chronic disease that usually re - quires an antimuscarinic agent, which has shown poor adher - ence, poor efficacy, and frequent adverse effects within 3 months of use [1,2].",Non-OADS,/arxiv_data1/oa_pdf/5a/97/inj-1632574-287.PMC5083833.pdf
"Implementing PRO involves assessing patient satis -Original Article http://dx.doi.org/10.5213/inj.1632574.287 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The goal of this study was to develop a Korean version of the Benefit, Satisfaction, and Willingness to Continue  (BSW) questionnaire from the original version, with subsequent linguistic validation by Korean patients with overactive blad - der who undergo active treatment by a physician.",Non-OADS,/arxiv_data1/oa_pdf/5a/97/inj-1632574-287.PMC5083833.pdf
http://dx.doi.org/10.1002/nau.22844.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/inj-1632574-287.PMC5083833.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Hann-Chorng Kuo     http://orcid.org/0000-0001-7165-4771 Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, 707, section  3, Chung Y ang Road, Hualien, Taiwan  E-mail: hck@tzuchi.com.tw / Tel: +886-0970333975 / Fax +886-266289009   Submitted:  May 12,  2016 / Accepted after revision:  June 23, 2016INTRODUCTION Ketamine, an antagonist of the N-methyl-D-aspartic acid re - ceptor complex, has been used since the 1960s as an anesthetic  or analgesic [1].",Non-OADS,/arxiv_data1/oa_pdf/a1/6d/inj-1632634-317.PMC5083834.pdf
Original Article http://dx.doi.org/10.5213/inj.1632634.317 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The aim of this study was to analyze patterns of sensory protein expression and urothelial dysfunction in ketamine- related cystitis (KC) in humans.,Non-OADS,/arxiv_data1/oa_pdf/a1/6d/inj-1632634-317.PMC5083834.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Taeg Keun Whangbo     http://orcid.org/0000-0003-1409-0580 Department of Computer Science, Gachon University, 1342 Seongnam-daero,  Sujeong-gu, Seongnam 13120, Korea E-mail: tkwhangbo@gachon.ac.kr / Tel: +82-32-750-5748 / Fax: +82-32-750-5596 Submitted:  September 18, 2016 / Accepted after revision:  September 26, 2016INTRODUCTION A new wave of virtual (VR) and augmented reality (AR) has  started.",Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
"The figure depicts the continuum from the real world to the Review Article http://dx.doi.org/10.5213/inj.1632714.357 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Recent developments in virtual, augmented, and mixed reality have introduced a considerable number of new devices into the  consumer market.",Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available  from: http://www.merriam-webster.com/dictionary/virtual%20reality 2.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from:  http://www.pcworld.com/article/3091028/intel-tunes-its-mega- chip-for-machine-learning.html.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from:  https://www.cnet.com/news/5-amazing-things-youll-be-able-to-do- with-5g/.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from: http://case.edu/hololens/.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from: http://news.nationalgeographic.com/ news/2001/09/0919_robotsurgery.html 39.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
http://dx.doi.org/10.1002/rcs.1758.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from:  http://www.cnds.jhu.edu/courses/cs667-2011/RemoteTeleSurgery/.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
Available from: http://my.clevelandclinic.org/ ccf/media/files/Digestive_Disease/woc-spring-symposium-2013/ biofeedback-for-pelvic-floor-muscle-reeducation.pdf 44.,Non-OADS,/arxiv_data1/oa_pdf/fc/18/inj-1632714-357.PMC5083835.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Chang-Shin Park     http://orcid.org/0000-0001-6519-2857 Department of Pharmacology & Medicinal Toxicology Research Center, Hypoxia- Related Disease Research Center, Inha Research Institute for Medical Sciences,  Inha University College of Medicine, 100 Inha-ro, Nam-gu, Incheon 22212, Korea E-mail: parkshin@inha.ac.kr / Tel: +82-32-860-9871 / Fax: +82-32-887-7488 Submitted:  September 20, 2016 / Accepted after revision:  September 26, 2016NUCLEAR FACTOR-KAPPA B ACTIVATION:  PHOSPHORYLATION AND ACETYLATION The transcriptional factor nuclear factor kappa B (NF- κB) is a  main regulator of the induction of several genes including in - flammatory and immune response genes and the proliferation  and death of cancer cells [1-4].",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/inj-1632718-359.PMC5083836.pdf
"In activated  cells, I κB-free NF- κB translocates into the nucleus where it acti -Review Article http://dx.doi.org/10.5213/inj.1632718.359  pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Generally, both lipopolysaccharide (LPS)- and hypoxia-induced nuclear factor kappa B (NF-κB) effects are alleviated through  differential posttranslational modification of NF-κB phosphorylation after pretreatment with 5´-AMP-activated protein ki - nase (AMPK) activators such as 5´-aminoimidazole-4-carboxamide ribonucleotide (AICAR) or the hypoglycemic agent met - formin.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/inj-1632718-359.PMC5083836.pdf
"Available from:  http://www.iss.it/binary/spva/cont/Determi  nazione_NoV_e_HAV_Integrazioni_Corre  zioni_Dichiarazione_validazione_Tabella  _comparativa_POMIAC01.002.pdf  Croci L, Suffredini E, 2003.",Non-OADS,/arxiv_data1/oa_pdf/6c/c7/ijfs-2014-2-1601.PMC5083858.pdf
"Available from:  http://www.iss.it/publ/anna/2003/1/39135.p  df  da Silva AK, Le Saux JC, Parnaudeau S,  Pommepuy M, Elimelech M, Le Guyader  FS, 2007.",Non-OADS,/arxiv_data1/oa_pdf/6c/c7/ijfs-2014-2-1601.PMC5083858.pdf
"Available from:  http://www.sardegnaagricoltura.it/docu - menti/14_43_20091201175044.pdf  Svraka S, Duizer E, Vennema H, de Bruni E,  van der Veer B, Dorresteijn B, Koopmans  M, 2007.",Non-OADS,/arxiv_data1/oa_pdf/6c/c7/ijfs-2014-2-1601.PMC5083858.pdf
Disponibile al sito: http://ec.europa.eu/ food/food/biosafety/irradiation/1786-1996_Article Figura 1.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijfs-2014-2-1602.PMC5083859.pdf
"Disponibile al sito: http://ec.europa.eu/ food/food/biosafety/irradiation/178 7- 2 000_en.pdf Commissione Europea, 2001.",Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijfs-2014-2-1602.PMC5083859.pdf
"Detection of irra- diated food containing crystalline sugar byESR spectroscopy, EN 13708 (2001).Disponibile al sito: http://ec.europa.eu/ food/food/biosafety/irradiation/13708-2001 _en.pdf Commissione Europea, 2012.",Non-OADS,/arxiv_data1/oa_pdf/41/b1/ijfs-2014-2-1602.PMC5083859.pdf
"Available from: http://www.chemi- calbulletin.ro/admin/articole/52240art_21  _91-94_.pdfLee Y, Howard LR, Villalon B, 1995.",Non-OADS,/arxiv_data1/oa_pdf/8d/4d/ijfs-2014-2-1637.PMC5083861.pdf
Disponibile al sito: http://www.regione.,Non-OADS,/arxiv_data1/oa_pdf/b4/65/ijfs-2014-2-1638.PMC5083862.pdf
"Available from: http://pubs.usgs.gov/twri/twri4a3/#pdf  Kim G, Hur J, 2010.",OADS,/arxiv_data1/oa_pdf/5e/d1/ijfs-2014-2-1645.PMC5083863.pdf
"Disponibile al sito: http://www.weber.hu/ PDFs/QuEChERS/AOAC_2007_01.pdf BSI, 2007.",Non-OADS,/arxiv_data1/oa_pdf/f8/05/ijfs-2014-2-1647.PMC5083864.pdf
"Disponibile al sito: http://ec.europa.eu/food/plant/protection/r  esources/qualcontrol_en.pdf Ecobichon DJ, 2000.",Non-OADS,/arxiv_data1/oa_pdf/f8/05/ijfs-2014-2-1647.PMC5083864.pdf
"Disponibile al sito: http://www.accredia.it/UploadDocs/1627_Q  UAAM2000_1__ITA.pdf European Food Safety Authority, 2011.",Non-OADS,/arxiv_data1/oa_pdf/f8/05/ijfs-2014-2-1647.PMC5083864.pdf
"Disponibile al sito: http://www.efsa.euro - pa.eu/it/supporting/doc/27e.pdf ISO, 1986.",Non-OADS,/arxiv_data1/oa_pdf/f8/05/ijfs-2014-2-1647.PMC5083864.pdf
"Disponibile al sito: http://www.grid.unep.ch /pro - ducts/3_Reports/Global_pollinator_decli- ne_literature_review_2007.pdf Kremen C, Williams NM, Aizen MA, Gemmill- Herren B, LeBuhn G, Minckley R, Packer L, Potts SG, Roulston Ta, Steffan-Dewenter I, Vazquez DP, Winfree R, Adams L, Crone  EE, Greenleaf SS, Keitt TH, Klein A-M, Regetz J, Ricketts TH, 2007.",OADS,/arxiv_data1/oa_pdf/f8/05/ijfs-2014-2-1647.PMC5083864.pdf
"Disponibile al sito: http://ec.europa.eu/food/food/biosafety/irradiation/1788-2001_en.pdf UNI, 2009.",Non-OADS,/arxiv_data1/oa_pdf/e8/40/ijfs-2014-2-1653.PMC5083865.pdf
"Available from: http://www.efsa.europa.eu/it/efsajournal/pub/3129.htm Hernandez J, Bonnedahl J, Waldenström J, Palmgren H, Olsen B, 2003.",Non-OADS,/arxiv_data1/oa_pdf/90/b2/ijfs-2014-2-1668.PMC5083866.pdf
"Available from: http://www.ers.usda.gov/media/887982/efan02009.pdf Carr D, Levins J, 2000.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Available from: http://www.ccm- network.it/documenti_Ccm/convegni/SANI T/materiali2008/25.6/6-Ristorazione_col- lettiva_Guidarelli.pdf Iapello A, Quaglia GB, Di Renzo L, De Lorenzo A, Bucarelli FM, 2011.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Available fro m: http://www.ilfattoalimentare.it/wp-con- tent/uploads/2013/03/iapello-et-al-la-rivi- s ta-di-scienza-dellalimentazione-2011.pdf La Pira R, 2012a.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Available from: http://www.ilfattoalimentare.it/mense-sco- lastiche-milano-ristorazione-spreco.html La Pira R, 2012b.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Available from: http://www.ilfattoalimenta-re.it/milano-ristorazione-berrino-scarti- mense-scolastiche.htmlMonasta L, Batty GD, Cattaneo A, Lutje V, Ronfani L, Van Lenthe FJ, Brug J, 2010.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Available from: http://www.pagepres-sjournals.org/index.php/ijfs/article/view/ijfs.2012.3.59/458 Scognamiglio U, Salvia A, Paolucci S, G arbagnati F, Caltagirone C, Musico M, 2012.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ijfs-2014-2-1669.PMC5083867.pdf
"Disponibile al sito: http://archimer.ifremer.fr/doc/2007/publication-2803.pdf  Paez-Osuna F, Frias-Espericuela MG, Osuna-Lopea JI, 1995.",Non-OADS,/arxiv_data1/oa_pdf/3e/93/ijfs-2014-2-1672.PMC5083868.pdf
"Available from: http://www.salute.gov.it/ imgs/C_17_pubblicazioni_1514_allegato.pdf De Alencar ER, faroni LR, Soares Nde F, da Silva WA, Carvalho MC, 2012.",Non-OADS,/arxiv_data1/oa_pdf/c1/92/ijfs-2014-2-1680.PMC5083869.pdf
"Available from: http://www.ego-gw.it/public/about/VIR-0558A-09.pdf Khadre MA, Yousef AE, 2001.",Non-OADS,/arxiv_data1/oa_pdf/c1/92/ijfs-2014-2-1680.PMC5083869.pdf
"Available  from: http://www.efsa.europa.eu/it/efsa -journal/doc/724.pdf  Euroepan Commission, 2004.",Non-OADS,/arxiv_data1/oa_pdf/88/31/ijfs-2014-2-1681.PMC5083870.pdf
"Available from:  http://www.niaid.nih.gov/topics/foodaller - gy/clinical/documents/faguidelinesexec - summary.pdf  Rona RJ, Keil T, Summers C, Gislason D,  Zuidmeer L, Sodergren E, Sigurdardottir  ST, Lindner T, Goldhahn K, Dahlstrom J,  McBride D, Madsen C, 2007.",Non-OADS,/arxiv_data1/oa_pdf/20/42/ijfs-2014-2-1700.PMC5083872.pdf
"Available from: http://www.health.gov.au/internet/main/pu  blishing.nsf/Content/cda-2004-  cdi2804p.htm  Eglezos S, Huang B, Dykes GA, Fegan N, 2010.",Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
"Available from: http://www.cfs.gov.hk/eng - lish/programme/programme_haccp/files/s  s_ras2_eng.pdf  Food and Environmental Hygiene Department  HKSAR, 2007.",Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
"Available at: http://www.cfs.gov.hk/english/whatsnew/w  hatsnew_act/files/MBGL_RTE%20food_e.p  df  Food Standards Australia New Zealand, 2001.",Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
Available  from: http://www.foodstandards.,Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
Available from: http://webarchive.nation - alarchives.gov.uk/+/http://www.hpa.org.uk/ cdph/issues/CDPHVol3/no3/guides_micro.,Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
"Available from: http://www.sivemp.it/userfiles/_docu - ments_/_rivista_/26_58_62_pesce.pdf  Millard G, Rockliff S, 2003.",Non-OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
"Available from: http://www.health.act.gov.au/c/health?a=d  a&did=10060511&pid=1094601516  Nogara M, Rossari C, Stella S, Cozzi M, Cantoni C, 2004.",OADS,/arxiv_data1/oa_pdf/29/7b/ijfs-2014-2-1701.PMC5083873.pdf
"Available from: http://web.tiscali.it/antonio.pirisi/2001- 2010-2.html UNI, 2010.",Non-OADS,/arxiv_data1/oa_pdf/cc/3c/ijfs-2014-2-1725.PMC5083875.pdf
"Available from: http://www.cdc.gov/mmwr/prev iew/ m mwrhtml/00036467.htm Barbuti S, Parolari G, 2002.",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ijfs-2014-2-3226.PMC5083877.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/eb/40/CG-CGCR160024.PMC5083881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/25/c0/CG-CGCR160081.PMC5083882.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/52/88/CG-CGCR160085.PMC5083883.pdf
"399Case Report https://doi.org/10.9758/cpn.2016.14.4.399 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):399-401 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  December 14, 2015/ Revised:  February 22, 2016 Accepted:  February 23, 2016 Address for correspondence: Chieh-Hsin Lin, MD, PhD Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospita l,  No.",Non-OADS,/arxiv_data1/oa_pdf/5c/a3/cpn-14-399.PMC5083932.pdf
"391Case Report https://doi.org/10.9758/cpn.2016.14.4.391 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):391-395 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  November 24, 2015/ Revised:  January 7, 2016 Accepted:  January 16, 2016 Address for correspondence: Takashi Tomita, PhD Department of Pharmacy, Hospital Bando, Kutsukake 411, Bando,  Ibaraki 306-0515, JapanTel: +81-297-44-2000, Fax: +81-297-44-2072E-mail: t.tomita@hpbando.jpThe current affiliation of Takashi Tomita is Department of Clin ical  Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University, 2-1-1, Nishitokuta, Yahabacho, Shiwagun, Iwate 028-3603, JapanTel: +81-19-651-5111 (ex.",Non-OADS,/arxiv_data1/oa_pdf/de/cd/cpn-14-391.PMC5083933.pdf
"388Case Report https://doi.org/10.9758/cpn.2016.14.4.388 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):388-390 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  October 27, 2015/ Revised:  December 24, 2015 Accepted:  January 19, 2016 Address for correspondence: Meltem Çobanoğullar ı Direk, MD Division of Pediatric Neurology, Department of Paediatrics,  University of Mersin Faculty of Medicine, 34, Cadde, Ciftlikkoy   Kampusu 33343 Mersin, TurkeyTel: +90-5066724367, Fax: +90-324-241-0092E-mail: m_lt_m82@hotmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Serotonin Syndrome after Clomipramine Overdose in a Child Meltem Çobano ğullar ı Direk1, Veli Y ıldırım2, Serkan Güne ş2, Gülçin Bozlu3, Çetin Okuyaz1 1Division of Pediatric Neurology, Department of Pediatrics, 2Department of Child and Adolescent Psychiatry, 3Department of Pediatrics,  University of Mersin School of Medicine, Mersin, Turkey Serotonin syndrome (SS) is a potentially life-threatening condi tion associated with increased serotonergic activity in central  nerv- ous system and may occur during the use of serotonergic drugs.",Non-OADS,/arxiv_data1/oa_pdf/e9/34/cpn-14-388.PMC5083934.pdf
"378Brief Report https://doi.org/10.9758/cpn.2016.14.4.378 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):378-382 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  June 10, 2016/ Revised:  June 23, 2016 Accepted:  June 24, 2016 Address for correspondence: Bon-Hoon Koo, MD, PhD Department of Psychiatry, Ye ungnam University College of  Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, KoreaTel: +82-53-620-3343, Fax: +82-53-629-0256E-mail: vijnana@chol.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Association between Cerebral Amyloid Deposition and Clinical Factors  Including Cognitive Function in Geriatri c Depression: Pilot Study Using Amyloid  Positron Emission Tomography Hye-Geum Kim1, Eun-Jung Kong2, Eun-Jin Cheon1, Hae-Won Kim3, Bon-Hoon Koo1 Departments of 1Psychiatry and 2Nuclear Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine,  3Department of Nuclear Medicine, Dongsan Medical Center, Keimyun g University School of Medicine, Daegu, Korea The purpose of this study was to explore the relationship betwe en cerebral amyloid deposition and overall clinical factors inc lud- ing cognitive functions in geriatric depression by using 18F-florbetaben positron emission tomography.",Non-OADS,/arxiv_data1/oa_pdf/62/e2/cpn-14-378.PMC5083935.pdf
"405Case Report https://doi.org/10.9758/cpn.2016.14.4.405 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):405-406 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  August 11, 2015/ Revised:  March 24, 2016 Accepted:  April 23, 2016 Address for correspondence: Chien-Han Lai, MD Department of Psychiatry, Cheng Hsin General Hospital, No.45,  Cheng Hsin St., Pai-Tou Destrict, Taipei, Taiwan, ROCTel: +886-2-28264400 ext 3502, Fax: +886-2-28264570E-mail: stephenlai99@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report Yi-Cheng Hou1, Chien-Han Lai2,3 1Department of Nutrition, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, 2Department of Psychiatry, Cheng  Hsin General Hospital, Taipei, 3Department of Biomedical Imaging and Radiological Sciences, Nat ional Yang-Ming University, Taipei,  Taiwan, ROC The selective melatonin receptor agonism effect of ramelteon is  useful for insomnia.",Non-OADS,/arxiv_data1/oa_pdf/6b/eb/cpn-14-405.PMC5083936.pdf
"383Brief Report https://doi.org/10.9758/cpn.2016.14.4.383 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):383-387 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  April 25, 2016/ Revised:  July 6, 2016 Accepted:  August 11, 2016 Address for correspondence: Hyun Ju Hong, MD, PhD Department of Psychiatry, Hallym University Sacred Heart Hospit al,  Hallym University College of Medicine, 22 Gwanpyeong-ro, 170 beon-gil, Dongan-gu, Anyang 14068, KoreaTel: +82-31-380-3750, Fax: +82-31-381-3753E-mail: honghj88@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Predictors of Suicide Attempts in Clinically Depressed Korean Adolescents Ahye Kwon1, Jungeun Song2, Ki-Hwan Yook3, Duk-In Jon1, Myung Hun Jung1, Narei Hong1, Hyun Ju Hong1,4 1Department of Psychiatry, Hallym University Sacred Heart Hospit al, Hallym University College of Medicine, Anyang, 2Department of  Psychiatry, National Health Insurance Service Ilsan Hospital, G oyang, 3Department of Psychiatry, CHA Bundang Medical Center, CHA  University, Seongnam, 4Suicide and School Mental Health Institute, Hallym University, Anyang, Korea We examined predictors of suicide attempts in clinically depres sed adolescents in Korea and gender differences in suicidal  behavior.",Non-OADS,/arxiv_data1/oa_pdf/df/47/cpn-14-383.PMC5083937.pdf
Available from: http://kostat.go.kr/portal/ korea/kor_nw/2/6/1/index.board?bmode=read&aSeq=308559 .,OADS,/arxiv_data1/oa_pdf/df/47/cpn-14-383.PMC5083937.pdf
Available from: http://kostat.go.kr/portal/  korea/kor_ko/5/2/index.board?bmode=read&aSeq=330389 .,Non-OADS,/arxiv_data1/oa_pdf/df/47/cpn-14-383.PMC5083937.pdf
Available from: http://kostat.go.kr/portal/ ■ Acknowledgments,Non-OADS,/arxiv_data1/oa_pdf/df/47/cpn-14-383.PMC5083937.pdf
"371Original Article https://doi.org/10.9758/cpn.2016.14.4.371 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):371-377 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  September 7, 2016/ Revised:  October 14, 2016 Accepted:  October 16, 2016 Address for correspondence: Jung-Jin Kim, MD, PhD Department of Psychiatry, Seoul St. Mary ’s Hospital, College of  Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, KoreaTel: +82-2-2258-6084, Fax: +82-2-2258-6084E-mail: jjean@catholic.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Amisulpride Switching in Schizophreni c Patients Who Showed Suboptimal  Effect and/or Tolerability to Current Anti psychotics in a Naturalistic Setting: An  Explorative Study Yongmin Kim1, Sheng-Min Wang1,2, Kyung-Phil Kwak3, Ho-Kyoung Yoon4, Chi-Un Pae1,5, Jung-Jin Kim1,  Won-Myong Bahk1 1Department of Psychiatry, College of Medicine, The Catholic Uni versity of Korea, Seoul, 2International Health Care Center, Seoul St. Mary ’s  Hospital, The Catholic University of Korea, Seoul, 3Department of Neuropsychiatry, Dongguk University School of Med icine, Gyeongju,  4Department of Psychiatry, Korea University College of Medicine,  Seoul, Korea, 5Department of Psychiatry and Behavioural Sciences,  Duke University Medical Center, Durham, NC, USA Objective:  Despite numerous atypical antipsychotics (AAP) available, many  patients with schizophrenia still experience lack of  efficacy and persistent side-effects.",Non-OADS,/arxiv_data1/oa_pdf/74/ac/cpn-14-371.PMC5083938.pdf
"407Letter to the Editor https://doi.org/10.9758/cpn.2016.14.4.407 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):407-408 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  January 16, 2016/ Revised:  January 29, 2016  Accepted:  January 30, 2016 Address for correspondence: Burak Can, MD Department of Internal Medicine, ToyotaSA Emergency Aid Hospita l,  Kirazca Mah.",Non-OADS,/arxiv_data1/oa_pdf/a6/9a/cpn-14-407.PMC5083939.pdf
"330Review https://doi.org/10.9758/cpn.2016.14.4.330 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):330-337 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  April 21, 2016/ Revised:  May 30, 2016 Accepted:  June 8, 2016 Address for correspondence: Sujita Kumar Kar, MD  Department of Psychiatry, King George ’s Medical University, Shah  Mina Road, Chowk, Lucknow 226003, Uttar Pradesh, India Tel: +91-9956273747, Fax: +91-0522-2258642E-mail: skkar1981@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Neuro-stimulation Techniques for the Management of Anxiety Disorders:  An Update Sujita Kumar Kar1, Siddharth Sarkar2 1Department of Psychiatry, King George ’s Medical University, Lucknow, 2Department of Psychiatry and National Drug Dependence  Treatment Centre, All India Institute of Medical Sciences, New Delhi, India Neuro-stimulation techniques have gradually evolved over the de cades and have emerged potential therapeutic modalities for  the treatment of psychiatric disorders, especially treatment re fractory cases.",Non-OADS,/arxiv_data1/oa_pdf/8e/fe/cpn-14-330.PMC5083940.pdf
Available from  http://www.ncbi.nlm.nih.gov/books/NBK254055 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/fe/cpn-14-330.PMC5083940.pdf
"402Case Report https://doi.org/10.9758/cpn.2016.14.4.402 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):402-404 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  December 7, 2015/ Revised:  March 17, 2016 Accepted:  March 24, 2016 Address for correspondence: Subodh BN, MD Department of Psychiatry, Postgraduate Institute of Medical  Education & Research, Nehru Hospital, Sector 12, Chandigarh 160012, IndiaTel: +91-0172-2756814, Fax: +91-0172-2744401E-mail: drsubodhbn2002@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Modafinil Dependence and Hypersexuality : A Case Report and Review of the  Evidence Sahoo Swapnajeet, Subodh BN, Gupta Gourav Department of Psychiatry, Postgraduate Institute of Medical Edu cation & Research, Chandigarh, India Apart from sleep wake disorders, nowadays, modafinil is being p rescribed for several psychiatric disorders including depressio n.  Despite being reported as to be having very low abuse potential , cases of modafinil dependence had come to the limelight.",Non-OADS,/arxiv_data1/oa_pdf/3f/84/cpn-14-402.PMC5083941.pdf
"323Review https://doi.org/10.9758/cpn.2016.14.4.323 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):323-329 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  November 24, 2015/ Revised:  February 20, 2016 Accepted:  February 21, 2016 Address for correspondence: Nilamadhab Kar, MD, DPM, DNB,  MRCPsych Department of Psychiatry, Black Country Partnership NHS Foundation Trust, The Beeches, Penn Hospital, Penn Road, Wolverhampton, WV4 5HN, UKTel: +44-1902-443665, Fax: +44-121-612-3740E-mail: kar.nilamadhab@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Clozapine Monitoring in Clinical Prac tice: Beyond the Mandatory Requirement Nilamadhab Kar1, Socorro Barreto1, Rahul Chandavarkar2 1Black Country Partnership NHS Foundation Trust, Wolverhampton, 2North Staffordshire Combined Healthcare NHS Trust, Stoke-on-Tre nt,  United Kingdom Clozapine is effective in treatment resistant schizophrenia; ho wever, it is underutilised probably because of its side effects .",Non-OADS,/arxiv_data1/oa_pdf/e0/a6/cpn-14-323.PMC5083942.pdf
Available from: http://www.priory.com/psych/TRS.htm .,Non-OADS,/arxiv_data1/oa_pdf/e0/a6/cpn-14-323.PMC5083942.pdf
"396Case Report https://doi.org/10.9758/cpn.2016.14.4.396 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):396-398 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  October 21, 2015/ Revised:  January 7, 2016 Accepted:  February 2, 2016 Address for correspondence: Ho-Kyoung Yoon, MD, PhD Department of Psychiatry, Korea University Ansan Hospital, Kore a  University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, KoreaTel: +82-31-412-5138, Fax: +82-31-412-5132E-mail: hkhkgogo@korea.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Recurrence of Panic Attacks after Influenza Vaccination: Two Case Reports Han-Joon Kim, Sang-Won Jeon, Ho-Kyoung Yoon Department of Psychiatry, Korea University Ansan Hospital, Kore a University College of Medicine, Ansan, Korea Human influenza is a contagious respiratory illness caused by t he influenza virus.",Non-OADS,/arxiv_data1/oa_pdf/49/94/cpn-14-396.PMC5083943.pdf
"338Original Article https://doi.org/10.9758/cpn.2016.14.4.338 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):338-344 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  April 28, 2016/ Revised:  May 11, 2016 Accepted:  May 14, 2016 Address for correspondence: Hee Jae Lee, PhD Department of Pharmacology, Kangwon National University School  of Medicine, 1 Gangwondaehak-gil, Chuncheon 24341, KoreaTel: +82-33-250-8852, Fax: +82-33-242-7571E-mail: heejaelee@kangwon.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Valproic Acid Exposure during Early Postna tal Gliogenesis Leads to Autistic-like  Behaviors in Rats Tamanna Jahan Mony1, Jae Won Lee1,2, Cheryl Dreyfus3, Emanuel DiCicco-Bloom3,4, Hee Jae Lee1 1Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon, 2Natural Medicine Research Center, Korea  Research Institute of Bioscience and Biotechnology, Cheongju, K orea, 3Department of Neuroscience and Cell Biology, Rutgers Robert  Wood Johnson Medical School, Rutgers, the State University of N ew Jersey, Piscataway, 4Department of Pediatrics, Rutgers Robert Wood  Johnson Medical School, Rutgers, the State University of New Je rsey, New Brunswick, NJ, USA  Objective:  We reported that postnatal exposure of rats to valproic acid ( VPA) stimulated proliferation of glial precursors during  cortical gliogenesis.",Non-OADS,/arxiv_data1/oa_pdf/88/1f/cpn-14-338.PMC5083944.pdf
"345Original Article https://doi.org/10.9758/cpn.2016.14.4.345 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):345-350 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  November 6, 2015/ Revised:  January 27, 2016 Accepted:  February 20, 2016 Address for correspondence: Mehmet Akif Camkurt, MD Department of Psychiatry, State Hospital of Afsin, Kemal Erteki n cd.",Non-OADS,/arxiv_data1/oa_pdf/70/0b/cpn-14-345.PMC5083945.pdf
"351Original Article https://doi.org/10.9758/cpn.2016.14.4.351 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):351-356 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  March 2, 2016/ Revised:  April 15, 2016 Accepted:  April 25, 2016 Address for correspondence: Cem Cerit, MD Department of Psychiatry, School of Medicine, Kocaeli Universit y,  Umuttepe Yerle şkesi 41380, İzmit/Kocaeli, Turkey Tel: +90-2623037508, Fax: +90-2623037079E-mail: cemcerit@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks  Follow-up Study on Efficacy and Tolerability Esma Akp ınar1, Cem Cerit2, An ıl Talas3, Ümit Tural2 1Psychiatry Clinic, Tokat Mental Health Hospital, Tokat, 2Department of Psychiatry, School of Medicine, Kocaeli Universit y, Kocaeli,  3Psychiatry Clinic, Tuzla State Hospital, Istanbul, Turkey Objective:  In this open-labeled, 12 weeks follow-up study, we aimed to co mpare the efficacy and tolerability of agomelatine  with sertraline Methods:  The outpatients of adult psychiatry clinic who have a new onse t of depression and diagnosed as ‘major depressive  episode ’ by clinician according to the Diagnostic and Statistical Manua l of Mental Disorders 4th edition and prescribed agomela- tine (25 mg/day) or sertraline (50 mg/day) were included in the  study.",Non-OADS,/arxiv_data1/oa_pdf/4d/b8/cpn-14-351.PMC5083946.pdf
"365Original Article https://doi.org/10.9758/cpn.2016.14.4.365 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):365-370 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  March 18, 2016/ Revised:  April 12, 2016 Accepted:  April 13, 2016 Address for correspondence: Ebru F ınd ıklı, MD Department of Psychiatry, Faculty of Medicine, Kahramanmara ş  Sütçü İmam University, 46100, Kahramanmara ş, Turkey Tel: +90-3442803367, Fax: +90-3442803409E-mail: ebrukanmaz@gmail.comThis study is presented as a poster presentation in 7th Interna tional Congress on Psychopharmacology and pressed in Bulletin of Clinical Psychopharmacology 2015;25(suppl 1):P63-64.",Non-OADS,/arxiv_data1/oa_pdf/91/83/cpn-14-365.PMC5083947.pdf
FRS was calculate d according to the formula  developed by Wilson et al.24) (see http://cvdrisk.nhlbi.nih.,OADS,/arxiv_data1/oa_pdf/91/83/cpn-14-365.PMC5083947.pdf
"357Original Article https://doi.org/10.9758/cpn.2016.14.4.357 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2016;14(4):357-364 Copyrightⓒ 2016, Korean College of Neuropsychopharmacology                       Received:  April 21, 2016/ Revised:  June 14, 2016 Accepted:  August 25, 2016 Address for correspondence: Bumseok Jeong, MD, PhD Laboratory of Clinical Neuroscience and Development, Graduate  School of Medical Science and Engineering, KAIST, 291 Daehak- ro, Yuseong-gu, Daejeon 34141, KoreaTel: +82-42-350-4245, Fax: +82-42-350-7168E-mail: bs.jeong@kaist.ac.krYoo-Sook Joung, MD, PhDDepartment of Psychiatry, Samsung Medical Center, Sungkyun-kwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-0930, Fax: +82-2-3410-0052E-mail: yschoung@skku.eduBumseok Jeong and Yoo-Sook Joung were co-corresponding au-thor of this article.",Non-OADS,/arxiv_data1/oa_pdf/09/66/cpn-14-357.PMC5083948.pdf
"Data Preprocessing  The MRI data were preprocessed with the FMRIB  Software Library (FSL, www.fmrib.ox.ac.uk/fsl) version  5.0, Analysis of Functional NeuroImages (http://afni.nimh.",OADS,/arxiv_data1/oa_pdf/09/66/cpn-14-357.PMC5083948.pdf
"nih.gov/afni/), and the FreeSu rfer image analysis suite  (http://surfer.nmr.mgh.harvard.",OADS,/arxiv_data1/oa_pdf/09/66/cpn-14-357.PMC5083948.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Wafaa M Ezzat, MD, Professor  of  Gastroenterology and Hepatology, Department of Internal  Medicine, National Research Center, Elbohoosst, Dokki, Cairo  12311, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/1f/12/WJH-8-1251.PMC5084054.pdf
"World J Hepatol  2016; 8(30): 1251-1261   Available from: URL:  http://www.wjgnet.com/ 1948-5182 /full/ v8/i30/1251.htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i30.1251 INTRODUCTION Primary liver cancer is an increasing malignant disease, Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i30.1251World J Hepatol   2016  October 28; 8(30): 1251-1261 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1f/12/WJH-8-1251.PMC5084054.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1f/12/WJH-8-1251.PMC5084054.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Karina Zamprogno de Souza, MD,  The  Center of Health Science, Federal University of Espírito Santo,  Marechal Campos Avenue, Number 1468, Vitória 29043-900,   Brazil.",Non-OADS,/arxiv_data1/oa_pdf/5e/7b/WJH-8-1262.PMC5084055.pdf
CONCLUSION The present study indicates that the FAB is a promising  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i30.1262World J Hepatol   2016  October 28; 8(30): 1262-1268 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/5e/7b/WJH-8-1262.PMC5084055.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5e/7b/WJH-8-1262.PMC5084055.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Elchanan Nussinson, MD,  Gastro -enterology Institute, Emek Medical Center, Duchifat 7 St, Afula   18742, Israel.",Non-OADS,/arxiv_data1/oa_pdf/e0/e4/WJH-8-1269.PMC5084056.pdf
"RESULTS Of the 119 patients, 80 (67%) developed SVR over the Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i30.1269World J Hepatol   2016  October 28; 8(30): 1269-1278 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e0/e4/WJH-8-1269.PMC5084056.pdf
wjgnet.com/ 1948-5182 /full/v8/i30/1269.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/e4/WJH-8-1269.PMC5084056.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e0/e4/WJH-8-1269.PMC5084056.pdf
Clinical trial registration statement:  This study is registered at  (https://clinicaltrials.gov/show/NCT02767622).,Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Sara M Abdelhakam, MD, Assistant  Professor  of Tropical Medicine, Department of Tropical Medicine,  Faculty of Medicine, Ain Shams University, Khalifa El ­Maamon  St., Abbassia, Cairo 11341, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
"saratropical@yahoo.com Telephone:  +20­100­1601548 Fax:  +20­22­2598751 Received:  May 28, 2016 Peer-review started:  May 30, 2016 First decision:  July 20, 2016 Revised:  August 6, 2016 Accepted:  September 13, 2016 Article in press:  September 18, 2016 Published online:  October 28, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i30.1279World J Hepatol   2016  October 28; 8(30): 1279-1286 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
World J Hepatol  2016; 8(30): 1279 ­1286   Available from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/v8/ i30/1279.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i30.1279 INTRODUCTION The prevalence of overt hepatic encephalopathy (HE) in  patients with decompensated liver cirrhosis ranges from  16% to 21%, while that of minimal HE (MHE) or covert  HE is 20%-80%[1].",Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/78/5c/WJH-8-1279.PMC5084057.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Hanan Fouad, Professor,  Department  of Medical Biochemistry, Faculty of Medicine, Cairo University,  110 Manial Street, Manial El-Roda District, Cairo 11562,  Egypt.",Non-OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
In HCV patients with antinuclear  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i30.1287World J Hepatol   2016  October 28; 8(30): 1287-1294 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
wjgnet.com/ 1948-5182 /full/v8/i30/1287.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
Primer sequence: PCR primers were got from Gen­ Bank RNA sequences cited at the following website:  http://www.ncbi.nlm.nih.gov/tools/primer ­blast (T able 1).,OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
"Available from: URL: http://www.ncbi.nlm.nih.gov/ books/NBK26921/ 6 Vantourout P , Hayday A. Six-of-the-best: unique contributions  of γδ T cells to immunology.",Non-OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a7/d3/WJH-8-1287.PMC5084058.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Carlo Aprile, MD,  Nuclear Medicine Unit,  Department of Oncohaematology, Fondazione IRCCS Policlinico  San Matteo, v.le Golgi 19, 27100 Pavia, Italy.",Non-OADS,/arxiv_data1/oa_pdf/81/91/WJR-8-816.PMC5084059.pdf
"World J Radiol  2016; 8(10): 816-818  Available from:  URL:  http://www.wjgnet.com/ 1949-8470 /full/v8/i10/816.htm   DOI: http://dx.doi.org/10.4329/wjr.v8.i10.816 COMMENTARY ON HOT TOPICS Several therapeutic options have been shown to be  clinically effective in treating metastatic castration  resistant prostate cancer (mCRPC), albeit real efficacy of  treatment is very difficult to establish due to a substantial World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v8.i10.816World J Radiol  2016 October 28; 8(10): 816-818 ISSN 1949-8470 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/81/91/WJR-8-816.PMC5084059.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/81/91/WJR-8-816.PMC5084059.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Matteo Bonatti, MD,  Department of  Radiology, Bolzano Central Hospital, 5 Boehler St., 39100  Bolzano, Italy.",Non-OADS,/arxiv_data1/oa_pdf/aa/d7/WJR-8-819.PMC5084060.pdf
wjgnet.com/ 1949-8470 /full/v8/i10/819.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/d7/WJR-8-819.PMC5084060.pdf
org/10.4329/wjr.v8.i10.819 INTRODUCTION Blunt diaphragmatic lesions (BDL) represent a relatively World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v8.i10.819World J Radiol  2016 October 28; 8(10): 819-828 ISSN 1949-8470 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/aa/d7/WJR-8-819.PMC5084060.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/aa/d7/WJR-8-819.PMC5084060.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Federico Caobelli, MD, FEBNM,  Department of Nuclear Medicine , Universitätsspital Basel,   Petersgraben 4, CH ­4032 Basel,  Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/fd/64/WJR-8-829.PMC5084061.pdf
federico.caobelli@usb.chWorld Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v8.i10.829World J Radiol  2016 October 28; 8(10): 829-845 ISSN 1949-8470 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/fd/64/WJR-8-829.PMC5084061.pdf
wjgnet.com/ 1949 ­8470 /full/v8/i10/829.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/64/WJR-8-829.PMC5084061.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fd/64/WJR-8-829.PMC5084061.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to:  Jae Young Lee, MD, PhD,  Department  of Radiology, Seoul National University Hospital, 101 Daehak- ro, Jongno-gu, Seoul 03080, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/69/2b/WJR-8-846.PMC5084062.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v8.i10.846World J Radiol  2016 October 28; 8(10): 846-850 ISSN 1949-8470 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/69/2b/WJR-8-846.PMC5084062.pdf
World J Radiol  2016; 8(10): 846-850  Available  from: URL:  http://www.wjgnet.com/ 1949-8470 /full/v8/i10/846.,Non-OADS,/arxiv_data1/oa_pdf/69/2b/WJR-8-846.PMC5084062.pdf
htm  DOI: http://dx.doi.org/10.4329/wjr.v8.i10.846 INTRODUCTION Sparganosis refers to a parasitic infestation of plerocercoid  larva of Spirometra .,Non-OADS,/arxiv_data1/oa_pdf/69/2b/WJR-8-846.PMC5084062.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/69/2b/WJR-8-846.PMC5084062.pdf
"[http://dx.doi.org/10.1016/j.genhosppsych.2003.08.002] [PMID: 14757302] [3] Allen  MH,  Currier  GW,  Carpenter  D,  Ross  RW,  Docherty  JP.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1097/00131746-200511001-00002] [PMID: 16319571] [4] De Fruyt J, Demyttenaere K. Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.eurpsy.2004.05.006] [PMID: 15276655] [5] Fiorentini A, Volonteri LS, Dragogna F, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.2174/1874473711104040228] [PMID: 21999698] [6] Leventhal AM, Zimmerman M. The relative roles of bipolar disorder and psychomotor agitation in substance dependence.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
[http://dx.doi.org/10.1037/a0019217] [PMID: 20565163],Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.4088/JCP.0706e01] [PMID: 16961418] [8] Marco CA, Vaughan J.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.ajem.2005.02.050] [PMID: 16182986] [9] Sankaranarayanan J, Puumala SE.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1185/030079907X187900] [PMID: 17594776] [10] Zeller SL, Rhoades RW.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.clinthera.2010.03.006] [PMID: 20399981] [11] Boudreaux ED, Allen MH, Claassen C, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.genhosppsych.2009.04.009] [PMID: 19892209] [12] Wittchen HU, Jacobi F, Rehm J, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.euroneuro.2011.07.018] [PMID: 21896369] [13] Pacciardi B, Mauri M, Cargioli C, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.3389/fpsyt.2013.00026] [PMID: 23675355] [14] Pascual JC, Madre M, Soler J, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
[http://dx.doi.org/10.1055/s-2006-941489] [PMID: 16721704] [15] Mintzer JE.,Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1017/S0033291706008920] [PMID: 17018170] [18] Escobar R, San L, Pérez V, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.4321/S0213-61632010000200002] [20] Judd LL, Schettler PJ, Akiskal H, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.jad.2011.12.046] [PMID: 22314261] [21] Pajonk FG, Schmitt P, Biedler A, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
[http://dx.doi.org/10.1016/j.genhosppsych.2008.03.005] [PMID: 18585541] [22] Citrome L. Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents.,Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.2147/TCRM.S31484] [PMID: 23723707] [23] Lehman AF, Lieberman JA, Dixon LB, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.5811/westjem.2011.9.6865] [PMID: 22461914] [26] Garriga M, Pacchiarotti I, Kasper S, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
[http://dx.doi.org/10.3109/15622975.2015.1132007] [PMID: 26912127] [27] Battaglia J. Pharmacological management of acute agitation.,Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.2165/00003495-200565090-00003] [PMID: 15916448] [28] Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/S0166-4328(01)00297-2] [PMID: 11682119] [29] Moritz F, Jenvrin J, Canivet S, Gerault D. Management of agitated patients in emergency departments.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/S1624-0693(04)00151-3] [30] Curran GM, Sullivan G, Williams K, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1067/mem.2003.154] [PMID: 12712033] [31] Wilson MP, Pepper D, Currier GW, Holloman GH Jr, Feifel D. The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.5811/westjem.2011.9.6866] [PMID: 22461918] [32] Valdes J, Shipley T, Rey JA.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.genhosppsych.2007.07.006] [PMID: 18022038] [35] Knox DK, Holloman GH Jr. Use and avoidance of seclusion and restraint: consensus statement of the american association for emergency psychiatry project Beta seclusion and restraint workgroup.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.5811/westjem.2011.9.6867] [PMID: 22461919] [36] Katsakou C, Bowers L, Amos T, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1176/ps.2010.61.3.286] [PMID: 20194406] [37] Richmond JS, Berlin JS, Fishkind AB, et al.",OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.5811/westjem.2011.9.6864] [PMID: 22461917] [38] San L, Arranz B, Querejeta I, Barrio S, De la Gándara J, Pérez V. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"[http://dx.doi.org/10.1016/j.eurpsy.2006.03.005] [PMID: 16697151] [39] Mavrogiorgou P, Brüne M, Juckel G. The management of psychiatric emergencies.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"; Licensee Bentham Open This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/12/CPEMH-12-75.PMC5084082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"Acidogenicity and acid tolerance of presumptive S. oralis isolates Acidogenicity (mean area under the curve for change in pH indicator OD over time 9standard deviation)Acid tolerance (mean area under the curve for growth OD at low pH 9standard deviation) All isolates Most acidogenic All isolates Most acid tolerant Visit 1 Group 1 11.74 94.93 15.13 99.13 0.041 90.020 0.049 90.022 Group 2 13.42 99.06 19.16 917.50 0.039 90.015 0.050 90.026 Group 3 13.16 99.41 15.85 912.37 0.046 90.050 0.051 90.050 Groups 2 /C273 13.26 99.16 17.17 914.52 0.043 90.040 0.051 90.042 Visit 2 Group 1 12.99 96.20 18.45 915.99 0.039 90.015 0.048 90.025 Group 2 13.25 911.69 16.74 914.78 0.045 90.033 0.058 90.051 Group 3 15.42 910.74 21.18 915.99 0.050 90.026 0.066 90.047 Groups 2 /C273 14.50 911.06 19.29 915.45 0.048 90.029 0.062 90.048Low pH streptococci in incipient dental caries Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"Panels b and c show the statistically signiﬁcant positive correlation between MS recovery and caries at Visits 1 and 2, respectively (subjectgroups are labeled as cohorts on the graphs).Low pH streptococci in incipient dental caries Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"oralisMilleri group Unknown Group 1 N/C3041 visits N/C3027 subjects22 3 46 4 0 5 10 13 142 Groups 2 /C273 N/C3055 visits N/C3035 subjects9 8 42 5 1 4 9 6 248 Group 2 N/C3023 visits N/C3016 subjects6 2 16 3 1 0 7 3 90 Group 3 N/C3032 visits N/C3019 subjects3 6 26 2 0 4 2 3 158 Strains that could not be assigned to a species by a PCR-based strategy were designated as Unknown.aNone were positive for S. mitis , none were positive for S. infantis , and none were positive for S. pseudopneumoniae ;bgrowth on pH 5.5 media was obtained for only a subset of subjects and sometimes for only one of the two visits.Low pH streptococci in incipient dental caries Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"Int J Dent 2016:3465163, doi: http://dx.doi.org/10.1155/2016/3465163 19.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
BMC Biol 2009; 7: 3 doi: http://dx.doi.org/10.1187/ 1741-7007-7-324.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
doi: http://dx.doi.org/10.1128/genomeA.,OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"00647-14Low pH streptococci in incipient dental caries Citation: Journal of Oral Microbiology 2016, 8: 32940 - http://dx.doi.org/10.3402/jom.v8.32940 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/6a/JOM-8-32940.PMC5084378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"No other outbreaks than the Srebarna outbreak nor other areas of strains isolation are described in the literature, institutional records, or known bypersonal communication to our knowledge (Marinov, personal communication).Introduction and persistence of tularemia Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"holarctica , Europe;fPrimer generates a product with double melt peaks.Introduction and persistence of tularemia Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"s /C30the numbers of canSNPs on the indicated branch.Introduction and persistence of tularemia Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"PLoS One 2014; 9: e85417.Introduction and persistence of tularemia Citation: Infection Ecology and Epidemiology 2016, 6: 32838 - http://dx.doi.org/10.3402/iee.v6.32838 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/dc/IEE-6-32838.PMC5084392.pdf
"2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d2/13/main.PMC5084415.pdf
"The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Braido et al.",OADS,/arxiv_data1/oa_pdf/d2/13/main.PMC5084415.pdf
"The full report is available on the Centre’s website (http://www.hsric.nihr.ac.uk/news/what- does-the-future-hold-for -copd-diagnosti c-and-moni- toring-technologies/) and will be used to inform healthcare policymakers, commissioners, researchers, research funders, clinicians and patients about new technologies ‘on the horizon’ for the management of COPD.",Non-OADS,/arxiv_data1/oa_pdf/11/8b/10.1177_1479972316636994.PMC5084418.pdf
"Source name Website link Published medical literature Medline & Medline in Progress, & EMBASE Accessed via http://www.elibrary.bham.ac.uk/ PubMed.gov http://www.ncbi.nlm.nih.gov/pubmed The Cochrane Library http://www.cochranelibrary.com/ ZETOC British Library Database http://zetoc.mimas.ac.uk/ HTA agencies AHRQ Healthcare Horizon Scanning System Status update reports and potential high impact reports via http:// www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction ¼displayproduct&productid ¼881 CADTH http://www.cadth.ca ECRI Institute http://www.ecri.org EuroScan International Network http://euroscan.org.uk/ NIHR Horizon Scanning Research & Intelligence Centre databasehttp://www.hsric.nihr.ac.uk/ Clinical trial registries and research funding databases ClinicalTrials.gov http://clinicaltrials.gov/ COPD clinical research network http://www.copdcrn.org/ Current-controlled trials http://www.controlled-trials.com/ MRC-funded research http://www.mrc.ac.uk/research/funded-research/ NIHR Biomedical Research Centres and Units annual dataset (2014)Not applicable NIHR Evaluation Trials and Studies Project portfoliohttp://www.nets.nihr.ac.uk/ projects?collection ¼netscc&meta_P_sand ¼Project UKCRN portfolio database http://public.ukcrn.org.uk/search/ World Health Organization International Clinical Trials Registry Platformhttp://www.who.int/ictrp/en/ Specialist media and commercial research and development databases AdvamedSmartbrief https://www2.smartbrief.com/news/ADVAMED/index.jsp Clinica http://www.clinica.co.uk/ Fierce Devices http://www.fiercemedicaldevices.com/ GlobalData Medical http://globaldata.com/medical/Login.aspx?ReturnUrl ¼%2fmedical MedGadget http://www.medgadget.com/ Medical News Today http://www.medicalnewstoday.com/ Regulatory authorities USFDA approvals http://www.fda.gov/newsevents/productsapprovals/default.htm Specialist journals American Journal of Respiratory and Critical Care Medicinehttp://www.atsjournals.org/journal/ajrccm COPD: Journal of Chronic Pulmonary Obstructive Diseasehttp://informahealthcare.com/loi/cop European Respiratory Journal http://erj.ersjournals.com/ Expert Reviews of Respiratory Medicine http://informahealthcare.com/loi/erx International Journal of Chronic Obstructive Pulmonary Diseasehttp://www.dovepress.com/international-journal-of-chronic-obstructive- pulmonary-disease-journal Thorax http://thorax.bmj.com/ Professional and patient groups American Thoracic Society http://www.thoracic.org/ British Lung Foundation http://www.blf.org.uk/Home British Thoracic Society https://www.brit-thoracic.org.uk/ COPD Foundation http://www.copdfoundation.org/ European Lung foundation http://www.europeanlung.org/en/ European Respiratory Society http://www.ersnet.org/ Primary Care Respiratory Society http://www.pcrs-uk.org/ Royal College of Physicians https://www.rcplondon.ac.uk/Dixon et al.",Non-OADS,/arxiv_data1/oa_pdf/11/8b/10.1177_1479972316636994.PMC5084418.pdf
"Birmingham Lung Improvement StudieS (BLISS), http://www.birming- ham.ac.uk/research/activity/mds/projects/HaPS/ PHEB/BLISS/index.aspx (2015, accessed 10 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/11/8b/10.1177_1479972316636994.PMC5084418.pdf
"FDA, http://www.fda.gov/ Drugs/DevelopmentApprovalProcess/DrugDevelop- mentToolsQualificationProgram/ucm284076.htm (2015, accessed 07/07/2015).",Non-OADS,/arxiv_data1/oa_pdf/11/8b/10.1177_1479972316636994.PMC5084418.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9f/79/tom197.PMC5084455.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00196 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 3 |SEPTEMBER 2016 197,Non-OADS,/arxiv_data1/oa_pdf/9f/79/tom197.PMC5084455.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/de/74/JOS-5-117.PMC5084472.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/de/74/JOS-5-117.PMC5084472.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/37/21/JOS-5-127.PMC5084474.pdf
Angle	 Orthod	2015.	doi:	http://dx.doi.org/10.2319/051315‑323.1.,OADS,/arxiv_data1/oa_pdf/ae/3c/JOS-5-132.PMC5084475.pdf
Available from: http://www.clinicaltrialsgov/ct2/show/ NCT01641939.,Non-OADS,/arxiv_data1/oa_pdf/7f/bf/JRPP-5-227.PMC5084478.pdf
Available  from: http://hdl.handle.net/10138/37096.,Non-OADS,/arxiv_data1/oa_pdf/7f/bf/JRPP-5-227.PMC5084478.pdf
Available from: http://www.whocc.no/.,Non-OADS,/arxiv_data1/oa_pdf/83/03/JRPP-5-234.PMC5084479.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs310/en/.,Non-OADS,/arxiv_data1/oa_pdf/e4/da/JRPP-5-238.PMC5084480.pdf
Available from:  https://www.cddep.org/sites/default/files/swa_2015_final.,Non-OADS,/arxiv_data1/oa_pdf/e4/da/JRPP-5-238.PMC5084480.pdf
Available  from: http://www.ncipd.org/control/images/NCIPD_docs/ CLSI_M100‑S24.pdf.,OADS,/arxiv_data1/oa_pdf/e4/da/JRPP-5-238.PMC5084480.pdf
Available  from: http://omr.bayer.ca/omr/online/avelox‑ pm‑en.pdf.,OADS,/arxiv_data1/oa_pdf/91/1c/JRPP-5-294.PMC5084489.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/13/86/10.1177_2325967116670117.PMC5084518.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b9/6e/10.1177_2325967116669490.PMC5084520.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/29/38/10.1177_2325967116669310.PMC5084521.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7b/cd/10.1177_2325967116668829.PMC5084526.pdf
http://www.covidien.com/imageServer.aspx/doc267039.pdf?,Non-OADS,/arxiv_data1/oa_pdf/7b/cd/10.1177_2325967116668829.PMC5084526.pdf
http://www.covidien.com/imageServer.aspx/doc336881.pdf?,Non-OADS,/arxiv_data1/oa_pdf/7b/cd/10.1177_2325967116668829.PMC5084526.pdf
Available from: http://www.dfda.goa.gov.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from  http://timesofindia.indiatimes.com/india/Govt‑ plans‑ exit‑ exam‑for‑MBBS‑doctors/articleshow/47494308.cms.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: https://www.indiaoppi.com/sites/ default/files/PDF%20files/Report%20on%20healthcare%20 access%20initiatives%20 (For%20web) pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: https://www.nrhm‑mis.nic.in/RURAL%20 HEALTH%20STATISTICS/(A) RHS%20‑%202015/Health%20 Manpower%20in%20rural%20areas.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: http://www.lobis.nic.in/ddir/dhc/ RSE/judgement/09‑04‑2016/RSE08042016CW78652010.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: http://www.pib.nic.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: http://www.njhonline.com/1995/ jul_aug_95_vol_1V_no_4/misc/can_homoeopath_practise_ allopathy.shtml.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
Available from: http://www.ima‑india.org/ima/left‑side‑bar.php?scid=245.,Non-OADS,/arxiv_data1/oa_pdf/63/1e/JFMPC-5-215.PMC5084535.pdf
This program was organized by the Vasco da Gama Movement (Vasco da  Gama Movement is WONCA Europe's Working group for New and Future GPs: http://vdgm.woncaeurope.org/).,Non-OADS,/arxiv_data1/oa_pdf/73/8e/JFMPC-5-220.PMC5084536.pdf
Available from: http://www.who.int/hpr/NPH/docs/ declaration_almaata.pdf.,OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.who.int/whr/2008/en/.,OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available  from: http://www.communityhealth.in/~commun26/ wiki/images/6/64/Nhp_1983.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available  from: https://www.imperial.ac.uk/media/imperial‑college/ institute‑of‑global‑health‑innovation/public/Primary‑care.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.iimahd.ernet.in/ assets/snippets/workingpaperpdf/3937368102011‑05‑03.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.who.int/nmh/publications/ essential_ncd_interventions_lr_settings.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.lgreen.net/precede.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.lgreen.net/patch.,Non-OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.naccho.org/topics/ infrastructure/mapp/.,OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available from: http://www.data.worldbank.,OADS,/arxiv_data1/oa_pdf/dd/d0/JFMPC-5-228.PMC5084538.pdf
Available  from: http://www.calicutmedicalcollege.ac.in.,Non-OADS,/arxiv_data1/oa_pdf/0e/ce/JFMPC-5-238.PMC5084540.pdf
Available  from: http://www.mciindia.org/tools/announcement/ MCI_booklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/ce/JFMPC-5-238.PMC5084540.pdf
Available from: http://www.un.org/esa/population/ publications/worldageing19502050/pdf/80 chapterii.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.censusindia.gov.in/2011‑prov‑results/indiaatglance.,OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.censusindia.gov.in/vital_ statistics/SRS_Report/9Chap%202%20‑%202011.pdf.,OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.prb.org/pdf12/ todaysresearchaging25.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.countryoffice.unfpa.org/ india/drive/LivingarrangementinIndia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.papers.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.mospi.nic.in/mospi_new/ upload/elderly_in_india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from:  http://www.socialjustice.nic.in/hindi/pdf/npopcomplete.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: http://www.socialjustice.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available from: https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ file/198033/National_Service_Framework_for_Older_ People.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/JFMPC-5-242.PMC5084541.pdf
Available  from: http://www.mhra.gov.uk/Safetyinformation/ DrugSafetyUpdate/CON087970.,Non-OADS,/arxiv_data1/oa_pdf/77/06/JFMPC-5-248.PMC5084542.pdf
Available from:  http://www.sign.ac.uk/pdf/sign70.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/06/JFMPC-5-248.PMC5084542.pdf
Available from:  http://www.nice.org.uk/nicemedia/pdf/cg020fullguideline.,Non-OADS,/arxiv_data1/oa_pdf/77/06/JFMPC-5-248.PMC5084542.pdf
Available from:  http://www.phac‑aspc.gc.ca/cd‑mc/publications/diabetes‑ diabete/facts‑figures‑faits‑chiffres‑2011/highlights‑ saillants‑eng.php#chp6.,Non-OADS,/arxiv_data1/oa_pdf/b4/64/JFMPC-5-259.PMC5084544.pdf
Available from:   http://www.publications.gc.ca/collections/ collection_2008/phac‑aspc/HP5‑5‑2‑2005E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/64/JFMPC-5-259.PMC5084544.pdf
Available  from: http://www.foodskillsforfamilies.ca/Food_Skills_ for_Families_Evaluation_Report_March_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/64/JFMPC-5-259.PMC5084544.pdf
Available from: http://www.foodskillsforfamilies.ca/ wp‑content/uploads/2011/03/Food‑Skills‑for‑Families‑ ADI‑Evaluation‑Report_October‑2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/64/JFMPC-5-259.PMC5084544.pdf
Available  from: http://www.foodskillsforfamilies.ca/wp‑content/ uploads/2013/11/Food‑Skills‑for‑Families_WEB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/64/JFMPC-5-259.PMC5084544.pdf
Available from:  http://www.c3health.org/wp‑content/uploads/2009/09/ C3_DIABETES_BOOK_SCOTLAND_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/JFMPC-5-270.PMC5084546.pdf
Available from:  http://www.divaportal.org/smash/get/diva2:322414/ FULLTEXT01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/JFMPC-5-270.PMC5084546.pdf
Available  from: http://www.chcf.org/publications/2006/12/ building‑peer‑support‑programs‑to‑manage‑chronic ‑ disease‑seven‑models‑for‑success.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/JFMPC-5-270.PMC5084546.pdf
Available from: http://www.who  int/diabetes/publications/Diabetes_final_13_6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/JFMPC-5-270.PMC5084546.pdf
Available from: http://www.drexel.edu/provost/ aard/resources‑programs/peer‑mentoring/faqs/.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/JFMPC-5-270.PMC5084546.pdf
Available from: http://www.ihf‑fih.org.,Non-OADS,/arxiv_data1/oa_pdf/4c/6e/JFMPC-5-291.PMC5084550.pdf
Available from:  http://www.who.int/classifications/en/WHOFICFamily.pdf.,OADS,/arxiv_data1/oa_pdf/4c/6e/JFMPC-5-291.PMC5084550.pdf
Available from: http://www.kith.no/ templates/kith_WebPage____1062.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4c/6e/JFMPC-5-291.PMC5084550.pdf
Available from: https://www.idf.org/sites/default/files/ EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/b6/JFMPC-5-302.PMC5084552.pdf
Available from: http://www.unicef.org/publications/ files/pub_brochure_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/8d/JFMPC-5-309.PMC5084553.pdf
Available from: http://www.wcd.nic.in/publication/ infantandyoungchildfeed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/8d/JFMPC-5-309.PMC5084553.pdf
Available from: http://www.pdf.usaid.gov/pdf_docs/ PNADK385.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/8d/JFMPC-5-309.PMC5084553.pdf
Available from: http://www.fao.org/es/ esa.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/JFMPC-5-314.PMC5084554.pdf
Available from: http://archive.unu.edu/unupress/ food/8F084e/8F084E08.htm.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/JFMPC-5-314.PMC5084554.pdf
Available from: http://www.fao.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/JFMPC-5-314.PMC5084554.pdf
Available from: http://www.apps.who.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/JFMPC-5-314.PMC5084554.pdf
Available  from: http://www.iipsindia.org/nfhs3.html.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/JFMPC-5-314.PMC5084554.pdf
: Prevalence of postpartum morbidities in Udupi TalukJournal of Family Medicine and Primary Care 325 April 2016 : Volume 5 : Issue 2from: http://www.cess.ac.in//cesshome/workingpaperoff.,Non-OADS,/arxiv_data1/oa_pdf/a1/3f/JFMPC-5-320.PMC5084555.pdf
Available from: http://urn.kb.se/resolve?urn=urn:nbn:se: kau:diva‑9023 urn:nbn:se:kau:diva‑9023.,OADS,/arxiv_data1/oa_pdf/b1/e8/JFMPC-5-338.PMC5084558.pdf
Available from: http://www.aafp.org/fpm/980700fm/ heane.html.,Non-OADS,/arxiv_data1/oa_pdf/b1/e8/JFMPC-5-338.PMC5084558.pdf
Available from: http://www.aafp.org/fpm/990100fm/40.,Non-OADS,/arxiv_data1/oa_pdf/b1/e8/JFMPC-5-338.PMC5084558.pdf
Available from: http://www.aafp.,Non-OADS,/arxiv_data1/oa_pdf/b1/e8/JFMPC-5-338.PMC5084558.pdf
"London, Department of Health, 2004  Available from: http://www.bhfactive.org.uk cmos‑report‑ at‑least‑five‑a‑week.pdf.",Non-OADS,/arxiv_data1/oa_pdf/bf/ad/JFMPC-5-349.PMC5084560.pdf
Available from:  http://www.mhrd.gov.in/sites/upload_files/mhrd/files/ document‑reports/XIIFYP_SocialSector.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available from:  https://www.ideas.repec.org/a/ebl/ecbull/eb‑12‑00716.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available from: http://www.epw.in/ special‑articles/economic‑burden‑cancer.html.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available  at: http://www.nrhmorissa.gov.in/writereaddata/Upload/ Documents/OUT%20of%20POCKET%20SPENDING%20on%20 Health%20in%20ODISHA%20%E2%80%93%20CURRENT%20 STATUS%20and%20SOME%20RECOMENDATIONS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available  from: http://www.censusindia.gov.in/vital_statistics/mmr_ bulletin_2011‑13.pdf.,OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available  at: http://mospi.nic.in/Mospi_New/upload/nss_71st_ki_ health_30june15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
DOI :  http://dx.doi.org/10.1596%2F978 ‑0‑8213 ‑9618 ‑6.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available from: http://www.documents.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/JFMPC-5-367.PMC5084563.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs339/en.,Non-OADS,/arxiv_data1/oa_pdf/5b/2f/JFMPC-5-373.PMC5084564.pdf
Available from:  http://www.whoindia.org/EN/Section20/Section25_1861.,Non-OADS,/arxiv_data1/oa_pdf/5b/2f/JFMPC-5-373.PMC5084564.pdf
Available from: http://www.cdc.gov/ncbddd/ actearly/milestones/.,OADS,/arxiv_data1/oa_pdf/06/a2/JFMPC-5-378.PMC5084565.pdf
Available  from: http://www.mdm.nic.in/Files/School%20Health%20 Programme/Nutrition_Support/Rastriya_Bal_Swaasthya_ Karyakram.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/a2/JFMPC-5-378.PMC5084565.pdf
Available from: http://www.jhpiego.org/files/BPCRtoolkit.,OADS,/arxiv_data1/oa_pdf/b6/7f/JFMPC-5-404.PMC5084570.pdf
Available from: http://www.who.int/healthinfo/ global_burden_disease/2004.update/en/.,Non-OADS,/arxiv_data1/oa_pdf/97/42/JFMPC-5-416.PMC5084572.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/97/42/JFMPC-5-416.PMC5084572.pdf
Available from: http://www.nihfw.org/ NDC/DocumentationServices/NationalHealthProgramme/ NATIONALCANCERCONTROLPROGRAMME.,OADS,/arxiv_data1/oa_pdf/34/27/JFMPC-5-430.PMC5084575.pdf
Available from:  http://www.tbfacts.org/tb‑statistics.html.,Non-OADS,/arxiv_data1/oa_pdf/c6/fc/JFMPC-5-435.PMC5084576.pdf
Available  from: http://www.who.int/hrh/documents/JLi_hrh_report.,OADS,/arxiv_data1/oa_pdf/5e/67/JFMPC-5-440.PMC5084577.pdf
Available from:  http://www.afro.who.int/en/nigeria/press‑materials/item /7766‑who‑nigeria‑supports‑synchronization‑of‑immuniz ation‑along‑international‑borders.html.,Non-OADS,/arxiv_data1/oa_pdf/80/72/JFMPC-5-457.PMC5084581.pdf
Available from: http://iris.paho.org/xmlui/bitstream/ handle/123456789/750/9275116199.pdf?sequence=1.,OADS,/arxiv_data1/oa_pdf/80/72/JFMPC-5-457.PMC5084581.pdf
Available from: http://www.epod.cid.harvard.edu/ health‑policy.,Non-OADS,/arxiv_data1/oa_pdf/74/a4/JFMPC-5-463.PMC5084583.pdf
Available from: http://www.ajol.info/index.php/eamj/ article/viewFile/8689/1927.,Non-OADS,/arxiv_data1/oa_pdf/74/a4/JFMPC-5-463.PMC5084583.pdf
Available from: http://www.who.int/neglected_ diseases/integrated_media_snakebite/en/.,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/JFMPC-5-474.PMC5084587.pdf
Available from: http://www.who.int/ neglected_diseases/diseases/snakebites/en/.,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/JFMPC-5-474.PMC5084587.pdf
Available from: http://www.files.,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/JFMPC-5-474.PMC5084587.pdf
Available  from: http://www.statehealthsocietybihar.org/ nationalsnakebitemanagementprotocol.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/JFMPC-5-474.PMC5084587.pdf
Available from: http://www.nhsrcindia.org/index.,Non-OADS,/arxiv_data1/oa_pdf/84/b9/JFMPC-5-498.PMC5084596.pdf
Available from: http://www.unicef.in/ PressReleases/227/Female‑foeticide‑in‑India.,Non-OADS,/arxiv_data1/oa_pdf/3e/0e/JFMPC-5-503.PMC5084599.pdf
Available from: http://www.wcd.nic.,Non-OADS,/arxiv_data1/oa_pdf/3e/0e/JFMPC-5-503.PMC5084599.pdf
Available from:  http://www.jpma.org.pk/full_article_text.php?article_ id=387.,Non-OADS,/arxiv_data1/oa_pdf/4c/ca/JFMPC-5-509.PMC5084602.pdf
Available  from: http://www.rchiips.org/nfhs/.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/JFMPC-5-512.PMC5084603.pdf
Available from: http://www.rchiips.org/ NFHS/NFHS4/manual/NFHS‑4%20Biomarker%20Field%20 Manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/JFMPC-5-512.PMC5084603.pdf
Letter to EditorJournal of Family Medicine and Primary Care 513 April 2016 : Volume 5 : Issue 2Available from: http://www.rchiips.org/nfhs/factsheet_ NFHS‑4.shtml.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/JFMPC-5-512.PMC5084603.pdf
Available  from: http://www.rchiips.org/NFHS/NFHS4/schedules/ NFHS‑4Mans.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/JFMPC-5-512.PMC5084603.pdf
Available  from: http://rchiips.org/NFHS/NFHS4/schedules/NFHS‑ 4Womans.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/JFMPC-5-512.PMC5084603.pdf
http://www.cdc.gov/growthcharts/clini- cal_charts.htm.,OADS,/arxiv_data1/oa_pdf/a9/12/10.1177_2333794X16674382.PMC5084611.pdf
"BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015, 2015, http://www.bhiva.org/HIV-1-treatment-guidelines.aspx  3.",Non-OADS,/arxiv_data1/oa_pdf/e4/a7/10.1177_2050312116675813.PMC5084612.pdf
"Triumeq 50mg, 300mg, 600mg tablets, 2016, https://www.medicines.org.uk/emc/medicine/29178  10.",Non-OADS,/arxiv_data1/oa_pdf/e4/a7/10.1177_2050312116675813.PMC5084612.pdf
METHODS Methods are available online as Supplemental Digital Con- tent ( http://links.lww.com/MPG/A759 ).,Non-OADS,/arxiv_data1/oa_pdf/ea/ac/jpga-63-531.PMC5084628.pdf
12-7486. http://www.nhlbi.nih.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/b0/1a/jpga-63-544.PMC5084629.pdf
"2012, http://www.ahrq.gov/ .",Non-OADS,/arxiv_data1/oa_pdf/b0/1a/jpga-63-544.PMC5084629.pdf
"2007, http://www.uspreventiveservicestaskforce.",Non-OADS,/arxiv_data1/oa_pdf/b0/1a/jpga-63-544.PMC5084629.pdf
"1, http://links.lww.com/MPG/A676 ) without esophageal perforation or chest pain.",Non-OADS,/arxiv_data1/oa_pdf/63/38/jpga-63-474.PMC5084639.pdf
"Only 2 small cases series fulfilled these criteria (Supplemental Digital Content, Table 1, http://links.lww.com/MPG/A677 ); they described 6 adolescents who underwent effective and safe esophageal dilation.",Non-OADS,/arxiv_data1/oa_pdf/63/38/jpga-63-474.PMC5084639.pdf
"Du¨sseldorf: German Medical Science GMS Publishing House 2011Available at: http://www.egms.de/static/en/meetings/ esm2011/11esm067.shtml .Prodeus et al JPGN /C15Volume 63, Number 5, November 2016 542 www.jpgn.org",Non-OADS,/arxiv_data1/oa_pdf/6b/b9/jpga-63-534.PMC5084641.pdf
"Those with poor mental well-being reported more depression and anxiety diagnoses and prescription history than those with good mental well-being (see Table 1 in Appendix, Supplemental Digital Content 1, http://links.lww.com/JOM/A310).",Non-OADS,/arxiv_data1/oa_pdf/89/51/joem-58-1121.PMC5084642.pdf
"Those with poor mental well-being reported more resource use than those with good mental well-being (see Table 3; individual regression tables located in Appendix: doctor visits—see Tables 6a and 6b, ER visits —see Tables 7a and 7b, and hospitalizations —see Tables 8a and 8b, Supplemental Digital Con- tent 1, http://links.lww.com/JOM/A310).",Non-OADS,/arxiv_data1/oa_pdf/89/51/joem-58-1121.PMC5084642.pdf
"Similarly, those with poor mental well-being reported more activity and work impairment than those with good mental well-being (see Table 3; individual regression tables located in Appendix: absenteeism —see Tables 2a and 2b, presenteeism- see Tables 3a and 3b, overall work impairment —see Tables 4a and 4b, and activity impairment —see Tables 5a and 5b, Supplemental Digital Content 1, http://links.lww.com/JOM/A310).",Non-OADS,/arxiv_data1/oa_pdf/89/51/joem-58-1121.PMC5084642.pdf
Available at: https://meps.ahrq.gov/mepsweb/data_stats/quick_ tables_results.jsp?component=1&subcomponent=0&year=2012&tableSer ies=1&searchText=&searchMethod=1&Action=Search.,OADS,/arxiv_data1/oa_pdf/89/51/joem-58-1121.PMC5084642.pdf
Available at: http://www.bls.gov/opub/reports/ womens-earnings/archive/womensearnings_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/51/joem-58-1121.PMC5084642.pdf
"2  187–202 https://doi.org/10.1083/jcb.201601061Introduction Induced pluripotent stem cells (iPSCs), derived by transduc - tion of somatic cells with OCT4 , SOX2 , KLF4 , and c- MYC  are  defined as pluripotent in view of their ability to self-renew and  differentiate into cell types representative of three embryonic  germ layers (Takahashi et al., 2007; Park and Daley, 2009);  however, several studies have shown considerable variation in  their differentiation potential (Narsinh et al., 2011; Tobin and  Kim, 2012).",Non-OADS,/arxiv_data1/oa_pdf/33/41/JCB_201601061.PMC5084643.pdf
2  151–166 https://doi.org/10.1083/jcb.201601083Introduction The primary role of the cell cycle is to generate two daughter  cells during mitosis that possess equivalent genomic DNA.,Non-OADS,/arxiv_data1/oa_pdf/75/1a/JCB_201601083.PMC5084644.pdf
"2  231–243 https://doi.org/10.1083/jcb.201602001Introduction Upon stimulation from the environment, many cell types use  calcium signals for intracellular processing of information  and the induction of appropriate biological responses through  activating specific gene expression programs (Berridge et al.,  2000; Clapham, 2007).",Non-OADS,/arxiv_data1/oa_pdf/c8/de/JCB_201602001.PMC5084645.pdf
"2  167–185 https://doi.org/10.1083/jcb.201602090Introduction Lysosomes degrade extra- and intracellular material delivered  by endocytosis, phagocytosis, or autophagy and recycle catabo - lites for reutilization in cellular metabolism.",Non-OADS,/arxiv_data1/oa_pdf/40/d1/JCB_201602090.PMC5084646.pdf
2  259–275 https://doi.org/10.1083/jcb.201604095Introduction A conserved feature of the central nervous system (CNS) is  its stratified organization.,Non-OADS,/arxiv_data1/oa_pdf/65/c7/JCB_201604095.PMC5084647.pdf
"2  217–229 https://doi.org/10.1083/jcb.201604097Introduction Normal development requires the self-organization of cells  by sorting or segregation to establish and maintain boundar - ies and ultimately form distinct tissues in the adult organism  (Fagotto, 2014).",Non-OADS,/arxiv_data1/oa_pdf/88/c5/JCB_201604097.PMC5084648.pdf
"2  245–258 https://doi.org/10.1083/jcb.201605065Introduction Opioids such as morphine are the most potent and efficacious  drugs currently available for pain management (Fields, 2011).",Non-OADS,/arxiv_data1/oa_pdf/b7/93/JCB_201605065.PMC5084649.pdf
2  203–216 https://doi.org/10.1083/jcb.201605073Introduction Mast cells (MCs) are granulated cells of hematopoietic lineage  that house most tissues in the body.,Non-OADS,/arxiv_data1/oa_pdf/8f/cb/JCB_201605073.PMC5084650.pdf
2  143–145 https://doi.org/10.1083/jcb.201609086Mitotic cyclins were serendipitously discovered by Tim Hunt  while studying mRNA translation in sea urchin oocytes in  1982.,Non-OADS,/arxiv_data1/oa_pdf/1c/96/JCB_201609086.PMC5084651.pdf
The online-only Data Supplement is available with this arti- cle at http://circ.ahajournals.org/lookup/suppl/doi: 10.1161/ CIRCULATIONAHA.115.020754/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b1/6d/cir-134-1353.PMC5084654.pdf
Circulation is available at http://circ.ahajournals.org.,Non-OADS,/arxiv_data1/oa_pdf/b1/6d/cir-134-1353.PMC5084654.pdf
Available from URL: http://www.dpncheck.com/resources/Resources/nc-stat_dpnch eck_normative_data_monograph_for_software_version_2_0_pn2203866_rev_ a.pdf.,OADS,/arxiv_data1/oa_pdf/33/a6/CAS-107-1453.PMC5084655.pdf
"For the correla- tion analysis using The Cancer Genome Atlas (TCGA) data- sets, the following types of the “level3” processed andnormalized dataset were downloaded from the TCGA website(https://tcga-data.nci.nih.gov/tcga/): Illumina HiSeq RNA-Seq v2 exon expression data (RPKM normalized) and reverse phase protein array (RPPA) proteomic data of lung adenocarci-noma.",OADS,/arxiv_data1/oa_pdf/6f/b9/CAS-107-1416.PMC5084657.pdf
Sequence data were analyzed using the QUMA quantiﬁcation tool (http://quma.cdb.riken.jp/) for methylation analysis.,OADS,/arxiv_data1/oa_pdf/8c/01/CAS-107-1399.PMC5084658.pdf
Avail- able from URL: http://www.mhlw.go.jp/.,Non-OADS,/arxiv_data1/oa_pdf/8c/01/CAS-107-1399.PMC5084658.pdf
The a-SMA- and periostin-positive areas and the proliferating cell nuclear antigen (PCNA)-positive cell rate (PCNA index) were calculated in FIVE ﬁelds at a magniﬁca-tion of 9200 with a light microscope using ImageJ software (http://rsb.info.nih.gov/ij/) provided by the US National Insti- tutes of Health.,OADS,/arxiv_data1/oa_pdf/80/81/CAS-107-1443.PMC5084662.pdf
"(33)We designed speciﬁc primers for a- SMA, periostin, and ﬁbroblast growth factor-2 (FGF-2) usingPrimer 3 software (http://primer3.sourceforge.net/).",Non-OADS,/arxiv_data1/oa_pdf/80/81/CAS-107-1443.PMC5084662.pdf
The Gene Set Enrichment Analysis (GSEA) algorithm was used to evaluate the statistical signiﬁcance of gene expression.Gene Set Enrichment Analysis is supported by the Broad Insti-tute (http://www.broadinstitute.org/gsea/index.jsp).,OADS,/arxiv_data1/oa_pdf/a1/db/CAS-107-1422.PMC5084664.pdf
"To identify potential binding proteins of PepE, the AnnotatedDatabase of Druggable Binding Sites from the Protein Data- Bank (sc-PDB), (http://bioinfo-pharma.u-strasbg.fr/scPDB/), which contains structural information (e.g., active sites) ofmore than 3678 known or potential protein drug targets, wasused.",OADS,/arxiv_data1/oa_pdf/80/18/CAS-107-1506.PMC5084666.pdf
Available from: http://www.jcog.jp/doctor/tool/ RECISTv11J_20100810.pdf (accessed 14 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/40/73/CAS-107-1465.PMC5084669.pdf
"We then displayed the results obtained with the aidof TreeView software (http://rana.lbl.gov/EisenSoftware.htm, accessed March 21, 2008).",OADS,/arxiv_data1/oa_pdf/59/fe/CAS-107-1527.PMC5084673.pdf
"In this study, we did not stain carcinoid tumors for YAP1, butcould conﬁrm that carcinoid tumors were completely negative for YAP1 in the human protein atlas database (http://www.pro- teinatlas.org/), which suggested that loss of YAP1 was notspeciﬁc to high-grade neuroendocrine tumors, but common inneuroendocrine tumors.",Non-OADS,/arxiv_data1/oa_pdf/59/fe/CAS-107-1527.PMC5084673.pdf
Western blots were quantitated by densitometric analysis by using the ImageJ software program (https://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/69/9f/CAS-107-1380.PMC5084678.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/11/ofw118.PMC5084713.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/dc/ofw157.PMC5084714.pdf
Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/ sb191-Hospitalization-Mental-Substance-Use-Disorders-2012.pdf .A c c e s s e d 1 May 2016.,Non-OADS,/arxiv_data1/oa_pdf/59/dc/ofw157.PMC5084714.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/cc/ofw135.PMC5084715.pdf
Available at: http://aidsinfo.nih.gov/content ﬁles/ lvguidelines/AdultandAdolescentGL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/79/cc/ofw135.PMC5084715.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/e5/ofw145.PMC5084717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivslicence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/14/ofw192.PMC5084718.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/af/ofw151.PMC5084719.pdf
Odds ratios forconversion of sputum culture or smear were calculated usingan online calculator ( https://www.medcalc.org/calc/odds_ratio.,OADS,/arxiv_data1/oa_pdf/56/af/ofw151.PMC5084719.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ofw127.PMC5084720.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/5f/ofw153.PMC5084721.pdf
Available at: http://www.theco mmunityguide.org/ emergencypreparedness/schooldismissals.html .,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/ofw113.PMC5084722.pdf
Available at: http://nces.ed.gov/ .,OADS,/arxiv_data1/oa_pdf/ad/1b/ofw113.PMC5084722.pdf
Available at: http://www.fns.usda.gov/nslp/national-school-lunch- program-nslp .,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/ofw113.PMC5084722.pdf
"All original costs were inﬂated to the year 2014, then converted to Euros ( €) if necessary, using a currency calculator available on http://www.x-rates.com/.",Non-OADS,/arxiv_data1/oa_pdf/ea/9c/CDR-34-152.PMC5084727.pdf
2013. http://www.idf.org/diabetesatlas/download-book.,Non-OADS,/arxiv_data1/oa_pdf/ea/9c/CDR-34-152.PMC5084727.pdf
2010. http://www.clinpage.com/images/uploads/endpoint-defs_11-16-2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/9c/CDR-34-152.PMC5084727.pdf
Available from:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri ¼OJ: L:2013:179:0001:0021:EN:PDF [Accessed 26 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/72/ae/BEM-37-423.PMC5084735.pdf
Available from: http://www.fingrid.fi/en/grid_projects/maintenance/Handling %20of%20border%20zone%20trees/Pages/default.aspx [ A c c e s s e d2 1F e b r u a r y2 0 1 6 ] .,OADS,/arxiv_data1/oa_pdf/72/ae/BEM-37-423.PMC5084735.pdf
Available at: http://www.bernergarde.org/home/de- fault.aspx.,Non-OADS,/arxiv_data1/oa_pdf/0d/fb/JVIM-30-1197.PMC5084741.pdf
Available at: http://bernergarde.org/db/.,Non-OADS,/arxiv_data1/oa_pdf/0d/fb/JVIM-30-1197.PMC5084741.pdf
Available at: http://www.cebm.net/index.aspx?o=5653.,Non-OADS,/arxiv_data1/oa_pdf/0d/fb/JVIM-30-1197.PMC5084741.pdf
Available at: http://www.caninelifetimehealth.org/.,Non-OADS,/arxiv_data1/oa_pdf/0d/fb/JVIM-30-1197.PMC5084741.pdf
"The FunRich software 2.1.2 (http://www.funrich.org) was used to classify the proteins, and the signiﬁcance level was set at 0.001.",OADS,/arxiv_data1/oa_pdf/b4/31/PRCA-10-554.PMC5084743.pdf
Supportin ginformat ionforthisarticle canbefound under http://dx.doi.or g/10.10 02/chem.20 1600892.,OADS,/arxiv_data1/oa_pdf/59/e5/CHEM-22-8685.PMC5084751.pdf
Experimental Section Sample preparation :TheDNA origami structure was designed by using caDNAno software (version 0.2.3 ;http://cadnano.org/ legacy ;[7]design schematics inFigure S1).,OADS,/arxiv_data1/oa_pdf/d5/99/CBIC-17-1093.PMC5084756.pdf
"dexamethasone for the treatment of patients with MM who have received at least one prior therapy (http://www.ninlaro.com/downloads/prescribing-information.pdf), based on datafrom the TOURMALINE-MM1 phase 3 trial in patients withRRMM (Moreau et al, 2015a).",Non-OADS,/arxiv_data1/oa_pdf/c9/dd/BJH-174-748.PMC5084759.pdf
http://www.fda.gov/downloads/Drugs/ .../Guidances/UCM204959.,Non-OADS,/arxiv_data1/oa_pdf/c9/dd/BJH-174-748.PMC5084759.pdf
Registration number: ISRCTN55784442 (http://www.controlled-trials.com).,Non-OADS,/arxiv_data1/oa_pdf/e3/dd/BJS-103-962.PMC5084762.pdf
http://www.pssru.ac.uk/ project-pages/unit-costs/2014/ [accessed 5 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/dd/BJS-103-962.PMC5084762.pdf
https://www.sheffield.ac.uk/polopoly_fs/1 ⋅227404!/ file/NHS_111_final_report_August_2012.pdf [accessed 5 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/dd/BJS-103-962.PMC5084762.pdf
https://www.gov.uk/government/publications/nhs- reference-costs-2013-to-2014 [accessed 5 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/dd/BJS-103-962.PMC5084762.pdf
"12 –26 12 This is an open access article distributed under the terms of the Creative Commons Attribution IGO license https://creativecommons.org/ licenses/by/3.0/igo/legalcode which permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/59/MCN-12-12.PMC5084763.pdf
Full details on the framework can be found at http://apps.who.int/gb/ebwha/ pdf_ﬁles/WHA68/A68_9-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/59/MCN-12-12.PMC5084763.pdf
(http://www.who.int/nutrition/en/).,Non-OADS,/arxiv_data1/oa_pdf/b0/59/MCN-12-12.PMC5084763.pdf
(http://www.who.int/childgrowth/training/en/.,Non-OADS,/arxiv_data1/oa_pdf/b0/59/MCN-12-12.PMC5084763.pdf
To view this mini commentary visit http://dx.doi.org/10.1111/1471-0528.14130.,Non-OADS,/arxiv_data1/oa_pdf/ec/2f/BJO-123-1609.PMC5084768.pdf
"37Since then, at least 36 potentially causal CLN5 sequence variants have been found in human NCL patients (http://www.ucl.ac.uk/ncl/cln5.",Non-OADS,/arxiv_data1/oa_pdf/cb/79/JVIM-30-1149.PMC5084771.pdf
A TPP1 -deﬁcient canine NCL model 5 has proven useful in the evaluation of therapies for the human CLN2 form of NCL including an enzyme replacement therapy that is currently in clinical trials inhuman patients (https://clinicaltrials.gov/ct2/show/NCT0 1907087).49–51Dogs with CLN5 deﬁciency have the potential for similar use.,Non-OADS,/arxiv_data1/oa_pdf/cb/79/JVIM-30-1149.PMC5084771.pdf
http://www.drugbase.de/de/datenbanken/hagers- enzyklopaedie.html.,OADS,/arxiv_data1/oa_pdf/1a/24/HUP-31-227.PMC5084772.pdf
"[Color ﬁgure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/ journal/ajmga].LUK ET AL.",OADS,/arxiv_data1/oa_pdf/ce/1d/AJMG-170-1938.PMC5084779.pdf
"[Color ﬁgure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/ journal/ajmga].1940 AMERICAN JOURNAL OF MEDICAL GENETICS PART A",Non-OADS,/arxiv_data1/oa_pdf/ce/1d/AJMG-170-1938.PMC5084779.pdf
Available from: http://www.cdc.gov/nchs/nhanes/nh3data.htm [Accessed on 5 March 2014].,OADS,/arxiv_data1/oa_pdf/30/e5/SIM-35-3453.PMC5084780.pdf
Availablefrom:http://smm.sagepub.com/content/ early/2015/04/30/0962280215584401.abstract.,Non-OADS,/arxiv_data1/oa_pdf/30/e5/SIM-35-3453.PMC5084780.pdf
Available from: http://ftp.cs.ucla.edu/pub/ stat_ser/r356.pdf [Accessedon 2February 2016].,Non-OADS,/arxiv_data1/oa_pdf/30/e5/SIM-35-3453.PMC5084780.pdf
"Available from: http://www.R-project.org/ [Accessed on 14 July 2015], ISBN3-900051-07-0.",Non-OADS,/arxiv_data1/oa_pdf/30/e5/SIM-35-3453.PMC5084780.pdf
"Available from: http://CRAN.R-project.org/package=dbarts [Accessed on 13 November 2014], R package version 0.8-5.",Non-OADS,/arxiv_data1/oa_pdf/30/e5/SIM-35-3453.PMC5084780.pdf
Avail- able from URL: https://studies.thegeorgeinstitute.org/nice/.,Non-OADS,/arxiv_data1/oa_pdf/3f/d5/DOM-18-648.PMC5084782.pdf
analysis was performed using the Gene Ontology enrichment analysis and visuaLizAtion tool (GOrilla) database (http://cbl-gorilla.cs.technion.ac.il) and the Kyoto Encyclopedia of Genesand Genomes (KEGG) pathway representation (http://www.genome.jp/kegg/pathway.html).,OADS,/arxiv_data1/oa_pdf/6c/bf/ANA-79-826.PMC5084783.pdf
"The project de-scribed in this report, Strengthening Human Resources Develop- ment System of Co-medicals in Cambodia , was co-jointly funded by a Japan –Cambodia bilateral cooperation by the Japan In- ternational Cooperation Agency and by a Research Grantfor International Health, H27-2, by the MoH, Welfareand Labor, Japan (http://www.ncgm.go.jp/kaihatsu/).",Non-OADS,/arxiv_data1/oa_pdf/b6/d6/IJN-22-22.PMC5084784.pdf
URL: http://apps.who.int/gb/ebwha/pdf_ ﬁles/WHA64/ A64_R7-en.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/b6/d6/IJN-22-22.PMC5084784.pdf
Available from URL: http://www.hrhresourcecenter.,Non-OADS,/arxiv_data1/oa_pdf/b6/d6/IJN-22-22.PMC5084784.pdf
Available from URL: http://www.asean.org/communities/asean- economic-community/item/asean-mutual-recognition-ar-rangement-on-nursing-services.,Non-OADS,/arxiv_data1/oa_pdf/b6/d6/IJN-22-22.PMC5084784.pdf
Available at: http://www.norc.org/PDFs/May 2011 Personal Validation and Entity Resolu- tion Conference/G-Link_Probabilistic Record Linkage paper_PVERConf_May2011.pdf.,OADS,/arxiv_data1/oa_pdf/0f/66/IJC-139-1209.PMC5084785.pdf
"6 GermanFederalInstituteforRisk Assessment.Chromium(VI)inleather clothingandshoesproblematicforallergy sufferers!2007.Availableat:http://www.bfr.bund.de/en/press_information/2007/10/chromium__vi__in_leather_clothing_and_shoes_problematic_for_allergy_sufferers_-9575.html,(lastaccessed25January2016).",Non-OADS,/arxiv_data1/oa_pdf/34/34/COD-75-82.PMC5084788.pdf
"Available: http://ideas.repec.org/p/wbk/wbrwps/3647.html De Onis M., Garza C., Onyango A.W.",Non-OADS,/arxiv_data1/oa_pdf/1e/0f/MCN-12-210.PMC5084796.pdf
"Available: http://www.ifpri.org/publication/understanding-rapid-reduction-undernutrition-nepal-2001-2011 Headey D., Chiu A.",Non-OADS,/arxiv_data1/oa_pdf/1e/0f/MCN-12-210.PMC5084796.pdf
Available: http://www.hks.harvard.edu/fs/rpande/pa-pers/Indianchildrenheight.pdf Jha P. & Laxminarayan R. (2009) Choosing Health: An Entitlement for all Indians .,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/MCN-12-210.PMC5084796.pdf
"Available from: http://globocan.iarc.fr,Accessed on April 24, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
Available from: http://www.medcol.,Non-OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
"Blumenthal PD, McIntosh N. Cervical Cancer Prevention Guidelines for Low-Resource Settings.Jhpiego 2005. http://reprolineplus.org/system/ﬁles/ resources/CeCaPfullmanual.pdf.",OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
"Washington, D.C.: PAHO, 2003. http://www1.paho.org/hq/dmdocu-ments/2011/cc-via.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
Available from: http://www.wisap.de.,Non-OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
Available from: http://apps.who.int/iris/bitstream/10665/ 94830/1/9789241548694_eng.pdf.,OADS,/arxiv_data1/oa_pdf/f4/42/IJC-139-908.PMC5084797.pdf
http://www.who.int/mediacentre/factsheets /fs360/en/ [accessed 12 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.who.int/mediacentre/factsheets/fs204/en/ [accessed 12 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.who.int/mediacentre/factsheets /fs164/en/ [accessed 12 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.who.int/mediacentre/factsheets/fs280/en/ [accessed 12 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
Prevention and control of viral hepatitis infection: framework for global action.http://www.who.int/hiv/pub/hepatitis/Framework/en/ [accessed 20 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.cdc.gov/hepatitis/hbv/in-dex.htm [accessed 20 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf[accessed 20 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
http://www.cdc.gov/hepa- titis/ [accessed 3 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/de/34/RMV-26-330.PMC5084801.pdf
Available from: http://www.audit.nsw.gov.au/publications/performance-audit-reports/2013-reports/improving-legal-and-safe-driving-among-aboriginal-people/legal-and-safe-driving-among-aboriginal-people 2.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Availablefrom: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Latestproducts/4714.0  3.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737418955 4.,OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.audit.nsw.gov.au/ArticleDocuments/143/Improving_Road_Safety_Young_Drivers.pdf.aspx?Embed=Y Performance Audit6.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: https://infrastructure.gov.au/roads/safety/publications/2010/pdf/community_att_09.pdf  15.,OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.atrf.info/papers/2010/2010_Raimond_Milthorpe.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001/ 17.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.naccho.org.au/download/naccho_health_futures/Full%20Report%20-%20Economic%20Value%20%20Final%20Report.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Available from: http://www.transport.wa.gov.au/mediaFiles/about-us/DOT_P_SubstantiveEqualityAccessingServices.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/42/6c/AZPH-40-377.PMC5084803.pdf
Version 2.2015. http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/ad/95/CNCR-122-2418.PMC5084806.pdf
Structural Segmentation The structural scans of each subject were segmented with in FreeSurfer toolkit version 5.1 (http://surfer.nmr.,OADS,/arxiv_data1/oa_pdf/81/d8/HBM-37-3310.PMC5084807.pdf
Rs-fMRI Data Preprocessing RS-fMRI data preprocessing was performed using FMRIB Software Library (FSL v5.07; http://fsl.fmrib.ox.ac.uk/fsl/) tools.,OADS,/arxiv_data1/oa_pdf/81/d8/HBM-37-3310.PMC5084807.pdf
"In order to increase the statisti- cal power of the analysis, the network-based statistic (NBS) procedure implemented in the NBS toolbox(https://sites.google.com/site/bctnet/comparison/nbs)was used [Zalesky et al., 2010].",OADS,/arxiv_data1/oa_pdf/81/d8/HBM-37-3310.PMC5084807.pdf
BrainNet viewer (http://www.nitrc.org/projects/bnv/) was used for visualization purposes.,OADS,/arxiv_data1/oa_pdf/81/d8/HBM-37-3310.PMC5084807.pdf
"The metrics werecomputed with weighted undirected networks, using the Brain Connectivity Toolbox (BCT, http://www.brain-con- nectivity-toolbox.net) [Rubinov and Sporns, 2010].",OADS,/arxiv_data1/oa_pdf/81/d8/HBM-37-3310.PMC5084807.pdf
"June10, 2013; Available at: http://clinicaltrials.gov/ct2/show/NCT00712348?term 5nct00712348&rank 51.",Non-OADS,/arxiv_data1/oa_pdf/9a/6b/AJH-91-661.PMC5084808.pdf
"August 13, 2013; Available at: http://clinicaltrials.gov/ct2/show/NCT00705939?term5nct00705939&rank 51.",Non-OADS,/arxiv_data1/oa_pdf/9a/6b/AJH-91-661.PMC5084808.pdf
"[*]E.Salom(o[)’, Dr.S.Orgu(o[;y, Prof. A.Riera, Prof. X.Verdaguer Institute forResearch inBiomedic ine(IRB Barcelona) TheBarcelona Institu teofScience andTechnology Baldiri Reixac 10,08028 Barcelona (Spain) E-mail :antoni.riera @irbbarcelo na.org xavier .verdagu er@irbbarcel ona.org Homepag e:http://www .ursa.cat Prof. A.Riera, Prof. X.Verdaguer Departame ntdeQu(o[’xmica Org(o[[)nica, Universitat deBarcelona Mart(o[’x iFranqu(o;zzs 1,08028 Barcelona (Spain) Supportin ginforma tionandtheORCID identifica tionnumber(s) for theauthor(s) ofthisarticle canbefound under http://dx.doi.org/ 10.",Non-OADS,/arxiv_data1/oa_pdf/a6/1b/ANIE-55-7988.PMC5084810.pdf
"Geneva: International Conference on Harmonisation of Technical Require- ments for Registration of Pharmaceuticals for Human Use, June 10,1996. http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good- clinical-practice.html (5 October 20 14).",Non-OADS,/arxiv_data1/oa_pdf/4c/d6/EJHF-18-1193.PMC5084812.pdf
http://www.wma.net/en/30publications/ 10policies/b3/index.html (5 October 20 14).,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/EJHF-18-1193.PMC5084812.pdf
Available at http://www.meddra.org/ 9.,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/EJHF-18-1193.PMC5084812.pdf
"http://dx.doi.org10.3892/etm.2015.2890 Abbreviations Used ALT, alanine aminotransferase; AST, aspartate aminotransferase; BCP ,basic core promoter; ELISA, enzyme linked immunosorbent assay; ε, encapsidation signal; GBD, global burden of disease; HBcAg, hepatitis B c antigen or core protein; HDV , hepatitis D virus; HBeAg, hepatitisB e antigen; HBsAg, hepatitis B s antigen; HCC, hepatocellular carci-noma; LiPa ™, line probe assay; MTCT, mother-to-child transmission; P, polymerase; pgRNA, pregenomic ribonucleic acid; preC/C, precore/ core; TLR-2, toll-like receptor 2; WHO, World Health Organization.Rev.",Non-OADS,/arxiv_data1/oa_pdf/78/84/RMV-26-285.PMC5084815.pdf
"Reprinted with permission from: Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, WHO, page 12, © World Health Organization 2015 [http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/78/84/RMV-26-285.PMC5084815.pdf
ALFRED ( AlleleFrequency Database; http://alfred.med.,Non-OADS,/arxiv_data1/oa_pdf/0d/41/AJPA-161-62.PMC5084816.pdf
ELECTRONIC RESOURCES CITED ALFRED: http://alfred.med.yale.edu HGDP-CEPH Database: http://www.cephb.fr/en/index.phpHGDP selection browser: http://hgdp.uchicago.edu/cgi- bin/gbrowse/HGDP/ CLUMPAK ( Cluster Markov Packager Across K): http://clumpak.tau.ac.il/ LITERATURE CITED Abdel Waheb HH.,Non-OADS,/arxiv_data1/oa_pdf/0d/41/AJPA-161-62.PMC5084816.pdf
"Le cas de Tunis, Cahiers de l’Urmis N88/En ligne http://urmis.revues.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/AJPA-161-62.PMC5084816.pdf
"ICH harmonised tripartite guide- line.Goodclinicalpractice,1May1996.AvailablefromURL:http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf.AccessedDecember2015.",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/DOM-18-803.PMC5084818.pdf
Available from URL: http://www.fda.gov/downloads/Drugs/ …/ Guidances/ucm071624.pdf.Accessed03May2016.18.,Non-OADS,/arxiv_data1/oa_pdf/9f/3a/DOM-18-803.PMC5084818.pdf
"It is composed of a catalytic subunit encoded by NAA10 (ARD1; MIM #300013) (http://www.ncbi.nlm.nih.gov/omim) and an auxiliary subunit encoded by NAA15 (NAT1/NATH; MIM #608000) [Mullen et al., 1989; Arnesen et al., 2005].",Non-OADS,/arxiv_data1/oa_pdf/19/fb/HUMU-37-755.PMC5084832.pdf
The identiﬁed vari- ants in NAA10 were submitted to the LOVD gene variant database at http://www.lovd.nl/NAA10 (individual IDs 60301—60312).,OADS,/arxiv_data1/oa_pdf/19/fb/HUMU-37-755.PMC5084832.pdf
"In silico prediction was performed with online programs SIFT [Kumar et al., 2009] (http://sift.jcvi.org/), PolyPhen-2 [Adzhubei et al., 2010] (http://genetics.bwh.harvard.edu/pph2/), and Mutation Taster [Schwarz et al., 2014] (http://www.mutationtaster.org/).",OADS,/arxiv_data1/oa_pdf/19/fb/HUMU-37-755.PMC5084832.pdf
"None of the ﬁve missense mutations was found in the ExAC browser [Lek et al., 2015] (status November 2015) (http://exac.broadinstitute.org/).",OADS,/arxiv_data1/oa_pdf/19/fb/HUMU-37-755.PMC5084832.pdf
"http://dx.doi.org/10.1101/030338 Liszczak G, Goldberg JM, Foyn H, Petersson EJ, Arnesen T, Marmorstein R. 2013.",OADS,/arxiv_data1/oa_pdf/19/fb/HUMU-37-755.PMC5084832.pdf
Causes of  deaths were defined using CoDe (“Coding of Death in HIV”) protocol ( http://www.cphiv.dk/ CoDe/ ) which is based on a detailed medical chart review and a centralized review process.,OADS,/arxiv_data1/oa_pdf/3b/25/nihms813249.PMC5084911.pdf
"10, 2634 –2639 http://dx.doi.org/10.1080/21645515.2016.1194147",Non-OADS,/arxiv_data1/oa_pdf/f3/73/khvi-12-10-1194147.PMC5084975.pdf
Vaccine 2012; 30(12):2060-7; PMID:22289511; http://dx.doi.org/ 10.1016/j.vaccine.2012.01.015 [2] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/f3/73/khvi-12-10-1194147.PMC5084975.pdf
Vaccine 2014; 32:2507-17; PMID:24120672; http://dx.doi.org/10.1016/j.vaccine.2013.09.074 [7] European Committee for Proprietary Medicinal Products.,Non-OADS,/arxiv_data1/oa_pdf/f3/73/khvi-12-10-1194147.PMC5084975.pdf
"Hum Vaccin Immunother 2013 2013-08- 01; 9(8):1725-34; PMID:23896581; http://dx.doi.org/10.4161/hv.24832 [12] Williams MS, Wood JM.",Non-OADS,/arxiv_data1/oa_pdf/f3/73/khvi-12-10-1194147.PMC5084975.pdf
Vac- cine 2001; 9(23 –24):3253-60; http://dx.doi.org/10.1016/S0264- 410X(01)00010-XHUMAN VACCINES & IMMUNOTHERAPEUTICS 2639,Non-OADS,/arxiv_data1/oa_pdf/f3/73/khvi-12-10-1194147.PMC5084975.pdf
"10, 2529 –2535 http://dx.doi.org/10.1080/21645515.2016.1190057",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Curr Opin Immunol 2016; 39:1-6; PMID:2660 9943; http://dx.doi.org/10.1016/j.coi.2015.10.009 [2] Razavi SM, Lee KE, Jin BE, Aujla PS, Gholamin S, Li G. Immunee strategies of glioblastoma.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Front Surg 2016; 3:11; PMID:26973839; http://dx.doi.org/10.3389/fsurg.2016.00011 [3] Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, Fraenkel E, Ince TA, Whitesell L, Lindquist S. HSF1 drives a tran- scriptional program distinct from heat shock to support highly malignant human cancers.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Cell 2012; 150:549-62; PMID:22863008;http://dx.doi.org/10.1016/j.cell.2012.06.031 [4] Scherz-Shouval R, Santagata S, Mendillo ML, Sholl LM, Ben-Aharon I, Beck AH, Dias-Santagata D, Koeva M, Stemmer SM, Whitesell L, et al.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Cell 2014; 158:564-78; PMID:25083868;http://dx.doi.org/10.1016/j.cell.2014.05.045 [5] Guzhova IV, Shevtsov MA, Abkin SV, Pankratova KM, Margulis BA.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Int J Hyperthermia 2013; 29:399-408; PMID:23845032;http://dx.doi.org/10.3109/02656736.2013.807439 [6] Mazzaferro V, Coppa J, Carrabba MG, Rivoltini L, Schiavo M, Rega- lia E, Mariani L, Camerini T, MarchianR A, Andreola S, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Int J Can- cer 2003; 105:226-31; PMID:12673684; http://dx.doi.org/10.1002/ijc.11058 [10] Manjili MH, Henderson R, Wang XY, Chen X, Li Y, Repasky E, Kazim L, Subjeck JR. Development of a recombinant HSP110-HER- 2/neu vaccine using the chaperoning properties of HSP110.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Gyne-col Oncol 2007; 107:404-12; PMID:17905417; http://dx.doi.org/ 10.1016/j.ygyno.2007.06.031 [12] Wang Y, Liu SY, Yuan M, Tang Y, Guo QY, Cui XM, Sui X, Peng J. Prophylactic antitumor Effect of Mixed Heat Shock Proteins/ Peptides in Mouse Sarcoma.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Chin Med J (Engl) 2015; 128:2234- 41; PMID:26265619; http://dx.doi.org/10.4103/0366-6999.162516HUMAN VACCINES & IMMUNOTHERAPEUTICS 2533,Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Biochem Biophys Res Commun 2016; 470:766-71; PMID:26713364; http://dx.doi.org/10.1016/j.bbrc.2015.12.076 [14] Murshid A, Gong J, Stevenson MA, Calderwood SK.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Expert Rev Vaccines 2011; 10:1553-68; PMID:22043955; http://dx.doi.org/10.1586/erv.11.124 [15] Blachere NE, Udono H, Janetzki S, Li Z, Heike M, Srivastava PK.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"J Immunother Emphasis Tumor Immunol 1993; 14:352-6; PMID:8280719; http://dx.doi.org/ 10.1097/00002371-199311000-00016 [16] Gong J, Zhang Y, Durfee J, Weng D, Liu C, Koido S, Song B, Apostolo- poulos V, Calderwood SK.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"J Exp Med 1997; 186:1315-22;PMID:9334371; http://dx.doi.org/10.1084/jem.186.8.1315 [18] Binder RJ, Blachere NE, Srivastava PK.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Curr MedChem 2012; 19:1765-70; PMID:22414085; http://dx.doi.org/10.2174/ 092986712800099767 [20] Etminan N, Peters C, Lakbir D, B €unemann E, B €orger V, Sabel MC, H€anggi D, Steiger HJ, Stummer W, Sorg RV.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Br J Cancer 2011; 105:961-9; PMID:21863026; http://dx.doi.org/10.1038/bjc.2011.327 [21] Zong J, Wang C, Liu B, Liu M, Cao Y, Sun X, Yao Y, Sun G. Human hsp70 and HPV16 oE7 fusion protein vaccine inducesan effective antitumor ef ﬁcacy.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Cancer Lett 2012; 319:154-63; PMID:22261331; http://dx.doi.org/ 10.1016/j.canlet.2012.01.009 [23] Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, Slattery K, Qure- shi M, Wei Y, Deng Y, et al.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Cancer Biother Radiopharm 2012; 27:189-97; PMID:22372558; http://dx.doi.org/10.1089/cbr.2011.1135 [25] Dodd K, Nance S, Quezada M, Janke L, Morrison JB, Williams RT, Beere HM.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Oncogene 2015; 34:1312-22; PMID:24662819; http://dx.doi.org/10.1038/onc.2014.63 [26] Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, Xing PX, Calderwood SK, Gong J.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"J Immunol 2006; 177:5946-55; PMID:17056519; http://dx.doi.org/10.4049/jimmunol.177.9.5946 [27] Calderwood SK, Gong J, Stevenson MA, Murshid A.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Int J Hyperthermia 2013; 29:376-9; PMID:23682824; http://dx.doi.org/10.3109/02656736.2013.792126 [28] Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, Arri ﬁn NH, Nguyen M, Jean-Mary G, Tong X, Uppal P, et al.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"J Hematol Oncol 2014; 7:15; PMID:24565018; http://dx.doi.org/10.1186/1756-8722-7-15 [29] Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, Multhoff G. The cell surface-localized heat shock protein 70 epitope TKD inducesmigration and cytolytic activity selectively in human NK cells.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"J Immunol 2004; 172:972-80; PMID:14707070; http://dx.doi.org/ 10.4049/jimmunol.172.2.972 [30] Moser C, Schmidbauer C, G €urtler U, Gross C, Gehrmann M, Tho- nigs G, P ﬁster K, Multhoff G. Inhibition of tumor growth in mice with severe combined immunode ﬁciency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killercells.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Cell Stress Chaperones 2002; 7:365-73; PMID:12653481; http://dx.doi.org/10.1379/1466-1268(2002)007%3c0365:IOTGIM%3e2.0.,OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Lasers Surg Med 2011; 43:632-43; PMID:22057491; http://dx.doi.org/10.1002/lsm.21108 [32] Specht HM, Ahrens N, Blankenstein C, Duell T, Fietkau R, Gaipl US, G€unther C, Gunther S, Habl G, Hautmann H, et al.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Cancer Immunol Immunother2004; 53:26-32; PMID:14551746; http://dx.doi.org/10.1007/s002 62-003-0416-5 [34] Berd D. A tale of two pities: autologous melanoma vaccines on the brink.,Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Hum Vaccin Immunother 2012; 8:1146-51; PMID:22854662;http://dx.doi.org/10.4161/hv.20923 [35] Guzhova IV, Margulis BA, Kaminskaya EV.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Int J Cancer 1992; 52:892-5; PMID:1459731; http://dx.doi.org/10.1002/ijc.2910520611 [36] Kaminskaia EV, Stepan ’ian LI, Vakhtin IuB.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Int J Cancer 2014; 135:2118-28; PMID:24691976; http://dx.doi.org/10.1002/ijc.28858 [39] Abkin SV, Pankratova KM, Komarova EY, Guzhova IV, Margulis BA.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"Cell Stress Chaperones 2013; 18:391-6;PMID:23233202; http://dx.doi.org/10.1007/s12192-012-0391-x [40] Abkin SV, Ostroumova OS, Komarova EY, Meshalkina DA, Shevtsov MA, Margulis BA, Guzhova IV.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Cancer Immunol Immun- other 2016; 65:83-92; PMID:26646850; http://dx.doi.org/10.1007/ s00262-015-1778-12534 I. V. GUZHOVA AND B.,Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"doi.org/10.18632/oncotarget.1820 [42] Gross C, Koelch W, DeMaio A, Arispe N, Multhoff G. Cell surface- bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by speci ﬁc binding and uptake of granzyme B. J Biol Chem 2003; 278:41173-81; PMID:12874291; http://dx.doi.org/10.1074/jbc.M302644200[43] Calderwood SK, Murshid A, Gong J.",OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Front Immu- nol 2012; 3:75; PMID:22566956; http://dx.doi.org/10.3389/ ﬁmmu.,OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
Onco Targets Ther 2014; 7:1071-81; PMID:24971017; http://dx.doi.org/10.2147/OTT.S62764HUMAN VACCINES & IMMUNOTHERAPEUTICS 2535,Non-OADS,/arxiv_data1/oa_pdf/33/5f/khvi-12-10-1190057.PMC5084976.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"10, 2519 –2522 http://dx.doi.org/10.1080/21645515.2016.1193277",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Annu Rev Med 2013; 64:71-90; PMID:23092383; http://dx.doi.org/10.1146/annurev-med-112311-083918 [2] Drake CG, Lipson EJ, Brahmer JR.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Clin Oncol 2014; 11:24-37; PMID:24247168; http://dx.doi.org/10.1038/nrclinonc.2013.208 [3] Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, andcombinations.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Sci Transl Med 2016; 8:328rv4; PMID:26936508;http://dx.doi.org/10.1126/scitranslmed.aad7118 [4] Cimino-Mathews A, Foote JB, Emens LA.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Annu Rev Immunol 2001; 19:225-52; PMID:11244036; http://dx.doi.org/ 10.1146/annurev.immunol.19.1.225 [7] Melero I, Berman DM, Aznar MA, Korman AJ, Perez Gracia JL, Haanen J.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Cancer 2015; 15:457-72; PMID:26205340; http://dx.doi.org/10.1038/nrc3973 [8] Postow MA, Callahan MK, Wolchok JD.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
J Clin Oncol 2015; 33:1974-82; PMID:25605845; http://dx.doi.org/10.1200/JCO.2014.59.4358 [9] Croft M. The role of TNF superfamily members in T-cell function and diseases.,OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Immunol 2009; 9:271-85; PMID:19319144; http://dx.doi.org/10.1038/nri2526 [10] Melero I, Hirschhorn-Cymerman D, Morales-Kastresana A, San- mamed MF, Wolchok JD.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Clin Cancer Res 2013; 19:1044-53; PMID:23460535; http://dx.doi.org/10.1158/1078-0432.CCR-12-2065 [11] Linch SN, McNamara MJ, Redmond WL.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"FrontOncol 2015; 5:34; PMID:25763356; http://dx.doi.org/10.3389/ fonc.2015.00034 [12] Sanmamed MF, Pastor F, Rodriguez A, Perez-Gracia JL, Rodriguez- Ruiz ME, Jure-Kunkel M, Melero I. Agonists of Co-stimulation inCancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
Semin Oncol 2015; 42:640-55; PMID:26320067; http://dx.doi.org/10.1053/j.seminoncol.2015.05.014 [13] Watts TH.,OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
Annu Rev Immunol 2005; 23:23-68; PMID:15771565; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115839HUMAN VACCINES & IMMUNOTHERAPEUTICS 2521,Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Immunol 2003; 3:609-20; PMID:12974476; http://dx.doi.org/10.1038/nri1148 [15] Redmond WL, Weinberg AD.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Immunol2004; 4:420-31; PMID:15173831; http://dx.doi.org/10.1038/nri1371 [17] Curti BD, Kovacsovics-Bankowski M, Morris N, Walker E, Chisholm L, Floyd K, Walker J, Gonzalez I, Meeuwsen T, Fox BA, et al.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"OX40 is a potent immune-stimulating target in late-stage cancer patients.Cancer Res 2013; 73:7189-98; PMID:24177180; http://dx.doi.org/10.1158/0008-5472.CAN-12-4174 [18] Houot R, Levy R. T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for che-motherapy.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Blood 2009; 113:3546-52; PMID:18941113; http://dx.doi.org/10.1182/blood-2008-07-170274 [19] Linch SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, Farhad M, Redmond WL.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"PLoS One 2014; 9:e89350; PMID:24586709; http://dx.doi.org/10.1371/journal.pone.0089350 [21] Linch SN, Redmond WL.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Oncoimmunology 2014; 3: e28245; PMID:25050194; http://dx.doi.org/10.4161/onci.28245 [22] Redmond WL, Linch SN, Kasiewicz MJ.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Can- cer Immunol Res 2014; 2:142-53; PMID:24778278; http://dx.doi.org/10.1158/2326-6066.CIR-13-0031-T [23] DeNardo DG, Barreto JB, Andreu P, Vasquez L, Taw ﬁk D, Kolhatkar N, Coussens LM.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Cancer Cell 2009; 16:91-102; PMID:19647220; http://dx.doi.org/10.1016/j.ccr.2009.06.018 [24] Schietinger A, Greenberg PD.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Trends Immunol 2014; 35:51-60;PMID:24210163; http://dx.doi.org/10.1016/j.it.2013.10.001 [25] Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Science 2012; 335:723-7; PMID:22267581; http://dx.doi.org/10.1126/science.1214277 [26] Redmond WL, Sherman LA.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Immunity 2005; 22:275-84; PMID:15780985; http://dx.doi.org/10.1016/j.immuni.2005.01.010 [27] Safford M, Collins S, Lutz MA, Allen A, Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, et al.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Immunol 2005;6:472-80; PMID:15834410; http://dx.doi.org/10.1038/ni1193 [28] Jeon MS, At ﬁe l dA ,V e n u p r a s a dK ,K r a w c z y kC ,S a r a oR ,E l l yC ,Y a n g C, Arya S, Bachmaier K, Su L, et al.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
Immunity 2004; 21:167-77;PMID:15308098; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Eur J Immunol 2009; 39:2184-94; PMID:19672905;http://dx.doi.org/10.1002/eji.200939348 [30] Wang B, Zaidi N, He LZ, Zhang L, Kuroiwa JM, Keler T, Steinman RM.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Breast Cancer Res 2012; 14:R39; PMID:22397502; http://dx.doi.org/10.1186/bcr3135 [31] Redmond WL, Triplett T, Floyd K, Weinberg AD.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"PLoS One 2012; 7:e34467; PMID:22496812; http://dx.doi.org/10.1371/journal.pone.0034467 [32] Johannsen A, Genolet R, Legler DF, Luther SA, Luescher IF.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"J Immunol 2010; 185:3445-55;PMID:20733200; http://dx.doi.org/10.4049/jimmunol.1001397 [33] Gonzalez-Martin A, Gomez L, Lustgarten J, Mira E, Manes S. Maxi- mal T cell-mediated antitumor responses rely upon CCR5 expressionin both CD4( C) and CD8( C) T cells.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Cancer Res 2011; 71:5455-66; PMID:21715565; http://dx.doi.org/10.1158/0008-5472.CAN-11-1687 [34] Kim TK, St John LS, Wieder ED, Khalili J, Ma Q, Komanduri KV.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Human late memory CD8 CT cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production.J Immunol 2009; 183:6167-74; PMID:19841187; http://dx.doi.org/ 10.4049/jimmunol.0902068 [35] Grange M, Verdeil G, Arnoux F, Griffon A, Spicuglia S, Maurizio J, Buferne M, Schmitt-Verhulst AM, Auphan-Anezin N. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-beta1 signaling.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
J Immunol 2013; 191:3712-24; PMID:24006458;http://dx.doi.org/10.4049/jimmunol.1300319 [36] Wolchok JD.,OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Cell 2015; 162:937; PMID:26317459; http://dx.doi.org/10.1016/j.cell.2015.07.045 [37] Dhodapkar MV, Sznol M, Zhao B, Wang D, Carvajal RD, Keohan ML, Chuang E, Sanborn RE, Lutzky J, Powderly J, et al.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Sci Transl Med 2014; 6:232ra51;PMID:24739759; http://dx.doi.org/10.1126/scitranslmed.3008068 [38] Ascierto ML, Melero I, Ascierto PA. Melanoma: From Incurable Beast to a Curable Bet.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"FrontOncol 2015; 5:152; PMID:26217587; http://dx.doi.org/10.3389/fonc.2015.00152 [39] Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Immunity 2013; 39:38-48; PMID:23890062; http://dx.doi.org/10.1016/j.immuni.2013.07.004 [40] Burotto M, Singh N, Heery CR, Gulley JL, Madan RA.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Front Oncol 2014; 4:351; PMID:25566495; http://dx.doi.org/ 10.3389/fonc.2014.00351 [41] van der Burg SH, Arens R, Ossendorp F, van Hall T, Melief CJ.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Nat Rev Cancer 2016; 16(4):219-33; PMID:26965076; http://dx.doi.org/10.1038/nrc.2016.16 [42] Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW, Jr. Listeria-basedcancer vaccines that segregate immunogenicity from toxicity.",Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"Seminars Radiation Oncol 2015; 25:54-64; http://dx.doi.org/10.1016/j.semradonc.2014.07.003 [44] Demaria S, Golden EB, Formenti SC.",OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
JAMA Oncol 2015; 1:1325-32; PMID:26270858; http://dx.doi.org/10.1001/jamaoncol.,Non-OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
Cancer Cell 2015; 28:690-714; PMID:26678337; http://dx.doi.org/ 10.1016/j.ccell.2015.10.0122522 W. L. REDMOND AND S. N. LINCH,OADS,/arxiv_data1/oa_pdf/45/80/khvi-12-10-1193277.PMC5084978.pdf
"10, 2546 –2559 http://dx.doi.org/10.1080/21645515.2016.1190489",Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
"Ann Intern Med 2002; 136:792-801; PMID: 12044127; http://dx.doi.org/10.7326/0003-4819-136-11-200206040-00007 [4] Hall KK, Lyman JA.",Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
"Clin Micro Rev 2006; 19:788-802; PMID:17041144; http://dx.doi.org/10.1128/CMR.00062-05 [5] Lee CK, Ho PL, Chan NK, Mak A, Hong J, Lin CK.",OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
"Vox Sang 2002; 83:204-8; PMID:12366760; http://dx.doi.org/10.1046/j.1423-0410.2002.00219.x [6] Recommendaciones nacionales de Vacunacion, Ministerio de Salud, Argentina 2012.",Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Acta Anaesthesiol Scand 1985; 29:764-6; PMID:4082876; http://dx.doi.org/10.1111/j.1399-6576.1985.tb02297.x.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Lancet 1978; 1072-3; PMID:77369; http://dx.doi.org/ 10.1016/S0140-6736(78)90916-9.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Clin Orthop Relat Res 2015; 473:351-7; PMID:25163689;http://dx.doi.org/10.1007/s11999-014-3903-4.2556 I. F. COOK,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Antimicrob Agents Chemo-ther 2009; 53:4778-82; http://dx.doi.org/10.1128/AAC.00582-09.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2013; 31:1431-7; PMID:22766247; http://dx.doi.org/10.1016/j.vaccine.2012.06.030.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2011; 29:5000-6; PMID:21569813; http://dx.doi.org/10.1016/j.vaccine.2011.04.099.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2007; 25:5803-20;PMID:17548135; http://dx.doi.org/10.1016/j.vaccine.2007.04.059.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Pediatrics 2011; 127:S45-53; PMID:21502240; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Pediatrics 2011; 127:e581-7; PMID:21300679; http://dx.doi.org/10.1542/peds.2010-1886.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2009; 27:4912-6; PMID:19567245; http://dx.doi.org/ 10.1016/j.vaccine.2009.06.038.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2006; 24:151-6; PMID: 16122845; http://dx.doi.org/10.1016/j.vaccine.2005.07.066.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
JAMA 2006; 296:1990-7; PMID:17062862; http://dx.doi.org/10.1001/jama.296.16.1990.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Hum Vaccin 2011; 7(supl):234-9; PMID:21301223; http://dx.doi.org/10.4161/hv.7.0.14613.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2014; 32:6360-3; PMID:25252195; http://dx.doi.org/10.1016/j.vaccine.2014.09.017.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2010; 28:7713-5; PMID: 20875495; http://dx.doi.org/10.1016/j.vaccine.2010.09.043.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Phar- macoepidemiol Drug Saf 2007; 16:753-61; PMID:17385786; http://dx.doi.org/10.1002/pds.1390.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
In ﬂuenza Other Respir Viruses 2015; 9:323-30; http://dx.doi.org/10.1111/irv.12328.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Infect Dis 2010; 202:1076-87; PMID:20735271; http://dx.doi.org/10.1086/656190.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2014; 32:965-72; PMID:24397906; http://dx.doi.org/10.1016/j.vaccine.2013.12.034.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Adolsc Health 2010; 46:414-21; http://dx.doi.org/10.1016/j.jadohealth.2010.02.006.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Arch Ped iatr Adolesc Med 2011; 165:749-55; PMID:21810637; http://dx.doi.org/10.1001/archpediatrics.2011.112.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Safety of quadrivalenthuman papillomavirus vaccine administered routinely to females.Arch Pediatr Adolesc Med 2012; 166:1140-8; PMID:23027469; http://dx.doi.org/10.1001/archpediatrics.2012.1451.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine 2007; 25: 5821-38; PMID:17540485; http://dx.doi.org/10.1016/j.vaccine.2007.04.057.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2557,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
"An outbreak of Mycobacterium tuberculosis infection associated withacupuncture in a private clinic of Zhejiang Province, China 2012.Int J Infect Dis 2014; 29:287-9; PMID:25448339; http://dx.doi.org/ 10.1016/j.ijid.2014.08.023.",Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Indian J Pediatr 2007; 74:771-3; PMID:17785903; http://dx.doi.org/10.1007/s12098-007- 0137-4.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Dermatol Clinics 2015; 33:563-77; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
South Med J 1963;56:949-52; PMID:13940841; http://dx.doi.org/10.1097/00007611-196309000-00004.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
PLoS One 2007; 2(9): e822; PMID:17786194; http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Pediatr Infect Dis J 1982; 1:388-90;http://dx.doi.org/10.1097/00006454-198211000-00005.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Exp Clin Med 2013; 30:181-2; http://dx.doi.org/10.5835/ jecm.omu.30.02.019.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Pediatr Infect Dis J 1990; 9:597-8; PMID:2235180; http://dx.doi.org/10.1097/00006454-199008000-00018.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vaccine2012; 30:5229-34; PMID:22709955; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Adverse events followingimmunization during mass vaccination campaigns at ﬁrst introduc- tion of a meningococcal A conjugate vaccine in Burkina Faso 2010.Vaccine 2012; 30:B46-51; PMID:22230584; http://dx.doi.org/10.1016/j.vaccine.2011.12.112.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Vac- cine 2007; 25:A72-8; PMID:17544552; http://dx.doi.org/10.1016/j.vaccine.2007.04.045.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
PloS ONE 9(6):e97376; PMID:24896582; http://dx.doi.org/10.1371/journal.pone.0097376.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Acta Chir Belg 2007; 107:29-36; PMID:17405595;http://dx.doi.org/10.1080/00015458.2007.11680007.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Vasc Bras 2011; 10:185-8; http://dx.doi.org/10.1590/S1677-54492011000200017.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Turkiye Klinikleri J Med Sci 2010; 30:384-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Korean J Pediatr 2006; 49:1116-9; http://dx.doi.org/10.3345/kjp.2006.49.10.1116.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
N Eng J Med 1997; 336:999- 1007; http://dx.doi.org/10.1056/NEJM199704033361406.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Eur J Radiol 2006; 60:221-32; PMID:16971078; http://dx.doi.org/10.1016/j.ejrad.2006.07.016.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
JAMA 2007; 297:1478-88; PMID:17405973; http://dx.doi.org/10.1001/jama.297.13.1478.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Clin Infect Dis 2011;52:e18-55; PMID:21208910; http://dx.doi.org/10.1093/cid/ciq146.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Clin Microbiol Infect 2012; 18:E355-61; PMID:22784359; http://dx.doi.org/10.1111/j.1469-0691.2012.03964.x.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Arch Intem Med 2003; 163:2066-72; http://dx.doi.org/ 10.1001/archinte.163.17.2066.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Soonchunhyang Med Sci2013; 19:133-5; http://dx.doi.org/10.15746/sms.13.030.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Neu-rology 2015; 85:1459-66; PMID:26423434; http://dx.doi.org/10.1212/WNL.0000000000002065.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Intens Care Med 2003; 29:530-8; http://dx.doi.org/10.1007/s00134-003-1662-x.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Infection 1999; 27:259-60; PMID:10885838; http://dx.doi.org/10.1007/s150100050024.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Surg Clin N Am 2009; 89:365-89; PMID:19281889; http://dx.doi.org/10.1016/j.suc.2009.01.001.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Am J Infect Control 2013; 41:1268-71; PMID:23890741; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Hosp Infect 2013; 85:206-12; PMID:24035582; http://dx.doi.org/10.1016/j.jhin.2013.07.010.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Clin Infect Dis 2002; 34:65-71;PMID:11731947; http://dx.doi.org/10.1086/324627.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Clin Infect Dis 2013; 56:1763-4; PMID:23457076; http://dx.doi.org/10.1093/cid/cit126.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Epidemol Infect 2010; 138:313-7; http://dx.doi.org/10.1017/S0950268809990483.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Infect 2012; 64:148-55; PMID: 22101078; http://dx.doi.org/10.1016/j.jinf.2011.11.004.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Medi- cine 2010; 89:217-26; PMID:20616661; http://dx.doi.org/ 10.1097/MD.0b013e3181e8d635.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Diag Microbiol Infect Dis 2013; 76:24-30;http://dx.doi.org/10.1016/j.diagmicrobio.2013.02.020.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
Tuberculosis 2015; 95:629-38; PMID:26616847; http://dx.doi.org/10.1016/j.tube.2014.12.006.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
[114] https://www.priceline.com.au/kendall-webcol-skin-cleansing-alcohol Swabs 200 pack .,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
JAMA 1992; 268:2420-5; PMID:1404801; http://dx.doi.org/10.1001/jama.1992.03490170092032.,OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
J Med Stat Inform 2014; 2:5; http://dx.doi.org/10.7243/2053-7662-2-5.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2559,Non-OADS,/arxiv_data1/oa_pdf/a7/99/khvi-12-10-1190489.PMC5084982.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"10, 2694 –2699 http://dx.doi.org/10.1080/21645515.2016.1218098",Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
There are various on-line resources of information concern- ing tick-borne diseases including TBE: /C15http://travelvaccination.co.uk/region/europe/ /C15http://travelhealthpro.org.uk/tick-borne-encephalitis/ /C15http://www.nhs.uk/Conditions/Tick-borne-encephalitis/ Pages/Beforeyougopage.aspx /C15http://cks.nice.org.uk/immunizations-travel#!scenario:9 Abbreviations TBE tick-borne encephalitis TBEV tick-borne encephalitis virusELISA enzyme-linked immunosorbent assayVNT virus neutralization test Disclosure of potential con ﬂicts of interest No potential con ﬂicts of interest were disclosed.,Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Travel Med Infect Dis 2010;8:223-32; http://dx.doi.org/10.1016/j.tmaid.2010.06.004 [2] Lindquist L, Vapalahti O. Tick-borne encephalitis.",OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Lancet 2008; 371:1861-71; PMID:18514730; http://dx.doi.org/10.1016/S0140-6736(08)60800-4 [3] Amicizia D, Domnich A, Panatto D, Lai PL, Cristina ML, Avio U, Gasparini R. Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines.",Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Hum VaccinImmunother 2013; 9:1163-71; PMID:23377671; http://dx.doi.org/ 10.4161/hv.23802 [4] Rendi-Wagner P, Jeschko E, Kollaritsch H. Oesterreichische Exper- tengruppe f €ur Reisemedizin.",OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Wien Klin Wochenschr 2005; 117(Suppl 4):11-9; PMID:16416380; http://dx.doi.org/10.1007/s00508-005-0442-8 [5] Kollaritsch H, Krasilnikov V, Holzmann H, Karganova G, Barrett A, S€uss J, Pervikov Y, Bjorvatn B, Duclos P, Hombach J.",OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Parasit Vectors 2013; 6:119; PMID:23617899; http://dx.doi.org/10.1186/1756-3305-6-119 [7] Kim SY, Yun SM, Han MG, Lee IY, Lee NY, Jeong YE, Lee BC, Ju YR.",OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Vector Borne Zoonotic Dis 2008; 8:7-13; PMID:18240970; http://dx.doi.org/10.1089/vbz.2006.0634 [8] Ko S, Kang JG, Kim SY, Kim HC, Klein TA, Chong ST, Sames WJ, Yun SM, Ju YR, Chae JS.",OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
J Vet Sci 2010; 11:197-203; PMID:20706026; http://dx.doi.org/10.4142/jvs.2010.11.3.197 [9] European Centers for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Travel Med Infect Dis 2008; 6:380-3; PMID:18984485;http://dx.doi.org/10.1016/j.tmaid.2008.06.004 [11] Reusken C, Reimerink J, Verduin C, Sabbe L, Cleton N, Koopmans M. Case report: Tick-borne encephalitis in two Dutch travellersreturning from Austria, Netherlands, July and August 2011.",Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
Intern Med J 2013; 43:93-6;PMID:23324091; http://dx.doi.org/10.1111/imj.12017 [14] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
http://webarchive.nationalarchives.gov.uk/ 20140714084352/ http://www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/TickborneEncephalitis/ Last accessed June 2016 [15] Steffen R. Epidemiology of tick-borne encephalitis (TBE) in interna- tional travellers to Western/Central Europe and conclusions on vac- cination recommendations.,Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"Available at: https://www.medicines.org.uk/emc/medi cine/30324 , Last accessed June 2016 [36] Hombach J, Barrett AD, Kollaritsch H. Vaccines against tick-borne encephalitis.",Non-OADS,/arxiv_data1/oa_pdf/74/26/khvi-12-10-1218098.PMC5085011.pdf
"10, 2572 –2579 http://dx.doi.org/10.1080/21645515.2016.1189038",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Emerg Infect Dis 2006; 12:304-6; PMID:16494759; http://dx.doi.org/10.3201/eid1202.050006 [2] Kilgore A, Donauer S, Edwards KM, Weinberg GA, Payne DC, Szila- gyi PG, Rice M, Cassedy A, Ortega-Sanchez IR, Parashar UD, et al.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2013; 31:4164-71; PMID:23845802; http://dx.doi.org/10.1016/j.vaccine.2013.06.085 [3] Morton VK, Thomas MK, McEWEN SA.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
Vaccine 2004; 22:2013-7; PMID:15121314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"N Engl J Med 2006; 354:23-33; PMID:16394299;http://dx.doi.org/10.1056/NEJMoa052664 [8] Ruiz-Palacios GM, P /C19erez-Schael I, Vel /C19azquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434 [9] Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor J, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Ef ﬁcacy of human rotavirus vaccine against rotavirus gastroenteritis during the ﬁrst 2 years of life in European infants: randomised, double-blind con- trolled study.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatrics 2010; 125:e208-13; PMID:20100757;http://dx.doi.org/10.1542/peds.2009-1246 [13] Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Para- shar UD.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatrics 2014; 134:15-23; PMID:24913793; http://dx.doi.org/10.1542/peds.2013-3849 [14] Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker JB, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatrics2010; 125:e199-207; PMID:20083525; http://dx.doi.org/10.1542/ peds.2009-1021 [15] Desai SN, Esposito DB, Shapiro ED, Dennehy PH, V /C19azquez M. Effec- tiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2010; 28:7501-6; PMID:20851087; http://dx.doi.org/10.1016/j.vaccine.2010.09.013 [16] Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatrics 2010; 126:e506-12; PMID:20732946; http://dx.doi.org/10.1542/peds.2010-0443 [18] Gagneur A, Nowak E, Lemaitre T, Segura J-F, Delaperri /C18ere N, Abalea L, Poulhazan E, Jossens A, Auzanneau L, Tran A, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"PediatrInfect Dis J 2013; 32:1365-73; PMID:24051998; http://dx.doi.org/10.1097/INF.0000000000000086 [20] Braeckman T, Van Herck K, Meyer N, Pircon J-Y, Soriano-Gabarro M, Heylen E, Zeller M, Azou M, Capiau H, De Koster J, et al.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
Bmj 2012; 345:e4752; PMID:22875947; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Jama 2009; 301:2243-51;PMID:19491186; http://dx.doi.org/10.1001/jama.2009.756 [22] Groome MJ, Page N, Cortese MM, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, et al.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Lancet Infect Dis 2014; 14:1096-104; PMID:25303843; http://dx.doi.org/10.1016/S1473-3099(14)70940-5 [23] Muhsen K, Chodick G, Goren S, Shalev V, Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroen- teritis in the community.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2010; 29:91-4; PMID:20969927;http://dx.doi.org/10.1016/j.vaccine.2010.10.010 [24] Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle- Loss B, V /C19ecsei A, Kundi M. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritisin Austria.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2011; 29:2791-6; PMID:21320539; http://dx.doi.org/10.1016/j.vaccine.2011.01.104 [25] Eberly MD, Gorman GH, Eide MB, Olsen CH, Rajnik M. The effect of rotavirus immunization on rotavirus gastroenteritis hospitaliza-tion rates in military dependents.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2011; 29:650-9; PMID:21129394; http://dx.doi.org/10.1016/j.vaccine.2010.11.041 [26] Rivera L, Pe ~na LM, Stainier I, Gillard P, Cheuvart B, Smolenov I, Ortega-Barria E, Han HH.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2011; 29:9508-13; PMID:22008819; http://dx.doi.org/ 10.1016/j.vaccine.2011.10.015 [27] Doll MK, Buckeridge DL, Morrison KT, Gagneur A, Tapiero B, Charest H, Quach C. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2015; 33:7307- 14; PMID:26546262; http://dx.doi.org/10.1016/j.vaccine.2015.10.118 [28] Gotuzzo E, Butron B, Seas C, Penny M, Ruiz R, Losonsky G, Lanata CF, Wasserman SS, Salazar E, Kaper JB, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Vaccine 2002; 21:138-45; PMID:12443672; http://dx.doi.org/10.1016/S0264-410X (02)00348-1 [30] Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
J Infect Dis 2009; 200:S39-48; PMID:19817613; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"J Med Virol 2007; 79:341-9; PMID:17245723; http://dx.doi.org/10.1002/jmv.20804 [32] Bradley RH, Corwyn RF.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"J Asthma 2002; 39:625-31; PMID:12442952; http://dx.doi.org/ 10.1081/JAS-120014927 [34] Payne DC, Szilagyi PG, Staat MA, Edwards KM, Gentsch JR, Wein- berg GA, Hall CB, Curns AT, Clayton H, Grif ﬁn MR, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatr Infect Dis J 2009; 28:948-53; PMID:19859013; http://dx.doi.org/10.1097/INF.0b013e3181a6ad6e [35] Bettinger JA, Wills K, Le Saux N, Scheifele DW, Halperin SA, Vaudry W. Heterogeneity of rotavirus testing and admitting practices forgastroenteritis among 12 tertiary care pediatric hospitals: Implica- tions for surveillance.",OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Pediatr Infect Dis J 2007; 26:914-9; PMID:17901797; http://dx.doi.org/ 10.1097/INF.0b013e31812e52fd [37] Roy M, G /C19en/C19ereux M, Laverdi /C18ere E, Vanasse A. Surveillance of social and geographic inequalities in housing-related issues: the case of the Eastern Townships, Quebec (Canada).",Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
Int J Environ Res Public Health 2014; 11:4825-44; PMID:24806192; http://dx.doi.org/10.3390/ijerph110504825 [38] Statistics Canada.,Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
Available at: http://www12.statcan.gc.ca/census- recensement/2011/ref/dict/geo021-eng.cfm (accessed 11 May 2015)HUMAN VACCINES & IMMUNOTHERAPEUTICS 2579,Non-OADS,/arxiv_data1/oa_pdf/3c/08/khvi-12-10-1189038.PMC5085015.pdf
"Creation and implementation of SAMPRO™: A school-based  asthma management program Robert F. Lemanske Jr, MDa, Sujani Kakumanu, MDd, Kathleen Shanovich, PNPg, Nicholas  Antos, MDb, Michelle M. Cloutier, MDc, Donna Mazyck, MS, RNe, Wanda Phipatanakul, MD,  MSf, Shirley Schantz, EdD, ARNP, RNe, Stanley Szefler, MDh, Renee Vandlik, MAi, and Paul  Williams, MDj aDepartment of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public  Health, Madison, Wis This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
"Role of the community The SAMPRO™ Workforce, NASN, and the American Academy of Pediatrics Council of  School Health ( http://pediatrics.aappublications.org/content/early/2016/05/19/peds.",Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
"One novel program is eSchoolCare, an online resource for school nurses to support  managing chronic diseases in children, including asthma ( http://son.wisc.edu/ eSchoolCare.htm ).",Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
Available  at: https://www.epa.gov/iaq-schools/guide-implementing-iaq-indoor-air-quality-iaq-tools-schools- action-kit .,Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
Available at: http://www2.epa.gov/indoor-air- quality-iaq/inside-story-guide-indoor-air-quality .,Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
Available at: http://www.cdc.gov/HealthyYouth/shpps/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/ca/95/nihms822048.PMC5085063.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/34/hp-4-099.PMC5085272.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia 2016:4 99–108submit your manuscript | www.dovepress.co m Dove press  99 http: //dx.doi.org/10.2147/HP .S10309 1Chronic intermittent hypoxia and obstructive  sleep apnea: an experimental and clinical approach emilia Sforza Fréderic Roche Service de Physiologie Clinique et de  l’exercice, Pole NOL, CHU, eA SNA- ePiS 4607, Faculté de Médecine J.   Lisfranc, UJM Saint-etienne, Université  de Lyon, Saint-etienne, France Correspondance: emilia Sforza   Service de Physiologie Clinique,   CHU Nord – Niveau 6, F-42055   Saint-etienne Cedex 2, France   T el +33 4 7782 8300   Fax +33 4 7782 8447   email emilia.sforza@gmail.co mAbstract:  Obstructive sleep apnea (OSA) is a prevalent sleep disorder considered as an  independent risk factor for cardiovascular consequences, such as systemic arterial hypertension,  ischemic heart disease, cardiac arrhythmias, metabolic disorders, and cognitive dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/e0/34/hp-4-099.PMC5085272.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/e0/34/hp-4-099.PMC5085272.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/34/hp-4-099.PMC5085272.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 181–192Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  181 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S100245Holmium laser enucleation of the prostate:  patient selection and perspectives Tracy Marien Mustafa Kadihasanoglu Nicole L Miller Department of Urology, vanderbilt  Medical Center, Nashville, TN, USABackground: Multiple endoscopic surgical options exist to treat benign prostatic hyperplasia  (BPH), including holmium laser enucleation of the prostate (HoLEP).",Non-OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
"Many studies have demonstrated the superiority of HoLEP to resect greater amounts of tissue compared  Correspondence: Nicole L Miller   Department of Urologic Surgery,  vanderbilt Medical Center, A-1302 MCN, Nashville, TN 37273, USA Tel +1 615 322 3807   Fax +1 615 322 8990   email nicole.miller@vanderbilt.eduJournal name: Research and Reports in Urology Article Designation: REViEwY ear: 2016V olume: 8Running head verso: Marien et alRunning head recto: HoLEP – patient selectionDOi: http://dx.doi.org/10.2147/RRU.S100245",Non-OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 192 Marien et al  33.,Non-OADS,/arxiv_data1/oa_pdf/d3/ad/rru-8-181.PMC5085273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2633–2640International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2633OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11712 9 C-reactive protein in outpatients with acute  exacerbation of COPD: its relationship with  microbial etiology and severity Miguel gallego1–3 Xavier Pomares1,3 silvia Capilla4 Maria angeles Marcos5,6 David suárez7 eduard Monsó1–3,* Concepción Montón1,8,* 1Department of respiratory Medicine,   hospital de sabadell, Institut  Universitari Parc Taulí-U aB, sabadell,   2Universitat autònoma de Barcelona,   esfera U aB, Barcelona, 3CIBer  de enfermedades respiratorias,   CIBeres, Bunyola, 4laboratory of  Microbiology, Institut Universitari  Parc Taulí-U aB, sabadell, 5Department  of Clinical Microbiology, hospital  Clínic, 6Isglobal, Barcelona  Centre for International health  research (CresIB), hospital Clínic,   Universitat de Barcelona, Barcelona,   7epidemiology and assessment Unit,   Fundació Parc Taulí, Universitat  autònoma de Barcelona, sabadell,   8health services research on Chronic  Diseases network-reDIsseC,   galdakao, spain *These authors contributed equally  to this workBackground:  C-reactive protein (CRP) measurement has proven valuable for detecting  exacerbations, but its usefulness in predicting etiology remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
"Microbiological studies Correspondence: Miguel gallego Department of respiratory Medicine,  hospital de sabadell, Institut Universitari  Parc Taulí-UaB, Parc Tauli 1, sabadell,  Barcelona, 08208, spain Tel +34 93 723 1010 Fax +34 93 717 5067 email mgallego@tauli.ca t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gallego et al Running head recto: C-reactive protein in outpatients with COPD exacerbations  DOI: http://dx.doi.org/10.2147/COPD.S117129",Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/copd-11-2633.PMC5085274.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/a6/por-7-011.PMC5085275.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPragmatic and Observational Research 2016:7 11–20Pragmatic and Observational Research Dove press submit your manuscript | www.dovepress.co m Dove press  11ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/POR.S7944 1Variations in the management of fibromyalgia   by physician specialty: rheumatology versus   primary care stephen l able1 Rebecca l Robinson2 Kurt Kroenke3,4 Philip Mease5,6 David a Williams7 Yi chen8 Madelaine Wohlreich9 Bill h Mccarberg10 1US Health Outcomes and T echnology  assessment, global health Outcomes,   Eli Lilly and Company, Indianapolis,   in, Usa;  2Lilly Research Labs,   Global Health Outcomes, Eli Lilly  and Company, Indianapolis, IN,   Usa;  3Department of Medicine,   Indiana University,  4Va health  services Research and Development  center for health information and  communication, Regenstrief institute,   indianapolis, in, Usa;  5Rheumatology  Associates, Division of Rheumatology  clinical Research, swedish Medical  center,  6University of Washington  school of Medicine, seattle, W a, Usa;   7chronic Pain and Fatigue Research  center, Michigan institute for clinical  and Health Research, University of  Michigan school of Medicine, ann  arbor, M i, Usa;  8inVentiv health  clinical, indianapolis, in, Usa;  9UsMD  Neuroscience, Lilly USA LLC, Eli Lilly  and Company, Indianapolis, IN, USA;   10Department of Family Medicine,   University of California at San Diego  school of Medicine, san Diego, ca,   Usa correspondence: stephen l able   Eli Lilly and Company, Lilly Corporate  center, indianapolis, in 46285, Usa   Tel +1 317 276 3612  Fax +1 317 276 7100  email able_stephen_l@lilly.co mPurpose:  To evaluate the effect of physician specialty regarding diagnosis and treatment of  fibromyalgia (FM) and assess the clinical status of patients initiating new treatment for FM  using data from Real-World Examination of Fibromyalgia: Longitudinal Evaluation of Costs  and Treatments.",Non-OADS,/arxiv_data1/oa_pdf/5b/a6/por-7-011.PMC5085275.pdf
"Pragmatic and Observational Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pragmatic-and-observational-research-journa lPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more  closely medical interventions in real-world clinical practice compared with  classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/5b/a6/por-7-011.PMC5085275.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/a6/por-7-011.PMC5085275.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pragmatic and Observational Research 2016:7 41–53Pragmatic and Observational Research Dovepress submit your manuscript | www.dovepress.com Dovepress  41 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/POR.S96670Evaluating the benefits of home-based  management of atrial fibrillation: current  perspectives Azfar B Sheikh1 Jamie R Felzer2 Abdullah Bin Munir3 Daniel P Morin4 Carl J Lavie5 1Department of Cardiology, Ochsner  Clinical Foundation, John Ochsner  Heart and Vascular Institute, New Orleans, LA,  2Department of  Medicine, Scripps Green Hospital, La Jolla, CA,  3Department of Medicine,   Northwell Health – Staten Island University Hospital, Staten Island, NY,   4Department of Electrophysiology,   5Department of Cardiac Rehabilitation  and Prevention, Ochsner Clinical Foundation, John Ochsner Heart and Vascular Institute, New Orleans, LA,  USAAbstract:  Atrial fibrillation (AF) is the most common arrhythmia worldwide, leading to an  extensive public health and economic burden.",Non-OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
"Episodes may or may not recur with variable frequency; •	 persistent	 AF:	AF	that	is	sustained	for	>7 days of onset; •	 long-standing	 persistent	 AF:	persistent	 AF	that	lasts	for	>12 months in duration; •	 permanent	 AF:	clinical	situation	in	which	the	patient	and	clinician	agree	not	 to pursue rhythm control strategy;Correspondence: Carl J Lavie Department of Cardiac Rehabilitation and Prevention, Ochsner Clinical School-UQ School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121-2483, USATel +1 504 842 5874Email clavie@ochsner.org;  Azfar B Sheikh Department of Cardiology, Ochsner Clinic Foundation/John Ochsner Heart and Vascular Institute, 1514 Jefferson Highway, New Orleans, LA 70121-2483, USATel +1 832 799 2721Email azfar.sheikh@ochsner.orgJournal name: Pragmatic and Observational Research Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Sheikh et alRunning head recto: Atrial fibrillation: current perspectivesDOI: http://dx.doi.org/10.2147/POR.S96670",Non-OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
"Pragmatic and Observational Research 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Pragmatic and Observational Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pragmatic-and-observational-research-journalPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more   closely medical interventions in real-world clinical practice compared with   classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 53 Atrial fibrillation: current perspectives 111.,Non-OADS,/arxiv_data1/oa_pdf/5e/72/por-7-041.PMC5085276.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia Hypoxia 2016:4 121–133Dove press submit your manuscript | www.dovepress.co m Dove press   Erythropoietin and a nonerythropoietic peptide  analog promote aortic endothelial cell repair  under hypoxic conditions: role of nitric oxide Lamia Heikal1 Pietro Ghezzi1 Manuela Mengozzi1 Blanka Stelmaszczuk2 Martin Feelisch2 Gordon AA Ferns1 1Brighton and Sussex Medical School,   Falmer, Brighton, 2Clinical and  Experimental Sciences, Faculty of  Medicine, University of Southampton,   Southampton General Hospital  and Institute for Life Sciences,   Southampton, UK Correspondence: Gordon AA Ferns   Room 345, Brighton and Sussex Medical  School, Division of Medical Education,  Mayfield House, Falmer, Brighton BN1  9PH, UK   T el +44 1273 644 001   Email g.ferns@bsms.ac.u kAbstract:  The cytoprotective effects of erythropoietin (EPO) and an EPO-related nonery- thropoietic analog, pyroglutamate helix B surface peptide (pHBSP), were investigated in an in  vitro model of bovine aortic endothelial cell injury under normoxic (21% O2) and hypoxic (1%  O2) conditions.",Non-OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
Or use: http://youtu.be/BjLc2VAmP7 4,Non-OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/91/hp-4-121.PMC5085277.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6519–6528OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6519Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10571 6 Novel therapeutic strategies for patients with  triple-negative breast cancer Jun-Fei Zhang1 Jia Liu1,2 Yu wang1,2 Bin Zhang1,2 1Affiliated Hospital of inner Mongolia  University for the Nationalities,   Tongliao, inner Mongolia, People’s  Republic of China; 2Medicinal  Chemistry and Pharmacology  institute, inner Mongolia University  for the Nationalities, T ongliao, inner  Mongolia, People’s Republic of ChinaAbstract:  Triple-negative breast cancer (TNBC) represents a very heterogeneous group of  breast diseases.",Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
"BL BC Correspondence: Bin Zhang Medicinal Chemistry and Pharmacology  institute, inner Mongolia University  for the Nationalities, No 1742 Holin  He Street, Tongliao, inner Mongolia,  Autonomous Region, 028007, People’s  Republic of China Tel +86 475 831 4245 email bzh9911@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Novel therapeutic strategies for TNBC patients DOI: http://dx.doi.org/10.2147/OTT.S105716",Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/ NCT02338622?term =TNBC +PARP&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT 01560663?term =platinum +TNBC&rank =4.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT01216124?term =  platinum +TNBC&rank =6.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT01276769?,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.gov/ct2/results?,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from:  https://www.clinicaltrials.gov/ct2/show/NCT00463788?term =NCT00 463788.&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/   NCT01097642?term =cetuximab +TNBC&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT02158507?term =l apatinib +TNBC&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Avail - able from: https://www.clinicaltrials.gov/ct2/show/NCT01426880?,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT00540 358?term =Epidermal +growth +factor +receptor +as+a+potential +ther apeutic +target +in+triple-negative +breast +cancer&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0046 8715?term =NCT00468715&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/5a/ott-9-6519.PMC5085278.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/hp-4-109.PMC5085279.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/bf/93/hp-4-109.PMC5085279.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Preconditioning with ethyl 3,4-dihydroxybenzoate  augments aerobic respiration in rat skeletal  muscle Charu Nimker Deependra Pratap Singh Deepika Saraswat Anju Bansal Experimental Biology Division,   Defence Institute of Physiology and  Allied Sciences, Defense Research and  Development Organisation, Timarpur,   Delhi, India Correspondence: Anju Bansal   Experimental Biology Division, Defence  Institute of Physiology and Allied Sciences,  Defense Research and Development  Organisation, Lucknow Road, Timarpur,  Delhi 110054, India   Email anjubansaldipas@gmail.co mAbstract:  Muscle respiratory capacity decides the amount of exertion one’ s skeletal muscle  can undergo, and endurance exercise is believed to increase it.",Non-OADS,/arxiv_data1/oa_pdf/bf/93/hp-4-109.PMC5085279.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/bf/93/hp-4-109.PMC5085279.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/hp-4-109.PMC5085279.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 333–336International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 333 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S118594Exceptionally elevated triglyceride in severe  lipemia retinalis Han Y Yin1–3 Roberto Warman2,4 Edward H Suh2 Anny MS Cheng2,3 1Wayne State University, School of  Medicine, Detroit, MI, 2Department of  Ophthalmology, Florida International  University, Herbert Wertheim College of Medicine,  3Ocular Surface  Center, Miami, 4Division of Pediatric  Ophthalmology, Nicklaus Children’s Hospital, Miami, FL, USA Purpose: To report a case of successful treatment for severe lipemia retinalis with extreme  severe hypertriglyceridemia (sHTG).",Non-OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
"Other laboratory data, including blood cell counts, electrolytes, liver function, thyroid function, glucose, and  Correspondence: Anny MS Cheng Ocular Surface Center, 7000 SW 97th Avenue, Suite 213, Miami, FL 33173, USATel +1 305 274 1299Fax +1 305 274 1297Email acheng@ocularsurface.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Yin et alRunning head recto: Exceptionally elevated TG in severe lipemia retinalisDOI: http://dx.doi.org/10.2147/IMCRJ.S118594",Non-OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 336 Yin et al,Non-OADS,/arxiv_data1/oa_pdf/b3/dc/imcrj-9-333.PMC5085280.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/47/opth-10-2085.PMC5085282.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2085–2091Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2085Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11271 1 Efficacy and tolerability of benzalkonium  chloride-free travoprost in glaucoma patients  switched from benzalkonium chloride-preserved  latanoprost or bimatoprost Julian garcía-Feijoo1 Francisco J Muñoz-Negrete2 Douglas A Hubatsch3 gemma C rossi4 On behalf of the study  investigators 1Department of Ophthalmology,   instituto de investigación sanitaria  del hospital Clínico san Carlos,   Universidad Complutense, OFT areD,   2hospital Univers itario ramón y  Cajal, Universidad de alcalá, irYCis,   OFTareD, Madrid, spain; 3alcon  Laboratories, Inc., Fort Worth, TX,   Usa; 4Department of Ophthalmology,   University eye Clinic, irCCs   Policlinico san Matteo Foundation,   Pavia, italyIntroduction:  The preservative benzalkonium chloride (BAK) is used to preserve several  topical, intraocular pressure (IOP)-lowering glaucoma medications but can cause tolerability  concerns that may lead to decreased adherence to treatment and ultimately diminish the effec - tiveness of IOP control.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/opth-10-2085.PMC5085282.pdf
"Keywords:  benzalkonium chloride, intraocular pressure, polyquad, polyquaternium-1,  prostaglandin analog, switch, travoprost Introduction Glaucoma is a progressive disease affecting the optic nerve1 and is the second leading  cause of blindness worldwide.2 The etiology of glaucoma is multifactorial, but elevated  intraocular pressure (IOP) has been associated with the risk and progression of the  disease, resulting in visual field loss and optic disk cupping.1,3–5 Reduction of IOP is the Correspondence: Julian garcía-Feijoo Department of Ophthalmology,  instituto de investigación sanitaria del  hospital Clínico san Carlos, Universidad  Complutense, OFTareD, Paseo de  san Francisco de sales 23, Casa 2,  10B, Madrid, spain Tel +34 609 88 9605 Fax +34 610 358 3636 email jgarciafeijoo@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: García-Feijoo et al Running head recto: Switching from latanoprost or bimatoprost to preservative-free travoprost  DOI: http://dx.doi.org/10.2147/OPTH.S112711",Non-OADS,/arxiv_data1/oa_pdf/b2/47/opth-10-2085.PMC5085282.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/opth-10-2085.PMC5085282.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/opth-10-2085.PMC5085282.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/02/hp-4-081.PMC5085283.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia Hypoxia 2016:4 81–90Dove press submit your manuscript | www.dovepress.co m Dove press  Original researcHopen access to scientific and medical research Open access Full T ext article 81 http: //dx.doi.org/10.2147/HP .S9866 0Sevoflurane mitigates shedding of hyaluronan  from the coronary endothelium, also during  ischemia/reperfusion: an ex vivo animal study Congcong Chen1,3 Daniel Chappell2,3 Thorsten Annecke2,3 Peter conzen2 Matthias Jacob2,3 Ulrich Welsch4 Bernhard Zwissler2 Bernhard F Becker3 1Department of Anesthesiology,   Second Affiliated Hospital of  Zhejiang University, Hangzhou,   People’s Republic of China; 2Clinic of  Anesthesiology, Ludwig-Maximilians- University, Munich, Germany; 3Walter- Brendel-Centre of Experimental  Medicine, Ludwig-Maximilians- University, Munich, Germany; 4institute  of Anatomy, Ludwig-Maximilians- University, Munich, Germany Correspondence: Bernhard F Becker   Walter-Brendel-Centre of Experimental  Medicine, Ludwig-Maximilians-University,  Schiller Street 44, 80336 Munich,  germany   T el +49 89 2180 76500   Fax +49 89 2180 75378   email B.F .Becker@lrz.uni-muenchen.d eAbstract:  Glycosaminoglycan hyaluronan (HA), a major constituent of the endothelial  glycocalyx, helps to maintain vascular integrity.",Non-OADS,/arxiv_data1/oa_pdf/95/02/hp-4-081.PMC5085283.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/95/02/hp-4-081.PMC5085283.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/02/hp-4-081.PMC5085283.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).PHD2: from hypoxia regulation to disease  progression Ana M Meneses Ben Wielockx Heisenberg Research Group,   Department of Clinical  Pathobiochemistry, Institute for  Clinical Chemistry and Laboratory  Medicine, Technische Universität  Dresden, Dresden, Germany Correspondence: Ben Wielockx   Heisenberg Research Group, Department  of Clinical Pathobiochemistry, Institute  for Clinical Chemistry and Laboratory  Medicine, T echnische Universität Dresden,  Fiedlerstrasse 42, 01307 Dresden,  Germany   T el +49 351 458 16260   Email Ben.Wielockx@tu-dresden.d eAbstract:  Oxygen represents one of the major molecules required for the development and  maintenance of life.",Non-OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
"Available from:  http://thebiogrid.org/120060/summary/homo-sapiens/egln1.htm l.  Accessed March 3, 2016.",OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/74/hp-4-053.PMC5085284.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/f3/hp-4-041.PMC5085285.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia 2016:4 41–52Hypoxia Dove press submit your manuscript | www.dovepress.co m Dove press  41Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/HP .S10308 8ascorbate availability affects tumor implantation- take rate and increases tumor rejection in gulo–/–  mice elizabeth J campbell1 Margreet cM Vissers2 gabi U Dachs1 1Mackenzie cancer research group,   2centre for Free radical research,   Department of Pathology, University  of Otago, christchurch, new Zealand correspondence: gabi U Dachs   Mackenzie cancer research group,  Department of Pathology, University of  Otago, 2 riccarton ave,   christchurch 8011, new Zealand   T el +64 3 364 0544   Fax +64 3 364 0525   email gabi.dachs@otago.ac.n zAbstract:  In solid tumors, HIF1 upregulates the expression of hundreds of genes involved in  cell survival, tumor growth, and adaptation to the hypoxic microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/26/f3/hp-4-041.PMC5085285.pdf
Available from: https://www.nrv.,Non-OADS,/arxiv_data1/oa_pdf/26/f3/hp-4-041.PMC5085285.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/26/f3/hp-4-041.PMC5085285.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/f3/hp-4-041.PMC5085285.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2e/85/hp-4-001.PMC5085286.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/2e/85/hp-4-001.PMC5085286.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).hypoxia 2016:4 1–14submit your manuscript | www.dovepress.co m Dove press  1 http: //dx.doi.org/10.2147/HP .S10113 3Fifteen days of 3,200 m simulated hypoxia  marginally regulates markers for protein synthesis  and degradation in human skeletal muscle gommaar D’hulst1 alessandra Ferri2,3 Damien naslain4 luc Bertrand5 sandrine horman5 Marc Francaux4 David J Bishop2 louise Deldicque1,4 1Department of Kinesiology, exercise  Physiology research group, FaBer,   KU leuven, leuven, Belgium; 2institute  of sport, exercise and active  living (iseal), Victoria University,   Melbourne, australia; 3Department of  health sciences, University of Milano- Bicocca, Monza, italy; 4institute of  neuroscience, Université catholique  de louvain, louvain-la-n euve,   5institut de recherche expérimentale  et clinique, Pôle de recherche  cardiovasculaire, Université  catholique de louvain, Brussels,   Belgium correspondence: louise Deldicque   institute of neuroscience, Université  catholique de louvain, Place Pierre de  coubertin 1, 1348 louvain-la-neuve,  Belgium   email louise.deldicque@uclouvain.b eAbstract:  Chronic hypoxia leads to muscle atrophy.",Non-OADS,/arxiv_data1/oa_pdf/2e/85/hp-4-001.PMC5085286.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/2e/85/hp-4-001.PMC5085286.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/85/hp-4-001.PMC5085286.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 393–413Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 393 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S113419 Vejle Diabetes Biobank – a resource for   studies of the etiologies of diabetes and its   comorbidities Eva Rabing Brix Petersen1,2 Aneta Aleksandra Nielsen1 Henry Christensen1 T orben Hansen3 Oluf Pedersen3 Cramer Kjeldahl  Christensen4 Ivan Brandslund1,2 1Department of Clinical Immunology  and Biochemistry, Lillebaelt Hospital,   Vejle, 2Faculty of Health Sciences,   Institute of Regional Health Research,  University of Southern Denmark,  Odense,  3Novo Nordisk Foundation  Center for Basic Metabolic Research,  Section of Metabolic Genetics,  Faculty of Health and Medical Sciences, University of Copenhagen,  Copenhagen,  4Department of Internal  Medicine and Endocrinology, Lillebaelt Hospital, Vejle, DenmarkAims:  Carefully designed and established biobanks are considered one of the most essential  resources to foster biomedical research as they provide cost-effective and rapid access to a  vast variety of biological materials and related anthropometrics allowing for testing of various  biomarkers as well as numerous original and pertinent bioclinical hypotheses related to human  disease etiology and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
"Recently, a Canadian study 2 suggested that Correspondence: Eva Rabing Brix  PetersenDepartment of Clinical Immunology and Biochemistry, Lillebaelt Hospital, Kabbeltoft 25, 7100 Vejle, DenmarkTel +45 7 940 6500Fax +45 7 940 6853Email eva.rabing.brix.petersen@rsyd.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Petersen et alRunning head recto: Vejle Diabetes Biobank – study designDOI: http://dx.doi.org/10.2147/CLEP .S113419",Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
"Data access Data on biomarkers in anonymized form can be accessed at http://dda.dk/catalogue/19269?lang=en Acknowledgments The project was funded by the Danish Council for Indepen-dent Research/Medical Sciences, the Research Council of  Vejle Hospital, the Department of Internal Medicine, Vejle Hospital, Vejle County, the Danish Research Fund, the Lions Club International Denmark, and anonymous donations.",Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
Available from: http://www.whocc.no/atc_ddd_index/.,OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
Available from: http://www.labquality.fi/eqa-eqas/.,OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
Available from: http://www.laeger.dk/nyhed/download/docs/F26051/kvalitetssikring%20og%20kvalitetsk-rav%20hovedrapport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
Avail-able from: https://www.sundhed.dk/content/cms/87/4687_kom_%C3%A5rsrapport_diabetes_2014_15_27082015_endelig.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/8f/80/clep-8-393.PMC5085288.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2016:7 117–124Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  117 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S95637Strategies to optimize treatment adherence in  adolescent patients with cystic fibrosis Lara C Bishay Gregory S Sawicki Division of Respiratory Diseases,   Boston Children’s Hospital, Boston,  MA, USAAbstract:  While development of new treatments for cystic fibrosis (CF) has led to a signifi- cant improvement in survival age, routine daily treatment for CF is complex, burdensome, and  time intensive.",Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
"These include pancreatic enzyme  replacement, fat-soluble vitamin replacement, high-caloric density diets, inhaled Correspondence: Lara C Bishay Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115, USATel +1 617 355 1900Fax +1 617 730 0084Email lara.bishay@childrens.harvard.eduJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: RevieWY ear: 2016volume: 7 Running head verso: Bishay and SawickiRunning head recto: Adherence in adolescents with cystic fibrosisDOi: http://dx.doi.org/10.2147/AHMT.S95637",Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
Available from: https://www.cff.,Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
"Adolescent Health, Medicine and Therapeutics 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
visit http://www.dovepress.com/testimonials.,Non-OADS,/arxiv_data1/oa_pdf/9d/56/ahmt-7-117.PMC5085292.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 235–238Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 235 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S117669Utility of preoperative in vitro platelet function  tests for predicting bleeding risk in patients  undergoing functional endoscopic sinus surgery A-Jin Lee   Sang-Gyung Kim Department of Laboratory Medicine,   Catholic University of Daegu School of Medicine, Daegu, Republic of KoreaBackground: It is necessary to predict the bleeding risk in patients undergoing functional  endoscopic sinus surgery (FESS).",Non-OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
"Therefore, it is critical to predict the risk of perioperative or postoperative bleeding in patients undergoing surgery.Correspondence: A-Jin Lee  Department of Laboratory Medicine, Catholic University of Daegu School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Republic of Korea   Tel +82 53 650 4102   Fax +82 53 653 8672   Email ajlee388@gmail.com.Journal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Lee and KimRunning head recto: Usefulness of platelet function testsDOI: http://dx.doi.org/10.2147/JBM.S117669",Non-OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 238 Lee and Kim This study has a limitation stemming from its small  sample size.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/jbm-7-235.PMC5085293.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/0c/ppa-10-2141.PMC5085294.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2141–2144Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2141Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11750 6 Averting the foul taste of pediatric medicines  improves adherence and can be lifesaving –  Pheburane® (sodium phenylbutyrate) Gideon Koren1 Michael J Rieder1 Y ona Amitai2 1Department of Physiology  and Pharmacology, The University  of western Ontario, London,   ON, Canada; 2Bar-ilan University,   Ramat Gan, israelBackground:  Children’s aversions to poor and mostly bitter tastes and their inability to swallow  tablets and capsules are major challenges in pediatric medicine.",Non-OADS,/arxiv_data1/oa_pdf/9b/0c/ppa-10-2141.PMC5085294.pdf
"In a recent pragmatic study among hospitalized children, nearly one-third of the  participants reported medicine refusal, which correlated significantly with child’s age,  drug taste, texture, and volume or quantity of the medicine.3Correspondence: Gideon Koren Department of Physiology and  Pharmacology, The University of  western Ontario, London, ON N6A  5C1, Canada Tel +1 647 300 6425 email gidiup_2000@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Koren et al Running head recto: Averting the foul taste of medicines is lifesaving DOI: http://dx.doi.org/10.2147/PPA.S117506",Non-OADS,/arxiv_data1/oa_pdf/9b/0c/ppa-10-2141.PMC5085294.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9b/0c/ppa-10-2141.PMC5085294.pdf
"Available from: http://www.aap.org/ en-us/professional-resources/Research/Pages/PS44_Exe cutive_ Summa ry_PatientCompliancewithPrescriptionRegimens.asp x. Accessed   December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/9b/0c/ppa-10-2141.PMC5085294.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/ott-9-6511.PMC5085295.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6511–6518OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6511Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11662 9 high-dose irradiation in combination with toll-like  receptor 9 agonist cpg oligodeoxynucleotide 7909  downregulates PD-l1 expression via the nF- κB  signaling pathway in non-small cell lung cancer cells Xue chen1 Qi Zhang1 Y oujun luo1 caixia gao1 Xibing Zhuang1 guoxiong Xu2 Tiankui Qiao1 1Department of Oncology, Jinshan  hospital, Medical center of Fudan  University, 2Department of center  laboratory, Jinshan hospital, Fudan  University, shanghai, People’s  republic of chinaObjectives:  Irradiation resistance appears as local recurrence and distant metastasis in  advanced stages of non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/ott-9-6511.PMC5085295.pdf
"Recent advancement in targeting therapy and immunotherapy offers correspondence: Tiankui Qiao Department of Oncology, Jinshan  hospital, Medical center of Fudan  University, 1508 longhang road, Jinshan  District, shanghai 201500, People’s  republic of china Tel +86 189 3077 8786 Fax +86 021 5703 9590 email qiaotk@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: CpG ODN 7909 plus irradiation regulated PD-L1 expression in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S116629",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/ott-9-6511.PMC5085295.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/ott-9-6511.PMC5085295.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/fd/ott-9-6511.PMC5085295.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2093–2098Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2093Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10980 9 intravitreal bevacizumab injections for diabetic  macular edema – predictors of response:  a retrospective study lavnish Joshi1–3 asaf Bar4 Oren T omkins-n etzer1,3 satish Yaganti1 Jiten Morarji1 Panayiotis Vouzounis1 sophie seguin-greenstein1,4 simon r Taylor3,5 sue lightman1,3 1Department of Clinical  Ophthalmology, UC l institute of  Ophthalmology and Moorfields eye  hospital, london, UK; 2Ophthalmology  Department, ashford & st Peter’s  nhs Foundation Trust, ashford,   Middlesex, UK; 3Ophthalmology  Department, royal surrey County  hospital nhs Foundation Trust,   guildford, surrey, UK; 4Ophthalmology  Department, Wolfson Medical  Center, holon israel; 5Ophthalmology  Department, University of surrey,   guildford, surrey, UKBackground:  Outcomes of intravitreal antivascular endothelial growth factor injections are  variable among patients with diabetic macular edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
"These have looked at systemic8,9 or ocular factors,10  but not in conjunction with each other, which could be important since these factors  may be interrelated.Correspondence: sue lightman UCl institute of Ophthalmology,  Moorfields Eye Hospital, 162 City Road,  london eC1V 2PD, UK Tel +44 20 7566 2266 email s.lightman@ucl.ac.u k Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Joshi et al Running head recto: Predictors of DME response to IVB DOI: http://dx.doi.org/10.2147/OPTH.S109809",Non-OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
Available from: http://www.rcophth.ac.uk/core/ core_picker/download.asp?id =167&filetitle =Guidelines +for+Intravitr eal+Injections +Procedure +2009.,OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/c6/opth-10-2093.PMC5085296.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ijn-11-5497.PMC5085298.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5497–5503International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5497OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11815 6 highly sensitive detection of protein biomarkers  via nuclear magnetic resonance biosensor with  magnetically engineered nanoferrite particles Minhong Jeun1 sungwook Park1,2 hakho lee3 Kwan hyi lee1,2 1center for Biomaterials, Biomedical  research Institute, Korea Institute  of science and T echnology, seoul,   2Department of Biomedical  engineering, Korea University of  science and T echnology, Daejeon,   republic of Korea; 3center for  systems Biology, Massachusetts  general hospital, harvard Medical  school, Boston, M a, UsaAbstract:  Magnetic-based biosensors are attractive for on-site detection of biomarkers due to the  low magnetic susceptibility of biological samples.",Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ijn-11-5497.PMC5085298.pdf
"In  addition, because the NMR  signal is generated from the whole volume, the binding kinetics for the NMR signal correspondence: Kwan hyi lee center for Biomaterials, Biomedical  research Institute, Korea Institute of  science and Technology, seoul 02792,  republic of Korea Tel +82 2 958 6804 Fax +82 2 958 5308 email kwanhyi@kist.re.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Jeun et al Running head recto: Highly sensitive NMR biosensor with MnMg-NFP DOI: http://dx.doi.org/10.2147/IJN.S118156",OADS,/arxiv_data1/oa_pdf/6f/e7/ijn-11-5497.PMC5085298.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ijn-11-5497.PMC5085298.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ijn-11-5497.PMC5085298.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/copd-11-2651.PMC5085299.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2651–2657International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2651OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11248 4 Prescription of opioids for breathlessness in  end-stage COPD: a national population-based  study Zainab ahmadi1,2 eva Bernelid2 David C Currow3 Magnus ekström1–3 1Department of Clinical sciences,   Division of respiratory Medicine and  allergology, lund University hospital,   lund, 2Department of Medicine,   Blekinge hospital, Karlskrona, sweden;   3Discipline, Palliative and supportive  services, Flinders University, adelaide,   sa, australiaBackground:  Low-dose opioids can relieve breathlessness but may be underused in late-stage  COPD due to fear of complications, contributing to poor symptom control.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/copd-11-2651.PMC5085299.pdf
"Keywords:  COPD, symptoms, breathlessness, opioids, prescriptions, LTOT Introduction COPD is a leading cause of mortality worldwide, and is associated with high burden  of symptoms, often poorly controlled in advanced disease stages.1–4 The prevalence  and severity of breathlessness are higher in end-stage COPD than in advanced lung  cancer, both during the final year of life and in the terminal weeks and days near  death.5,6 Despite long-term oxygen therapy (LTOT), most COPD patients suffer  from breathlessness at rest or on minimal exertion that greatly limits even the basic  activities of daily living.7–9 Breathlessness that persists at rest or on minimal exer - tion despite optimal treatment of the underlying disease(s) is termed “refractory  breathlessness.”10,11 Opioids have a growing evidence base for decreasing refractory breathlessness  in advanced COPD.10,12 Jennings et al concluded in a Cochrane meta-analysis that Correspondence: Zainab ahmadi Department of Clinical sciences, Division  of respiratory Medicine and allergology,  lund University hospital, Klinikgatan 18,  se-221 00 lund, sweden Tel +46 46 17 1000 email zai.ahmd@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ahmadi et al Running head recto: Opioids for breathlessness in end-stage COPD DOI: http://dx.doi.org/10.2147/COPD.S112484",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/copd-11-2651.PMC5085299.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/copd-11-2651.PMC5085299.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/c3/copd-11-2651.PMC5085299.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/10/ijn-11-5519.PMC5085300.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5519–5529International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5519OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11159 4 Quantum dot-based immunofluorescent imaging  and quantitative detection of TOP2a and  prognostic value in triple-negative breast cancer Hongmei Zheng1 Xiang Li1 Chuang Chen2 Jian Chen3 Jinzhong Sun2 si sun4 Liting Jin1 Juanjuan li2 Shengrong Sun2 Xinhong Wu1 1Department of Breast Surgery, Hubei  Cancer Hospital, 2Department of  Breast and Thyroid Surgery, Renmin  Hospital of Wuhan University,   3Department of head and Neck  Surgery, Hubei Cancer Hospital,   4Department of Clinical Laboratory,   Renmin Hospital of Wuhan  University, Wuhan, Hubei, People’s  Republic of ChinaBackground:  Topoisomerase 2 alpha (TOP2A) is a key enzyme in DNA replication and a target  of various cytotoxic agents including anthracyclines.",Non-OADS,/arxiv_data1/oa_pdf/ab/10/ijn-11-5519.PMC5085300.pdf
"Keywords:  triple-negative breast cancer, quantum dot, TOP2A, disease-free survival,  prognosis Introduction Breast cancer is the leading cause of cancer death among women and accounts for ~30%  of all estimated new cancer cases in this population.1 Therapeutic advancements have  come in the form of endocrine therapies and HER2-targeting therapies for hormone  receptor (HR)-positive and HER2-positive breast cancer.2 However, improvement in  survival of patients with triple-negative breast cancer (TNBC), a subtype characterized by  tumors that are negative for all three of HER2, estrogen receptor (ER), and progesterone Correspondence: Xinhong Wu Department of Breast Surgery, Hubei  Cancer Hospital, No 116, Zhuo Daoquan  South Road, Hongshan District, Wuhan  430079, Hubei Province, People’s  Republic of China email wuxinhong_9@sina.co m  Shengrong Sun Department of Breast and Thyroid  Surgery, Renmin Hospital of Wuhan  University, Tower 238 Jiefang Road,  Wuchang District, Wuhan 430060, Hubei  Province, People’s Republic of China email sun13712@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zheng et al Running head recto: Quantum dot-based detection of TOP2A and prognostic value in TNBC DOI: http://dx.doi.org/10.2147/IJN.S111594",Non-OADS,/arxiv_data1/oa_pdf/ab/10/ijn-11-5519.PMC5085300.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ab/10/ijn-11-5519.PMC5085300.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/10/ijn-11-5519.PMC5085300.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1579–1585Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1579ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11376 9 Therapy of psoriasis with narrowband  ultraviolet-B light influences plasma  concentrations of MMP-2 and TiMP-2 in patients Edyta Katarzyna Głażewska1  Marek niczyporuk1 Sławomir Ławicki2 Maciej szmitkowski2 Monika Zajkowska2  Grażyna Ewa Będkowska3 andrzej Przylipiak1 1Department of esthetic Medicine,   2Department of Biochemical  Diagnostics, 3Department of  haematological Diagnostics, Medical  University, Białystok, PolandBackground:  Matrix metalloproteinases (MMPs), which show a significant ability to cleave  the components of extracellular matrix, and tissue inhibitors of metalloproteinases (TIMPs),  which slow down the activity of those enzymes, may be implicated in the pathogenesis and  spread of psoriatic disease.",Non-OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
"Scientists assumed that the occur - rence of the described condition can be associated with genetic predisposition and  environmental triggering factors as well as other disorders.3Correspondence: edyta Katarzyna  Głażewska Department of esthetic Medicine, Medical  University Białystok,  akademicka 3,  15-267 Białystok, Poland Tel +48 857 485 822 email kasiaglazewska@wp.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Głaz ˙ewska et al Running head recto: Pre- and posttreatment MMP-2 and TIMP-2 plasma levels in psoriatic patients DOI: http://dx.doi.org/10.2147/TCRM.S113769",Non-OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/d3/tcrm-12-1579.PMC5085301.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/ott-9-6529.PMC5085302.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6529–6537OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6529Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11729 0 The postoperative neutrophil-to-lymphocyte ratio  and changes in this ratio predict survival after  the complete resection of stage i non-small cell  lung cancer Feng Jin1,2 anqin han2 Fang shi2 li Kong2 Jinming Yu2 1school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department of  radiation Oncology, shandong cancer  hospital affiliated to shandong  University, shandong academy of  Medical sciences, Jinan, People’s  republic of chinaPurpose:  Although numerous studies have demonstrated associations between the  preoperative neutrophil-to-lymphocyte ratio (NLR) and long-term outcomes in patients with  non-small cell lung cancer (NSCLC), the prognostic significance of postoperative NLR and  change in NLR ( ∆NLR) is unknown for patients who underwent complete resection of stage  I NSCLC.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/ott-9-6529.PMC5085302.pdf
"Keywords:  neutrophil-to-lymphocyte ratio, non-small-cell lung cancer, stage I,  prognosis, surgery Introduction Lung cancer is the second most common newly diagnosed cancer and one of the leading  causes of cancer-related death among both men and women worldwide.1 Surgical  resection is the treatment of choice for patients with early-stage non-small cell lung  cancer (NSCLC).2 Despite aggressive surgical therapy, ~30%–40% of patients with correspondence: Jinming Yu Department of radiation Oncology,  Shandong Cancer Hospital Affiliated  to shandong University, shandong  academy of Medical sciences, Jiyan  road 440, Jinan 250117, shandong,  People’s republic of china Tel +86 531 8798 4729 Fax +86 531 8798 4079 email sdyujinming@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jin et al Running head recto: Postoperative NLR and ∆NLR in stage I NSCLC DOI: http://dx.doi.org/10.2147/OTT.S117290",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/ott-9-6529.PMC5085302.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/ott-9-6529.PMC5085302.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/ea/ott-9-6529.PMC5085302.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/5d/hp-4-091.PMC5085303.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia 2016:4 91–97Hypoxia Dove press submit your manuscript | www.dovepress.co m Dove press  91ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S9768 1Oxygen-dependent regulation of aquaporin-3  expression David Hoogewijs1,2 Melanie Vogler3 Eveline Zwenger3 Sabine Krull3 Anke Zieseniss3 1Institute of Physiology, University  of Duisburg-Essen, Essen, Germany;   2Institute of Physiology, University of  Zürich, Zürich, Switzerland; 3Institute  of Cardiovascular Physiology,   University Medical Center Göttingen,   University of Göttingen, Göttingen,   Germany Correspondence: Anke Zieseniss   Institute of Cardiovascular Physiology,   University Medical Center Göttingen,   Humboldtallee 23, 37073   Göttingen, Germany   T el +49 551 395 648   Fax +49 551 395 895   Email anke.zieseniss@med.uni-goettingen.d eAbstract:  The purpose of this study was to investigate whether aquaporin-3 (AQP3)  expression  is altered in hypoxia and whether hypoxia-inducible transcription factor (HIF)-1 regulates the  hypoxic expression.",Non-OADS,/arxiv_data1/oa_pdf/57/5d/hp-4-091.PMC5085303.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/57/5d/hp-4-091.PMC5085303.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/5d/hp-4-091.PMC5085303.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/eb/por-7-001.PMC5085304.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPragmatic and Observational Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pragmatic-and-observational-research-journa lPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more  closely medical interventions in real-world clinical practice compared with  classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/c5/eb/por-7-001.PMC5085304.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/eb/por-7-001.PMC5085304.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/8f/ott-9-6539.PMC5085305.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6539–6548OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6539Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10716 6 WisP-1 overexpression upregulates cell  proliferation in human salivary gland carcinomas  via regulating MMP-2 expression Fu-Jun li Xin-Juan Wang Xiao-li Zhou Department of stomatology, The  First affiliated hospital of henan  University of science and T echnology,   luoyang, People’s republic of chinaBackground:  WISP-1 is a member of the CCN family of growth factors and has been reported  to play an important role in tumorigenesis by triggering downstream events via integrin sig - naling.",Non-OADS,/arxiv_data1/oa_pdf/25/8f/ott-9-6539.PMC5085305.pdf
"SGCs account for ~3%–6% of all head  and neck malignancies.3,4 In recent years, multiple molecular markers, such as PTTG,  CDKN2A, TP53, and EGFR, have been found to be prognostic of SGCs.5–8 In particular,  the EGFR positivity has been recognized in ~82%–91% of SGC samples.6,9 The CCN family of growth factors derived their name from the acronym of the first  three members of the family: cyr61, CTGF, and NOV.10 They share properties including  stimulation of cell proliferation, migration, adhesion, and extracellular matrix (ECM) correspondence: Fu-Jun li Department of stomatology, The First  Affiliated Hospital of Henan University of  science and Technology, no 24, Jinghua  road, Jianxi District, luoyang 471003,  henan Province, People’s republic of  china Tel +86 379 6483 0803 email forjunelee@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: WISP-1 upregulates cell proliferation and MMP-2 expression in SGCs DOI: http://dx.doi.org/10.2147/OTT.S107166",Non-OADS,/arxiv_data1/oa_pdf/25/8f/ott-9-6539.PMC5085305.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/25/8f/ott-9-6539.PMC5085305.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/8f/ott-9-6539.PMC5085305.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d2/b2/hp-4-135.PMC5085306.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/d2/b2/hp-4-135.PMC5085306.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Phosphorylation of the pyruvate dehydrogenase  complex precedes HIF-1-mediated effects and  pyruvate dehydrogenase kinase 1 upregulation  during the first hours of hypoxic treatment in  hepatocellular carcinoma cells Andreas David Zimmer Geoffroy Walbrecq Ines Kozar  Iris Behrmann Claude Haan Life Sciences Research Unit,   University of Luxembourg, Belvaux,   Luxembourg Correspondence: Claude Haan   Life Sciences Research Unit,   University of Luxembourg,   6 avenue du Swing, 4367 Belvaux,  Luxembourg   Email claude.haan@uni.l uAbstract:  The pyruvate dehydrogenase complex (PDC) is an important gatekeeper enzyme  connecting glycolysis to the tricarboxylic acid (TCA) cycle and oxidative phosphorylation  (OXPHOS).",Non-OADS,/arxiv_data1/oa_pdf/d2/b2/hp-4-135.PMC5085306.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/d2/b2/hp-4-135.PMC5085306.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/b2/hp-4-135.PMC5085306.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 865–869Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  865 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S120470D2-like receptors in the descending dopaminergic  pathway are not involved in the decreased  postoperative nociceptive threshold induced by  plantar incision in adult rats Norimasa Ohtani Eiji Masaki Division of Dento-oral Anesthesiology,   T ohoku University Graduate School of Dentistry, Sendai, Miyagi, JapanBackground: Approximately half of all patients who undergo surgery develop postoperative  pain, the mechanisms of which are not well understood by anesthesiologists.",Non-OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
"4Correspondence:  Eiji Masaki Division of Dento-oral Anesthesiology,  Tohoku University Graduate School of Dentistry, 4-1 Seiryomachi, Aoba-ku, Sendai 980-8575, JapanTel/Fax +81 22 717 8401Email ejmasaki@m.tohoku.ac.jpJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ohtani and MasakiRunning head recto: D2-like receptor and postoperative nociceptive thresholdDOI: http://dx.doi.org/10.2147/JPR.S120470",Non-OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 869 D2-like receptor and postoperative nociceptive threshold Conclusion IT administration of a D2-like agonist had an antinociceptive  effect on the decreased nociceptive threshold induced by a surgical incision in a mouse model of neurological pain, while a D2-like antagonist had no such effect.",Non-OADS,/arxiv_data1/oa_pdf/88/d2/jpr-9-865.PMC5085307.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/02/48/por-7-003.PMC5085308.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/02/48/por-7-003.PMC5085308.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Pragmatic and Observational Research 2016:7 3–10Pragmatic and Observational Research Dove press submit your manuscript | www.dovepress.co m Dove press  3ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/POR.S9445 6Optimizing insulin initiation in primary care:   the Diabetes costars patient support program Olga K lutzko1 helen schifferle2 Marita ariola3 antonia Rich4 Khen Meng Kon5 1Kardinia health, gP super clinic,   Belmont, Vic , 2Medicross Rothwell,   Rothwell, QlD, 3innerwest specialist  centre, Burwood, nsW, australia;   4atlantis healthcare Pty ltd, sydney,   australia; 5sanofi australia Pty ltd,   Macquarie Park, nsW, australia correspondence: Olga K lutzko   Kardinia health, gP super clinic,  2-18 colac Rd, Belmont, Vic 3216,  australia   Tel +61 4 3194 6898   email olutzko@gmail.co mPurpose:  The purpose of this study was to evaluate the optimization of fasting blood glucose  (FBG) levels in patients with type 2 diabetes mellitus newly initiated on insulin glargine who  were enrolled in the Australian Diabetes CoStars Patient Support Program (PSP).",Non-OADS,/arxiv_data1/oa_pdf/02/48/por-7-003.PMC5085308.pdf
"Pragmatic and Observational Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pragmatic-and-observational-research-journa lPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more  closely medical interventions in real-world clinical practice compared with  classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/02/48/por-7-003.PMC5085308.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/48/por-7-003.PMC5085308.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 175–186Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 175 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S114635 Insights into the molecular etiology of   exercise-induced inflammation: opportunities   for optimizing performance Ioannis G Fatouros Athanasios Z Jamurtas School of Physical Education and  Sport Sciences, University of Thessaly,  Karies, Trikala, GreeceAbstract:  The study of exercise-induced muscle damage (EIMD) is of paramount importance  not only because it affects athletic performance but also because it is an excellent model to  study the mechanisms governing muscle cachexia under various clinical conditions.",Non-OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
"Since myofilaments of these sarcomeres may not return to their original overlapping state during the relaxation phase of the muscle, a mechanical disruption of these sarcomeres develops which is eventually transmitted to neighboring areas in muscle vicinity resulting in subcellular  Correspondence:  Ioannis G Fatouros School of Physical Education and Sport  Science, University of Thessaly, Karies, Trikala 42100, GreeceTel +30 24310 47047Fax +30 24310 47042Email ifatouros@pe.uth.grJournal name: Journal of Inflammation Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Fatouros and JamurtasRunning head recto: Exercise and skeletal muscle damageDOI: http://dx.doi.org/10.2147/JIR.S114635",Non-OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 186 Fatouros and Jamurtas  171.,Non-OADS,/arxiv_data1/oa_pdf/65/82/jir-9-175.PMC5085309.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/e2/tcrm-12-1587.PMC5085310.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1587–1592Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1587Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10009 1 Secukinumab for ankylosing spondylitis and  psoriatic arthritis ennio Lubrano Fabio Massimo Perrotta Dipartimento di Medicina e Scienze  della Salute “ vincenzo Tiberio”,   Università degli Studi del Molise,   Campobasso, italyAbstract:  The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively  changed since the introduction of anti-TNF α drugs.",Non-OADS,/arxiv_data1/oa_pdf/07/e2/tcrm-12-1587.PMC5085310.pdf
"These drugs also show  effectiveness in the improvement of function, disease activity, pain, and quality of  life in AS patients.6–12 In recent years, however, a more in-depth understanding of Correspondence: ennio Lubrano Dipartimento di Medicina e Scienze  della Salute “vincenzo Tiberio”,  Università degli Studi del Molise, via  Giovanni Paolo ii, C/da Tappino, 86100  Campobasso, italy Tel +39 0874 404745 Fax +39 0874 404745 email enniolubrano@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Lubrano and Perrotta Running head recto: Secukinumab for AS and PsA DOI: http://dx.doi.org/10.2147/TCRM.S100091",Non-OADS,/arxiv_data1/oa_pdf/07/e2/tcrm-12-1587.PMC5085310.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/07/e2/tcrm-12-1587.PMC5085310.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/e2/tcrm-12-1587.PMC5085310.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2127–2139Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2127OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11417 2 Physician and patient benefit–risk preferences  from two randomized long-acting injectable  antipsychotic trials eva g Katz1 Brett hauber2 srihari gopal3 Angie Fairchild2 Amy Pugh4 rachel B Weinstein3  Bennett s levitan3 1Janssen research & Development,   llc, raritan, nJ, 2rTi health  Solutions, Research Triangle Park, NC,   3Janssen research & Development,   llc, Titusville, nJ, 4The University  of california, san Francisco  (UcsF), cA, UsAPurpose:  To quantify clinical trial participants’ and investigators’ judgments with respect to the  relative importance of efficacy and safety attributes of antipsychotic treatments for schizophrenia,  and to assess the impact of formulation and adherence.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"These value judgments have traditionally been based on  a physician’s perspective,4 but there is increasing interest in using patient’s input5–7 correspondence: eva g Katz Janssen research & Development,   llc, 920 Us highway 202 south,   1136, raritan, nJ 08869, UsA Tel +1 908 218 7015 Email ek atz1@its.jnj.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Katz et al Running head recto: Antipsychotic physician/patient preference surveys DOI: http://dx.doi.org/10.2147/PPA.S114172",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"Available from: http://www.fda.gov/ForIndustry/UserFees/Pre - scriptionDrugUserFee/ucm368342.ht m. Accessed February 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Report/2013/10/WC500153276.pd f. Accessed  September 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Press_release/2014/09/WC500173511.pd f.  Accessed 4 Jan 2016.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
Available from: http://news.gc.ca/web/article-en.do?mthd =tp&crtr.,OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"Available from: http://www.fda.gov/ucm/groups/fdagov- public/@fdagov-meddev-gen/documents/document/ucm446680.pd f.  Accessed September 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"Available from: http://mdic.org/wp- content/uploads/2015/05/MDIC_PCBR_Framework_P roof5_Web.pd f.  Accessed September 8, 2015.",OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
Available from: http://www.imi.europa.eu/sites/ default/files/uploads/documents/IMI2Call5/IMI2_C5_PUBLICATION.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/ppa-10-2127.PMC5085312.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypoxia Hypoxia 2016:4 29–39Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 29 http: //dx.doi.org/10.2147/HP .S8354 0erythropoietin and the use of a transgenic model  of erythropoietin-deficient mice Aurélien Pichon1–3 Florine Jeton1,2 Raja el Hasnaoui-Saadani4 Luciana Hagström5 Thierry Launay6 Michèle Beaudry1 Dominique Marchant1 Patricia Quidu1 Jose-Luis Macarlupu7 Fabrice Favret8 Jean-Paul Richalet1,2 Nicolas voituron1,2 1Laboratory “Hypoxia and Lung”  eA 2363, University Paris 13,   Sorbonne Paris Cité, Bobigny Cedex,   2Laboratory of excellence GR-ex,   Paris, 3Laboratory MO ve eA 6314,   FSS, Poitiers University, Poitiers,   France; 4Research Unit, College of  Medicine, Princess Noura University,   Riyadh, Saudi Arabia; 5Laboratório  interdisciplinar de Biociências,   Universidade de Brasília, Brasília,   Brazil; 6Unité de Biologie intégrative  des Adaptations à l’exercice,   University Paris Saclay and Genopole®,  University Sorbonne-Paris-Cité,   Paris, France; 7High Altitude Unit,   Laboratories for Research and  Development, Universidad Peruana  Cayetano Heredia, Lima, Peru;   8Laboratory “Mitochondrie, Stress  Oxydant et Protection Musculaire”  eA 3072, University of Strasbourg,   Strasbourg, France Correspondence: Nicolas voituron   Laboratory “Hypoxia and Lung” eA 2363,  UFR SMBH, 74 rue Marcel Cachin, 93017  Bobigny Cedex, France   email nicolas.voituron@univ-paris13.f rAbstract:  Despite its well-known role in red blood cell production, it is now accepted that  erythropoietin (Epo) has other physiological functions.",Non-OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
Or use: http://youtu.be/v6FpNxgeLx M,Non-OADS,/arxiv_data1/oa_pdf/8a/80/hp-4-029.PMC5085313.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/3b/ott-9-6499.PMC5085314.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6499–6509OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6499Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10916 3 The diagnostic value of 99TcM-2-(2-methyl-5-nitro- 1H-imidazol-1-yl) ethyl dihydrogen phosphate  hypoxia imaging and its evaluation performance for  radiotherapy efficacy in non-small-cell lung cancer Y ongkun Yang gaohua han Wansong Xu Department of Oncology, Taizhou  People’s hospital, Taizhou, Jiangsu,   People’s republic of chinaBackground and aim:  This study was designated to assess the diagnostic value of  99TcM-2-(2-methyl-5-nitro-1 H-imidazol-1-yl) ethyl dihydrogen phosphate (99TcM-MNLS)  hypoxia imaging and its evaluation performance for radiotherapy efficacy in patients with  non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/49/3b/ott-9-6499.PMC5085314.pdf
"Keywords:  99TcM-MNLS hypoxia imaging, non-small-cell lung cancer, diagnosis, therapeutic  effect evaluation, radiotherapy Introduction Primary lung cancer is the second common malignancy across the world, and currently  non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer cases.1 The  crude incidence rate of NSCLC is significantly associated with tobacco popularity and  consumptions in each region, and it has been reported to range from 2 to 80/100,000  and 1 to 39/100,000 for males and females, respectively.2 There has been an emerging correspondence: Wansong Xu Department of Oncology, Taizhou  People’s hospital, no 399, hailing road,  hailing District, Taizhou 225300, Jiangsu,  People’s republic of china Tel/fax +86 523 8660 6001 email wansongxu@126.com  Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: 99TcM-MNLS hypoxia imaging in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S109163",Non-OADS,/arxiv_data1/oa_pdf/49/3b/ott-9-6499.PMC5085314.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/49/3b/ott-9-6499.PMC5085314.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/3b/ott-9-6499.PMC5085314.pdf
The Clinical Genome Resource (ClinGen) is a National  Institutes of Health–funded consortium of researchers and  clinicians who are building an open-access and centralized  resource to define the clinical relevance and actionability of  genomic variants (http://clinicalgenome.org/).9 The ClinGen  Actionability Working Group (AWG) is developing practical methods to identify genetic disorders with the greatest clini- cal utility when detected in previously undiagnosed adults.,Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"12 Briefly, online resources (such as Online  Mendelian Inheritance in Man (OMIM) (http://www.ncbi.nlm.nih.gov/omim), GeneReviews (http://www.ncbi.nlm.nih.gov/ books/NBK1116/), OrphaNet (http://www.orpha.net), PubMed  GeNeTICs in MeDICINe  |   Volume 18  |  Number 12  |  December 2016",Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"1260 HUNTER et al  |  Assessing clinical actionabilityOriginal research article (http://www.ncbi.nlm.nih.gov/pubmed), and the National  Guideline Clearinghouse (http://www.guideline.gov/)) were tar - geted and filtered to identify clinical guidelines and secondary literature, such as systematic reviews and meta-analyses.",Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
This issue may  eventually be addressed by new guideline criteria submitted to the  National Guidelines Clearinghouse (http://www.guideline.gov/ about/inclusion-criteria.aspx) as well as the Institute of Medicine’s  recommendations for developing trustworthy guidelines.,Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS This project has been funded in part with Federal funds from the  National Cancer Institute, National Institutes of Health, under con- tract no.",Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"OrphaNet Encyclopedia, 2009.   http://www.orpha.net/.",Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
http://www.ncbi.nlm.nih.gov/books/NBK1311/.,Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
https://www.nice.org.uk/guidance/cg164.,Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/  Volume 18  |  Number 12  |  December 2016  |  GeNeTICs in MeDICINe",Non-OADS,/arxiv_data1/oa_pdf/47/f2/gim201640a.PMC5085884.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/26/jjm-09-09-39132.PMC5086027.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/16/jjm-09-09-35410.PMC5086028.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/ea/jjm-09-09-40137.PMC5086029.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/ea/jjm-09-09-40137.PMC5086029.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/91/jjm-09-09-38031.PMC5086032.pdf
"Acknowledgments The authors would like to sincerely thank the ministry of higher education of Malaysia and the Uni- versiti Sains Malaysia (USM) for the fundamental re- search grant scheme (FRGS) funding (203/CIPPT/11242, http://jpt.mohe.gov .my), which supported this work.",Non-OADS,/arxiv_data1/oa_pdf/a4/91/jjm-09-09-38031.PMC5086032.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/56/jjm-09-09-37437.PMC5086078.pdf
http://dx.doi.org/ 10.4314/tjpr.v11i6.18 .,Non-OADS,/arxiv_data1/oa_pdf/09/56/jjm-09-09-37437.PMC5086078.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/70/jjm-09-09-34804.PMC5086079.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/f8/jjm-09-09-30000.PMC5086080.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/d2/jjm-09-09-35520.PMC5086081.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/8c/ijhrba-05-03-27785.PMC5086403.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/36/ijhrba-05-03-27554.PMC5086404.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/7b/ijhrba-05-03-22588.PMC5086406.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/ff/ijhrba-05-03-25130.PMC5086407.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijhrba-05-03-27976.PMC5086415.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/fb/ijhrba-05-03-28028.PMC5086419.pdf
"http://immunenetwork.org 261pISSN 1598-2629 · eISSN 2092-6685 Original Antigenic Sin Response to RNA Viruses and  Antiviral Immunity Mee Sook Park#, Jin Il Kim#, Sehee Park#, Ilseob Lee# and Man-Seong Park* Department of Microbiology, The Institute of Viral Diseases, College of Medicine, Korea University, Seoul 02841, Koreahttps://doi.org/10.4110/in.2016.16.5.261REVIEW ARTICLE Original antigenic sin In an effort to develop effective vaccines against patho- gens that severely affect humans, the concept of original  antigenic sin (OAS) has become a guiding light, making  sense of baffling observations on the infection profiles  of foreign pathogens and vaccine efficacies in humans.",Non-OADS,/arxiv_data1/oa_pdf/d2/20/in-16-261.PMC5086450.pdf
Original Antigenic Sin Response to Viruses http://immunenetwork.org 263is generally low (16).,Non-OADS,/arxiv_data1/oa_pdf/d2/20/in-16-261.PMC5086450.pdf
Original Antigenic Sin Response to Viruses http://immunenetwork.org 265Original antigenic sin and influenza virus  iMMunity: ‘gOOd’ O as?,Non-OADS,/arxiv_data1/oa_pdf/d2/20/in-16-261.PMC5086450.pdf
Original Antigenic Sin Response to Viruses http://immunenetwork.org 267different from the virus to which an individual has already  been exposed.,Non-OADS,/arxiv_data1/oa_pdf/d2/20/in-16-261.PMC5086450.pdf
"Original Antigenic Sin Response to Viruses http://immunenetwork.org 269The origins, function, and regulation of T follicular helper  cells.",Non-OADS,/arxiv_data1/oa_pdf/d2/20/in-16-261.PMC5086450.pdf
"http://immunenetwork.org 271pISSN 1598-2629 · eISSN 2092-6685 Potential of Cells and Cytokines/Chemokines to Regulate  Tertiary Lymphoid Structures in Human Diseases Feifeng Jing and Eun Young Choi* Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul 05505, Korea https://doi.org/10.4110/in.2016.16.5.271REVIEW ARTICLE develOpMent Of secOndary lyMphOid  Organs (slO) SLO include encapsulated organs such as the spleen and  lymph nodes and un-encapsulated mucosal lymphoid  organs such as Peyer’s patches, tonsils, and nasal-asso- ciated lymphoid tissues.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/in-16-271.PMC5086451.pdf
"Regulation of TLS in Diseases http://immunenetwork.org 273tion of synovial CD8+ T cells causes disintegration  of GC-containing follicles, disappearance of FDCs,  significantly reduced production of LT a1b2 and a lack of  immunoglobulin (Ig) secretion (38).",Non-OADS,/arxiv_data1/oa_pdf/31/fb/in-16-271.PMC5086451.pdf
Regulation of TLS in Diseases http://immunenetwork.org 275by Th9 cells in RA patients correlates with the degree of  synovial inflammatory infiltrate and TLS organization (72).,Non-OADS,/arxiv_data1/oa_pdf/31/fb/in-16-271.PMC5086451.pdf
"Regulation of TLS in Diseases http://immunenetwork.org 27722-producing lymphoid tissue-inducer cells, and formation of  isolated lymphoid follicles.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/in-16-271.PMC5086451.pdf
Regulation of TLS in Diseases http://immunenetwork.org 279S.,Non-OADS,/arxiv_data1/oa_pdf/31/fb/in-16-271.PMC5086451.pdf
"http://immunenetwork.org 281pISSN 1598-2629 · eISSN 2092-6685 Development of Auto Antigen-specific Regulatory T Cells  for Diabetes Immunotherapy Jianxun Song* Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USAhttps://doi.org/10.4110/in.2016.16.5.281REVIEW ARTICLE Regulatory T cells (Tregs) are an integral component of the  normal immune system and contribute to the maintenance  of peripheral tolerance.",Non-OADS,/arxiv_data1/oa_pdf/4b/a0/in-16-281.PMC5086452.pdf
Stem Cell-derived Regulatory T Cells for Therapeutic Use http://immunenetwork.org 283resulting in the development of Ag-specific CD4+ Tregs.,Non-OADS,/arxiv_data1/oa_pdf/4b/a0/in-16-281.PMC5086452.pdf
Stem Cell-derived Regulatory T Cells for Therapeutic Use http://immunenetwork.org 285pairing and expression of TCR chains introduced into human  T cells.,Non-OADS,/arxiv_data1/oa_pdf/4b/a0/in-16-281.PMC5086452.pdf
"pISSN 1598-2629 · eISSN 2092-6685 Enhanced Viral Replication by Cellular Replicative  Senescence Ji-Ae Kim, Rak-Kyun Seong and Ok Sarah Shin* Brain Korea 21 Plus for Biomedical Science, College of Medicine, Korea University , Seoul 08308, Koreahttps://doi.org/10.4110/in.2016.16.5.286ORIGINAL ARTICLE intrOductiOn Aging is suggested to be promoted by cellular senescence  because senescent cells accumulate in tissues and organs  with age (1).",Non-OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
Senescence Effect on Viral Infection http://immunenetwork.org 287influenza-related deaths occur in the older adult popula- tion.,Non-OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
Senescence Effect on Viral Infection http://immunenetwork.org 289statistical analysis Paired comparisons were performed using the Student's  t-test.,OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
Senescence Effect on Viral Infection http://immunenetwork.org 291data suggest that viral infection-mediated host anti- viral signaling pathways can be affected by replicative senescence (Fig.,OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
Senescence Effect on Viral Infection http://immunenetwork.org 293resulted in increased numbers of viral plaques as well  as viral replication measured by rPR8-GFP-expressing virus infection model (Fig.,OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
Senescence Effect on Viral Infection http://immunenetwork.org 295J.,Non-OADS,/arxiv_data1/oa_pdf/f9/b0/in-16-286.PMC5086453.pdf
"pISSN 1598-2629 · eISSN 2092-6685 Cytokine-like Activity of Liver Type Fatty Acid Binding  Protein (L-FABP) Inducing Inflammatory Cytokine  Interleukin-6 Hyunwoo Kim1,2#, Gaae Gil3#, Siyoung Lee3,4, Areum Kwak3,5, Seunghyun Jo3,5, Ensom Kim3,   Tam T.Nguyen3, Sinae Kim3, Hyunjhung Jhun3,5, Somi Kim1, Miyeon Kim1, Youngmin Lee6   and Soohyun Kim3,5* 1Division of Nephrology, Department of Internal Medicine, Jeju National University School of Medicine, Jeju 63243, Korea, 2Department  of Medicine, University of Colorado Denver, Aurora, Colorado 80045, USA, 3Laboratory of Cytokine Immunology, Department  of Biomedical Science and Technology, Konkuk University, Seoul 05029, 4YbdYbiotech research center, Seoul 08589, 5College of  Veterinary Medicine, Konkuk University, Seoul 05029, 6Department of Medicine, Pusan Paik Hospital, College of Medicine, Inje  University, Busan 47392, Koreahttps://doi.org/10.4110/in.2016.16.5.296ORIGINAL ARTICLE intrOductiOn Fatty acid-binding proteins (FABPs) are a family of cyto- solic proteins with a molecular weight of 14 to 15 kDa  that are involved in the intracellular lipid responses in cells (1).",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/in-16-296.PMC5086454.pdf
"Biological Activity of Recombinant L-FABP http://immunenetwork.org 297described FABP, liver-type FABP (L-FABP) is highly  expressed in the liver (2~5% of cytosolic protein) as well as in the kidney, lung, pancreas and intestine (1), and a  key regulator of hepatic lipid metabolism by influencing the uptake, transport, mitochondrial oxidation, and  esterification of fatty acids (2).",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/in-16-296.PMC5086454.pdf
"Biological Activity of Recombinant L-FABP http://immunenetwork.org 29916-, 32-, and 48-kDa human L-FABP (not shown).",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/in-16-296.PMC5086454.pdf
Biological Activity of Recombinant L-FABP http://immunenetwork.org 301resistance without altering beta-cell responsiveness in  the pancreas (20).,Non-OADS,/arxiv_data1/oa_pdf/f2/dd/in-16-296.PMC5086454.pdf
"Biological Activity of Recombinant L-FABP http://immunenetwork.org 303Borchers, and F. Spener.",OADS,/arxiv_data1/oa_pdf/f2/dd/in-16-296.PMC5086454.pdf
"http://immunenetwork.org 305pISSN 1598-2629 · eISSN 2092-6685 Membrane-bound p35 Subunit of IL-12 on Tumor Cells is  Functionally Equivalent to Membrane-bound Heterodimeric  Single Chain IL-12 for Induction of Anti-tumor Immunity  Hyun-Jin Kim1, Sang Min Park1, Hayyoung Lee2* and Young Sang Kim1* 1Department of Biochemistry, College of Natural Sciences, 2Institute of Biotechnology, Chungnam National University, Daejeon 34134,  Koreahttps://doi.org/10.4110/in.2016.16.5.305BRIEF COMMUNICATION intrOductiOn IL-12 is a heterodimeric cytokine consisting of p35 and  p40 subunits (1) that is produced by phagocytic cells, B  cells, and other antigen presenting cells (2).",OADS,/arxiv_data1/oa_pdf/2b/c0/in-16-305.PMC5086455.pdf
"Tumor Cell Vaccine Based on Membrane-bound IL-12 http://immunenetwork.org 307mb-scIL-12 on MethA tumor clones, ConA-activated  splenocytes were induced by the MethA clones, and proliferation was measured.",OADS,/arxiv_data1/oa_pdf/2b/c0/in-16-305.PMC5086455.pdf
Tumor Cell Vaccine Based on Membrane-bound IL-12 http://immunenetwork.org 309presence of ectopic IL-12 expression.,Non-OADS,/arxiv_data1/oa_pdf/2b/c0/in-16-305.PMC5086455.pdf
"http://immunenetwork.org 311pISSN 1598-2629 · eISSN 2092-6685 Genetic Characteristics and Immunogenicity of Pandemic  H1N1 Influenza Virus Isolate from Pig in Korea Hyoung Joon Moon1, Jin Sik Oh3, Woonsung Na2, Minjoo Yeom2, Sang Yoon Han1, Sung Jae Kim1,  Bong Kyun Park4, Dae Sub Song2* and Bo Kyu Kang1* 1Research Unit, Green Cross Veterinary Products, Yongin 17066, 2Department of Pharmacy, College of Pharmacy, Korea University,  Sejong 30019, 3MEDIAN Diagnostics Inc., Chuncheon 24339, 4Department of Veterinary Medicine Virology Lab, College of Veterinary  Medicine, and School of Agricultural Biotechnology, BK21 Program for Veterinary Science, Seoul National University, Seoul 08826,  Koreahttps://doi.org/10.4110/in.2016.16.5.311BRIEF COMMUNICATION intrOductiOn Human influenza A (H1N1) virus (also known as pande- mic H1N1 or pH1N1), which contains a genome of swine  origin, has caused outbreaks throughout the world since  April 2009.",Non-OADS,/arxiv_data1/oa_pdf/78/9a/in-16-311.PMC5086456.pdf
"SIV H1N1 Isolation and Vaccine Candidate http://immunenetwork.org 313in the animals, vaccinated animals were observed for 7  days and 14 days after vaccination in Guinea pigs and  piglets, respectively.",Non-OADS,/arxiv_data1/oa_pdf/78/9a/in-16-311.PMC5086456.pdf
SIV H1N1 Isolation and Vaccine Candidate http://immunenetwork.org 315Microbiol.,Non-OADS,/arxiv_data1/oa_pdf/78/9a/in-16-311.PMC5086456.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.102 Korean J Spine 13(3):102-106, 2016 www.e-kjs.org 102   Copyright © 2016 The Korean Spinal Neurosurgery SocietyBalloon Kyphoplasty: An Effective Treatment for Kummell Disease ?",Non-OADS,/arxiv_data1/oa_pdf/32/b3/kjs-13-102.PMC5086459.pdf
"Key Words : Osteonecrosis ㆍOsteoporosis ㆍKyphoplasty ●Received: April 1, 2016  ●Revised: June 7, 2016 ●Accepted: June 14, 2016 Corresponding Author: Seok Won Kim Department of Neurosurgery, Chosun University College of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju 61453, KoreaTel: +82-62-220-3126, Fax: +82-62-227-4575 E-mail: ns64902@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The frequency of osteoporotic compression fractures increa-  ses with aging.",Non-OADS,/arxiv_data1/oa_pdf/32/b3/kjs-13-102.PMC5086459.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.107 Korean J Spine 13(3):107-113, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  107Three-Years Outcome of Microdiscectomy via Paramedian Approach  for Lumbar Foraminal or Extraforaminal Disc Herniations in Elde rly  Patients over 65 Years Old Chang Gi Yeo1, Ikchan Jeon1, Sang Woo Kim1, Sam Kyu Ko2, Byung Kil Woo2, Kwang Chul Song2 1Department of Neurosurgery, Yeungnam University College of Medicine, Daegu, 2Department of Neurosurgery, Bokwang Spine Hospital, Daegu, Korea Objective: Lumbar foraminal or extraforaminal disc herniations (FEFDH) have unusual clinical features and higher incidence in  elderly patients compared to usual intraspinal canal disc herniations.",Non-OADS,/arxiv_data1/oa_pdf/25/71/kjs-13-107.PMC5086460.pdf
"Key Words : Intervertebral disc displacement ㆍExtraforaminal disc herniation ㆍParaspinal approach ㆍAged ●Received: June 2, 2016  ●Revised: August 29, 2016 ●Accepted: August 30, 2016 Corresponding Author: Ikchan Jeon Department of Neurosurgery, Yeungnam University College of  Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-620-3790, Fax: +82-53-620-3770E-mail: jicns@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Surgery for lumbar disc herniation is one of the most com- monly performed surgical procedures.",Non-OADS,/arxiv_data1/oa_pdf/25/71/kjs-13-107.PMC5086460.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.114 Korean J Spine 13(3):114-119, 2016 www.e-kjs.org 114   Copyright © 2016 The Korean Spinal Neurosurgery SocietySurgical Outcomes of Anterior Cervical Fusion Using Deminaraliz ed Bone  Matrix as Stand-Alone Graft Material: Single Arm, Pilot Study Ho-Jung Chung, Jung-Woo Hur, Kyeong-Sik Ryu, Jin-Sung Kim, Ji-H oon Seong Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Objective: To investigate the safety and efficacy of demineralized bone matrix (DBM) as a bone graft substitute for anterior cervical  discectomy and fusion (ACDF) surgery.",Non-OADS,/arxiv_data1/oa_pdf/ed/01/kjs-13-114.PMC5086461.pdf
"Key Words : Anterior cervical diskectomy and fusion ㆍPolyestheretherketone cage ㆍDemineralized bone matrix ㆍBone grafting ●Received: June 6, 2016  ●Revised: August 24, 2016 ●Accepted: August 29, 2016 Corresponding Author: Jung-Woo Hur Department of Neurosurgery, Seoul St. Mary’s Hospital, The CatholicUniversity of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-6265, Fax: +82-2-594-4248E-mail: neurotique79@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Historically, autologous bone harvested from a patient’s iliac  crest has been used as a cervical interbody fusion material19,42).",Non-OADS,/arxiv_data1/oa_pdf/ed/01/kjs-13-114.PMC5086461.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.120 Korean J Spine 13(3):120-123, 2016 www.e-kjs.org 120   Copyright © 2016 The Korean Spinal Neurosurgery SocietyThe Safety and Decision Making of Instrumented Surgery  in Infectious Spondylitis Kyeong Hee Baek, Young-Seok Lee,  Dong Ho Kang, Chul Hee Lee,  Soo Hyun Hwang, In Sung Park Department of Neurosurgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Objective: Infectious spondylitis is mostly managed by appropriate antibiotic treatment options, and some patients may require  surgical interventions.",Non-OADS,/arxiv_data1/oa_pdf/11/98/kjs-13-120.PMC5086462.pdf
"Key Words : Infectious spondylitis ㆍInstrumented surgery ㆍRecurrence rate ㆍPrimary failure ●Received: June 15, 2016  ●Revised: July 26, 2016 ●Accepted: July 27, 2016 Corresponding Author: Young-Seok Lee Department of Neurosurgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, 79  Gangnam-ro, Jinju 52727, Korea Tel: +82-55-750-8112, Fax: +82-55-750-8737E-mail: leeys1026@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Antibiotics, bed rest, and general supportive care are the  main treatment options in infectious spondylitis3).",Non-OADS,/arxiv_data1/oa_pdf/11/98/kjs-13-120.PMC5086462.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.124 Korean J Spine 13(3):124-128, 2016 www.e-kjs.org 124   Copyright © 2016 The Korean Spinal Neurosurgery SocietyThe Factors That Affect Improvement of Neurogenic Bladder  by Severe Lumbar Disc Herniation in Operation Joon Bok Jeon1, Seung Hwan Yoon1, Do Keun Kim1, Ji-Yong Kim2  1Department of Neurosurgery, Inha University School of Medicine, Incheon, 2Department of Neurosurgery, Naeun Hospital, Incheon, Korea Objective: This study analyzed retrospectively the bladder function of patients after early surgery for cauda equina syndrome  (CES) performed within 24 or 48 hours, or after 48 hours of the onset of autonomic symptoms.Methods:  We retrospectively reviewed the clinical data of 31 patients after decompression surgery for lumbar disc herniation (LDH)  who had been diagnosed with CES between January 2001 and December 2014 at Inha University Hospital.",Non-OADS,/arxiv_data1/oa_pdf/09/6f/kjs-13-124.PMC5086463.pdf
"Key Words : Polyradiculopathy ㆍTreatment outcome ㆍIntervertebral disc displacement ㆍNeurogenic urinary bladder ㆍSpinal cord  compression ●Received: July 12, 2016  ●Revised: August 29, 2016 ●Accepted: September 7, 2016 Corresponding Author: Seung Hwan Yoon Department of Neurosurgery, Inha University School of Medicine,  366 Seohae-daero, Jung-gu, Incheon 22332, Korea Tel: +82-32-890-2619, Fax: +82-32-890-2619E-mail: nsyoon@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The classic presentation of cauda equine syndrome (CES)  is a middle-aged adult complaining of bilateral sciatica, bila-  teral lower extremity weakness, particularly below the knees,  saddle anesthesia, and urinary or rectal incontinence8).",Non-OADS,/arxiv_data1/oa_pdf/09/6f/kjs-13-124.PMC5086463.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.129 Korean J Spine 13(3):129-133, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  129The Use of Gentamicin-Impregnated Collagen Sponge for Reducing  Surgical Site Infection after Spine Surgery Jin-Sol Han, Se-Hoon Kim, Sung-Won Jin, Seung-Hwan Lee, Bum-Joo n Kim,  Sang-Dae Kim, Dong-Jun Lim Department of Neurosurgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea Objective: Surgical site infection (SSI) is the one of the most frequent complications in hospitalized patients, and it extends hospital  stays and causes extra morbidities.",Non-OADS,/arxiv_data1/oa_pdf/9e/41/kjs-13-129.PMC5086464.pdf
"Key Words : Gentamicin ㆍCollagenㆍSurgical wound infection ●Received: July 12, 2016  ●Revised: August 22, 2016 ●Accepted: August 25, 2016 Corresponding Author: Se-Hoon Kim Department of Neurosurgery, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea Tel: +82-31-412-5050, Fax: +82-31-412-5054E-mail: sehoonkim.ns@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Surgical site infection (SSI) is one of the most frequent com- plications among the hospitalized patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/41/kjs-13-129.PMC5086464.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.134 Korean J Spine 13(3):134-138, 2016 www.e-kjs.org 134   Copyright © 2016 The Korean Spinal Neurosurgery SocietyRadiologic Changes of Operated and Adjacent Segments after  Anterior Cervical Microforaminotomy Jang Ho Ahn, Moon Sun Park, Seong Min Kim, Seung Young Chung,  Do Sung Lee, Ki Seok Park Department of Neurosurgery, Eulji University School of Medicine, Daejeon, Korea Objective: Anterior cervical microforaminotomy (ACMF) is a motion ‐preserving surgical procedure.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/kjs-13-134.PMC5086465.pdf
"Key Words : Cervical radiculopathy ㆍAnterior foraminotomy ㆍAdjacent segment disease ㆍDisc height ㆍRange of motion ●Received: July 20, 2016  ●Revised: September 22, 2016 ●Accepted: September 24, 2016 Corresponding Author: Ki Seok Park Department of Neurosurgery, Eulji University Hospital, Eulji University School of Medicine, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, KoreaTel: +82-42-611-3275, Fax: +82-42-611-3826 E-mail: ks3432@eulji.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Cervical radiculopathy caused by a compressive lesion aris- ing from degenerative spondylotic change tends to be surgi-cally treated either by discectomy with or without interbody  fusion via an anterior or posterior surgical approach.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/kjs-13-134.PMC5086465.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.139 Korean J Spine 13(3):139-143, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  139Increased Prevalence of Ossification of Posterior Longitudinal Ligament and Increased Bone Mineral Density in Patients with Ossification of Nuchal Ligament Ki-Wan Kim, Young-Min Oh, Jong-Pil Eun Department of Neurosurgery, Chonbuk National University Medical School, Jeonju, Korea Objective:  There are also few studies demonstrating the relationship between ossification of nuchal ligament (ONL) and ossifica- tion of posterior longitudinal ligament (OPLL).",Non-OADS,/arxiv_data1/oa_pdf/b5/87/kjs-13-139.PMC5086466.pdf
"Key Words : Ossification of posterior longitudinal ligament ㆍBone density ㆍSpineㆍNuchal ligament ●Received: August 11, 2016  ●Revised: September 5, 2016 ●Accepted: September 13, 2016 Corresponding Author: Young-Min Oh Department of Neurosurgery, Chonbuk National University Hospital,  Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 54907, KoreaTel: +82-63-250-1870, Fax: +82-63-277-3273 E-mail: timoh@jbnu.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Various ligaments surround the vertebral column, including  the anterior longitudinal ligament, posterior longitudinal liga- ment, ligamentum flavum, posterior ligament complex, and the nuchal ligament.",Non-OADS,/arxiv_data1/oa_pdf/b5/87/kjs-13-139.PMC5086466.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.144 Korean J Spine 13(3):144-150, 2016 www.e-kjs.org 144   Copyright © 2016 The Korean Spinal Neurosurgery SocietyTransforaminal Percutaneous Endoscopic Discectomy in Parkinson  Disease: Preliminary Results and Short Review of the Literature Stylianos Kapetanakis1, Eirini Giovannopoulou1, Triphonas Thomaidis1, George Charitoudis1,  Pavlos Pavlidis3, Konstantinos Kazakos2 1Spine Department and Deformities, Interbalkan European Medical Center, Thessaloniki,  2Department of Orthopaedic Surgery, University Hospital of Alexandroupolis, Medical School, Democritus University of  Thrace, Alexandroupolis,  3Laboratory of Forensic Sciences, Medical School, Democritus University of Thrace, Alexandroupolis, Greece Objective: To study the effectiveness of Transforaminal Percutaneous Endoscopic Discectomy (TPED) for lumbar disc herniation  in patients with Parkinson disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/df/70/kjs-13-144.PMC5086467.pdf
"Key Words : Parkinson disease ㆍEndoscopy ㆍPercutaneous discectomy ㆍQuality of life ●Received: July 27, 2016  ●Revised: September 8, 2016 ●Accepted: September 13, 2016 Corresponding Author: Kapetanakis Stylianos Spine Department and Deformities, Interbalkan European Medical Center, Thessaloniki, PC 57001, Greece Tel: +30-6972707384, Fax: +30-23112-89109 E-mail: stkapetanakis@yahoo.gr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Parkinson disease (PD) is a degenerative disorder of the basal  ganglions, pathophysiologically characterized by the loss of  dopaminergic neurons in the area of substantia nigra pars  compacta that leads mainly to motor dysfunstion4,21).",Non-OADS,/arxiv_data1/oa_pdf/df/70/kjs-13-144.PMC5086467.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.151 Korean J Spine 13(3):151-156, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  151The Surgical Overcorrection of Lenke Type 1 Deformities with Se lective  Fusion Segments: What Happens to the Coronal Balance ?",Non-OADS,/arxiv_data1/oa_pdf/1e/b2/kjs-13-151.PMC5086468.pdf
"Key Words : Selective fusion ㆍScoliosisㆍOvercorrection ㆍCoronal balance ●Received: May 5, 2016  ●Revised: July 26, 2016 ●Accepted: July 28, 2016 Corresponding Author: Yunus Atici Department of Orthopaedics and Traumatolgy, Carsamba State  Hospital, Carsamba State Hospital, Carsamba, Samsun, TurkeyTel: +90-505-492-1945, Fax: +90-362-834-2222 E-mail: yunatici@hotmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Performing selective fusion in scoliosis surgery gained pop- ularity through the possibility of obtaining more correction  by the help of new developed surgical techniques.",Non-OADS,/arxiv_data1/oa_pdf/1e/b2/kjs-13-151.PMC5086468.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.157 Korean J Spine  13(3):157-159, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  157Postlaminectomy Bilateral Lumbar Intraspinal Synovial Cysts Sung Ik Cho, Jung Hwan Lee, Chung Kee Chough Department of Neurosurgery, Yeouido St. Mary’s Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea Lumbar intraspinal synovi al cysts are included in t he difference diagnosis of lumbar r adiculopathy.",Non-OADS,/arxiv_data1/oa_pdf/8e/d9/kjs-13-157.PMC5086469.pdf
"Key Words : Epidural space ㆍSynovial cyst ㆍLaminectomy ㆍLumbar vertebrae ●Received: November 12, 2015  ●Revised: June 29, 2016 ●Accepted: July 12, 2016 Corresponding Author: Chung Kee Chough Department of Neurosurgery, Yeouido St. Mary’s Hospital, The  Catholic University of Korea School of Medicine, 10 63(yuksam)-ro,  Yeongdeungpo-gu, Seoul 07345, KoreaTel: +82-2-3779-1187, Fax: +82-2-786-5809 E-mail: chough@catholic.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/d9/kjs-13-157.PMC5086469.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.160 Korean J Spine  13(3):160-163, 2016 www.e-kjs.org 160   Copyright © 2016 The Korean Spinal Neurosurgery SocietyA 20-Year-Old Retained Surgical Gauze Mimicking a Spinal Tumor: A Case Report Sungjoon Lee1, Bomi Kim2, Jung Soo Kim1, Byeong Sam Choi1 Departments of 1Neurosurgery and 2Pathology, Inje University Haeundae Paik Hospital, Busan, Korea A 79-year-old man visited our clinic complaining of lower back and left leg radiating pain that began 1 month prior to his pres enta-  tion.",Non-OADS,/arxiv_data1/oa_pdf/10/85/kjs-13-160.PMC5086470.pdf
"Key Words : Foreign bodies ㆍGossypiboma ㆍTextiloma ㆍRetained surgical gauze ㆍSpinal surgery ㆍSpinal tumor ●Received: May 3, 2016  ●Revised: July 19, 2016 ●Accepted: July 25, 2016 Corresponding Author: Byung Sam Choi Department of Neurosurgery, Inje University, Haeundae Paik Hospital, 875 Haeun-daero, Haeundae-gu, Busan 48108, KoreaTel: +82-51-797-0241, Fax: +82-51-797-0841 E-mail: ttt333@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/85/kjs-13-160.PMC5086470.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.164 Korean J Spine  13(3):164-166, 2016 www.e-kjs.org 164   Copyright © 2016 The Korean Spinal Neurosurgery SocietyPneumocephalus and Pneumorrhachis due to a Subarachnoid Pleural   Fistula That Developed after Thoracic Spine Surgery Gun-Sang Lee, Myung-Ki Lee, Woo-Jae Kim, Ho-Sang Kim, Jeong-Ho Kim, Yun-Suk Kim Department of Neurosurgery, Maryknoll Medical Center, Busan, Korea Development of a communication between the spinal subarachnoid space and the pleural space after thoracic spine surgery is uncommon.",Non-OADS,/arxiv_data1/oa_pdf/26/8a/kjs-13-164.PMC5086471.pdf
"Key Words : Pneumorrhachis ㆍSurgeryㆍPneumocephalus ●Received: November 27, 2015  ●Revised: August 2, 2016 ●Accepted: August 3, 2016 Corresponding Author: Gun-Sang Lee Department of Neurosurgery, Maryknoll Medical Center, 121,  Junggu-ro, Jung-gu, Busan 48972, Korea Tel: +82-51-461-2456, Fax: +82-51-465-7470E-mail: mkhns2012@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/8a/kjs-13-164.PMC5086471.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.167 Korean J Spine  13(3):167-169, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  167Spontaneous Spinal Epidural Hematoma Coexisting Guillan-Barre ΄  Syndrome in a Child: A Case Report Chi Hyung Lee, Geun Sung Song, Young Ha Kim, Dong Wuk Son, Sang  Weon Lee Department of Neurosurgery, Pusan National University Yangsan Hospital,  Pusan National University School of Medicine, Yangsan, Korea Spontaneous spinal epidural hematoma (SSEH) has been reported as a rare cause of spinal cord compression, especially in  children.",Non-OADS,/arxiv_data1/oa_pdf/7a/b4/kjs-13-167.PMC5086472.pdf
"Key Words : Pediatrics ㆍGuillain-Barré syndrome ㆍSpinal epidural hematoma ●Received: April 1, 2016  ●Revised: July 18, 2016 ●Accepted: July 22, 2016 Corresponding Author: Geun Sung Song Department of Neurosurgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea Tel: +82-55-360-2126, Fax: +82-55-360-2156E-mail: gnsong@pusan.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/b4/kjs-13-167.PMC5086472.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.170 Korean J Spine  13(3):170-172, 2016 www.e-kjs.org 170   Copyright © 2016 The Korean Spinal Neurosurgery SocietyClinical Experiences of Uncommon Motor Neuron Disease: Hirayama Disease Kyoung Hee Lee1, Dae Seob Choi2, Young Suk Lee1, Dong Ho Kang1 Departments of 1Neurosurgery and 2Radiology, Gyeongsang National University Hospital,  Gyeongsang National University School of Medicine, Jinju, Korea Hirayama disease, juvenile muscular atrophy of the distal upper limb, is a rare disease predominantly affecting the anterior  horn cells of the cervical spinal cord in young men.",Non-OADS,/arxiv_data1/oa_pdf/53/1c/kjs-13-170.PMC5086473.pdf
"Key Words : Hirayama disease ㆍJuvenile spinal muscular atrophy ㆍMyelopathy ●Received: November 12, 2015  ●Revised: June 29, 2016 ●Accepted: July 12, 2016 Corresponding Author: Dong-Ho Kang Department of Neurosurgery, Gyeongsang National University  Hospital, Gyeongsang National University School of Medicine, 79  Gangnam-ro, Jinju 52727, KoreaTel: +82-55-750-8112, Fax: +82-55-750-8737 E-mail: ns4793@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/1c/kjs-13-170.PMC5086473.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.173 Korean J Spine  13(3):173-175, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  173Single-Stage Operation for Giant Schwannoma at the Craniocervic al  Junction with Minimal Laminectomy: A Case Report and Literature  Review Sun Yoon1, Hunho Park1, Kyu-Sung Lee1, Seoung Woo Park2, Chang-Ki Hong1,2 1Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 2Department of Neurosurgery, Kangwon National University Hospital, Chuncheon, Korea Here we report a single-stage operation we performed on a patient with a large schwannoma that extended from the lower  clivus to the cervico-thoracic junction caudally.",Non-OADS,/arxiv_data1/oa_pdf/92/cc/kjs-13-173.PMC5086474.pdf
"Key Words : Spinal cord neoplasms ㆍNeurilemmoma ㆍLaminectomy ㆍLaminoplasty ●Received: June 10, 2016  ●Revised: July 22, 2016 ●Accepted: August 3, 2016 Corresponding Author: Chang-Ki Hong Department of Neurosurgery, Brain Tumor Clinic, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro,  Gangnam-gu, Seoul 06273, KoreaTel: +82-2-2019-3391, Fax: +82-2-3461-9229 E-mail: yedamin@yuhs.ac ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/cc/kjs-13-173.PMC5086474.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.91 Korean J Spine 13(3):91-96, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  91Comparison of Radiologic Outcomes of Different Methods in Singl e-Level  Anterior Cervical Discectomy and Fusion O Ik Kwon, Dong Wuk Son, Sang Weon Lee, Geun Sung Song Department of Neurosurgery, Pusan National University Yangsan Hospital,  Pusan National University School of Medicine, Yangsan, Korea Objective: Anterior cervical discectomy and fusion (ACDF) is a choice of surgical procedure for cervical degenerative diseases  associated with radiculopathy or myelopathy.",Non-OADS,/arxiv_data1/oa_pdf/de/21/kjs-13-91.PMC5086475.pdf
"Key Words : Cervical vertebrae ㆍRadiography ㆍPostoperative complications ㆍSpinal fusion ●Received: March 10, 2016  ●Revised: July 6, 2016 ●Accepted: August 1, 2016 Corresponding Author: Dong Wuk Son Department of Neurosurgery, Pusan National University Yangsan  Hospital, Pusan National University School of Medicine, 20  Geumo-ro, Mulgeum-eup, Yangsan 50612, KoreaTel: +82-55-360-2126, Fax: +82-55-360-2156 E-mail: oik99@naver.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Anterior cervical discectomy and fusion (ACDF) is a choice  of surgical procedure for cervical degenerative diseases asso- ciated with radiculopathy or myelopathy12).",Non-OADS,/arxiv_data1/oa_pdf/de/21/kjs-13-91.PMC5086475.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.3.97 Korean J Spine 13(3):97-101, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  97Infectious Spondylodiscitis by Uncommon Pathogens: A Pitfall of   Empirical Antibiotics Seung Han Yu, Dong Hwan Kim, Hwan Soo Kim, Kyoung Hyup Nam,  Byung Kwan Choi, In Ho Han Department of Neurosurgery and Medical Research Institute, Pusan National University Hospital,  Pusan National University College of Medicine, Busan, Korea Objective: The goal of this study is to evaluate the prevalence of spondylodiscitis (SD) caused by uncommon pathogens and  review the efficacy of the treatment strategy including the coverage by usual empirical broad-spectrum antibiotic therapy.",Non-OADS,/arxiv_data1/oa_pdf/6a/fa/kjs-13-97.PMC5086476.pdf
"Key Words : Spondylodiscitis ㆍPathogens ㆍAntibiotics ●Received: March 21, 2016  ●Revised: July 27, 2016 ●Accepted: July 29, 2016 Corresponding Author: In Ho Han Department of Neurosurgery, Pusan National University Hospital,  Pusan National University College of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-51-240-7257, Fax: +82-51-244-0282 E-mail: farlateral@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Infectious spondylodiscitis (SD) is an infection of interver-  tebral discs and adjacent vertebral bodies7,10).",Non-OADS,/arxiv_data1/oa_pdf/6a/fa/kjs-13-97.PMC5086476.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/f1/ijhrba-05-03-29121.PMC5086576.pdf
"/MT67/MT117/MT114/MT114/MT101/MT110/MT116 /MT77/MT101/MT100/MT105/MT99/MT105/MT110/MT97/MT108 /MT67/MT104/MT101/MT109/MT105/MT115/MT116/MT114/MT121 /MT73/MT83/MT83/MT78/MT58/MT32/MT48/MT57/MT50/MT57/MT45/MT56/MT54/MT55/MT51 /MT101/MT73/MT83/MT83/MT78/MT58/MT32/MT49/MT56/MT55/MT53/MT45/MT53/MT51/MT51/MT88 /MT84/MT104/MT101 /MT73/MT110/MT116/MT101/MT114/MT110/MT97/MT116/MT105/MT111/MT110/MT97/MT108 /MT74/MT111/MT117/MT114/MT110/MT97/MT108/MT32/MT102/MT111/MT114 /MT84/MT105/MT109/MT101/MT108/MT121/MT32/MT73/MT110/MT45/MT100/MT101/MT112/MT116/MT104 /MT82/MT101/MT118/MT105/MT101/MT119/MT115 /MT105/MT110/MT32/MT77/MT101/MT100/MT105/MT99/MT105/MT110/MT97/MT108 /MT67/MT104/MT101/MT109/MT105/MT115/MT116/MT114/MT121/MT73/MT109/MT112/MT97/MT99/MT116 /MT70/MT97/MT99/MT116/MT111/MT114/MT58 /MT51/MT46/MT56/MT53 /MT66/MT69/MT78/MT84/MT72/MT65/MT77 /MT83/MT67/MT73/MT69/MT78/MT67/MT69/g38/g88/g85/g85/g72/g81/g87/g3/g48/g72/g71/g76/g70/g76/g81/g68/g79/g3/g38/g75/g72/g80/g76/g86/g87/g85/g92Wojciech Filipiak1,2, Pawel Mochalski1, Anna Filipiak1, Clemens Ager1, Raquel Cumeras3, Cristina E. Davis3, Agapios Agapiou4, Karl Unterkofler1 and Jakob Troppmair5,* 1Breath Research Institute of the University of Innsbruck, Dornbirn, Austria 2Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria 3Department of Mechanical and Aerospace Engineering, University of California, Davis, CA, USA 4Department of Chemistry, University of Cyprus, Nicosia, Cyprus 5Daniel Swarovski Research Laboratory, Department of Visceral-, Transplant- and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria ARTICLE HISTORY Received: February 10, 2016 Revised: May 02, 2016Accepted: May 10, 2016 DOI: http://dx.doi.org/10.2174/09 2986732366616031612505Abstract: Volatile organic compounds (VOCs) offer unique insights intoongoing biochemical processes in healthy and diseased humans.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.trac.2012.03.019 ] Filipiak, W.; Filipiak, A.; Sponring, A.; Schmid, T.; Zelger,[4] B.;  Ager,  C.;  Klodzinska,  E.;  Denz,  H.;  Pizzini,  A.;Lucciarini,  P.;  Jamnig,  H.;  Troppmair,  J.;  Amann,  A.Comparative analyses of volatile organic compounds (VOCs) from  patients,  tumors  and  transformed  cell  lines  for  the validation of lung cancer-derived breath markers.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/8/2/027111 ]  [PMID: 24862102 ] Poli, D.; Carbognani, P.; Corradi, M.; Goldoni, M.; Acampa,[5] O.;  Balbi,  B.;  Bianchi,  L.;  Rusca,  M.;  Mutti,  A.  Exhaled volatile organic compounds in patients with non-small celllung cancer: cross sectional and nested short-term follow-upstudy.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1465-9921-6-71 ]  [PMID: 16018807 ] de Lacy Costello, B.; Amann, A.; Al-Kateb, H.; Flynn, C.;[6] Filipiak,  W.;  Khalid,  T.;  Osborne,  D.;  Ratcliffe,  N.M.  Areview  of  the  volatiles  from  the  healthy  human  body.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/8/1/014001 ]  [PMID: 24421258 ] Bernier,  U.R.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/ac990963k ] [PMID: 10701259 ] Gallagher, M.; Wysocki, C.J.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1111/j.1365-2133.2008.08748.x ] [PMID: 18637798 ] Schmidt,  F.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/7/1/017109 ]  [PMID: 23445955 ] Haze, S.; Gozu, Y.; Nakamura, S.; Kohno, Y.; Sawano, K.; [10] Ohta,  H.;  Yamazaki,  K.  2-Nonenal  newly  found  in  humanbody odor tends to increase with aging.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1046/j.0022-202x.2001.01287.x ] [PMID: 11286617 ] Mochalski,  P.;  King,  J.;  Unterkofler,  K.;  Hinterhuber,  H.; [11] Amann,  A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2014.04.006 ]  [PMID: 24768920 ] Mochalski, P.; Unterkofler, K.; Hinterhuber, H.; Amann, A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/ac404242q ] [PMID: 24611620 ] Curran, A.M.; Prada, P.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1111/j.1556-4029.2009.01236.x ] [PMID: 20002268 ] Mochalski,  P.;  King,  J.;  Klieber,  M.;  Unterkofler,  K.; [14] Hinterhuber, H.; Baumann, M.; Amann, A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1039/c3an36756h ] [PMID: 23435188 ] Miekisch,  W.;  Schubert,  J.K.;  Vagts,  D.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.3891/acta.chem.scand.19-0159 ]  [PMID: 14280839 ] Soini,  H.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s10886-010-9846-7 ]  [PMID: 20809147 ] AL-Kateb, H.; Costello, B.D.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/anie.201500153 ]  [PMID:26235374 ] Amann, A.; Ligor, M.; Ligor, T.; Bajtarevic, A.; Ager, C.; [20] Pienz, M.; Denz, H.; Fiegl, M.; Hilbe, W.; Weiss, W.; Lukas, P.; Jamnig, H.; Hackl, M.; Haidenberger, A.; Sponring, A.; Filipiak,  W.;  Miekisch,  W.;  Schubert,  J.;  Troppmair,  J.;Buszewski, B.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s12254-010-0219-2 ] Haick, H.; Broza, Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1039/C3CS60329F ] [PMID: 24305596 ] Hakim, M.; Broza, Y.Y.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/cr300174a ] [PMID: 22991938 ] Mazzone, P. Progress in the development of a diagnostic test [23] for  lung  cancer  through  the  analysis  of  breath  volatiles.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/2/3/037014 ]  [PMID: 21386175 ] Ligor,  M.;  Ligor,  T.;  Bajtarevic,  A.;  Ager,  C.;  Pienz,  M.; [24] Klieber,  M.;  Denz,  H.;  Fiegl,  M.;  Hilbe,  W.;  Weiss,  W.;Lukas, P.; Jamnig, H.; Hackl, M.; Buszewski, B.; Miekisch,W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1515/CCLM.2009.133 ]  [PMID: 19397483 ] Amann, A.; Corradi, M.; Mazzone, P.; Mutti, A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1586/erm.10.112 ] [PMID: 21405971 ] Bajtarevic, A.; Ager, C.; Pienz, M.; Klieber, M.; Schwarz, K.; [26] Ligor, M.; Ligor, T.; Filipiak, W.; Denz, H.; Fiegl, M.; Hilbe,W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1471-2407-9-348 ]  [PMID: 19788722 ] Fuchs, P.; Loeseken, C.; Schubert, J.K.; Miekisch, W. Breath [27] gas aldehydes as biomarkers of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.cca.2010.06.005 ]  [PMID: 20542019 ] Mazzone, P.J.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1097/JTO.0b013e318233d80f ]  [PMID: 22071780 ] Kischkel, S.; Miekisch, W.; Fuchs, P.; Schubert, J.K.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
[http://dx.doi.org/10.1183/09031936.00125411 ]  [PMID:,Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/8/1/016003 ]  [PMID: 24566039 ] Phillips,  M.;  Altorki,  N.;  Austin,  J.H.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.cca.2008.02.021 ]  [PMID: 18420034 ] Chen, S.; Zieve, L.; Mahadevan, V. Mercaptans and dimethyl [34] sulfide in the breath of patients with cirrhosis of the liver.Effect of feeding methionine.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/0891-5849(92)90145-7 ]  [PMID: 1459476 ] Sehnert,  S.S.;  Jiang,  L.;  Burdick,  J.F.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1080/13547500110118184 ]  [PMID: 12101636 ] Davies,  S.;  Spanel,  P.;  Smith,  D.  Quantitative  analysis  of [38] ammonia on the breath of patients in end-stage renal failure.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1038/ki.1997.324 ] [PMID:  9211367 ] Simenhoff,  M.L.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1056/NEJM197707212970303 ]  [PMID: 865584 ] Endre,  Z.H.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0967-3334/32/1/008 ]  [PMID: 21149927 ] Mochalski, P.; King, J.; Haas, M.; Unterkofler, K.; Amann, [41] A.; Mayer, G. Blood and breath profiles of volatile organiccompounds  in  patients  with  end-stage  renal  disease.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1471-2369-15-43 ]  [PMID: 24607025 ] Filipiak,  W.;  Ruzsanyi,  V.;  Mochalski,  P.;  Filipiak,  A.; [42] Bajtarevic, A.; Ager, C.; Denz, H.; Hilbe, W.; Jamnig, H.;Hackl,  M.;  Dzien,  A.;  Amann,  A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/6/3/036008 ]  [PMID: 22932429 ] Fischer, S.; Bergmann, A.; Steffens, M.; Trefz, P.; Ziller, M.; [43] Miekisch, W.; Schubert, J.S.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/9/4/047113 ]  [PMID: 26670078 ] Fischer, S.; Trefz, P.; Bergmann, A.; Steffens, M.; Ziller, M.; [44] Miekisch,  W.;  Schubert,  J.S.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/9/2/027108 ]  [PMID: 25971714 ] Taucher, J.; Hansel, A.; Jordan, A.; Lindinger, W. Analysis of [45] compounds in human breath after ingestion of garlic usingproton-transfer-reaction  mass  spectrometry.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/jf960640e ] King,  J.;  Koc,  H.;  Unterkofler,  K.;  Mochalski,  P.; [46] Kupferthaler,  A.;  Teschl,  G.;  Teschl,  S.;  Hinterhuber,  H.;Amann, A. Physiological modeling of isoprene dynamics inexhaled breath.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jtbi.2010.09.028 ]  [PMID: 20869370 ] Unterkofler, K.; King, J.; Mochalski, P.; Jandacka, M.; Koc, [47] H.;  Teschl,  S.;  Amann,  A.;  Teschl,  G.  Modeling-baseddetermination of physiological parameters of systemic VOCsby breath gas analysis: a pilot study.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/9/3/036002 ]  [PMID: 25972041 ] Umber, B.J.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/2001-1326-2-13 ]  [PMID: 23842518 ] Chippendale,  T.W.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/rcm.5099 ] [PMID: 21710596 ] King,  J.;  Kupferthaler,  A.;  Frauscher,  B.;  Hackner,  H.; [50] Unterkofler,  K.;  Teschl,  G.;  Hinterhuber,  H.;  Amann,  A.;Högl, B.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0967-3334/33/3/413 ]  [PMID: 22370046 ] King, J.; Kupferthaler, A.; Unterkofler, K.; Koc, H.; Teschl, [51] S.; Teschl, G.; Miekisch, W.; Schubert, J.; Hinterhuber, H.;Amann,  A.  Isoprene  and  acetone  concentration  profilesduring exercise on an ergometer.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/3/2/027006 ]  [PMID: 21383461 ] King,  J.;  Mochalski,  P.;  Kupferthaler,  A.;  Unterkofler,  K.; [52] Koc, H.; Filipiak, W.; Teschl, S.; Hinterhuber, H.; Amann, A.Dynamic profiles of volatile organic compounds in exhaledbreath as determined by a coupled PTR-MS/GC-MS study.Physiol.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
[http://dx.doi.org/10.1088/0967-3334/31/9/008 ]  [PMID:,Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/cbic.201200011 ]  [PMID: 22488873 ] Wichmann,  G.;  Mühlenberg,  J.;  Fischäder,  G.;  Kulla,  C.; [54] Rehwagen, M.; Herbarth, O.; Lehmann, I.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.tiv.2005.03.012 ]  [PMID: 15885978 ] Sarma, S.N.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.tox.2010.03.014 ]  [PMID: 20359517 ] Proctor, L.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.chom.2011.10.001 ]  [PMID: 22018227 ] Aksenov,  A.A.;  Sandrock,  C.E.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/cbic.201300695 ]  [PMID: 24719290 ] Filipiak, W.; Sponring, A.; Filipiak, A.; Ager, C.; Schubert, [58] J.;  Miekisch,  W.;  Amann,  A.;  Troppmair,  J.  TD-GC-MSAnalysis of Volatile Metabolites of Human Lung Cancer andNormal Cells in vitro .",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1475-2867-8-17 ]  [PMID: 19025629 ] Kwak,  J.;  Gallagher,  M.;  Ozdener,  M.H.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2013.05.007 ]  [PMID: 23770738 ] Mochalski,  P.;  Sponring,  A.;  King,  J.;  Unterkofler,  K.; [61] Troppmair,  J.;  Amann,  A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s12013-014-0201-4 ]  [PMID: 25123840 ] Schivo, M.; Aksenov, A.A.; Linderholm, A.L.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/8/3/037110 ]  [PMID: 25189196 ] Sponring, A.; Filipiak, W.; Ager, C.; Schubert, J.; Miekisch, [64]W.; Amann, A.; Troppmair, J.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1039/b916158a ] [PMID: 19918611 ] Zhang, Y.; Gao, G.; Liu, H.; Fu, H.; Fan, J.; Wang, K.; Chen, [67] Y.; Li, B.; Zhang, C.; Zhi, X.; He, L.; Cui, D. Identification ofvolatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au- Ag  alloy  coated  MWCNTs.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.7150/thno.7560 ] [PMID: 24465273 ] Zimmermann,  D.;  Hartmann,  M.;  Moyer,  M.P.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s11306-006-0038-y ] Peled, N.; Barash, O.; Tisch, U.; Ionescu, R.; Broza, Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/9/1/016004 ]  [PMID: 25557917 ] Diskin,  A.M.;  Spanel,  P.;  Smith,  D.  Time  variation  of [71] ammonia,  acetone,  isoprene  and  ethanol  in  breath:  aquantitative  SIFT-MS  study  over  30  days.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0967-3334/24/1/308 ]  [PMID: 12636190 ] Kroemer, G.; Pouyssegur, J. Tumor cell metabolism: cancer’s [72] Achilles’ heel.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.ccr.2008.05.005 ]  [PMID: 18538731 ] Zechman,  J.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0378-4347(00)80760-4 ]  [PMID: 3086354 ] Preti,  G.;  Thaler,  E.;  Hanson,  C.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2009.05.028 ]  [PMID: 19553163 ] Allardyce, R.A.; Langford, V.S.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
[http://dx.doi.org/10.1016/j.mimet.2005.09.003 ]  [PMID:,OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1128/AEM.02069-07 ]  [PMID: 18245241 ] Scotter,  J.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.mimet.2005.09.016 ]  [PMID: 16271408 ] Filipiak, W.; Sponring, A.; Baur, M.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1099/mic.0.062687-0 ]  [PMID: 23059976 ] Filipiak, W.; Sponring, A.; Baur, M.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1471-2180-12-113 ]  [PMID: 22716902 ] Poli, D.; Goldoni, M.; Corradi, M.; Acampa, O.; Carbognani, [80] P.; Internullo, E.; Casalini, A.; Mutti, A.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2010.01.022 ]  [PMID: 20149763 ] Wehinger,  A.;  Schmid,  A.;  Mechtcheriakov,  S.; [81] Ledochowski, M.; Grabmer, C.; Gastl, G.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.ijms.2007.05.012 ] Deng,  C.;  Zhang,  X.;  Li,  N.  Investigation  of  volatile [82] biomarkers  in  lung  cancer  blood  using  solid-phase microextraction  and  capillary  gas  chromatography-mass spectrometry.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2004.05.015 ]  [PMID: 15261821 ] Nozoe, T.; Goda, S.; Selyanchyn, R.; Wang, T.; Nakazawa, [83] K.; Hirano, T.; Matsui, H.; Lee, S.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2015.04.016 ]  [PMID: 25932789 ] Schallschmidt, K.; Becker, R.; Jung, C.; Rolff, J.; Fichtner, I.; [84] Nehls, I.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2015.10.004 ]  [PMID: 26551208 ] Schallschmidt,  K.;  Becker,  R.;  Zwaka,  H.;  Menzel,  R.; [85] Johnen, D.; Fischer-Tenhagen, C.; Rolff, J.; Nehls, I. in vitrocultured lung cancer cells are not suitable for animal-based breath  biomarker  detection.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/9/2/027103 ]  [PMID: 25667342 ] Calenic,  B.;  Amann,  A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.4155/bio.13.306 ] [PMID: 24471956 ] Baker,  R.R.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.pecs.2006.01.001 ] Uhde, E.; Salthammer, T. Impact of reaction products from [88] building materials and furnishings on indoor air quality - A review  of  recent  advances  in  indoor  chemistry.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.atmosenv.2006.05.082 ] Musa-Veloso, K.; Likhodii, S.S.; Rarama, E.; Benoit, S.; Liu, [89] Y.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.nut.2005.04.008 ]  [PMID: 16183255 ] Spaněl, P.; Dryahina, K.; Rejšková, A.; Chippendale, T.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0967-3334/32/8/N01 ]  [PMID: 21725144 ] Buszewski,  B.;  Ulanowska,  A.;  Ligor,  T.;  Denderz,  N.; [91] Amann, A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/bmc.1141 ] [PMID: 19039804 ] Scheepers,  P.T.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.scitotenv.2010.06.037 ]  [PMID: 20619876 ] Brugnone,  F.;  Perbellini,  L.;  Romeo,  L.;  Bianchin,  M.; [93] Tonello, A.; Pianalto, G.; Zambon, D.; Zanon, G. Benzene inenvironmental  air  and  human  blood.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s004200050323 ] [PMID: 9860165 ] Holzinger,  R.;  Jordan,  A.;  Hansel,  A.;  Lindinger,  W. [94] Automobile  emissions  of  acetonitrile:  Assessment  of  its contribution  to  the  global  source.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1023/A:1006435723375 ] Abbott, S.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S1387-3806(03)00212-4 ] Pinggera, G.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
[http://dx.doi.org/10.1111/j.1464-410X.2005.05288.x ],Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1515/CCLM.2008.181 ]  [PMID: 18605961 ] Gelmont,  D.;  Stein,  R.A.;  Mead,  J.F.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/0006-291X(81)90782-8 ]  [PMID: 7259787 ] Foster, W.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2012.05.159 ]  [PMID: 22683640 ] Del Monte, M.; Citti, L.; Gervasi, P.G.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.3109/00498258509045888 ]  [PMID: 4049899 ] Bogaards, J.J.; Freidig, A.P.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0009-2797(01)00276-9 ]  [PMID: 11714482 ] Watson,  W.P.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0009-2797(01)00192-2 ]  [PMID: 11397393 ] Mlakar, A.; Spiteller, G. Reinvestigation of lipid peroxidation [104] of  linolenic  acid.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/0005-2760(94)90046-9 ]  [PMID: 7918602 ] Kalluri,  U.;  Naiker,  M.;  Myers,  M.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/8/2/027109 ]  [PMID: 24861817 ] Mitsui,  T.;  Kondo,  T.  Inadequacy  of  theoretical  basis  of [106] breath  methylated  alkane  contour  for  assessing  oxidativestress.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0009-8981(03)00173-6 ]  [PMID: 12809740 ] Kneepkens, C.M.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/0891-5849(94)90110-4 ]  [PMID: 7959173 ] Watanabe,  M.  Polymorphic  CYP  genes  and  disease [108] predisposition--what have the studies shown so far?",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0378-4274(98)00303-8 ]  [PMID: 10022250 ] Roos,  P.H.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1517/17425255.1.2.187 ]  [PMID: 16922636 ] Marchitti, S.A.; Brocker, C.; Stagos, D.; Vasiliou, V. Non- [110] P450  aldehyde  oxidizing  enzymes:  the  aldehyde dehydrogenase  superfamily.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1517/17425255.4.6.697 ]  [PMID: 18611112 ] Marcato,  P.;  Dean,  C.A.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.4161/cc.10.9.15486 ] [PMID: 21552008 ] Zhao, D.; McCaffery, P.; Ivins, K.J.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1111/j.1432-1033.1996.0015h.x ] [PMID: 8797830 ] Rexer,  B.N.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1186/1479-5876-7-31 ]  [PMID: 19402909 ] Kato, S.; Post, G.C.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1006/abio.2002.5682 ]  [PMID: 12054454 ] Patel,  M.;  Lu,  L.;  Zander,  D.S.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.lungcan.2007.08.033 ]  [PMID: 17920722 ] Jiang, F.; Qiu, Q.; Khanna, A.;  Todd, N.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1158/1541-7786.MCR-08-0393 ] [PMID: 19276181 ] Rutter,  A.V.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1039/C2AN36185J ] [PMID: 23136643 ] Vaupel,  P.;  Mayer,  A.;  Höckel,  M.  Tumor  hypoxia  and [119] malignant  progression.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0076-6879(04)81023-1 ]  [PMID: 15063685 ] Vaupel,  P.  Tumor  microenvironmental  physiology  and  its [120] implications for radiation oncology.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.semradonc.2004.04.008 ]  [PMID: 15254862 ] Frezza,  C.;  Zheng,  L.;  Tennant,  D.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1371/journal.pone.0024411 ]  [PMID: 21912692 ] Pyo, J.S.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2008.10.031 ]  [PMID: 19027370 ] Phillips,  M.;  Basa-Dalay,  V.;  Blais,  J.;  Bothamley,  G.; [123] Chaturvedi,  A.;  Modi,  K.D.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.tube.2012.04.002 ]  [PMID: 22647661 ] Phillips, M.; Basa-Dalay, V.; Bothamley, G.; Cataneo, R.N.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.tube.2010.01.003 ]  [PMID: 20189456 ] Erhart, S.; Amann, A.; Haberlandt, E.; Edlinger, G.; Schmid, [125] A.; Filipiak, W.; Schwarz, K.; Mochalski, P.; Rostasy, K.;Karall, D.; Scholl-Bürgi, S. 3-Heptanone as a potential newmarker for valproic acid therapy.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/3/1/016004 ]  [PMID: 21383452 ] Diskin, A.M.; Spanel, P.; Smith, D. Increase of acetone and [126] ammonia  in  urine  headspace  and  breath  during  ovulationquantified using selected ion flow tube mass spectrometry.Physiol.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0967-3334/24/1/314 ]  [PMID: 12636196 ] Pysanenko,  A.;  Spaněl,  P.;  Smith,  D.  A  study  of  sulfur- [127] containing compounds in mouth- and nose-exhaled breath andin  the  oral  cavity  using  selected  ion  flow  tube  massspectrometry.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/2/4/046004 ]  [PMID: 21386191 ] Baumbach,  J.I.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/7/4/046008 ]  [PMID: 24287589 ] Ruzsanyi,  V.;  Baumbach,  J.I.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.chroma.2005.01.055 ]  [PMID: 16114247 ] Parameswaran, K.R.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1364/AO.48.000B73 ]  [PMID: 19183584 ] von Basum, G.; Dahnke, H.; Halmer, D.; Hering, P.; Mürtz, [132] M.  Online  recording  of  ethane  traces  in  human  breath  via infrared  laser  spectroscopy.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1152/japplphysiol.00542.2003 ]  [PMID: 12897034 ] Von  Basum,  G.;  Halmer,  D.;  Hering,  P.;  Murtz,  M.  Laser [133] Spectroscopic On-Line Monitoring of Exhaled Trace Gases.,In:  Conference  of  Breath  Analysis:  For  Clinical  Diagnosisand Atherapeutic Monitoring, 2005 , pp.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1164/rccm.200409-1184OC ]  [PMID: 15750044 ] Hunter, G.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/5/3/037111 ]  [PMID: 21896970 ] Righettoni,  M.;  Schmid,  A.;  Amann,  A.;  Pratsinis,  S.E.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/7/3/037110 ]  [PMID: 23959908 ] Righettoni, M.; Tricoli, A.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/5/3/037109 ]  [PMID: 21828897 ] Xu, Z.Q.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1038/bjc.2013.44 ] [PMID: 23462808 ] Gardner,  J.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/0957-0233/9/1/016 ] Hockstein, N.G.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1097/00005537-200410000-00005 ] [PMID: 15454757 ] Broza,  Y.Y.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.2217/nnm.13.64 ] [PMID: 23656265 ] Buhr, K.; van Ruth, S.; Delahunty, C. Analysis of volatile [142] flavour  compounds  by  Proton  Transfer  Reaction-MassSpectrometry:  fragmentation  patterns  and  discrimination between  isobaric  and  isomeric  compounds.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S1387-3806(02)00896-5 ] Schwarz,  K.;  Filipiak,  W.;  Amann,  A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1088/1752-7155/3/2/027002 ]  [PMID: 21383457 ] Mochalski, P.; Unterkofler, K.; Španěl,  P.; Smith, D.; Amann, [144] A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.ijms.2014.02.016 ]  [PMID: 25844049 ] Bojko, B.; Reyes-Garces, N.; Bessonneau, V.; Gorynski, K.; [145] Mousavi,  F.;  Silva,  E.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.trac.2014.07.005 ] Pan,  L.;  Pawliszyn,  J.  Derivatization/solid-phase [146] microextraction:  New  approach  to  polar  analytes.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/ac9606362 ] Svensson,  S.;  Lärstad,  M.;  Broo,  K.;  Olin,  A.C. [147] Determination  of  aldehydes  in  human  breath  by  on-fibre derivatization,  solid-phase  microextraction  and  GC-MS.  J. Chromatogr.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2007.10.021 ]  [PMID: 17996502 ] Deng, C.; Li, N.; Zhang, X.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2004.09.007 ]  [PMID: 15556514 ] Filipiak, W.; Filipiak, A.; Ager, C.; Wiesenhofer, H.; Amann, [149] A. Optimization of sampling parameters for collection and preconcentration  of  alveolar  air  by  needle  traps.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[ http://dx.doi.org/10.1088/1752-7155/6/2/027107 ]  [PMID: 22621839 ] Guillot, J.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1051/analusis:2000280180 ] Dettmer, K.; Knobloch, T.; Engewald, W. Stability of reactive [151] low  boiling  hydrocarbons  on  carbon  based  adsorbents typically  used  for  adsorptive  enrichment  and  thermaldesorption.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s002160050014 ] Buszewski, B.; Ligor, T.; Filipiak, W.; Vasconcelos, M.T.",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1080/02772240701384418 ] Dettmer, K.; Engewald, W. Ambient air analysis of volatile [153] organic  compounds  using  adsorptive  enrichment.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/BF02492126 ] Fastyn,  P.;  Kornacki,  W.;  Gierczak,  T.;  Gawłowski,  J.; [154] Niedzielski, J. Adsorption of water vapour from humid air byselected  carbon  adsorbents.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/j.chroma.2005.04.096 ]  [PMID: 16007975 ] Sumner, L.W.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1007/s11306-007-0082-2 ]  [PMID: 24039616 ] Vessman,  J.;  Stefan,  R.I.;  Van  Staden,  J.F.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1351/pac200173081381 ] Nomenclature, D.C.; Pure, S.R.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1016/S0003-2670(99)00105-1 ] Konvalina,  G.;  Haick,  H.  Sensors  for  breath  testing:  from [160] nanomaterials  to  comprehensive  disease  detection.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1021/ar400070m ] [PMID: 23926883 ] Vishinkin, R.; Haick, H. Nanoscale Sensor Technologies for [161] Disease  Detection  via Volatolomics.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"[http://dx.doi.org/10.1002/smll.201501904 ]  [PMID: 26448487 ] Acevedo,  C.A.",OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
[http://dx.doi.org/10.4067/S0716-97602007000400009 ] [PMID: 18449462 ],Non-OADS,/arxiv_data1/oa_pdf/c3/a0/CMC-23-2112.PMC5086670.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/1f/ijhrba-05-03-29640.PMC5086781.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/ijhrba-05-03-30127.PMC5086782.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/bd/ijhrba-05-03-30342.PMC5086873.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"These long-term impacts, termed“change in condition” in logic models (http://www.uwex.edu/ces/ pdande/evaluation/evallogicmodel.html, accessed 9 September 2016) are due to many factors, including adoption of IPM.",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"2015 ), available at http://westernipm.org/index.",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.azdeq.gov/environ/water/compliance/download/table3.pdf, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://cals.arizona.edu/apmc/docs/APMC%20Impact%20narrativep1-4_ 4-29-14.pdf, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.cdfa.ca.gov/ Statistics/, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.cdpr.ca.gov/docs/pur/pur09rep/09sum.html, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.cdpr.ca.gov/docs/enforce/residue/ resi2013/rsfr2013.htm, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.cdpr.ca.gov/docs/emon/airinit/ air_network_results.htm, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.cdpr.ca.gov/docs/pur/pur14 rep/14sum.htm, accessed 9 September 2016).",OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://westernipm.org/index.cfm/about-the-cen ter/publications/special-reports/adoption-and-impact-of-ipm-in-western-agriculture/, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.ers.usda.gov/publications/eib-economic-information-bulletin/ eib124.aspx, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://apps.cdfa.ca.gov/frep/docs/ Tomato_Production_CA.pdf, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://dx.doi.org/10.3133/sir20145154, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.usinﬂationcalculator.com/, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
(http://www.ams.,Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
(http://www.gao.,Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"(http://www.gao.gov/assets/320/311986.pdf, accessed 9 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/df/6b/pmw012.PMC5087092.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/4d/pmw013.PMC5087093.pdf
"(http://www.ces.ncsu.edu/depts/ent/notes/Urban/kudzubug.htm) Zhang, Y., J. L. Hanula, and S. Horn.",Non-OADS,/arxiv_data1/oa_pdf/25/4d/pmw013.PMC5087093.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/ijpbs-10-02-2448.PMC5087110.pdf
Continuing  mediCAl  eduCAtion Inflammasomes and dermatology* Daniel Coelho de Sá1 Cyro Festa Neto1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20165577 Abstract:	Inflammasomes	 are	intracellular	 multiprotein	 complexes	 that	comprise	part	of	the	innate	immune	response.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/abd-91-05-0566.PMC5087212.pdf
2016;91(5):580-3investigAtion C-reactive protein serum level in patients with psoriasis before and after  treatment with narrow-band ultraviolet B* Mahmoud Farshchian1	 Akram	Ansar1 Mohammadreza	Sobhan1	 Valiollah	Hoseinpoor1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164655 Abstract:  Background :	C-reactive	 protein	is	an	inflammatory	 biomarker	 and	its	level	increases	in	the	serum	of	psoriatic	pa- tients.,Non-OADS,/arxiv_data1/oa_pdf/0e/d8/abd-91-05-0580.PMC5087213.pdf
"©2016	by	Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165124 Abstract:  Background :	Pigmented	 purpuric	dermatosis 	is	a	chronic	skin	disorder	of	unknown	aetiology	characterised	 by	sym- metrical	petechial	and	pigmented	 macules,	often	confined	to	the	lower	limbs.",Non-OADS,/arxiv_data1/oa_pdf/0c/09/abd-91-05-0584.PMC5087214.pdf
investigAtion Histochemical and immunohistochemical differences between solitary  oral fibroma and fibrous papule of the face* Águida	Cristina	Gomes	Henriques1		 Roseana	de	 Almeida	Freitas2 Bruno Cunha Pires3	 Clarissa	Araújo	Gurgel1 Jean Nunes dos Santos1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20165077 Abstract:  Background :	The	morphological	 similarities	 between	fibrous	papules	of	the	face	and	multiple	sporadic	oral	fibromas	 were mentioned long ago and a relationship between them has been reported in the literature.,Non-OADS,/arxiv_data1/oa_pdf/e6/27/abd-91-05-0589.PMC5087215.pdf
"investigAtion Expression of heparanase in basal cell carcinoma and   squamous cell carcinoma* Maria	Aparecida	Silva	Pinhal1,2	Maria	Carolina	Leal	 Almeida2 Alessandra	Scorse	Costa1	 Thérèse	Rachell	Theodoro1,2 Rodrigo	Lorenzetti	Serrano1	 Carlos	D´Apparecida	Santos	Machado	Filho1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164957 Abstract:  Background :	Heparanase	 is	an	enzyme	that	cleaves	heparan	sulfate	chains.",Non-OADS,/arxiv_data1/oa_pdf/5e/35/abd-91-05-0595.PMC5087216.pdf
Pele não melanoma [acesso 21 Jul 2015]  Disponível em: http://www.inca.gov.br/estimativa/2014/sintese-de-resultados- comentarios.asp.,Non-OADS,/arxiv_data1/oa_pdf/5e/35/abd-91-05-0595.PMC5087216.pdf
"A case control study* Anargyros Kouris1 Eftychia Platsidaki1 Christos Christodoulou2 Kalliopi Armyra1 Panagiota Korkoliakou2 Christina Stefanaki1 Revekka Tsatovidou2 Dimitrios Rigopoulos2 George Kontochristopoulos1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20164935 Abstract:  Background :  Bullous pemphigoid (BP) is a chronic, autoimmune blistering skin disease that affects patients’ daily  life and psychosocial well-being.",Non-OADS,/arxiv_data1/oa_pdf/64/b5/abd-91-05-0601.PMC5087217.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164860 Abstract:  Background : Topical	antimicrobial	 drugs	are	indicated	for	limited	superficial	 pyodermitis	 treatment,	 although	they	 are	largely	used	as	self-prescribed	 medication	 for	a	variety	of	inflammatory	 dermatoses,	 including	atopic	dermatitis.",Non-OADS,/arxiv_data1/oa_pdf/57/2b/abd-91-05-0604.PMC5087218.pdf
Available form: http://www.eucast.org  19.,Non-OADS,/arxiv_data1/oa_pdf/57/2b/abd-91-05-0604.PMC5087218.pdf
Available from: http://www.bsac.org.uk  22.,Non-OADS,/arxiv_data1/oa_pdf/57/2b/abd-91-05-0604.PMC5087218.pdf
"Mutation	is	the	most	common	genetic	cause	of	 increased homocysteine levels.10 These	frequently	 seen	polymor - phisms were found to be associated with cardiovascular diseas - es,	cancer,	chronic	idiopathic	 acrocyanosis	 and	homocysteinemia,	 which	is	a	risk	factor	for	developing	psoriasis.8,11-13 Our research was geared towards investigating MTHFR  C677T	polymorphism	in	psoriasis	patients	in	southern	Turkey.DOI: http://dx.doi.org/10.1590/abd1806-4841.20164766 Abstract: Background : Psoriasis	is	a	multigenic	 and	multifactorial	 dermatological	 disease	linked	to	cardiovascular	 diseases.",Non-OADS,/arxiv_data1/oa_pdf/77/6c/abd-91-05-0611.PMC5087219.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI:	http://dx.doi.org/10.1590/abd1806-4841.20164808 Abstract:	Mohs	micrographic	 surgery	is	a	technique	 used	to	excise	skin	tumors	based	on	comprehensive	 surgical	mapping,	in	 which the surgeon removes the tumor, followed by a complete histological evaluation of the tumor’s margins.",Non-OADS,/arxiv_data1/oa_pdf/27/eb/abd-91-05-0621.PMC5087221.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI:	http://dx.doi.org/10.1590/abd1806-4841.20164931 Abstract: 	Discrepancies	 in	the	terminology	 of	elementary	 lesions	persist	when	texts	from	Dermatology	 and	Semiology	 books	 are compared, which can cause some confusion in both the teaching of undergraduate medical students and the learning  acquired	 by	professionals	 in	the	field.",Non-OADS,/arxiv_data1/oa_pdf/62/b3/abd-91-05-0629.PMC5087222.pdf
DeRmatopathology Histological variability and the importance of clinicopathological  correlation in cutaneous Rosai-Dorfman disease* Ana Gameiro1  Miguel Gouveia1 José Carlos Cardoso1  Oscar Tellechea1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164477 Abstract:  Rosai-Dorfman disease is a benign histiocytic proliferative disorder of unknown etiology.,Non-OADS,/arxiv_data1/oa_pdf/cf/1d/abd-91-05-0634.PMC5087223.pdf
Avaiable in: http://www.histiocytesociety.,Non-OADS,/arxiv_data1/oa_pdf/cf/1d/abd-91-05-0634.PMC5087223.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164919 Abstract:  A 54 year-old woman with a 3-year history of rheumatoid arthritis (RA) consulted us because of weight loss, fever  and skin eruption.",Non-OADS,/arxiv_data1/oa_pdf/1e/ef/abd-91-05-0639.PMC5087224.pdf
"2016;91(5):642-4.642 Case RepoRt Alemtuzumab in refractory Sézary syndrome* Carmen María Alcántara Reifs1 Rafael Salido-Vallejo1 Gloria María Garnacho-Saucedo1 Sofía De la Corte-Sánchez1 Alberto González-Menchen1 Antonio Vélez García-Nieto1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164322 Abstract:   Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by the triad of erythroderma, lymphade- nopathy and circulating atypical cells.",Non-OADS,/arxiv_data1/oa_pdf/aa/46/abd-91-05-0642.PMC5087225.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164778 Abstract:  Eosinophilic pustular folliculitis (EPF) or Ofuji disease is a rare dermatosis, prone to recurrence and chronicity.",Non-OADS,/arxiv_data1/oa_pdf/8e/ba/abd-91-05-0646.PMC5087226.pdf
©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164203 Abstract:  Necrolytic acral erythema is a rare skin disease associated with hepatitis C virus infection.,Non-OADS,/arxiv_data1/oa_pdf/53/5d/abd-91-05-0649.PMC5087227.pdf
"2016;91(5):652-4.652 CAse report Fixed drug eruption by etoricoxib confirmed by patch test* Aline	Soares	de	Sousa1		 José	Carlos	Cardoso2 Miguel Pinto Gouveia2	 Ana	Rita	Gameiro2 Vera	Barreto	Teixeira2 Maria Gonçalo2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164301 Abstract: Non-steroidal,	 anti-inflammatory	 drugs,	followed	by	antibiotics,	 are	the	main	causes	of	fixed	drug	eruption.",Non-OADS,/arxiv_data1/oa_pdf/4d/41/abd-91-05-0652.PMC5087228.pdf
Available from: http://www.uptodate.com 7.,Non-OADS,/arxiv_data1/oa_pdf/4d/41/abd-91-05-0652.PMC5087228.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164560 Abstract:	Milia-like	idiopathic	 calcinosis	cutis	(MICC)	is	a	very	rare	dermatological	 disorder	characterized	 by	multiple	whitish	 to	skin	colored,	milia-like	papules,	mostly	found	on	the	hands.",Non-OADS,/arxiv_data1/oa_pdf/53/fd/abd-91-05-0655.PMC5087229.pdf
"CAse report Agminated blue nevus - Case report* Alice	Paixão	Lisboa1 Keline Jácome Silvestre1 Renata Leite Pedreira1	 Natália	Ribeiro	de	Magalhães	 Alves1 Daniel Lago Obadia1,2	 Luna	Azulay-Abulafia1,3,4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164448 Abstract:	Blue	nevi	are	benign	melanocytic		 lesions	located	in	the	deeper	reticular	dermis,	consequence	 of	failure	of	melanocytic	 migration	 into	the	dermal-epidermal	 junction	from	the	neural	crest.",Non-OADS,/arxiv_data1/oa_pdf/13/f0/abd-91-05-0658.PMC5087230.pdf
©2016 by Anais Brasileiros de DermatologiaDOI:	http://dx.doi.org/10.1590/abd1806-4841.20164316 Abstract: 	Primary	 localized	 cutaneous	 amyloidosis	 is	a	skin-limited	 amyloidosis	 that	does	not	involve	internal	 organs.,Non-OADS,/arxiv_data1/oa_pdf/a4/ee/abd-91-05-0661.PMC5087231.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20163804 Abstract:  Generalized pustular psoriasis, or psoriasis of von Zumbusch, is an acute and severe clinical form of psoriasis,  which usually occurs in patients with psoriasis undergoing aggravating factors.",Non-OADS,/arxiv_data1/oa_pdf/3e/66/abd-91-05-0664.PMC5087232.pdf
©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164181 Abstract:  The Henoch-Schönlein purpura is the vasculitis associated with deposits of immunoglobulin A in small vessels.,Non-OADS,/arxiv_data1/oa_pdf/13/e2/abd-91-05-0667.PMC5087233.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164174 Abstract:	Gastric	syphilis	is	an	uncommon	 extracutaneous	 manifestation	 of	syphilis,	occurring	 in	less	than	1%	of	patients,	 presenting	 nonspecific	 clinical	manifestations.",Non-OADS,/arxiv_data1/oa_pdf/d7/a9/abd-91-05-0670.PMC5087234.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164149 Abstract:  In Brazil, leprosy is a widespread infectious and contagious disease.",Non-OADS,/arxiv_data1/oa_pdf/c0/2c/abd-91-05-0673.PMC5087235.pdf
12 p. [cited 2014 Oct 25] Available from: <http://www.who.int/wer/2010/ wer8535.pdf?ua=1>.,OADS,/arxiv_data1/oa_pdf/c0/2c/abd-91-05-0673.PMC5087235.pdf
2016;91(5):676-8.imAges  in dermAtology Bacillus cereus  strain isolated from Demodex folliculorum  in patients  with topical steroid-induced rosaceiform facial dermatitis* Alin	Laurentiu	Tatu1	 Marius	Anton	Ionescu2 Victor	Gabriel	Clatici3	 Violeta	Corina	Cristea4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20165214 Abstract:  The aim of the study was to identify Bacillus species from the Demodex folliculorum  of patients with topical steroid- induced	facial	rosaceiform	 dermatitis.,Non-OADS,/arxiv_data1/oa_pdf/82/80/abd-91-05-0676.PMC5087236.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165142 Abstract:	Chromoblastomycosis	 is	a	chronic	fungal	infection	of	the	epidermis,	 dermis	and	subcutaneous	 tissue,	in	which	the	 most	common	etiologic	agent	in	Brazil	is	Fonsecaea pedrosoi.",Non-OADS,/arxiv_data1/oa_pdf/88/64/abd-91-05-0679.PMC5087237.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164449683 CASE REPORT A	woman	patient,	41	years	of	age,	presented	 a	dry	cough	 and	dyspnea	upon	moderate	exertion,	which	has	become	progres- sively	worse	over	the	past	four	years.",Non-OADS,/arxiv_data1/oa_pdf/72/4a/abd-91-05-0683.PMC5087238.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164814 Abstract:	Due	to	mounting	 evidences	 of	interaction	 between	Hansen’s	bacilli	with	endothelial	 cells	and	the	paucity	of	studies	 addressing	 the	presence	of	nailfold	capillaroscopic	 alterations	 in	patients	with	Hansen’s	disease,	a	study	was	carried	out	in	 order to verify the presence of capillaroscopic alterations in patients with leprosy in its various forms and its correlation with  clinical	parameters.",Non-OADS,/arxiv_data1/oa_pdf/cd/dd/abd-91-05-0686.PMC5087239.pdf
2016;91(5):688-90.CommuniCAtion Nail clipping in onychomycosis* Laura Bertanha1 Nilton Di Chiacchio1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164968 Abstract:	Onychomycosis	 is	the	most	prevalent	onychopathy	 and	it	requires	a	correct	early	diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/abd-91-05-0688.PMC5087240.pdf
"2016;91(5):691-3.CommuniCAtion Profile of patients receiving medical care at a reference, support, and  treatment center for psoriasis patients at a university hospital* Túlio Germano Machado Cordeiro Júnior1		 Bruno	D’	Paula	 Andrade1 Esther Bastos Palitot1	 Márcia	Regina	Piuvezam1 Sandra Rodrigues Mascarenhas1  DOI: http://dx.doi.org/10.1590/abd1806-4841.201644945 Abstract:	Psoriasis	is	a	chronic,	inflammatory,	 immune-mediated	 disease	affecting	1-3%	of	the	population	 worldwide.",Non-OADS,/arxiv_data1/oa_pdf/03/a3/abd-91-05-0691.PMC5087241.pdf
2016;91(5):694-6.694 CommuniCAtion Pityriasis amiantacea: a study of seven cases* Gustavo	Moreira	 Amorim1 Nurimar Conceição Fernandes1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20164951 Abstract:	Pityriasis	amiantacea	 was	first	described	in	1832.,Non-OADS,/arxiv_data1/oa_pdf/a0/11/abd-91-05-0694.PMC5087242.pdf
"2016;91(5):697-9.CommuniCAtion Dermal tunneling: a proposed treatment for depressed scars* Emerson	Vasconcelos	de	 Andrade	Lima1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20164959 Abstract:	Depressed	 facial	scars	are	still	a	challenge	 in	medical	literature,	 despite	the	wide	range	of	proposed	treatments.",Non-OADS,/arxiv_data1/oa_pdf/36/c4/abd-91-05-0697.PMC5087243.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20164886 To the Editor, Dermatofibrosarcoma protuberans (DFSP) is an uncommon  sarcoma of the skin and soft tissue with an intermediate level of  malignancy.",Non-OADS,/arxiv_data1/oa_pdf/e7/cc/abd-91-05-0700.PMC5087244.pdf
©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165446 The referred article presents an all-encompassing view re- garding	the	hair	of	 Afro-American	women.1 We	consider	relevant	to	emphasize	 an	association	 observed	 with	greater	frequency	 in	black	patients:	frontal	fibrosing	alopecia	 (FFA)	and	lichen	planus	pigmentosus	(LPP).,Non-OADS,/arxiv_data1/oa_pdf/3a/55/abd-91-05-0702.PMC5087245.pdf
"©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165504 It was with great interest that I read the recently published,  brief communication by Roesner et al., which analyzed the circula- tion frequency of forkhead box P3 (Foxp3)+ regulatory T cells (Tregs)  in adult patients with atopic dermatitis (AD).1 The study found a  positive correlation between these cells and disease severity.",Non-OADS,/arxiv_data1/oa_pdf/19/93/abd-91-05-0703.PMC5087246.pdf
"©2016	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165769 Dear	Editor, This	is	a	case	report	of	a	male	patient,	47	years	of	age,	with	 a one-year history of an asymptomatic nodular mass on the left hal- lux.",Non-OADS,/arxiv_data1/oa_pdf/21/25/abd-91-05-0704.PMC5087247.pdf
©2016 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20165345 To the Editor:   A 31-year-old male visited our hospital seeking dermato- logical care.,Non-OADS,/arxiv_data1/oa_pdf/67/12/abd-91-05-0706.PMC5087248.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/32/ijpbs-10-02-4500.PMC5087256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32651 - http://dx.doi.org/10.3402/jchimp.v6.32651 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ba/8d/JCHIMP-6-32651.PMC5087257.pdf
doi: http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/ba/8d/JCHIMP-6-32651.PMC5087257.pdf
doi: http://dx.doi.org/10.1080/00015550510027784 5.,Non-OADS,/arxiv_data1/oa_pdf/ba/8d/JCHIMP-6-32651.PMC5087257.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32651 - http://dx.doi.org/10.3402/jchimp.v6.32651",Non-OADS,/arxiv_data1/oa_pdf/ba/8d/JCHIMP-6-32651.PMC5087257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32101 - http://dx.doi.org/10.3402/jchimp.v6.32101 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/58/39/JCHIMP-6-32101.PMC5087258.pdf
Surgery 2016. doi: http://dx.doi.org/10.1016/j.surg.2016.06.029 Fig.,OADS,/arxiv_data1/oa_pdf/58/39/JCHIMP-6-32101.PMC5087258.pdf
"CT shows right renal mass (short arrow), and IVC thrombus (long arrow).Majd Alfreijat 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32101 - http://dx.doi.org/10.3402/jchimp.v6.32101",Non-OADS,/arxiv_data1/oa_pdf/58/39/JCHIMP-6-32101.PMC5087258.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/license s/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/0b/47/JCHIMP-6-32361.PMC5087259.pdf
"0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32361 - http://dx.doi.org/10.3402/jchimp.v6.32361 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0b/47/JCHIMP-6-32361.PMC5087259.pdf
"CT head with IV contrast with an arrow that indicates cerebral venous sinus thrombosis.Marcelle G. Meseeha and Maximos Attia 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32361 - http://dx.doi.org/10.3402/jchimp.v6.32361",Non-OADS,/arxiv_data1/oa_pdf/0b/47/JCHIMP-6-32361.PMC5087259.pdf
"N Engl J Med 2005; 352(17): 1791 /C18.A case study on throbbing headache Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32361 - http://dx.doi.org/10.3402/jchimp.v6.32361 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0b/47/JCHIMP-6-32361.PMC5087259.pdf
"J Pak Med Assoc 2006; 56(11): 547/C151.Marcelle G. Meseeha and Maximos Attia 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32361 - http://dx.doi.org/10.3402/jchimp.v6.32361",Non-OADS,/arxiv_data1/oa_pdf/0b/47/JCHIMP-6-32361.PMC5087259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32686 - http://dx.doi.org/10.3402/jchimp.v6.32686 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0e/e1/JCHIMP-6-32686.PMC5087260.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32686 - http://dx.doi.org/10.3402/jchimp.v6.32686",Non-OADS,/arxiv_data1/oa_pdf/0e/e1/JCHIMP-6-32686.PMC5087260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32827 - http://dx.doi.org/10.3402/jchimp.v6.32827 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32827 - http://dx.doi.org/10.3402/jchimp.v6.32827",Non-OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
doi: http://dx.doi.org/10.1007/s15010-004-3022-3 5.,Non-OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
"doi: http://dx.doi.org/10.1161/CIR.0000000000000296Isolated pulmonary valve endocarditis Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32827 - http://dx.doi.org/10.3402/jchimp.v6.32827 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2d/f7/JCHIMP-6-32827.PMC5087261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32816 - http://dx.doi.org/10.3402/jchimp.v6.32816 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/48/JCHIMP-6-32816.PMC5087262.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32816 - http://dx.doi.org/10.3402/jchimp.v6.32816",Non-OADS,/arxiv_data1/oa_pdf/57/48/JCHIMP-6-32816.PMC5087262.pdf
"Cost savings analysis LFT CK CK-MB Troponin Myoglobin Total Y1 $24,649.30 $173,066.30 139,803.80 787,584.60 180,892.80 Total Y2 $10,469.40 $19,574.8 $24,508.40 $762,973.20 $247,26.20 TSTS by test $14,179.90 $153,491.50 $115,295.40 $246,11.40 $156,166.60 $463,744.70 TS, total savings; LFT, liver function test; CK, creatinine kinaseReduction in cardiac enzyme testing after CPOE change Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32816 - http://dx.doi.org/10.3402/jchimp.v6.32816 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/57/48/JCHIMP-6-32816.PMC5087262.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32816 - http://dx.doi.org/10.3402/jchimp.v6.32816",Non-OADS,/arxiv_data1/oa_pdf/57/48/JCHIMP-6-32816.PMC5087262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32217 - http://dx.doi.org/10.3402/jchimp.v6.32217 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/9a/JCHIMP-6-32217.PMC5087263.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32217 - http://dx.doi.org/10.3402/jchimp.v6.32217",Non-OADS,/arxiv_data1/oa_pdf/3d/9a/JCHIMP-6-32217.PMC5087263.pdf
"Radiographics 2007; 27(2): 497 /C1507.Impending aortic aneurysm rupture Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32217 - http://dx.doi.org/10.3402/jchimp.v6.32217 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/9a/JCHIMP-6-32217.PMC5087263.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32217 - http://dx.doi.org/10.3402/jchimp.v6.32217",Non-OADS,/arxiv_data1/oa_pdf/3d/9a/JCHIMP-6-32217.PMC5087263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32372 - http://dx.doi.org/10.3402/jchimp.v6.32372 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32372 - http://dx.doi.org/10.3402/jchimp.v6.32372",Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
"Histologic section of the tumor, demonstrating a proliferation of pleomorphic, small cells, with regions ofnecrosis (H&E stain, 100x original magniﬁcation).Glioblastoma management Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32372 - http://dx.doi.org/10.3402/jchimp.v6.32372 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
doi: http://dx.doi.org/10.1002/cncr.29742 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
Surg Neurol Int 2014; 5: 64. doi: http://dx.doi.org/10.4103/2152- 7806.132138 3.,OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
doi: http://dx.doi.o rg/10.1188/11.CJON.291- 297 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
doi: http://dx.do i.org/10.5114/wo.2014.40559 5.,Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
doi: http://dx.doi.org/10.1055/s-0032- 1330113 7.,Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32372 - http://dx.doi.org/10.3402/jchimp.v6.32372",Non-OADS,/arxiv_data1/oa_pdf/ef/05/JCHIMP-6-32372.PMC5087265.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32662 - http://dx.doi.org/10.3402/jchimp.v6.32662 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
"Incidence of Kaposi’s Sarcoma (KS), Pneumocystis carinii Pneumonia (PCP), and Other Opportunistic infections in the United States, 1979 /C11981.Robert Ferguson 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32662 - http://dx.doi.org/10.3402/jchimp.v6.32662",Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
"J Community Hosp Intern Med Perspect 2012; 1(4): 15884, doi: http://dx.doi.org/ 10.3402/jchimp.v1i4.15884 2.",Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
"J Community Hosp Intern Med Perspect 2014; 4(3): 25046, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
Available from: http://www.nytimes.com/2006/08/01/health/01docs.html?8dpc /C30 &r/C300&pagewanted /C30print 7.,Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
"Available from: http://www.nytimes.com/1984/ 10/10/us/14-san-francisco-sex-club s-told-to-close-to-curb-aids.html [cited 10 October 1984].Emerging infectious diseases Citation: Journal of Community Hospital Internal Medicine Perspectives 2016, 6: 32662 - http://dx.doi.org/10.3402/jchimp.v6.32662 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/92/d6/JCHIMP-6-32662.PMC5087266.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/d6/ijpbs-10-02-4962.PMC5087286.pdf
"10, e1227897 (10 pages)http://dx.doi.org/10.1080/2162402X.2016.1227897",Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
ORCID Adam E. Snook http://orcid.org/0000-0001-9216-4560 References 1.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
"Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted tothe SEER web site, April 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Science 2013; 342:1432-3; PMID:24357284; http://dx.doi.org/10.1126/science.342.6165.1432 3.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Science 2002; 298:850-4; PMID: 12242449; http://dx.doi.org/10.1126/science.1076514 4.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
N Engl J Med 2013; 368:1509-18; PMID:23527958; http://dx.doi.org/10.1056/NEJMoa12- 15134 5.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
N Engl J Med 2011; 365:725-33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849 6.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Blood 2011; 118:6050-6; PMID:21984804; http://dx.doi.org/10.1182/blood-2011-05-354449 7.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Mol Ther 2010; 18:843-51; PMID:20179677; http://dx.doi.org/10.1038/mt.2010.248.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Mol Ther 2011; 19:620-6; PMID:21157437; http://dx.doi.org/10.1038/mt.2010.272 9.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Immunol 2009; 183:5563-74; PMID:19843940; http://dx.doi.org/10.4049/jimmunol.0900447 10.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2009; 15:169-80; PMID:19118044; http://dx.doi.org/10.1158/1078-0432.CCR-08-1638 11.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2014; 20:972-84; PMID:24352643; http://dx.doi.org/10.1158/1078-0432.CCR-13-0709 12.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
ExpertRev Mol Diagn 2005; 5:701-13; PMID:16149873; http://dx.doi.org/10.1586/14737159.5.5.701 15.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Proc NatlAcad Sci U S A 1996; 93:14827-32; PMID:8962140; http://dx.doi.org/ 10.1073/pnas.93.25.14827 16.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Hum Pathol 2005; 36:170- 9; PMID:15754294; http://dx.doi.org/10.1016/j.humpath.2004.12.002 18.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2006; 12:4545-52; PMID:16899600; http://dx.doi.org/10.1158/1078-0432.CCR-06-0865 19.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Physiol 1994; 479(Pt 3):433- 40; PMID:7837099; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Dig Dis Sci 1987; 32:1017-26; PMID:3304888; http://dx.doi.org/10.1007/BF01297193 22.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Trafﬁc 2006; 7:456-64; PMID:16536743; http://dx.doi.org/10.1111/ j.1600-0854.2006.00398.x 23.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2016; PMID:27178743; http://dx.doi.org/ 10.1158/1078-0432.ccr-15-2474 25.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
OncoTarget 2014; 5:9460- 71; PMID:25294806; http://dx.doi.org/10.18632/oncotarget.2455 26.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Eur J Immunol 2014; 44:1956-66; PMID: 24771148; http://dx.doi.org/10.1002/eji.201444539 27.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Cancer Res 2009; 69:3537-44; PMID:19351847; http://dx.doi.org/10.1158/0008-5472.CAN-08-3386 28.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Natl Cancer Inst 2008; 100:950-61; PMID:18577748;http://dx.doi.org/10.1093/jnci/djn178 29.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Cytometry 1997; 27:71-6; PMID:9000587; http://dx.doi.org/10.1002/ (SICI)1097-0320(19970101)27:1%3c71::AID-CYT-O9%3e3.0.CO;2-O 31.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Science 1984; 225:1487-9; PMID:6332379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Exp Med 2005; 202:907-12; PMID:16203864; http://dx.doi.org/10.1084/jem.20050732 3 4 .,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393; http://dx.do i.org/10.1158/1078-0432.CCR-11-0116 35.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Nat Biotechnol 2013; 31:999-1008; PMID:24142051; http://dx.doi.org/10.1038/nbt.2725 36.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Gene Ther 2013;20:1029-32; PMID:23804078; http://dx.doi.org/10.1038/gt.2013.34 37.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Cancer Res 2005; 11:8549-56;PMID:16361536; http://dx.doi.org/10.1158/1078-0432.CCR-05-1624 38.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Gastroenterology 2012; 143:1095-107 e2; PMID:22750462; http://dx.doi.org/10.1053/j.gastro.2012.06.037 39.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Cancer Res 2008; 68:8446-55; PMID:18922918; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Clin Invest 2011; 121:3578-88; PMID:21865642; http://dx.doi.org/10.1172/JCI57925 41.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Natl Cancer Inst 2016; 108; PMID: 26819347; https://dx.doi.org/10.1093/jnci/djv439 43.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Nature 1985; 317:359-61; PMID:3876513; http://dx.doi.org/10.1038/317359a0 44.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Clin Exp Immunol 2013; 172:280-9; PMID:23574324;http://dx.doi.org/10.1111/cei.12047 45.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Exp Med 2003; 197:985-95; PMID:12695490; http://dx.doi.org/10.1084/jem.20021804 46.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Mol Ther 2014; 22:1029-38; PMID: 24572294; http://dx.doi.org/10.1038/mt.2014.28 47.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Cancer Res 2010; 70:9591-8; PMID:21098715; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-2884 48.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Immunol 2010; 184:1885-96; PMID:20089697; http://dx.doi.org/10.4049/jimmunol.0901440 49.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Clin Invest 2010; 120:3953-68; PMID:20978347; http://dx.doi.org/10.1172/JCI43490 50.,Non-OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Gene Ther 2013; 20(11):1029-32; PMID:23804078; https://dx.doi.org/10.1038/gt.2013.34 51.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Oncotarget 2016; https://dx.doi.org/ 10.18632/oncotarget.10510 52.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
Proc Natl Acad Sci U S A 1992; 89:4285-9; PMID:1350088; http://dx.doi.org/10.1073/ pnas.89.10.4285 53.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
J Immunol Methods 2014; 405:192-8; PMID:24486140; http://dx.doi.org/10.1016/j.jim.2014.01.012e1227897-10 M. S. MAGEE ET AL.,OADS,/arxiv_data1/oa_pdf/01/d3/koni-05-10-1227897.PMC5087292.pdf
"10, e1219826 (16 pages)http://dx.doi.org/10.1080/2162402X.2016.1219826",Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
The microarray data from this publication have beensubmitted to the GEO database ( http://www.ncbi.nlm.nih.gov/ geo/) and assigned the identi ﬁerGSE33115 .,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Lancet 2014; 383:816-27; PMID:24054424; http://dx.doi.org/10.1016/S0140-6736(13)60802-8 2.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Mayo Clinic pro-ceedings 2006; 81:500-7; PMID:16610570; http://dx.doi.org/10.4065/81.4.500 3.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Surg Oncol 2011; 104:425-9;PMID:21858838; http://dx.doi.org/10.1002/jso.22034 4.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Clin Oncol 2009; 27:6199- 206; PMID:19917835; http://dx.doi.org/10.1200/JCO.2009.23.4799 5.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
2015; 1:15003; PMID :27188223; http://dx.doi.org/ 10.1038/nrdp.2015.3 6.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
N Engl J Med2011; 364:2507-16; PMID:21639808; http://dx.doi.org/10.1056/NEJMoa1103782 7.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
JAMA 2011; 305:2327-34; PMID:21642685; http://dx.doi.org/10.1001/ jama.2011.746 9.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
NEngl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 10.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
N Engl JMed 2015; 372:320-30; PMID:25399552; http://dx.doi.org/10.1056/ NEJMoa1412082 11.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
N Engl J Med 2015; 372:2521-32; PMID:25891173; http://dx.doi.org/10.1056/NEJMoa1503093 12.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
N Engl J Med 2015; 373:23-34; PMID:26027431; http://dx.doi.org/10.1056/NEJMoa1504030 13.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Expert Rev Anticancer Ther 2009; 9:1583-98; PMID:19895243; http://dx.doi.org/10.1586/era.09.135 14.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Semin Oncol 2007; 34:555-65; PMID:18083379; http://dx.doi.org/10.1053/j.seminoncol.2007.09.009 15.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Clin Oncol 2002; 20:1826-31; PMID:11919240;http://dx.doi.org/10.1200/JCO.2002.07.082 16.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
HumPathol 2010; 41:375-84; PMID:20004943; http://dx.doi.org/10.1016/j.humpath.2009.08.016 17.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Pathol 1999; 189:546-51; PMID:10629556; http://dx.doi.org/10.1002/(SICI)1096-9896(199912) 189:4<546::AID-PATH487 >3.0.CO;2-L 19.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Melanoma Res 2006; 16:405-11; PMID:17013089; http://dx.doi.org/10.1097/01.cmr.0000222598.27438.82ONCOIMMUNOLOGY e1219826-15,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Eur J Cancer 2009; 45:1407-14; PMID:19157860; http://dx.doi.org/ 10.1016/j.ejca.2008.12.015 22.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Curr Top Med Chem 2012; 12:32-49; PMID:22196268; http://dx.doi.org/10.2174/156802612798919240 23.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
ClinDermatol 2013; 31:257-63; PMID:23608445; http://dx.doi.org/ 10.1016/j.clindermatol.2012.08.018 24.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Cancer Metastasis Rev 2007; 26:281-90; PMID:17603752; http://dx.doi.org/10.1007/s10555-007-9066-y 26.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Br J Cancer 2002;86:301-8; PMID:11870523; http://dx.doi.org/10.1038/sj.bjc.6600052 28.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Circ Res 2000; 86:974-81;PMID:10807870; http://dx.doi.org/10.1161/01.RES.86.9.974 29.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Br J Cancer 1997; 76:561-70; PMID:9303353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Clin Exp Metastasis 1991; 9:259-72; PMID:2060184; http://dx.doi.org/10.1007/BF01753729 31.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Int J Cancer 2000; 86:768-76; PMID:10842189; http://dx.doi.org/10.1002/ (SICI)1097-0215(20000615)86:6%3c768::AID-IJC3%3e3.0.CO;2-E 32.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Int J Oncol 2007; 30:701-7; PMID:17273772; http://dx.doi.org/10.3892/ijo.30.3.701 33.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Cytokine 2000; 12:547-54; PMID:10843728; http://dx.doi.org/10.1006/cyto.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Cancer Cell 2006; 10:515-27; PMID:17157791; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Cell Death Differ 2015; 22:526-39; PMID:25526085; http://dx.doi.org/10.1038/cdd.2014.216 39.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
"Wang Y, Becker D. Antisense targeting of basic ﬁbroblast growth factor and ﬁbroblast growth factor receptor-1 in human melano- m a sb l o c k si n t r a t u m o r a la n g i o g e n e s i sa n dt u m o rg r o w t h .N a t Med 1997; 3:887-93; PMID:9256280; http://dx.doi.org/10.1038/ nm0897-887 40.",Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Clin Invest 1999; 103:159-65; PMID:9916127; http://dx.doi.org/10.1172/JCI5028 42.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Cell Mol Life Sci 2004;61:2224-43; PMID:15338053; http://dx.doi.org/10.1007/s00018-004- 4070-7 44.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Microvasc Res 2009; 78:338-57; PMID:19747926; http://dx.doi.org/10.1016/j.mvr.2009.09.001 45.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Int J Cancer 2001; 92:26-30; PMID:11279602;http://dx.doi.org/10.1002/1 097-0215(200102)9999:9999%3c::AID- IJC1151%3e3.0.CO;2-T 46.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Natl Cancer Inst 2003; 95:723-32; PMID:12759390; http://dx.doi.org/10.1093/jnci/95.10.723 47.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
J Clin Invest 1973; 52:2745-56; PMID:4355998; http://dx.doi.org/10.1172/JCI107470 48.,Non-OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
Clin ExpImmunol 2010; 162:474-86; PMID:20846162; http://dx.doi.org/ 10.1111/j.1365-2249.2010.04256.xe1219826-16 A. M. DAS ET AL.,OADS,/arxiv_data1/oa_pdf/d8/86/koni-05-10-1219826.PMC5087299.pdf
"10, e1219827 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1219827",Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
"Nat Rev Immunol 2009; 9:581-93; PMID:19498381; http://dx.doi.org/10.1038/nri2567 2. van den Boorn JG, Daßler J, Coch C, Schlee M, Hartmann G. Exo- somes as nucleic acid nanocarriers.",OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Advanced Drug Delivery Reviews 2013; 65(3):331-5; PMID:22750807; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Biochimica et Biophysica Acta (BBA) - Rev Cancer 2012; 1826:103-11; PMID:22503823; http://dx.doi.org/ 10.1016/j.bbcan.2012.03.006 4.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Res 2007; 67:2912-5; PMID:17409393; http://dx.doi.org/10.1158/0008-5472.CAN-07-0520 5.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
PLoS ONE 2012; 7:e46874; PMID:23056502; http://dx.doi.org/10.1371/journal.pone.0046874 6.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Res 2010; 70:1281-5; PMID:20145139; http://dx.doi.org/10.1158/0008-5472.CAN-09-3276 7.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Oncoimmunology 2015; 5:e1071008; PMID:27141373; http://dx.doi.org/10.1080/2162402X.2015.1071008 8.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Biol Chem 2013; 288:34295-303;PMID:24133212; http://dx.doi.org/10.1074/jbc.M113.483602 9.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
PLoS ONE 2008; 3:e3377; PMID:18852879; http://dx.doi.org/10.1371/journal.pone.0003377 11.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Blood 2013; 121:3658-65;PMID:23509156; http://dx.doi.org/10.1182/blood-2013-01-476606 12.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Front Immunol 2014; 5:1074; PMID:24639679;http://dx.doi.org/10.3389/ ﬁmmu.2014.00091 13.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nat Rev Immunol 2014; 14:195-208; PMID:24566916; http://dx.doi.org/10.1038/nri3622 14.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nat Med 2012; 18:883-91; PMID:22635005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell Death Differ 2007; 15:80-8; PMID:17932500; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Immunol 2011; 186:2219-28; PMID:21242526; http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Biol Chem2012; 287:15874-85; PMID:22396543; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
PLoS ONE 2012; 7: e42310; PMID:22879938; http://dx.doi.org/10.1371/journal.pone.0042310 19.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Int J Oncol 2010; 36:133-40; PMID:19956842; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell Host & Microb 2012; 12:558-70; PMID:23084922; http://dx.doi.org/10.1016/j.chom.2012.08.010 21.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Recogni- tion of 50triphosphate by RIG-I helicase requires short blunt double- stranded RNA as contained in panhandle of negative-strand virus.Immunity 2009; 31:25-34; PMID:19576794; http://dx.doi.org/10.1016/ j.immuni.2009.05.008 23.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Curr OpinImmunol 2008; 20:389-95; PMID:18652893; http://dx.doi.org/ 10.1016/j.coi.2008.07.007 24.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Clin Invest 2009;119:2399-411; PMID:19620789; http://dx.doi.org/10.1172/JCI37155 25.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Stem Cells 2013; 31:1064-74; PMID:23390110; http://dx.doi.org/10.1002/stem.1350 26.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J InnateImmun 2011; 3:264-73; PMID:21454965; http://dx.doi.org/10.1159/ 000326891 27.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nat Med 2008; 14:1256-63; PMID:18978796; http://dx.doi.org/ 10.1038/nm.1887 28.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Immunol Immunother 2003; 52:387-95;PMID:12682787; http://dx.doi.org/10.1007/s00262-003-0375-x 29.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell Mol Life Sci 2011; 68:2667-88; PMID:21560073; http://dx.doi.org/10.1007/s00018-011- 0689-3 31.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J ExtracelVesicles 2013; 2:20677-; PMID:24223256; http://dx.doi.org/10.3402/jev.v2i0.20677 32.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell Death Differ 2014; 21:1825-37; PMID:25012502; http://dx.doi.org/ 10.1038/cdd.2014.96 33.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nature 2012; 490:412-6; PMID:23051752; http://dx.doi.org/10.1038/nature11538 34.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
"Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts.Semin Cancer Biol 2011; 21:139-46; PMID:21251983; http://dx.doi.org/10.1016/j.semcancer.2011.01.002 35.",OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Immunol 2008; 180:7249-58; PMID:18490724; http://dx.doi.org/10.4049/jimmunol.180.11.7249 36.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Immunol 2006; 176:1375-85; PMID:16424164; http://dx.doi.org/ 10.4049/jimmunol.176.3.1375 37.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nat Cell Biol 2008; 10:1470-6;PMID:19011622; http://dx.doi.org/10.1038/ncb1800 38.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Res 2011; 71:3792-801; PMID:21478294; http://dx.doi.org/10.1158/0008-5472.CAN-10-4455e1219827-10 J. DAßLER-PLENKER ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S et al.Tumour exosome integrins determine organotropic metastasis.Nature 2015; 527:329-35; PMID:26524530; http://dx.doi.org/10.1038/ nature15756 40.",OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Res 2006; 66:9290-8; PMID:16982774; http://dx.doi.org/10.1158/0008-5472.CAN-06-1819 41.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Semin Cancer Biol 2014; 28:39-50; PMID:24631836; http://dx.doi.org/10.1016/j.semcancer.2014.02.011 43.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell Mol Life Sci 2014; 71:1829-37; PMID:24305946; http://dx.doi.org/10.1007/s00018-013-1522-y 44.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Exp Med 2009; 206:1495-503; PMID:19528259; http://dx.doi.org/10.1084/jem.20090681 45.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
PLoS ONE 2012; 7: e40836; PMID:22808273; http://dx.doi.org/10.1371/journal.pone.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Nat Genet 2008; 40:1407- 9; PMID:18978787; http://dx.doi.org/10.1038/ng.273 48.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Oncogene 2007;26:2873-84; PMID:17086209; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J Immunol 2007;179:5523-33; PMID:17911639; http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cancer Res 2005; 65:5238-47; PMID:15958569; http://dx.doi.org/ 10.1158/0008-5472.CAN-04-3804 51.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
EMBO J 2001; 20:1033- 41; PMID:11230127; http://dx.doi.org/10.1093/emboj/20.5.1033 52.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
J BiolChem 2005; 280:23349-55; PMID:15826944; http://dx.doi.org/ 10.1074/jbc.M502017200 53.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
PLoS ONE 2012; 7:e46874; PMID:23056502; http://dx.doi.org/10.1371/journal.pone.0046874 54.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Cell 2014; 159:499-513;PMID:25417103; http://dx.doi.org/10.1016/j.cell.2014.09.051 55.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Eur J Immunol 2010; 40:1541-4; PMID:20468008; http://dx.doi.org/10.1002/eji.201040616 56.,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Proteomics 2004; 4:4019-31; PMID:15478216;http://dx.doi.org/10.1002/pmic.200400876 57.,OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
Int J Cancer 2015; 136:E74-84; PMID:25066479; http://dx.doi.org/10.1002/ijc.29100ONCOIMMUNOLOGY e1219827-11,Non-OADS,/arxiv_data1/oa_pdf/2f/1a/koni-05-10-1219827.PMC5087302.pdf
"10, e1220467 (14 pages)http://dx.doi.org/10.1080/2162402X.2016.1220467",Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Oncoimmunology 2014; 3:e28694;PMID:25097804; http://dx.doi.org/10.4161/onci.28694 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
J clin Oncol 2015; 33:2780-8; PMID:26014293; http://dx.doi.org/10.1200/JCO.2014.58.3377ONCOIMMUNOLOGY e1220467-13,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Exp Rev Vaccines 2010; 9:1353-6; PMID:21105770; http://dx.doi.org/10.1586/erv.10.137 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Annu Rev Virol 2014; 1:119-41; PMID:25839047; http://dx.doi.org/10.1146/annurev- virology-031413-085442 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Mol Ther 2012; 20:749-58; PMID:22186794; http://dx.doi.org/10.1038/mt.2011.276 8.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Onco- lytic vaccinia virus disrupts tumor-associated vasculature in humans.Cancer Res 2013; 73:1265-75; PMID:23393196; http://dx.doi.org/10.1158/0008-5472.CAN-12-2687 9.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Nat Rev Cancer2009; 9:64-71; PMID:19104515; http://dx.doi.org/10.1038/nrc2545 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Nat Med 2014; 20:1301-9; PMID:25344738; http://dx.doi.org/10.1038/nm.3708 11.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
FrontOncol 2014; 4:74; PMID:24782985; http://dx.doi.org/10.3389/fonc.2014.00074 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Cancer Res 2012; 72:1651-60; PMID:22315352; http://dx.doi.org/10.1158/0008-5472.CAN-11-2788 13.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
24:5543-51; PMID:26187615; http://dx.doi.org/ 10.1158/1078-0432.CCR-14-2009 14.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
J Oncol 2015; 2015:847383; PMID:26060497; http://dx.doi.org/10.1155/2015/847383 15.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Scient World J 2011; 11:726-35; PMID:21442150;http://dx.doi.org/10.1100/tsw.2011.6517.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
mAbs 2013; 5:565-75;PMID:23751726; http://dx.doi.org/10.4161/mabs.24814 18.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
J Exp Med 2003; 198:63-9; PMID:12847137; http://dx.doi.org/10.1084/jem.20022125 19.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Cancer Gene Ther 2000; 7:615-23; PMID:10811480; http://dx.doi.org/10.1038/sj.cgt.7700161 20.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
CancerGene Ther 2002; 9:470-7; PMID:11961670; http://dx.doi.org/10.1038/sj.cgt.7700461 21.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Proc Natl Acad Sci U S A 2009; 106:12915-20; PMID:19617539; http://dx.doi.org/ 10.1073/pnas.0900660106 22.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Mol Thera 2014; 22:1949-59; PMID:25156126; http://dx.doi.org/10.1038/mt.2014.160 23.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Gene Ther 2012; 19:988- 98; PMID:22071969; http://dx.doi.org/10.1038/gt.2011.176 24.,OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Clin Cancer Res 2014; 20:1747-56;PMID:24691639; http://dx.doi.org/10.1158/1078-0432.CCR-13-2116 25.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Clin Cancer Res 2013; 19:5261-3; PMID:23965900; http://dx.doi.org/10.1158/1078-0432.CCR-13-1923 26.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
Cancer Dis 2012; 2:608-23; PMID:22719018; http://dx.doi.org/10.1158/2159-8290.CD-11-0314 27.,Non-OADS,/arxiv_data1/oa_pdf/2b/18/koni-05-10-1220467.PMC5087307.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/ijpbs-10-02-1822.PMC5087336.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/0c/ijpbs-10-02-122.PMC5087560.pdf
",2 0 1 0 ; http://muta tiontaster.org/ ); PolyPhen-2, version 2.2.2 (Adzhubei et al., 2010; http://genetics.bwh.harvard.edu/pph2/ ); and SIFT (Ng and Henikoff, 2001; http://sift.jcvi.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
",1 9 9 6 ; http://www.gene-regulation.com/pub/databases.html ).",Non-OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
", 2010; Total European Ancestry EUR; http://www.1000genomes.org/ ), and the Exome Variant Server (European American population; Exome Variant Server, NHLBI GO Exome Sequencing Project, Seattle, Washington, USA ( http://evs.",OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
"In the European (non-Finnish) sample ascertained by the Exome Aggregation Consortium (ExAC)(Cambridge, Massachusetts, USA) ( http://exac.broadinstitute.",OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
"The mutation was not detected in theSchizophrenia Exome Sequencing Genebook (Purcell et al., 2014; http://atgu.mgh.harvard.edu/ ∼spurcell/genebook/genebook.cgi?",Non-OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
"In the Swedish SCZ exome-sequencing study, this mutation was identified in one patient and in one control (Purcell et al., 2014; http://atgu.mgh.harvard.edu/ ∼spurcell/genebook/genebook.cgi?",Non-OADS,/arxiv_data1/oa_pdf/10/27/ypg-26-293.PMC5087564.pdf
http://athn.org/ﬁles/resources/athnready/ Emergency%20Care%20for%20Patients%20with%20Hemophilia% 20FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/62/blcof-27-845.PMC5087566.pdf
"National Kidney Registry Home Page: National Kidney Registry, http://www.kid neyregistry.org/.",Non-OADS,/arxiv_data1/oa_pdf/0d/45/txd-2-e85.PMC5087568.pdf
http://srtr.transp lant.hrsa.gov/annual_reports/2012/ pdf/01_kidney_13.pdf.,OADS,/arxiv_data1/oa_pdf/0d/45/txd-2-e85.PMC5087568.pdf
The Economic Impact of End-stage Kidney Disease in Australia —Projections to 2020. http://kidney.org.au/cms_uploads/docs/kha-economic-impact- of-eskd-in-australia-projections-2020.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/da/txd-2-e87.PMC5087569.pdf
"McDonald S , Clayton P , Hurst K. Australia and New Zealand Dialysis and Transplant Registry The 35th Annual ANZDATA Report (2012).http://www.anzdata.org.au/v1 /report_2012.html.",Non-OADS,/arxiv_data1/oa_pdf/a6/da/txd-2-e87.PMC5087569.pdf
http://www.anzdata.org.au/anzod/ updates/anzodsummary.htm.,Non-OADS,/arxiv_data1/oa_pdf/a6/da/txd-2-e87.PMC5087569.pdf
Monthly Report on Deceased Organ Donation in Australia December 2015. http://www.anzdata.org.au/anzod/updates/ anzod2015summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/da/txd-2-e87.PMC5087569.pdf
"1, SDC, http://links.lww.com/TXD/A27), independent of the presence or absence of the cognate ligand HLA-C1.",Non-OADS,/arxiv_data1/oa_pdf/b4/85/txd-2-e89.PMC5087575.pdf
"0 0 1 ; Figure 1, SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/b4/85/txd-2-e89.PMC5087575.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 641–648ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  641 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S115025Health care resource use and costs associated  with possible side effects of high oral  corticosteroid use in asthma: a claims-based  analysis Allan T Luskin1 Evgeniya N Antonova2 Michael S Broder3 Eunice Y Chang3 Theodore A Omachi2 Dennis K Ledford4 1HealthyAirways, Madison, WI,   2Genentech, Inc., South San Francisco,   3Partnership for Health Analytic  Research, LLC, Beverly Hills, CA,   4Division of Allergy and Immunology,   Department of Medicine, James A.   Haley Veterans’ Hospital, Morsani College of Medicine, University of South Florida, Tampa, FL, USABackground: The objective of this study was to estimate the prevalence of possible oral cortico- steroid (OCS)-related side effects and health care resource use and costs in patients with asthma.",Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
"4 The National Heart, Lung, and Blood Institute’ s asthma Correspondence: Evgeniya N Antonova Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990, USATel +1 415 606 6245Email antonova.evgeniya@gene.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Luskin et alRunning head recto: Costs associated with oral corticosteroid useDOI: http://dx.doi.org/10.2147/CEOR.S115025",Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
Available from: http://www.cdc.gov/asthma/most_recent_data.htm.,OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 648 Luskin et al  2.,Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
Available from: http://www.cdc.gov/asthma/pdfs/asthma_facts_program_grantees.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
Available from: http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp.,OADS,/arxiv_data1/oa_pdf/1d/50/ceor-8-641.PMC5087584.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 617–622Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 617 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S113144 T en steps to plan, design, and implement an  endocrinology and endocrine surgery module for  the Faculty of Medicine, Al-Baha University Walyeldin EM Elfakey1,2 Ahmed H Al-Ghamdi1 1Pediatrics Department, Faculty of  Medicine, Al-Baha University, Al-Baha,   Saudi Arabia; 2Pediatrics Department,   University of Bahri, Khartoum, SudanIntroduction: The Faculty of Medicine, Al-Baha University (FMBU), is a newly established  medical school that implements a community-oriented and integrated system-based curriculum  which is suitable for both medical students and serving the needs of the local community.",Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
"As well FMBU implements a triangular approach in teaching and the assessment places as described  Correspondence: Walyeldin EM Elfakey Pediatrics Department, Faculty of Medicine, Al-Baha University, PO Box 1988, Al-Baha, Saudi ArabiaTel +966 5 3745 9602Email walyeldin@aol.co.ukJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Elfakey and Al-GhamdiRunning head recto: Endocrine module planning and implementingDOI: http://dx.doi.org/10.2147/AMEP .S113144",Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 622 Elfakey and Al-Ghamdi and became ready for implementation.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
Available from: http://www.endocrinology.org/clinical/undergraduate/UndergraduateEducation.Full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/amep-7-617.PMC5087585.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 605–610Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 605 EXPERT OPINION open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S83374 Advancement of laparoscopic surgery in Guyana:  a working model for developing countries Shamir O Cawich1  Cheetnand Mahadeo2  Madan Rambaran2  Sheik Amir2  Shilindra Rajkumar2  Ivor W Crandon1  Vijay Naraynsingh1 1Department of Clinical Surgical  Sciences, University of the West  Indies, St Augustine Campus, Trinidad and T obago;  2Department of Surgery,   Guyana Public Hospital Corporation,  Georgetown, GuyanaAbstract:  In the late 20th century, the volume and complexity of laparoscopic operations  being performed have increased worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
"Correspondence: Shamir O Cawich   Department of Clinical Surgical Sciences,  University of the West Indies, St Augustine Campus, Trinidad and Tobago   Tel +1 868 622 9909   Email socawich@hotmail.comJournal name: Advances in Medical Education and Practice Article Designation: EXPERT OPINIONY ear: 2016V olume: 7Running head verso: Cawich et alRunning head recto: Laparoscopy in GuyanaDOI: http://dx.doi.org/10.2147/AMEP .S83374",Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
Available from: http://www.landofsixpeoples.com/news022/ ns211277.htm.,Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
Available from: http://www.kaieteurnewsonline.com/2013/05/01/gphc-equipped-to-perform-laparoscopic-surgery/.,Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 610 Cawich et al  11.,Non-OADS,/arxiv_data1/oa_pdf/0d/fe/amep-7-605.PMC5087586.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 603–604Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 603 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S121242 Parallel to the Situational Judgement T est: is  the Educational Performance Measure fair in  ranking medical students on the UK Foundation  Programme?",Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
"In addition, the author raises an argument that an “off-day” during the SJT could  potentially jeopardize their ranking; this is also applicable to students sitting their Correspondence:  Harmeet Singh Sidhu Faculty of Medicine, Imperial College London, 40 Princes Gardens, London SW7 1LY, London, UKTel +44 7507 554 853Email harmeet.sidhu11@imperial.ac.uk Journal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Singh Sidhu et alRunning head recto: Short titleDOI: http://dx.doi.org/10.2147/AMEP .S121242",Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 604 Singh Sidhu et al  university examinations.,Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
Available from: http://www.foundationprogramme.nhs.uk/pages/home/keydocs.,Non-OADS,/arxiv_data1/oa_pdf/bf/15/amep-7-603.PMC5087587.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 649–655ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  649 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S107992Residual cardiovascular risk in patients who  received lipid-lowering treatment in a real-life  setting: retrospective study Valentina Perrone Diego Sangiorgi Stefano Buda Luca Degli Esposti CliCon S.r.l., Health, Economics &  Outcomes Research, Ravenna, ItalyIntroduction: The objective of this study was twofold: 1) to assess the residual cardiovascular  (CV) risk among patients treated with statins according to guidelines and at the recommended  dosages; and 2) to assess the difference, if any, in the frequency of CV events when patients  were treated with other lipid-lowering agents alongside statins.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
"3,4 Many international guidelines recognize low-density lipoprotein cholesterol (LDL-C)   as a primary target for lipid-lowering therapies.5 Statins are the first-line therapy for  lowering LDL-C levels in blood;5 studies have shown that whereas treatment with statins  reduces the rate of cardiovascular (CV) events, it is not fully abated and a considerable Correspondence: Luca Degli Esposti CliCon S.r.l., Health, Economics & Outcomes Research, Via Salara, 36 - 48100 Ravenna, ItalyTel +39 544 38393Fax +39 544 212 699Email luca.degliesposti@clicon.itJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Perrone et alRunning head recto: Residual CV risk in patients who received lipid-lowering treatmentDOI: http://dx.doi.org/10.2147/CEOR.S107992",Non-OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 655 Residual CV risk in patients who received lipid-lowering treatment  6.,Non-OADS,/arxiv_data1/oa_pdf/c6/44/ceor-8-649.PMC5087588.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 611–615Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress  A small group learning model for evidence-based  medicine Morhaf Al Achkar M Kelly Davies Department of Family Medicine,   Indiana University School of Medicine,  Indianapolis, IN, USABackground: Evidence-based medicine (EBM) skills are invaluable tools for residents and  practicing physicians.",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
"4 Many of these studies, however, had  methodological or outcome evaluation limitations.5–7 Recently, scholars have called for educational approaches to EBM that are authen- tic, engaging, and student-centered.8 Small-group learning (SGL), sometimes called Correspondence: Morhaf Al Achkar Department of Family Medicine, Indiana University School of Medicine, 1520 N. Senate Avenue, Indianapolis, IN 46202, USATel +1 317 962 8893Email alachkar@iupui.eduJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Al Achkar and DaviesRunning head recto: Small group learning for EBMDOI: http://dx.doi.org/10.2147/AMEP .S117672 611 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S117672",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 4.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/amep-7-611.PMC5087589.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 623–633Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 623 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S116699 The impact of rural-exposure strategies on the  intention of dental students and dental graduates  to practice in rural areas: a systematic review and  meta-analysis rapeepong suphanchaimat1 nisachol cetthakrikul1 Alexander Dalliston2 Weerasak Putthasri1 1international health Policy Program,   Ministry of Public health, nonthaburi,   Thailand; 2Master’s student, school  of Oriental and African studies,   University of london, london, UKBackground and objectives: The objective of this study was to assess the impact of strategies  on the intention of dental students/graduates to practice in rural areas.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
"4 Of the 16 recommended interventions, correspondence: rapeepong  suphanchaimatinternational health Policy Program, Ministry of Public health, Tiwanon road, nonthaburi 11000, ThailandTel +66 2 590 2366Fax +66 2 590 2385Email rapeepong@ihpp.thaigov.netJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Suphanchaimat et alRunning head recto: Strategies encouraging dental graduates toward rural practiceDOI: http://dx.doi.org/10.2147/AMEP .S116699",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 633 strategies encouraging dental graduates toward rural practice 15.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/amep-7-623.PMC5087590.pdf
Email: lualcastro2003@yahoo.com.br doi: http://dx.doi.org/10.14740/jocmr2735w,Non-OADS,/arxiv_data1/oa_pdf/32/67/jocmr-08-841.PMC5087621.pdf
Email: msano@a8.keio.jp doi: http://dx.doi.org/10.14740/jocmr2760w,Non-OADS,/arxiv_data1/oa_pdf/ff/31/jocmr-08-844.PMC5087622.pdf
"Silver Spring; Food and Drug Administration,  2013. http://www.fda.gov/downloads/AdvisoryCommit - tees/CommitteesMeetingMaterials/Drugs/Endocrinologi - candMetabolicDrugsAdvisoryCommittee/UCM334551.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ff/31/jocmr-08-844.PMC5087622.pdf
"Dapagliflozin oral tablets, 5 and 10  MG. Silver Spring; Food and Drug Administration, 2013. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/Endocrinologican- dMetabolicDrugsAdvisoryCommittee/UCM378076.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ff/31/jocmr-08-844.PMC5087622.pdf
Email: kazukotani@jichi.ac.jp doi: http://dx.doi.org/10.14740/jocmr2767w,Non-OADS,/arxiv_data1/oa_pdf/42/c5/jocmr-08-848.PMC5087623.pdf
Email: enomoto@hyo-med.ac.jp doi: http://dx.doi.org/10.14740/jocmr2725w,Non-OADS,/arxiv_data1/oa_pdf/45/5d/jocmr-08-854.PMC5087624.pdf
Email: rvender@psu.edu doi: http://dx.doi.org/10.14740/jocmr2764w,Non-OADS,/arxiv_data1/oa_pdf/f0/00/jocmr-08-859.PMC5087625.pdf
Email: enomoto@hyo-med.ac.jp doi: http://dx.doi.org/10.14740/jocmr2734w,Non-OADS,/arxiv_data1/oa_pdf/b3/42/jocmr-08-863.PMC5087626.pdf
Email: alvaradocosme@yahoo.com doi: http://dx.doi.org/10.14740/jocmr2789w,Non-OADS,/arxiv_data1/oa_pdf/95/f3/jocmr-08-870.PMC5087627.pdf
Extraction of DNA from whole blood  was performed following a protocol described by Iranpour and Esmailizadeh (http://www.protocol-online.org/prot/Protocols/ Rapid-Extraction-of-High-Quality-DNA-from-Whole-Blood- Stored-at-4-C-for-Long-Period-4175.html).,Non-OADS,/arxiv_data1/oa_pdf/95/f3/jocmr-08-870.PMC5087627.pdf
"Statistical analysis Results were analyzed with the aid of the software Microsoft  Excel 2010, Epi Info version 7 (Centers for Disease Control  and Prevention: http://wwwn.cdc.gov/epiinfo/) and SPSS ver - sion 15.0 (SPSS Inc. Chicago, IL).",OADS,/arxiv_data1/oa_pdf/95/f3/jocmr-08-870.PMC5087627.pdf
Email: tsunoda9939@gmail.com doi: http://dx.doi.org/10.14740/jocmr2754w,Non-OADS,/arxiv_data1/oa_pdf/a7/44/jocmr-08-878.PMC5087628.pdf
Email: miuras@cis.fukuoka-u.ac.jp doi: http://dx.doi.org/10.14740/jocmr2768w,Non-OADS,/arxiv_data1/oa_pdf/b8/ba/jocmr-08-888.PMC5087629.pdf
Email: fionasan@rediffmail.com doi: http://dx.doi.org/10.14740/jocmr2790w,Non-OADS,/arxiv_data1/oa_pdf/8f/02/jocmr-08-893.PMC5087630.pdf
Email: miuras@cis.fukuo - ka-u.ac.jp doi: http://dx.doi.org/10.14740/jocmr2773w,Non-OADS,/arxiv_data1/oa_pdf/71/01/jocmr-08-899.PMC5087631.pdf
Email: sensuke_konno@nymc.edu doi: http://dx.doi.org/10.14740/jocmr2781w,Non-OADS,/arxiv_data1/oa_pdf/7d/b3/jocmr-08-908.PMC5087632.pdf
Email: Nitin.Bhanot@ahn.org doi: http://dx.doi.org/10.14740/jocmr2753w,Non-OADS,/arxiv_data1/oa_pdf/34/73/jocmr-08-916.PMC5087633.pdf
Email: mikhael.laskine.chum@ssss.gouv.qc.ca doi: http://dx.doi.org/10.14740/jocmr2751w,Non-OADS,/arxiv_data1/oa_pdf/92/92/jocmr-08-919.PMC5087634.pdf
Email: HTARIQ@bronxleb.org doi: http://dx.doi.org/10.14740/jocmr2701w,Non-OADS,/arxiv_data1/oa_pdf/a0/59/jocmr-08-921.PMC5087635.pdf
Email: drzhangxiquan@sina.com doi: http://dx.doi.org/10.14740/jocmr2777w,Non-OADS,/arxiv_data1/oa_pdf/a1/8d/jocmr-08-925.PMC5087636.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/49/ott-9-6407.PMC5087701.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6407–6415OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6407Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11184 6 Double-edged role of g protein-coupled estrogen  receptor 1 in breast cancer prognosis: an analysis  of 167 breast cancer samples and online data sets Fan Yang1,2 Zhi-Min shao1,2 1Department of Breast surgery, Fudan  University shanghai cancer center,   2Department of Oncology, shanghai  Medical college, Fudan University,   shanghai, People’s republic of chinaAbstract:  G protein-coupled estrogen receptor 1 (GPER1) is widely expressed in breast  cancer;  however, its prognostic significance in breast cancer patients remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/11/49/ott-9-6407.PMC5087701.pdf
"Later, it was found  that GPER1 can activate epidermal growth factor receptor (EGFR) through matrix  metalloproteinases-mediated release of heparin-binding EGF (HB-EGF).6–8 Then,  EGFR substrates mitogen-activated protein kinases (MAPKs)8 and PI3-kinase (PI3K)9  may be activated, followed by the activation of c-fos10 and c-jun.11 In addition, GPER1  can also lead to rapid activation of protein kinase A (PKA) pathway12 and of PKA’s correspondence: Zhi-Min shao Department of Breast surgery, Fudan  University shanghai cancer center, 270  Dongan road, shanghai, 200032, People’s  republic of china email zhimingshao@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang and Shao Running head recto: Expression of GPER1 in patients with breast cancer DOI: http://dx.doi.org/10.2147/OTT.S111846",Non-OADS,/arxiv_data1/oa_pdf/11/49/ott-9-6407.PMC5087701.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/11/49/ott-9-6407.PMC5087701.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/49/ott-9-6407.PMC5087701.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/4f/tcrm-12-1599.PMC5087702.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1599–1608Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1599CliniC al TRial Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11789 1 laparoscopic total extraperitoneal repair under  spinal anesthesia versus general anesthesia:  a randomized prospective study T urgut Donmez1 Vuslat Muslu erdem2 oguzhan Sunamak3 Duygu ayfer erdem2 Huseyin imam avaroglu1 1Department of General Surgery,   2Department of anesthesiology and  Reanimation, lutfiye nuri Burat  State Hospital, 3Department of  General Surgery, Haydarpasa numune  Training and Research Hospital,   istanbul, T urkeyBackground:  Laparoscopic total extraperitoneal (TEP) inguinal hernia repair is a well-known  approach to inguinal hernia repair that is usually performed under general anesthesia (GA).",Non-OADS,/arxiv_data1/oa_pdf/9f/4f/tcrm-12-1599.PMC5087702.pdf
"Etap.B2  D36, 34300 istanbul, Turkey Tel +90 534 740 0967 email surgeont73@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Clinical Trial Report Y ear: 2016 Volume: 12 Running head verso: Donmez et al Running head recto: SA versus GA in laparoscopic inguinal hernia repair DOI: http://dx.doi.org/10.2147/TCRM.S117891",Non-OADS,/arxiv_data1/oa_pdf/9f/4f/tcrm-12-1599.PMC5087702.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9f/4f/tcrm-12-1599.PMC5087702.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/tcrm-12-1599.PMC5087702.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/a3/copd-11-2671.PMC5087703.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2671–2679International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2671OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11345 0 survival after pulmonary rehabilitation in patients  with COPD: impact of functional exercise capacity  and its changes Carlos a Camillo1,2 Daniel langer1,2 Christian r Osadnik1,3–5 lisa Pancini2 heleen Demeyer1,2 Chris Burtin1,6 rik gosselink1,2 Marc Decramer2 Wim Janssens2 Thierry Troosters1,2 1KU leuven, Department of  rehabilitation sciences, leuven,   Belgium; 2University hospital  leuven, respiratory Division and  rehabilitation, leuven, Belgium;   3Monash University, Department  of Physiotherapy, Melbourne, VIC,   australia; 4Institute for Breathing  and sleep, Melbourne, VIC, australia;   5Monash health, Monash lung and  sleep, Melbourne, VIC, australia;   6hasselt University, rehabilitation  research Centre, Biomedical research  Institute, Faculty of Medicine and life  sciences, Diepenbeek, BelgiumAbstract:  The impact of rehabilitation-induced changes in 6-minute walk distance (6MWD) on  the survival of patients with chronic obstructive pulmonary disease (COPD) has not been fully  elucidated.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/copd-11-2671.PMC5087703.pdf
"Low 6MWD has consistently been associated with poor outcomes  such as higher risks of respiratory and all-cause mortality in patients with COPD.2  It has been shown that patients who walk less than 350 m have a high risk of mortality.3  Twenty years ago, Gerardi et al reported that the distance covered in a 12MWT after  exercise training is the strongest mortality predictor in patients with COPD.4 Increases  in exercise capacity have also been demonstrated to improve the likelihood of 6-year Correspondence: Thierry Troosters University hospital leuven,  respiratory Division and rehabilitation,  UZ gasthuisberg, Onderwijs en  navorsing 1, labo Pneumologie,  herestraat 49, Bus 706, B-3000, leuven,  Belgium Tel +32 16 33 07 98 Fax +32 16 33 08 05 email thierry.troosters@kuleuven.b e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Camillo et al Running head recto: 6MWD improvement and 5-year survival in COPD after PR DOI: http://dx.doi.org/10.2147/COPD.S113450",Non-OADS,/arxiv_data1/oa_pdf/50/a3/copd-11-2671.PMC5087703.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/copd-11-2671.PMC5087703.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/a3/copd-11-2671.PMC5087703.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/76/ott-9-6605.PMC5087704.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6605–6608OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6605Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12192 3 effective treatment with icotinib in lung  adenocarcinoma with eGFr and aLK   co-alterations and brain metastasis Chenyang Ye1,* Ji Wang2,* shu Zheng1 Ying Chai3 1Cancer Institute, Key Laboratory of  Cancer prevention and Intervention,   National Ministry of education,   provincial Key Laboratory of  Molecular Biology in Medical sciences,   The second affiliated Hospital,   Zhejiang University school of  Medicine, 2Department of surgical  Oncology, sir run run shaw Hospital,   College of Medicine, Zhejiang  University, 3Department of Thoracic  surgery, The second affiliated  Hospital, Zhejiang University school  of Medicine, Hangzhou, people’s  republic of China *These authors contributed equally  to this workAbstract:  We report a rare case of advanced lung cancer with epidermal growth factor  receptor and anaplastic lymphoma kinase co-alterations and brain metastasis, in which icotinib  treatment was effective for both the primary lung tumor and the brain metastasis.",Non-OADS,/arxiv_data1/oa_pdf/bc/76/ott-9-6605.PMC5087704.pdf
"EGFR mutation and ALK  translocation status were identified by direct Sanger sequencing, real-time polymerase  chain reaction, and fluorescence in situ hybridization (FISH) analysis, and both were Correspondence: Ying Chai Department of Thoracic surgery, The  Second Affiliated Hospital, Zhejiang  University school of Medicine, 88 Jiefang  road, Hangzhou 310009, people’s  republic of China Tel +86 571 8778 3367 Fax +86 571 8778 3318 email chaiy@126.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Y e et al Running head recto: Treatment with icotinib in lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S121923",Non-OADS,/arxiv_data1/oa_pdf/bc/76/ott-9-6605.PMC5087704.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bc/76/ott-9-6605.PMC5087704.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/76/ott-9-6605.PMC5087704.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1505–1517Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1505OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11466 9 Inappropriate nutrients intake is associated with  lower functional status and inferior quality of life  in older adults with depression Agnieszka guligowska1 Małgorzata Pigłowska1 elizaveta Fife1 Joanna Kostka2 Bartłomiej K Sołtysik1 Łukasz Kroc1 T omasz Kostka1 1Department of geriatrics, healthy  Ageing research Centre, Medical  University of Lodz, Lodz, Poland;   2Department of Physical Medicine,   Medical University of lodz,   Lodz, PolandObjectives:  The study is a case-control analysis of whether depression impairs physical and  cognitive functioning and quality of life, and whether there is a relationship between nutrient  deficiencies and these adverse changes.",Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
"Zeromskiego 113,  90–549 Lodz, Poland Tel/fax +48 42 639 3609 email agnieszka.guligowska@umed.lodz.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Guligowska et al Running head recto: Inappropriate nutrients intake is associated with lower functional status DOI: http://dx.doi.org/10.2147/CIA.S114669",Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
Available from: http://www.who.int/mental_health/ management/depression/en /.,Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
"Available from: http://www.ehnheart.org/publications/ publications/publication/521-diet-physical-activity-and-cardiovascular- disease-prevention.htm l. Accessed September 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/08/17/cia-11-1505.PMC5087705.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2113–2119Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2113Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11362 3 Trends in incidence, survival, and management  of uveal melanoma: a population-based study of  7,516 patients from the surveillance, epidemiology,  and end results database (1973–2012) Krishnaraj Mahendraraj1 Christine sM lau1,2 injoon lee2 ronald s Chamberlain1–3 1Department of surgery, saint  Barnabas Medical Center, livingston,   nJ, Usa; 2st george’s University  school of Medicine, grenada, West  indies; 3Department of surgery,   new Jersey Medical school, rutgers  University, newark, nJ, UsaIntroduction:  Uveal melanoma (UM) is the most common primary intraocular malignancy,  despite comprising ,5% of all melanomas.",Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
"Keywords:  uveal melanoma, ocular melanoma, SEERCorrespondence: ronald s Chamberlain Department of surgery, saint Barnabas  Medical Center, 94 Old short hills road,  livingston, nJ 07039, Usa Tel +1 973 322 5195 Fax +1 973 322 2471 email rchamberlain@barnabashealth.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mahendraraj et al Running head recto: Trends in incidence, survival, and management of uveal melanoma DOI: http://dx.doi.org/10.2147/OPTH.S113623",Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0110052 8.,Non-OADS,/arxiv_data1/oa_pdf/75/af/opth-10-2113.PMC5087706.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/8d/ndt-12-2737.PMC5087707.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2737–2743Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2737OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10726 6 clinical outcomes with olanzapine long-acting  injection: impact of the 3-hour observation period  on patient satisfaction and well-being ernie anand1 lovisa Berggren2 John landry3 Ágoston Tóth4 holland c Detke5 1Neuroscience Medical affairs,   eli lilly & company ltd,   Windlesham, UK; 2global statistical  sciences, lilly Deutschland gmbh,   Bad homburg, germany; 3global  statistical sciences, eli lilly  canada inc., T oronto, ON, canada;   4Neuroscience, lilly hungary,   Budapest, hungary; 5Psychiatry  and Pain Disorders, lilly research  laboratories, eli lilly and company,   indianapolis, iN, UsaBackground:  The objective of the present analysis is to determine the impact of the 3-hour  observation period for olanzapine long-acting injection (LAI) on patient satisfaction and well- being by comparing data collected before and after its implementation.",Non-OADS,/arxiv_data1/oa_pdf/15/8d/ndt-12-2737.PMC5087707.pdf
"Because olanzapine LAI is a salt-based formulation,  it is more soluble in blood than in muscle tissue, resulting in symptoms consistent correspondence: ernie anand Neuroscience Medical affairs, eli lilly &  company ltd, lilly research center  erl Wood Manor, sunninghill road,  Windlesham, surrey, UK, gU 20 6Ph Tel +44 1276 483 063 email anand_ernie@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Anand et al Running head recto: Olanzapine LAI: impact of the 3-hour observation period DOI: http://dx.doi.org/10.2147/NDT.S107266",Non-OADS,/arxiv_data1/oa_pdf/15/8d/ndt-12-2737.PMC5087707.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/15/8d/ndt-12-2737.PMC5087707.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/8d/ndt-12-2737.PMC5087707.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/23/ppa-10-2151.PMC5087708.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2151–2162Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2151OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11619 8 A socioeconomic and behavioral survey of  patients with difficult-to-control type 2 diabetes  mellitus reveals an association between diabetic  retinopathy and educational attainment naoya emoto1,2 Fumitaka Okajima1,2 hitoshi sugihara2 rei goto3 1Department of endocrinology,   Nippon Medical School Chiba- hokusoh hospital, chiba,   2Department of endocrinology,   Diabetes and Metabolism, graduate  school of Medicine, nippon Medical  school, T okyo, 3graduate school  of Business Administration, Keio  University, Kanagawa, JapanBackground:  We have recently reported that the attitude of patients toward risk could be a  factor in the progression of diabetic complications.",Non-OADS,/arxiv_data1/oa_pdf/c7/23/ppa-10-2151.PMC5087708.pdf
